147-94-4 | 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one

Packsize	Purity	Availability	Price	Discounted Price
250mg	98%	in stock	$6.00	$4.00
1g	98%	in stock	$9.00	$6.00
5g	98%	in stock	$13.00	$9.00
25g	98%	in stock	$55.00	$39.00
100g	98%	in stock	$190.00	$133.00

Description

• Catalog Number: AB45830
• Chemical Name: 4-amino-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one
• CAS Number: 147-94-4
• Molecular Formula: C9H13N3O5
• Molecular Weight: 243.2166
• MDL Number: MFCD00066487
• SMILES: OC[C@H]1O[C@H]([C@H]([C@@H]1O)O)n1ccc(nc1=O)N

Computed Properties

• Complexity: 383
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 4
• Heavy Atom Count: 17
• Hydrogen Bond Acceptor Count: 5
• Hydrogen Bond Donor Count: 4
• Rotatable Bond Count: 2
• XLogP3: -2.1

Literature

• Thiosemicarbazone derivatives, thiazolyl hydrazones, effectively inhibit leukemic tumor cell growth: Down-regulation of ribonucleotide reductase activity and synergism with arabinofuranosylcytosine.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20171001

• Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles.

  Molecular cancer therapeutics 20170601

• [Influence of HMGB1/MAPK/m-TOR signaling pathway on cell autophagy and chemotherapy resistance in K562 cells].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20161028

• Mantle Cell Lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20160410

• Identification of N-(4-((1R,3S,5S)-3-Amino-5-methylcyclohexyl)pyridin-3-yl)-6-(2,6-difluorophenyl)-5-fluoropicolinamide (PIM447), a Potent and Selective Proviral Insertion Site of Moloney Murine Leukemia (PIM) 1, 2, and 3 Kinase Inhibitor in Clinical Trials for Hematological Malignancies.

  Journal of medicinal chemistry 20151112

• Reversible epigenetic regulation of 14-3-3σ expression in acquired gemcitabine resistance by uhrf1 and DNA methyltransferase 1.

  Molecular pharmacology 20141101

• Retinoic acid synergizes ATO-mediated cytotoxicity by precluding Nrf2 activity in AML cells.

  British journal of cancer 20140826

• Chromosome breakage induced by the genotoxic agents mitomycin C and cytosine arabinoside is concentration and p53 dependent.

  Toxicological sciences : an official journal of the Society of Toxicology 20140701

• Vascular endothelial growth factor-C modulates proliferation and chemoresistance in acute myeloid leukemic cells through an endothelin-1-dependent induction of cyclooxygenase-2.

  Biochimica et biophysica acta 20140201

• Phase 2 study of arsenic trioxide followed by autologous hematopoietic cell transplantation for relapsed acute promyelocytic leukemia.

  Blood 20130418

• Hematopoietic recovery following chemotherapy is improved by BADGE-induced inhibition of adipogenesis.

  International journal of hematology 20130101

• A case report of acute myeloid leukemia after liver transplantation.

  Acta haematologica 20130101

• Efficacy of RNA polymerase II inhibitors in targeting dormant leukaemia cells.

  BMC pharmacology & toxicology 20130101

• Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells.

  Pediatric blood & cancer 20121215

• Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.

  International journal of cancer 20121201

• Preparation and biological evaluation of tumor-specific Ara-C liposomal preparations containing RGDV motif.

  Journal of pharmaceutical sciences 20121201

• Synthesis of cytarabine lipid drug conjugate for treatment of meningeal leukemia: development, characterization and in vitro cell line studies.

  Journal of biomedical nanotechnology 20121201

• Clinical and proteomic characterization of acute myeloid leukemia with mutated RAS.

  Cancer 20121115

• Cholesterol depletion by methyl-β-cyclodextrin enhances cell proliferation and increases the number of desmin-positive cells in myoblast cultures.

  European journal of pharmacology 20121105

• Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.

  Leukemia & lymphoma 20121101

• Combination of cytarabine and topotecan in patients treated for acute myeloid leukemia with persistent disease after frontline induction.

  Leukemia & lymphoma 20121101

• Cyclophosphamide promotes engraftment of gene-modified cells in a mouse model of Fanconi anemia without causing cytogenetic abnormalities.

  Journal of molecular medicine (Berlin, Germany) 20121101

• Randomized phase II study of two schedules of flavopiridol given as timed sequential therapy with cytosine arabinoside and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.

  Haematologica 20121101

• Therapeutic gene expression in transduced mesenchymal stem cells can be monitored using a reporter gene.

  Nuclear medicine and biology 20121101

• Recombinant human soluble thrombomodulin safely and effectively rescues acute promyelocytic leukemia patients from disseminated intravascular coagulation.

  Leukemia research 20121101

• Iodine-131 rituximab radioimmunotherapy with BEAM conditioning and autologous stem cell transplant salvage therapy for relapsed/refractory aggressive non-Hodgkin lymphoma.

  Cancer biotherapy & radiopharmaceuticals 20121101

• Pleiotrophin suppression of receptor protein tyrosine phosphatase-β/ζ maintains the self-renewal competence of fetal human oligodendrocyte progenitor cells.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20121024

• Acute Myeloid Leukemia (AML): different treatment strategies versus a common standard arm--combined prospective analysis by the German AML Intergroup.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20121010

• Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia.

  Leukemia & lymphoma 20121001

• Metabolism and accumulation of the lipophilic deoxynucleoside analogs elacytarabine and CP-4126.

  Investigational new drugs 20121001

• Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.

  Cancer 20121001

• Prolonged immunochemotherapy with rituximab, cytarabine and fludarabine added to cyclophosphamide, doxorubicin, vincristine and prednisolone and followed by rituximab maintenance in untreated elderly patients with mantle cell lymphoma: a prospective study by the Finnish Lymphoma Group.

  Leukemia & lymphoma 20121001

• Synergy of sequential administration of a deglycosylated ricin A chain-containing combined anti-CD19 and anti-CD22 immunotoxin (Combotox) and cytarabine in a murine model of advanced acute lymphoblastic leukemia.

  Leukemia & lymphoma 20121001

• Over-expression of RPL23 in myelodysplastic syndromes is associated with apoptosis resistance of CD34+ cells and predicts poor prognosis and distinct response to CHG chemotherapy or decitabine.

  Annals of hematology 20121001

• Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia.

  Leukemia research 20121001

• Nilotinib and imatinib inhibit cytarabine cellular uptake: implications for combination therapy.

  Leukemia research 20121001

• D-Amino acid oxidase-induced oxidative stress, 3-bromopyruvate and citrate inhibit angiogenesis, exhibiting potent anticancer effects.

  Journal of bioenergetics and biomembranes 20121001

• Treatment of young patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia using increased dose of imatinib and deintensified chemotherapy before allogeneic stem cell transplantation.

  British journal of haematology 20121001

• Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia.

  Leukemia research 20121001

• Effects of selective checkpoint kinase 1 inhibition on cytarabine cytotoxicity in acute myelogenous leukemia cells in vitro.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20121001

• Phase 1 trial of gemtuzumab ozogamicin in combination with enocitabine and daunorubicin for elderly patients with relapsed or refractory acute myeloid leukemia: Japan Adult Leukemia Study Group (JALSG)-GML208 study.

  International journal of hematology 20121001

• Calcinosis cutis at cytarabine injection site in three dogs receiving prednisolone.

  The Veterinary record 20120929

• Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients.

  Cancer 20120915

• Nine years interval between first and second bone marrow transplantations and subsequent long-term survival--a case of acute myeloid leukemia with MLL-AF6 fusion gene.

  Annals of hematology 20120901

• Phase II study of cytarabine in men with docetaxel-refractory, castration-resistant prostate cancer with evaluation of TMPRSS2-ERG and SPINK1 as serum biomarkers.

  BJU international 20120901

• Characteristics of medication errors with parenteral cytotoxic drugs.

  European journal of cancer care 20120901

• Clofarabine in pediatric acute leukemia: current findings and issues.

  Pediatric blood & cancer 20120901

• Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

  Leukemia 20120901

• Flow cytometry-based assessment of mitoxantrone efflux from leukemic blasts varies with response to induction chemotherapy in acute myeloid leukemia.

  Cytometry. Part B, Clinical cytometry 20120901

• High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007.

  Haematologica 20120901

• Flow cytometric detection of liposomal cytarabine in cerebrospinal fluid of patients treated with intrathecal chemotherapy.

  Cytometry. Part B, Clinical cytometry 20120901

• Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients.

  Annals of hematology 20120901

• Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemia.

  Leukemia 20120901

• Elacytarabine has single-agent activity in patients with advanced acute myeloid leukaemia.

  British journal of haematology 20120901

• Outcome of children with refractory anaemia with excess of blast (RAEB) and RAEB in transformation (RAEB-T) in the Japanese MDS99 study.

  British journal of haematology 20120901

• Numb chin syndrome in acute myeloid leukemia.

  The American journal of the medical sciences 20120901

• Acute myeloid leukaemia with abnormal eosinophil precursors without inversion 16.

  British journal of haematology 20120901

• Altered spatial learning, cortical plasticity and hippocampal anatomy in a neurodevelopmental model of schizophrenia-related endophenotypes.

  The European journal of neuroscience 20120901

• Treatment of Burkitt lymphoma in equatorial Africa using a simple three-drug combination followed by a salvage regimen for patients with persistent or recurrent disease.

  British journal of haematology 20120901

• Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial.

  The Lancet. Oncology 20120901

• Idiopathic hypertrophic pachymeningitis in six dogs: MRI, CSF and histological findings, treatment and outcome.

  The Journal of small animal practice 20120901

• Aurora A kinase expression is increased in leukemia stem cells, and a selective Aurora A kinase inhibitor enhances Ara-C-induced apoptosis in acute myeloid leukemia stem cells.

  The Korean journal of hematology 20120901

• Emerging agents for the treatment of mantle cell lymphoma.

  Expert review of anticancer therapy 20120901

• Successful importation of cytarabine into the United States during a critical national drug shortage.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120815

• Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.

  Investigational new drugs 20120801

• Posterior reversible encephalopathy syndrome (PRES) during induction chemotherapy for acute myeloblastic leukemia (AML).

  Annals of hematology 20120801

• Chemotherapy-related magnetic resonance imaging abnormalities mimicking disease progression following intraventricular liposomal cytarabine and high dose methotrexate for neurolymphomatosis.

  Leukemia & lymphoma 20120801

• Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan.

  Leukemia & lymphoma 20120801

• Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia.

  Leukemia & lymphoma 20120801

• How to manage acute promyelocytic leukemia.

  Leukemia 20120801

• Twice-daily fludarabine and cytarabine combination with or without gentuzumab ozogamicin is effective in patients with relapsed/refractory acute myeloid leukemia, high-risk myelodysplastic syndrome, and blast- phase chronic myeloid leukemia.

  Clinical lymphoma, myeloma & leukemia 20120801

• Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series.

  Journal of neuro-oncology 20120801

• The addition of the farnesyl transferase inhibitor, tipifarnib, to low dose cytarabine does not improve outcome for older patients with AML.

  British journal of haematology 20120801

• Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC + autologous stem-cell support: still very long survival but late relapses do occur.

  British journal of haematology 20120801

• Leptomeningeal metastases.

  Current treatment options in neurology 20120801

• Sapacitabine, the prodrug of CNDAC, is a nucleoside analog with a unique action mechanism of inducing DNA strand breaks.

  Chinese journal of cancer 20120801

• The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia.

  Blood cancer journal 20120801

• Who benefits from maintenance therapy in acute promyelocytic leukemia?

  Journal of the National Comprehensive Cancer Network : JNCCN 20120801

• [Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].

  Gan to kagaku ryoho. Cancer & chemotherapy 20120801

• The clinically relevant pharmacogenomic changes in acute myelogenous leukemia.

  Pharmacogenomics 20120801

• [Direct contact with bone stromal HS-5 cells reduces the sensitivity of HEL to drugs].

  Zhongguo shi yan xue ye xue za zhi 20120801

• Rehabilitation for ataxia following chemotherapy for burkitt lymphoma involving the rectum.

  Annals of rehabilitation medicine 20120801

• Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120720

• Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710

• Going beyond 7 + 3 regimens in the treatment of adult acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710

• Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120710

• Development and validation of an in vitro micronucleus assay platform in TK6 cells.

  Mutation research 20120704

• Chirality effects on the IRMPD spectra of basket resorcinarene/nucleoside complexes.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20120702

• Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells.

  Leukemia & lymphoma 20120701

• Phase I and pharmacokinetic study of elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies.

  Leukemia 20120701

• Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.

  Haematologica 20120701

• Abnormal erythroid cell proliferation and myelofibrosis in a cat.

  The Journal of veterinary medical science 20120701

• Combination therapy with arsenic trioxide, all-trans retinoic acid, and chemotherapy in acute promyelocytic leukemia patients with various relapse risks.

  Leukemia research 20120701

• Bortezomib combined with low-dose cytarabine in Intermediate-2 and high risk myelodysplastic syndromes. A phase I/II Study by the GFM.

  British journal of haematology 20120701

• Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management.

  American journal of hematology 20120701

• Microwave freeze-thaw treatment of dose-banded cytotoxics injectable drugs: a review of the literature from 1980 to 2011.

  Annales pharmaceutiques francaises 20120701

• Sequential arabinosylcytosin with or without fludarabine in paracmastic patients with acute myeloid leukemia.

  Die Pharmazie 20120701

• High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia.

  British journal of cancer 20120626

• Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120620

• Drug shortages delay cancer clinical trials.

  Journal of the National Cancer Institute 20120620

• Lytic bone disease as the presenting feature of Philadelphia-positive monosomy 7 myelodysplasia progressing to acute myeloid leukaemia.

  Gene 20120615

• Structure-activity relationship (SAR) study of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and the potential of the lead against multidrug resistance in cancer treatment.

  Journal of medicinal chemistry 20120614

• Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells.

  Cell 20120608

• Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.

  Oncogene 20120607

• Favorable effect of priming with granulocyte colony-stimulating factor in remission induction of acute myeloid leukemia restricted to dose escalation of cytarabine.

  Blood 20120607

• Be quick, but don't hurry.

  Blood 20120607

• Subtle recognition of 14-base pair DNA sequences via threading polyintercalation.

  Biochemistry 20120605

• Successful treatment of recurrent malignancy-associated hemophagocytic lymphohistiocytosis with a modified HLH-94 immunochemotherapy and allogeneic stem cell transplantation.

  Medical oncology (Northwood, London, England) 20120601

• Successful administration of rituximab-bendamustine regimen in the relapse of Hodgkin lymphoma after autologous hemopoietic stem cell transplantation.

  Hematological oncology 20120601

• Gemcitabine-induced posterior reversible encephalopathy syndrome: a case report.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20120601

• Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity.

  Leukemia & lymphoma 20120601

• Mixed phenotype acute leukemia of T/myeloid type with a prominent cellular heterogeneity and unique karyotypic aberration 45,XY, dic(11;17).

  International journal of laboratory hematology 20120601

• The proteasome inhibitor bortezomib targets cell cycle and apoptosis and acts synergistically in a sequence-dependent way with chemotherapeutic agents in mantle cell lymphoma.

  Annals of hematology 20120601

• Integrated genomic analyses identify WEE1 as a critical mediator of cell fate and a novel therapeutic target in acute myeloid leukemia.

  Leukemia 20120601

• Long-term remission in a case of acute promyelocytic leukemia patient with marked myelofibrosis treated with arsenic trioxide, all-trans retinoic acid and consolidation therapy with daunorubicin plus cytarabine.

  Leukemia research 20120601

• Single cell ganglioside catabolism in primary cerebellar neurons and glia.

  Neurochemical research 20120601

• Mini-BEAM is effective as a bridge to transplantation in patients with refractory or relapsed Hodgkin lymphoma who have failed to respond to previous lines of salvage chemotherapy but not in patients with salvage-refractory DLBCL.

  British journal of haematology 20120601

• Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience.

  American journal of hematology 20120601

• Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.

  Annals of hematology 20120601

• A facile whole-cell biocatalytic approach to regioselective synthesis of monoacylated 1-β-D-arabinofuranosylcytosine: influence of organic solvents.

  Bioresource technology 20120601

• Bilateral ear swelling and erythema after chemotherapy: a case of ara-C ears.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120601

• Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.

  American journal of hematology 20120601

• Autologous transplantation and management of younger patients with mantle cell lymphoma.

  Best practice & research. Clinical haematology 20120601

• [Effect of bortezomib and low concentration cytarabine on apoptosis in U937 cell line].

  Zhongguo shi yan xue ye xue za zhi 20120601

• [Late appearing Philadelphia chromosome as another clone in a patient with myelodysplastic syndrome harboring der(5;12)(q10;q10) at diagnosis].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20120601

• Association of polymorphisms of cytosine arabinoside-metabolizing enzyme gene with therapeutic efficacy for acute myeloid leukemia.

  Chinese medical journal 20120601

• The mechanism of γ-Secretase dysfunction in familial Alzheimer disease.

  The EMBO journal 20120516

• Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicin.

  Cancer 20120515

• Sterilization stability of vesicular phospholipid gels loaded with cytarabine for brain implant.

  International journal of pharmaceutics 20120510

• Haploidentical/mismatched hematopoietic stem cell transplantation without in vitro T cell depletion for T cell acute lymphoblastic leukemia.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120501

• The value of rituximab for the treatment of fludarabine-refractory chronic lymphocytic leukemia: a systematic review and qualitative analysis of the literature.

  Leukemia & lymphoma 20120501

• The T_T genotype within the NME1 promoter single nucleotide polymorphism -835 C/T is associated with an increased risk of cytarabine induced neurotoxicity in patients with acute myeloid leukemia.

  Leukemia & lymphoma 20120501

• Improving circulatory disturbance in transient abnormal myelopoiesis.

  Journal of pediatric hematology/oncology 20120501

• Salvage chemotherapy and autologous stem cell transplant in primary refractory diffuse large B-cell lymphoma: outcomes and prognostic factors.

  Leukemia & lymphoma 20120501

• Second-line salvage chemotherapy for transplant-eligible patients with Hodgkin's lymphoma resistant to platinum-containing first-line salvage chemotherapy.

  Haematologica 20120501

• DESI-MS2: a rapid and innovative method for trace analysis of six cytostatic drugs in health care setting.

  Analytical and bioanalytical chemistry 20120501

• Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia.

  Cancer chemotherapy and pharmacology 20120501

• Anticancer drug discovery from the marine environment.

  Recent patents on anti-cancer drug discovery 20120501

• Improving survival in patients with transformed B cell non Hodgkin lymphoma: consolidation with ⁹⁰Yttrium ibritumomab tiuxetan-BEAM and autologous stem cell transplantation.

  British journal of haematology 20120501

• Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers.

  Cancer chemotherapy and pharmacology 20120501

• Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development.

  Glia 20120501

• Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non-Hodgkin lymphoma.

  American journal of hematology 20120501

• MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation.

  Blood 20120501

• Central nervous system lesions due to juvenile myelomonocytic leukemia progressed in a boy undergoing first line chemotherapy.

  International journal of hematology 20120501

• Myeloperoxidase expression in acute myeloid leukemia helps identifying patients to benefit from transplant.

  Yonsei medical journal 20120501

• An evaluation of small-molecule p53 activators as chemoprotectants ameliorating adverse effects of anticancer drugs in normal cells.

  Cell cycle (Georgetown, Tex.) 20120501

• Role of keratinocytes in the development of vitiligo.

  Annals of dermatology 20120501

• A case of blastic plasmacytoid dendritic cell neoplasm.

  Annals of dermatology 20120501

• [Percutaneous coronary intervention in a patient with acute myeloid leukemia].

  Deutsche medizinische Wochenschrift (1946) 20120501

• Nature and dynamics of nucleosome release from neoplastic and non-neoplastic cells.

  Anticancer research 20120501

• Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): explanation and elaboration.

  PLoS medicine 20120501

• [Lethal pulmonary hemorrhage caused by Stenotrophomonas maltophilia pneumonia in a patient with acute myeloid leukemia].

  Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases 20120501

• A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia.

  Blood 20120426

• Neurogenic subventricular zone stem/progenitor cells are Notch1-dependent in their active but not quiescent state.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20120418

• ABC transporters and their role in nucleoside and nucleotide drug resistance.

  Biochemical pharmacology 20120415

• Unique dual targeting of thymidylate synthase and topoisomerase1 by FdUMP[10] results in high efficacy against AML and low toxicity.

  Blood 20120412

• Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype.

  The pharmacogenomics journal 20120401

• Multivariate models to detect genomic signatures for a class of drugs: application to thiopurines pharmacogenomics.

  The pharmacogenomics journal 20120401

• Induction therapy of AML with ara-C plus daunorubicin versus ara-C plus gemtuzumab ozogamicin: a randomized phase II trial in elderly patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20120401

• Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma.

  Leukemia & lymphoma 20120401

• Primary B-cell lymphoma of the cauda equina, successfully treated with high-dose methotrexate plus high-dose cytarabine: a case report with MRI findings.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20120401

• Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.

  American journal of hematology 20120401

• Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report.

  Leukemia 20120401

• Therapy-related acute leukemia with mixed phenotype and t(9;22)(q32;q11.2): a case report and review of the literature.

  Human pathology 20120401

• De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.

  British journal of haematology 20120401

• Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia.

  Leukemia research 20120401

• Methylated chrysin reduced cell proliferation, but antagonized cytotoxicity of other anticancer drugs in acute lymphoblastic leukemia.

  Anti-cancer drugs 20120401

• miR-181a sensitizes resistant leukaemia HL-60/Ara-C cells to Ara-C by inducing apoptosis.

  Journal of cancer research and clinical oncology 20120401

• Elacytarabine, a novel 5'-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia.

  Leukemia research 20120401

• Effects of silver nanoparticles on primary mixed neural cell cultures: uptake, oxidative stress and acute calcium responses.

  Toxicological sciences : an official journal of the Society of Toxicology 20120401

• In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application.

  Cytotherapy 20120401

• Cytarabine in relapsed acute myeloid leukemia.

  Leukemia research 20120401

• Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.

  American journal of hematology 20120401

• NMS-P937, an orally available, specific small-molecule polo-like kinase 1 inhibitor with antitumor activity in solid and hematologic malignancies.

  Molecular cancer therapeutics 20120401

• Are low-intensity induction strategies better for older patients with acute myeloid leukemia?

  Leukemia research 20120401

• Arsenic compounds: revived ancient remedies in the fight against human malignancies.

  Current opinion in chemical biology 20120401

• Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment.

  American journal of hematology 20120401

• Acute megakaryoblastic leukemia and severe pulmonary fibrosis in a child with Down syndrome: successful treatment with ultra low-dose cytarabine using GATA1 mutation to monitor minimal residual disease.

  American journal of hematology 20120401

• FLAG-liposomal doxorubicin (Myocet) regimen for refractory or relapsed acute leukemia pediatric patients.

  Journal of pediatric hematology/oncology 20120401

• Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine.

  Expert opinion on investigational drugs 20120401

• Autologous noncryopreserved hematopoietic stem cell transplant with CEAM as a modified conditioning regimen in patients with Hodgkin lymphoma: a single-center experience with a new protocol.

  Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 20120401

• Liposomal cytarabine in central nervous system disease of haematological malignancies: more effective but more toxic?

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120401

• Efficacy and safety of liposomal cytarabine in children with primary CNS tumours with leptomeningeal involvement.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20120401

• Low-dose cytarabine plus aclarubicin for patients with previously untreated acute myeloid leukemia or high-risk myelodysplastic syndrome ineligible for standard-dose cytarabine plus anthracycline.

  Anticancer research 20120401

• Novel therapeutic strategies for AML in 2012.

  Hematology (Amsterdam, Netherlands) 20120401

• [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].

  Klinische Padiatrie 20120401

• CLEC5A regulates Japanese encephalitis virus-induced neuroinflammation and lethality.

  PLoS pathogens 20120401

• [Clinical observation of thalidomide combined with VAD regimen for treatment of osteosclerotic myeloma (POEMS syndrome)].

  Zhongguo shi yan xue ye xue za zhi 20120401

• [An unusual child case of myeloid/natural killer cell precursor acute leukemia treated successfully with acute myeloid leukemia-oriented chemotherapy].

  Zhongguo shi yan xue ye xue za zhi 20120401

• High Dose Cytosine Arabinoside in the consolidation of adult acute myeloid leukemia.

  Mymensingh medical journal : MMJ 20120401

• Inhibition of hepatitis C virus replication and viral helicase by ethyl acetate extract of the marine feather star Alloeocomatella polycladia.

  Marine drugs 20120401

• RNAi screening of the kinome with cytarabine in leukemias.

  Blood 20120322

• Smoking adversely affects survival in acute myeloid leukemia patients.

  International journal of cancer 20120315

• Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma.

  Cancer 20120315

• Single-cell pharmacodynamic monitoring of S6 ribosomal protein phosphorylation in AML blasts during a clinical trial combining the mTOR inhibitor sirolimus and intensive chemotherapy.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120315

• Phospho-specific flow: fixating on the target.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120315

• Cytarabine induced cerebellar neuronal damage in juvenile rat: correlating neurobehavioral performance with cellular and genetic alterations.

  Toxicology 20120311

• γ-Glutamylcysteine detoxifies reactive oxygen species by acting as glutathione peroxidase-1 cofactor.

  Nature communications 20120306

• FAME, a novel conditioning regimen for allogeneic stem cell transplantation for lymphoma, does not earn fame.

  Hematological oncology 20120301

• Wipe sampling procedure coupled to LC-MS/MS analysis for the simultaneous determination of 10 cytotoxic drugs on different surfaces.

  Analytical and bioanalytical chemistry 20120301

• Matched-cohort analysis of autologous hematopoietic cell transplantation with radioimmunotherapy versus total body irradiation-based conditioning for poor-risk diffuse large cell lymphoma.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120301

• Acute painful lumbosacral paresthesia after intrathecal rituximab.

  Journal of neurology 20120301

• Extended retreatment with brentuximab vedotin (SGN-35) maintains complete remission in patient with recurrent systemic anaplastic large-cell lymphoma.

  Leukemia & lymphoma 20120301

• Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.

  Leukemia research 20120301

• Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma.

  Leukemia & lymphoma 20120301

• High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).

  Leukemia & lymphoma 20120301

• Is obesity a prognostic factor for acute myeloid leukemia outcome?

  Annals of hematology 20120301

• Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast.

  Annals of hematology 20120301

• Upfront allogeneic blood stem cell transplantation for patients with high-risk myelodysplastic syndrome or secondary acute myeloid leukemia using a FLAMSA-based high-dose sequential conditioning regimen.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20120301

• Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene.

  Leukemia research 20120301

• Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.

  Leukemia research 20120301

• Efficacy of combining dasatinib and FLAG-IDA for patients with chronic myeloid leukemia in blastic transformation.

  Haematologica 20120301

• Comparison of total body irradiation before and after chemotherapy in pretreatment for hematopoietic stem cell transplantation.

  Cancer biotherapy & radiopharmaceuticals 20120301

• Rituximab for the treatment of adult relapsed/refractory CD20 positive B-ALL patients: a pilot series.

  Leukemia research 20120301

• Tipifarnib and tanespimycin show synergic proapoptotic activity in U937 cells.

  Journal of cancer research and clinical oncology 20120301

• Feasibility of outpatient consolidation chemotherapy in older versus younger patients with acute myeloid leukemia.

  American journal of hematology 20120301

• Biodistribution, radiation dosimetry and scouting of 90Y-ibritumomab tiuxetan therapy in patients with relapsed B-cell non-Hodgkin's lymphoma using 89Zr-ibritumomab tiuxetan and PET.

  European journal of nuclear medicine and molecular imaging 20120301

• Characteristics of translocation (16;16)(p13;q22) acute myeloid leukemia.

  American journal of hematology 20120301

• New induction and postinduction strategies in acute myeloid leukemia.

  Current opinion in hematology 20120301

• Increased proliferation and chemosensitivity of human mesenchymal stromal cells expressing fusion yeast cytosine deaminase.

  Stem cell research 20120301

• Chemotherapy drug shortages in the United States: genesis and potential solutions.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120301

• Bullous acral erythema: an additional consideration in the differential diagnosis of pauci-inflammatory subepidermal bullae*.

  Journal of cutaneous pathology 20120301

• Pediatric acute myeloid leukemia.

  Expert review of anticancer therapy 20120301

• CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations.

  Pharmacogenomics 20120301

• Novel mutations in CEBPA in Korean Patients with acute myeloid leukemia with a normal karyotype.

  Annals of laboratory medicine 20120301

• A case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma in a Korean child.

  Annals of laboratory medicine 20120301

• Antiproliferative and antitumor effects of azacitidine against the human myelodysplastic syndrome cell line SKM-1.

  Anticancer research 20120301

• Effects of polychlorinated biphenyls on the development of neuronal cells in growth period; structure-activity relationship.

  Experimental neurobiology 20120301

• Outcome of allogeneic hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia in second complete remission: a single institution study.

  Korean journal of pediatrics 20120301

• Treatment strategies for Hodgkin lymphoma recurring following autologous hematopoietic stem cell transplantation.

  The Korean journal of hematology 20120301

• Relapse pattern and prognostic factors for patients with primary central nervous system lymphoma.

  The Korean journal of hematology 20120301

• Asymptomatic pneumatosis intestinalis following chemotherapy for B lymphoblastic leukemia with recurrent genetic abnormalities in an adolescent patient.

  The Korean journal of hematology 20120301

• Update of adjuvant chemotherapy for resected gastric cancer.

  Journal of gastric cancer 20120301

• Antiviral activities and putative identification of compounds in microbial extracts from the Hawaiian coastal waters.

  Marine drugs 20120301

• Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies.

  Blood cancer journal 20120301

• [Current treatment of acute myeloid leukaemia in adults].

  Orvosi hetilap 20120219

• Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20120215

• Dose modification of alemtuzumab in combination with dexamethasone, cytarabine, and cisplatin in patients with relapsed or refractory peripheral T-cell lymphoma: analysis of efficacy and toxicity.

  Investigational new drugs 20120201

• AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia: a report from the Children's Oncology Group.

  Cancer 20120201

• Risk factors for early death after high-dose cytosine arabinoside (HiDAC)-based chemotherapy for adult AML.

  Leukemia 20120201

• DNA building blocks: keeping control of manufacture.

  Critical reviews in biochemistry and molecular biology 20120201

• Identification of potential markers related to neoadjuvant chemotherapy sensitivity of breast cancer by SELDI-TOF MS.

  Applied biochemistry and biotechnology 20120201

• Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.

  British journal of haematology 20120201

• Renaissance of autologous stem cell transplantation for AML?

  The Lancet. Oncology 20120201

• Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.

  Molecular cancer therapeutics 20120201

• Stability of extemporaneously prepared cytarabine, methotrexate sodium, and methylprednisolone sodium succinate.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120201

• Amonafide: a future in treatment of resistant and secondary acute myeloid leukemia?

  Expert review of hematology 20120201

• Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.

  The oncologist 20120201

• The dual kinase inhibitor NVP-BEZ235 in combination with cytotoxic drugs exerts anti-proliferative activity towards acute lymphoblastic leukemia cells.

  Anticancer research 20120201

• A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia.

  Anticancer research 20120201

• Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20120201

• Cytidine deaminase genetic variants influence RNA expression and cytarabine cytotoxicity in acute myeloid leukemia.

  Pharmacogenomics 20120201

• Multiple myeloma invasion of the central nervous system.

  Vojnosanitetski pregled 20120201

• Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling.

  Blood 20120119

• A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia.

  Cancer 20120115

• High-dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years.

  Cancer 20120115

• Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia.

  Cancer 20120115

• The cytotoxic effects of bendamustine in combination with cytarabine in mantle cell lymphoma cell lines.

  Blood cells, molecules & diseases 20120115

• The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99-15 study.

  Pediatric blood & cancer 20120101

• Time controlled release of arabinofuranosylcytosine (Ara-C) from agarose hydrogels using layer-by-layer assembly: an in vitro study.

  Journal of biomaterials science. Polymer edition 20120101

• Early allo-SCT for AML with a complex aberrant karyotype--results from a prospective pilot study.

  Bone marrow transplantation 20120101

• Second line chemotherapy in patients with enteropathy-associated T cell lymphoma: a retrospective single center analysis.

  Annals of hematology 20120101

• Devastating bilateral optic nerve leukaemic infiltration.

  Clinical & experimental ophthalmology 20120101

• Targeting PIM kinase activity significantly augments the efficacy of cytarabine.

  British journal of haematology 20120101

• Institutional experience with clofarabine and cytarabine in relapsed pediatric acute myeloid leukemia.

  Journal of pediatric hematology/oncology 20120101

• Prophylactic intrathecal chemotherapy in primary CNS lymphoma.

  Journal of neuro-oncology 20120101

• A novel biocatalytic approach to acetylation of 1-β-D-arabinofuranosylcytosine by Aspergillus oryzae whole cell in organic solvents.

  Applied microbiology and biotechnology 20120101

• Mutations in epigenetic modifiers in myeloid malignancies and the prospect of novel epigenetic-targeted therapy.

  Advances in hematology 20120101

• Inherited prothrombotic risk factors in Turkish children with acute lymphoblastic leukemia: significance of concomitant genetic mutation.

  Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20120101

• Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome.

  European journal of haematology 20120101

• Antifungal management and resource use in patients with acute myeloid leukaemia after chemotherapy--retrospective analysis of changes over 3 yr in a German hospital.

  European journal of haematology 20120101

• Angiogenesis in acute myeloid leukemia and opportunities for novel therapies.

  Journal of oncology 20120101

• Comparison of effects of the ethanolic extracts of brazilian propolis on human leukemic cells as assessed with the MTT assay.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• The Medical Research Council Myeloma IX trial: the impact on treatment paradigms.

  European journal of haematology 20120101

• The ToxTracker assay: novel GFP reporter systems that provide mechanistic insight into the genotoxic properties of chemicals.

  Toxicological sciences : an official journal of the Society of Toxicology 20120101

• FLAGIDA-lite is an effective regimen for patients between 70 and 80 years with acute myeloid leukemia or refractory anemia with excess blasts-2 and is feasible as outpatient treatment.

  American journal of hematology 20120101

• Antioxidant and antiproliferative activity of Laurus nobilis L. (Lauraceae) leaves and seeds essential oils against K562 human chronic myelogenous leukaemia cells.

  Natural product research 20120101

• Recent and remote spatial memory in mice treated with cytosine arabinoside.

  Pharmacology, biochemistry, and behavior 20120101

• Salvage therapy with endostatin, low-dose homoharringtonine, and cytarabine in combination with granulocyte-colony stimulating factor for elderly patients with primary refractory acute myeloid leukemia.

  American journal of hematology 20120101

• Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French association.

  American journal of hematology 20120101

• Excellent survival after sibling or unrelated donor stem cell transplantation for chronic granulomatous disease.

  The Journal of allergy and clinical immunology 20120101

• Acute isolated transmural neutropenic gastritis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120101

• Intensive short-term chemotherapy regimen induces high remission rate (over 90%) and event-free survival both in children and adult patients with advanced sporadic Burkitt lymphoma/leukemia.

  American journal of hematology 20120101

• RD-CODOX-M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and 'unclassifiable' highly aggressive B-cell lymphoma.

  British journal of haematology 20120101

• Diffuse osteosclerosis-associated acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120101

• Generation of primary astrocyte cultures devoid of contaminating microglia.

  Methods in molecular biology (Clifton, N.J.) 20120101

• Clofarabine in the treatment of newly diagnosed acute myeloid leukemia in older adults.

  The Annals of pharmacotherapy 20120101

• Acute myeloid leukemia: 2012 update on diagnosis, risk stratification, and management.

  American journal of hematology 20120101

• A rare case of supraspinatus tendon rupture.

  Annals of hematology 20120101

• HIV-Associated Burkitt Lymphoma: Good Efficacy and Tolerance of Intensive Chemotherapy Including CODOX-M/IVAC with or without Rituximab in the HAART Era.

  Advances in hematology 20120101

• Long term cultured HL-60 cells are intrinsically resistant to Ara-C through high CDA activity.

  Frontiers in bioscience (Landmark edition) 20120101

• Neurological complications of chemotherapy to the central nervous system.

  Handbook of clinical neurology 20120101

• Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons.

  PloS one 20120101

• Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.

  Acta haematologica 20120101

• Bullous leukaemia cutis.

  European journal of dermatology : EJD 20120101

• Isolated granulocytic sarcoma of the pancreas: a tricky diagnostic for primary pancreatic extramedullary acute myeloid leukemia.

  World journal of surgical oncology 20120101

• Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation.

  PloS one 20120101

• CD5-negative blastoid variant mantle cell lymphoma with complex CCND1/IGH and MYC aberrations.

  Annals of laboratory medicine 20120101

• Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.

  Diagnostic pathology 20120101

• Erythrocyte inosine triphosphatase activity is decreased in HIV-seropositive individuals.

  PloS one 20120101

• Speciation of arsenic trioxide metabolites in peripheral blood and bone marrow from an acute promyelocytic leukemia patient.

  Journal of hematology & oncology 20120101

• Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy.

  International journal of nanomedicine 20120101

• HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.

  PloS one 20120101

• The role of calcifying nanoparticles in biology and medicine.

  International journal of nanomedicine 20120101

• Combined experimental and computational analysis of DNA damage signaling reveals context-dependent roles for Erk in apoptosis and G1/S arrest after genotoxic stress.

  Molecular systems biology 20120101

• Deregulation of apoptosis-related genes is associated with PRV1 overexpression and JAK2 V617F allele burden in Essential Thrombocythemia and Myelofibrosis.

  Journal of hematology & oncology 20120101

• Invasive fungal infections in patients with hematologic malignancies (aurora project): lights and shadows during 18-months surveillance.

  International journal of molecular sciences 20120101

• Oncolytic virotherapy for hematological malignancies.

  Advances in virology 20120101

• The role of autologous stem cell transplantation in the treatment of diffuse large B-cell lymphoma.

  Advances in hematology 20120101

• Nonengraftment haploidentical cellular therapy for hematologic malignancies.

  Advances in hematology 20120101

• Online availability and safety of drugs in shortage: a descriptive study of internet vendor characteristics.

  Journal of medical Internet research 20120101

• Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation.

  Journal of experimental & clinical cancer research : CR 20120101

• Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models.

  Journal of neuroinflammation 20120101

• The co-presence of deletion 7q, 20q and inversion 16 in therapy-related acute myeloid leukemia developed secondary to treatment of breast cancer with cyclophosphamide, doxorubicin, and radiotherapy: a case report.

  Journal of medical case reports 20120101

• Dilated cardiomyopathy following trastuzumab chemotherapy.

  Indian journal of pharmacology 20120101

• Impact of nanotechnology in cancer: emphasis on nanochemoprevention.

  International journal of nanomedicine 20120101

• Emerging pharmacotherapies for adult patients with acute lymphoblastic leukemia.

  Clinical Medicine Insights. Oncology 20120101

• Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.

  TheScientificWorldJournal 20120101

• Allotransplanted neurons used to repair peripheral nerve injury do not elicit overt immunogenicity.

  PloS one 20120101

• CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate.

  Frontiers in pharmacology 20120101

• Bacillus cereus catheter related bloodstream infection in a patient with acute lymphoblastic leukemia.

  Mediterranean journal of hematology and infectious diseases 20120101

• Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3.

  Mediterranean journal of hematology and infectious diseases 20120101

• NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9.

  Journal of neuroinflammation 20120101

• Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.

  Diagnostic pathology 20120101

• DNA replication fading as proliferating cells advance in their commitment to terminal differentiation.

  Scientific reports 20120101

• Molecular targeting therapy against promyelocytic leukemia protein using arsenic acids in experimental intracranial medulloblastoma.

  Neurologia medico-chirurgica 20120101

• The Safety of EXPAREL ® (Bupivacaine Liposome Injectable Suspension) Administered by Peripheral Nerve Block in Rabbits and Dogs.

  Journal of drug delivery 20120101

• Instability of (CTG)n•(CAG)n trinucleotide repeats and DNA synthesis.

  Cell & bioscience 20120101

• [CAG-GO therapy for patients with relapsed or primary refractory CD33-positive acute myelogenous leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20120101

• HIF-1 and c-Src mediate increased glucose uptake induced by endothelin-1 and connexin43 in astrocytes.

  PloS one 20120101

• Novel model of neuronal bioenergetics: postsynaptic utilization of glucose but not lactate correlates positively with Ca2+ signalling in cultured mouse glutamatergic neurons.

  ASN neuro 20120101

• Molecular alterations of isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) metabolic genes and additional genetic mutations in newly diagnosed acute myeloid leukemia patients.

  Journal of hematology & oncology 20120101

• AIDS-Related Non-Hodgkin's Lymphoma in the Era of Highly Active Antiretroviral Therapy.

  Advances in hematology 20120101

• Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma.

  BMC cancer 20120101

• Poly (ADP-ribose) polymerase plays an important role in intermittent hypoxia-induced cell death in rat cerebellar granule cells.

  Journal of biomedical science 20120101

• The cytochrome c gene proximal enhancer drives activity-dependent reporter gene expression in hippocampal neurons.

  Frontiers in molecular neuroscience 20120101

• Liposomes prolong the therapeutic effect of anti-asthmatic medication via pulmonary delivery.

  International journal of nanomedicine 20120101

• Cytotoxic effects of chemotherapeutic drugs and heterocyclic compounds at application on the cells of primary culture of neuroepithelium tumors.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20120101

• Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.

  Journal of hematology & oncology 20120101

• DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.

  PloS one 20120101

• CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma.

  PloS one 20120101

• Dopamine D1-D2 receptor heteromer in dual phenotype GABA/glutamate-coexpressing striatal medium spiny neurons: regulation of BDNF, GAD67 and VGLUT1/2.

  PloS one 20120101

• Severe paraneoplastic hypereosinophilia in metastatic renal cell carcinoma.

  BMC urology 20120101

• A proteome map of primary cultured rat Schwann cells.

  Proteome science 20120101

• [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].

  Vnitrni lekarstvi 20120101

• Modulation of TTX-sensitive voltage-dependent Na+ channels by β-bungarotoxin in rat cerebellar neurons.

  BMC neuroscience 20120101

• The use of mouse models for understanding the biology of down syndrome and aging.

  Current gerontology and geriatrics research 20120101

• Hyccin, the molecule mutated in the leukodystrophy hypomyelination and congenital cataract (HCC), is a neuronal protein.

  PloS one 20120101

• Cost-effectiveness of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infections among high-risk neutropenic patients in Spain.

  BMC infectious diseases 20120101

• State-of-the-Art Management of Patients Suffering from Chronic Lymphocytic Leukemia.

  Clinical Medicine Insights. Oncology 20120101

• Neuroprotective Effects of San-Huang-Xie-Xin-Tang in the MPP(+)/MPTP Models of Parkinson's Disease In Vitro and In Vivo.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• 18-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Management of Aggressive Non-Hodgkin's B-Cell Lymphoma.

  ISRN hematology 20120101

• Predictive models for maximum recommended therapeutic dose of antiretroviral drugs.

  Computational and mathematical methods in medicine 20120101

• Vancomycin-induced Henoch-Schönlein purpura: a case report.

  Journal of medical case reports 20120101

• Icariside II induces apoptosis in U937 acute myeloid leukemia cells: role of inactivation of STAT3-related signaling.

  PloS one 20120101

• Genetic association studies of copy-number variation: should assignment of copy number states precede testing?

  PloS one 20120101

• In vivo analysis of MEF2 transcription factors in synapse regulation and neuronal survival.

  PloS one 20120101

• Unchanged antibiotic susceptibility in Escherichia coli and Pseudomonas aeruginosa after long-term in vitro exposure to antineoplastic drugs.

  Chemotherapy 20120101

• Proteasome inhibition is partially effective in attenuating pre-existing immunity against recombinant adeno-associated viral vectors.

  PloS one 20120101

• Cryopreservation of ovarian tissue in pediatric patients.

  Obstetrics and gynecology international 20120101

• Polysaccharides from wolfberry prevents corticosterone-induced inhibition of sexual behavior and increases neurogenesis.

  PloS one 20120101

• Ablation of proliferating cells in the CNS exacerbates motor neuron disease caused by mutant superoxide dismutase.

  PloS one 20120101

• A systems biology approach to characterize the regulatory networks leading to trabectedin resistance in an in vitro model of myxoid liposarcoma.

  PloS one 20120101

• Ewing's Sarcoma: Development of RNA Interference-Based Therapy for Advanced Disease.

  ISRN oncology 20120101

• Proceedings of tumor board meeting.

  Journal of Indian Association of Pediatric Surgeons 20120101

• Cellulitis with leukocytopenia as an initial sign of acute promyelocytic leukemia.

  Case reports in dermatology 20120101

• Acute leukemic appendicitis in a patient with acute promyelocytic leukemia.

  Journal of cancer research and therapeutics 20120101

• Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a man with AIDS.

  International journal of general medicine 20120101

• Secondary Metabolites from Plants Inhibiting ABC Transporters and Reversing Resistance of Cancer Cells and Microbes to Cytotoxic and Antimicrobial Agents.

  Frontiers in microbiology 20120101

• Priority in selenium homeostasis involves regulation of SepSecS transcription in the chicken brain.

  PloS one 20120101

• In vitro study of uptake and synthesis of creatine and its precursors by cerebellar granule cells and astrocytes suggests some hypotheses on the physiopathology of the inherited disorders of creatine metabolism.

  BMC neuroscience 20120101

• Necrotic ulcer: a manifestation of leukemia cutis.

  Skinmed 20120101

• Unilateral hydronephrosis and renal damage after acute leukemia.

  Case reports in medicine 20120101

• Development of myelodysplastic syndrome and acute myeloid leukemia 15 years after hydroxyurea use in a patient with sickle cell anemia.

  Clinical Medicine Insights. Oncology 20120101

• Relapsed and/or Refractory Mantle Cell Lymphoma: What Role for Temsirolimus?

  Clinical Medicine Insights. Oncology 20120101

• Expression and clinical significance of antiapoptotic gene (survivin) in NB4 and acute promyelocytic leukemia cells.

  TheScientificWorldJournal 20120101

• Implications of therapy-induced selective autophagy on tumor metabolism and survival.

  International journal of cell biology 20120101

• Methotrexate induced lung injury in a patient with primary CNS lymphoma: a case report.

  Mediterranean journal of hematology and infectious diseases 20120101

• Adult neurogenesis transiently generates oxidative stress.

  PloS one 20120101

• NT2 derived neuronal and astrocytic network signalling.

  PloS one 20120101

• Plerixafor Salvage Is Safe and Effective in Hard-to-Mobilize Patients Undergoing Chemotherapy and Filgrastim-Based Peripheral Blood Progenitor Cell Mobilization.

  Journal of oncology 20120101

• Paradigms and Controversies in the Treatment of HIV-Related Burkitt Lymphoma.

  Advances in hematology 20120101

• Functional neuromuscular junctions formed by embryonic stem cell-derived motor neurons.

  PloS one 20120101

• The social environment and neurogenesis in the adult Mammalian brain.

  Frontiers in human neuroscience 20120101

• FKBP5 as a selection biomarker for gemcitabine and Akt inhibitors in treatment of pancreatic cancer.

  PloS one 20120101

• BOSS: context-enhanced search for biomedical objects.

  BMC medical informatics and decision making 20120101

• Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.

  PloS one 20120101

• Tetrahydrouridine inhibits cell proliferation through cell cycle regulation regardless of cytidine deaminase expression levels.

  PloS one 20120101

• Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

  International journal of nanomedicine 20120101

• Coseeded Schwann cells myelinate neurites from differentiated neural stem cells in neurotrophin-3-loaded PLGA carriers.

  International journal of nanomedicine 20120101

• Rhynchophylline Protects Cultured Rat Neurons against Methamphetamine Cytotoxicity.

  Evidence-based complementary and alternative medicine : eCAM 20120101

• Combination drug delivery approaches in metastatic breast cancer.

  Journal of drug delivery 20120101

• Divergent modulation of neuronal differentiation by caspase-2 and -9.

  PloS one 20120101

• Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosis.

  PloS one 20120101

• Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.

  BMC medicine 20120101

• Poly(ethylene glycol)-Prodrug Conjugates: Concept, Design, and Applications.

  Journal of drug delivery 20120101

• Suppression of AP1 transcription factor function in keratinocyte suppresses differentiation.

  PloS one 20120101

• Acute myeloid leukemia: focus on novel therapeutic strategies.

  Clinical Medicine Insights. Oncology 20120101

• Current and emerging pharmacotherapies for primary CNS lymphoma.

  Clinical Medicine Insights. Oncology 20120101

• FK228 Analogues Induce Fetal Hemoglobin in Human Erythroid Progenitors.

  Anemia 20120101

• Preparation and evaluation of polymeric microparticulates for improving cellular uptake of gemcitabine.

  International journal of nanomedicine 20120101

• Pan-pathway based interaction profiling of FDA-approved nucleoside and nucleobase analogs with enzymes of the human nucleotide metabolism.

  PloS one 20120101

• The first European interdisciplinary ewing sarcoma research summit.

  Frontiers in oncology 20120101

• A rare case of myeloid sarcoma presenting as an anorectal ulcer.

  Case reports in medicine 20120101

• The Link between Hypersensitivity Syndrome Reaction Development and Human Herpes Virus-6 Reactivation.

  International journal of hepatology 20120101

• Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases.

  International journal of nanomedicine 20120101

• Targeted therapy in Ewing sarcoma.

  ISRN oncology 20120101

• Human stanniocalcin-1 suppresses angiotensin II-induced superoxide generation in cardiomyocytes through UCP3-mediated anti-oxidant pathway.

  PloS one 20120101

• Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma without Cryopreservation.

  Bone marrow research 20120101

• Extensive fusion of mitochondria in spinal cord motor neurons.

  PloS one 20120101

• Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome.

  Clinical interventions in aging 20120101

• Isolated central nervous system relapse of chronic myeloid leukemia after allogeneic hematopoietic stem cell transplantation.

  BMC blood disorders 20120101

• A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.

  Molecular vision 20120101

• Overexpression of MN1 confers resistance to chemotherapy, accelerates leukemia onset, and suppresses p53 and Bim induction.

  PloS one 20120101

• Optimal therapy for adults with Langerhans cell histiocytosis bone lesions.

  PloS one 20120101

• Influence of chemotherapy on the lipid peroxidation and antioxidant status in patients with acute myeloid leukemia.

  Acta medica Iranica 20120101

• G-CSF-Associated Bone Marrow Necrosis in AML after Induction Chemotherapy.

  Case reports in hematology 20120101

• Successful treatment of fanconi anemia and T-cell acute lymphoblastic leukemia.

  Case reports in hematology 20120101

• Thrombotic microangiopathy with skin localization secondary to cytarabine-daunorubicin association: report of a case.

  Case reports in hematology 20120101

• Bing and neel syndrome.

  Case reports in hematology 20120101

• [Lesions in the nervous system during chemotherapy of acute leukosis and non-Hodgkin lymphomas].

  Klinicheskaia meditsina 20120101

• Adult lymphoblastic lymphoma.

  Cancer journal (Sudbury, Mass.) 20120101

• Rapidly progressing fatal adult multi-organ Langerhans cell histiocytosis complicated with fatty liver disease.

  Journal of clinical and experimental hematopathology : JCEH 20120101

• [The first results of treatment for adult acute myeloid leukemia according to the AML-01.10 protocol of the Research Group of the Hematology Centers of Russia].

  Terapevticheskii arkhiv 20120101

• Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer.

  PloS one 20120101

• Complete remission following chemotherapy with low-dose cytosine arabinoside and macrophage colony-stimulating factor/granulocyte colony-stimulating factor in a patient with relapsed acute myeloid leukemia after stem cell transplantation.

  Internal medicine (Tokyo, Japan) 20120101

• Response of the G2-prophase checkpoint to genotoxic drugs in lymphocytes from healthy individuals.

  Biological research 20120101

• Natural history of transient myeloproliferative disorder clinically diagnosed in Down syndrome neonates: a report from the Children's Oncology Group Study A2971.

  Blood 20111222

• Enigmatic variation.

  Blood 20111222

• The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPδ and RhoGAP2.

  Human molecular genetics 20111215

• Vincristine potentiates the anti-proliferative effect of an aurora kinase inhibitor, VE-465, in myeloid leukemia cells.

  Biochemical pharmacology 20111215

• Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study.

  Blood 20111215

• Important role of caspase-8 for chemosensitivity of ALL cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20111215

• Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis.

  Investigational new drugs 20111201

• FLANG salvage chemotherapy is an effective regimen that offers a safe bridge to transplantation for patients with relapsed or refractory acute myeloid leukemia.

  Medical oncology (Northwood, London, England) 20111201

• Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20111201

• The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20111201

• Bilateral irreversible blindness in leukaemic meningitis: cause or cure?

  Annals of hematology 20111201

• Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.

  Annals of hematology 20111201

• MRI restricted diffusion in lymphomatous optic neuropathy.

  Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20111201

• t(4;22)(q12;q11.2) involving presumptive platelet-derived growth factor receptor A and break cluster region in a patient with mixed phenotype acute leukemia.

  Human pathology 20111201

• Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas.

  European journal of haematology 20111201

• Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia.

  Haematologica 20111201

• Treatment of elderly acute myeloid leukemia patients.

  Current treatment options in oncology 20111201

• Acute lymphoblastic leukemia of adulthood: progress or not?

  Current treatment options in oncology 20111201

• Endogenous Bmp4 in myoblasts is required for myotube formation in C2C12 cells.

  Biochimica et biophysica acta 20111201

• Necrotic intramuscular chloroma with infection: magnetic resonance imaging features.

  Japanese journal of radiology 20111201

• Elacytarabine--lipid vector technology overcoming drug resistance in acute myeloid leukemia.

  Expert opinion on investigational drugs 20111201

• Successful treatment of lymphoid blastic crisis in chronic myelogenous leukemia with the additional bcr/abl transcript using imatinib-combined chemotherapy and high-dose chemotherapy with allogeneic bone marrow stem cell transplantation.

  International journal of hematology 20111201

• Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.

  Current medicinal chemistry 20111201

• Pharmacogenomics of cytarabine in childhood leukemia.

  Pharmacogenomics 20111201

• Evaluation of prognostic factors in AML. Preface.

  Best practice & research. Clinical haematology 20111201

• Should the presence of minimal residual disease (MRD) in morphologic complete remission alter post-remission strategy in AML?

  Best practice & research. Clinical haematology 20111201

• What is the optimal induction strategy for older patients?

  Best practice & research. Clinical haematology 20111201

• Does therapy-related AML have a poor prognosis, independent of the cytogenetic/molecular determinants?

  Best practice & research. Clinical haematology 20111201

• Is a nadir bone marrow required and, if so, what to do with residual disease?

  Best practice & research. Clinical haematology 20111201

• Combination effects of digalloylresveratrol with arabinofuranosylcytosine and difluorodeoxycytidine in human leukemia and pancreatic cancer cells.

  Nucleosides, nucleotides & nucleic acids 20111201

• Regulation of deoxycytidine kinase expression and sensitivity to gemcitabine by micro-RNA 330 and promoter methylation in cancer cells.

  Nucleosides, nucleotides & nucleic acids 20111201

• Hematopoietic stem cell transplantation in children with leukemia: a single institution experience with respect to donors.

  Journal of Korean medical science 20111201

• Structural insights into the inhibition of cytosolic 5'-nucleotidase II (cN-II) by ribonucleoside 5'-monophosphate analogues.

  PLoS computational biology 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Solitary primary gastric mantle cell lymphoma.

  Gut and liver 20111201

• Current treatment strategy of acute promyelocytic leukemia.

  Frontiers of medicine 20111201

• [A systematic review of MA versus IA regimen for patients with acute myelogenous leukemia].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20111201

• Second induction with high-dose cytarabine and mitoxantrone: different impact on pediatric AML patients with t(8;21) and with inv(16).

  Blood 20111117

• Tandem high-dose therapy in relapsed and refractory B-cell lymphoma: results of a prospective phase II trial of myeloablative chemotherapy, followed by escalated radioimmunotherapy with (131)I-anti-CD20 antibody and stem cell rescue.

  Annals of hematology 20111101

• Clofarabine and high-dose cytosine arabinoside in the treatment of refractory or relapsed acute myeloid leukaemia.

  Annals of hematology 20111101

• Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia.

  Cancer 20111101

• A prediction model for complete remission upon reinduction for patients with acute myeloid leukemia after failure of anthracycline and cytarabine standard chemotherapy.

  Annals of hematology 20111101

• Platine and cytarabine-based salvage treatment for primary central nervous system lymphoma.

  Journal of neuro-oncology 20111101

• p53 independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia.

  Leukemia 20111101

• Complete response induced by fotemustine given as single agent in a patient with primary central nervous system non-Hodgkin aggressive lymphoma relapsed after high-dose chemotherapy and autologous stem cell support.

  Leukemia & lymphoma 20111101

• Leptomeningeal melanomatosis: stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine.

  Acta oncologica (Stockholm, Sweden) 20111101

• Massive postpartum hemorrhage after chemotherapy in a patient with acute promyelocytic leukemia.

  The journal of obstetrics and gynaecology research 20111101

• Advances in therapies for acute promyelocytic leukemia.

  Cancer science 20111101

• Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia.

  Haematologica 20111101

• High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.

  Haematologica 20111101

• Results of a randomized trial in children with Acute Myeloid Leukaemia: medical research council AML12 trial.

  British journal of haematology 20111101

• A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy.

  Cancer chemotherapy and pharmacology 20111101

• Primary refractory acute myeloid leukaemia - in search of better definitions and therapies.

  British journal of haematology 20111101

• Synthesis and anticancer activity of 5'-chloromethylphosphonates of 3'-azido-3'-deoxythymidine (AZT).

  Bioorganic & medicinal chemistry 20111101

• The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20111101

• Eccrine hidradenitis sine neutrophils: a toxic response to chemotherapy.

  Journal of cutaneous pathology 20111101

• Simultaneous determination of a selected group of cytostatic drugs in water using high-performance liquid chromatography-triple-quadrupole mass spectrometry.

  Journal of separation science 20111101

• Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.

  Journal of pediatric surgery 20111101

• Do AML patients with DNMT3A exon 23 mutations benefit from idarubicin as compared to daunorubicin? A single center experience.

  Oncotarget 20111101

• Mantle cell lymphoma manifesting neurological symptoms similar to those of hypertrophic cranial pachymeningitis.

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20111101

• [Clinical study of kangai injection plus FLAG regimen for refractory/relapsed acute leukemia].

  Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20111101

• Moving forward with new data and approaches: a fresh look at anthracyclines in non-Hodgkin's lymphoma.

  Hematology reports 20111028

• Current approaches to the treatment of non-Hodgkin's lymphoma.

  Hematology reports 20111028

• Glucocorticoids dexamethasone and hydrocortisone inhibit proliferation and accelerate maturation of chicken cerebellar granule neurons.

  Brain research 20111018

• 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCζ.

  Journal of medicinal chemistry 20111013

• A randomized trial comparing standard versus high-dose daunorubicin induction in patients with acute myeloid leukemia.

  Blood 20111006

• CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.

  International journal of radiation oncology, biology, physics 20111001

• High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20111001

• Augmented therapy improves outcome for pediatric high risk acute lymphocytic leukemia: results of Children's Oncology Group trial P9906.

  Pediatric blood & cancer 20111001

• Treatment of acute myeloid leukemia in children: experience from a tertiary care hematology centre in India.

  Indian journal of pediatrics 20111001

• Acute promyelocytic leukemia with complex translocation t(5;17;15)(q35;q21;q22): case report and review of the literature.

  Journal of pediatric hematology/oncology 20111001

• Methotrexate area under the curve as a prognostic factor in primary central nervous system lymphoma treated with immunochemoradiotherapy.

  Leukemia & lymphoma 20111001

• Intrathecal administration of trastuzumab with cytarabine and methotrexate in breast cancer patients with leptomeningeal carcinomatosis.

  Breast (Edinburgh, Scotland) 20111001

• Poor-risk cytogenetics may be associated with inferior outcome after fludarabine, cytarabine, and amsacrine reduced intensity conditioning in patients with high-risk acute myeloid leukemia.

  Leukemia & lymphoma 20111001

• Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

  The Journal of pharmacology and experimental therapeutics 20111001

• Upfront therapy of acute myeloid leukemia.

  Current oncology reports 20111001

• Treatment strategies in patients with core-binding factor acute myeloid leukemia.

  Current oncology reports 20111001

• Fulminant chemical ventriculomeningitis following intrathecal liposomal cytarabine administration.

  Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20111001

• Lack of teratological effects in rats exposed to 20 or 60 kHz magnetic fields.

  Birth defects research. Part B, Developmental and reproductive toxicology 20111001

• MicroRNA-32 upregulation by 1,25-dihydroxyvitamin D3 in human myeloid leukemia cells leads to Bim targeting and inhibition of AraC-induced apoptosis.

  Cancer research 20111001

• Efficacy and safety of CHG regimen (low-dose cytarabine, homoharringtonine with G-CSF priming) as induction chemotherapy for elderly patients with high-risk MDS or AML transformed from MDS.

  Journal of cancer research and clinical oncology 20111001

• Clofarabine with high dose cytarabine and granulocyte colony-stimulating factor (G-CSF) priming for relapsed and refractory acute myeloid leukaemia.

  British journal of haematology 20111001

• Unrepairable DNA double-strand breaks initiate cytotoxicity with HSV-TK/ganciclovir.

  Cancer gene therapy 20111001

• WT1 overexpression at diagnosis may predict favorable outcome in patients with de novo non-M3 acute myeloid leukemia.

  Leukemia & lymphoma 20111001

• What is your guess? Which count is correct?

  Clinical chemistry 20111001

• Understanding and treating opioid addiction in a patient with cancer pain.

  The journal of pain : official journal of the American Pain Society 20111001

• [A case of meningeal carcinomatosis due to gastric cancer treated with intrathecal chemotherapy].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20111001

• [Treatment of Burkitt lymphoma and Burkitt-like lymphoma].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20111001

• Evaluation of F-18-labeled 5-iodocytidine (18F-FIAC) as a new potential positron emission tomography probe for herpes simplex virus type 1 thymidine kinase imaging.

  Nuclear medicine and biology 20111001

• Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases.

  Oncotarget 20111001

• A triple-drug combination to prevent nausea and vomiting following BEAM chemotherapy before autologous hematopoietic stem cell transplantation.

  Transplantation proceedings 20111001

• Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience.

  Transplantation proceedings 20111001

• Mycobacterium tuberculosis: an infection we should suspect in bone marrow transplantation.

  Journal of chemotherapy (Florence, Italy) 20111001

• Case of the season: Large B-cell lymphoma involving both breasts.

  Seminars in roentgenology 20111001

• [Clinical study on combination of homoharringtonine, Ara-C and idarubicin induction for treatment of newly diagnosed acute myeloid leukemia patients].

  Zhongguo shi yan xue ye xue za zhi 20111001

• Primary granulocytic sarcoma of the face.

  Annals of dermatology 20111001

• A chemical-genetic screen reveals a mechanism of resistance to PI3K inhibitors in cancer.

  Nature chemical biology 20110925

• BeEAM (bendamustine, etoposide, cytarabine, melphalan) before autologous stem cell transplantation is safe and effective for resistant/relapsed lymphoma patients.

  Blood 20110922

• Targeting levels or oligomerization of nucleophosmin 1 induces differentiation and loss of survival of human AML cells with mutant NPM1.

  Blood 20110915

• Letter: Neutrophilic eccrine hidroadenitis with atypical findings.

  Dermatology online journal 20110915

• Reversal of leukostasis-related pulmonary distress syndrome after leukapheresis and low-dose chemotherapy in acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110910

• A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma.

  Hematological oncology 20110901

• Activation of stress kinases in the brain of mucopolysaccharidosis IIIB mice.

  Journal of neuroscience research 20110901

• Infections in relapsed or refractory acute myeloid leukemia patients given clofarabine+cytarabine.

  Leukemia research 20110901

• Directed differentiation of human embryonic stem cells to interrogate the cardiac gene regulatory network.

  Molecular therapy : the journal of the American Society of Gene Therapy 20110901

• Biweekly rituximab, cyclophosphamide, vincristine, non-pegylated liposome-encapsulated doxorubicin and prednisone (R-COMP-14) in elderly patients with poor-risk diffuse large B-cell lymphoma and moderate to high 'life threat' impact cardiopathy.

  British journal of haematology 20110901

• Efficacy of an intensive post-induction chemotherapy regimen for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia, given predominantly in the out-patient setting.

  Annals of hematology 20110901

• Applicability of a 'Pick a Winner' trial design to acute myeloid leukemia.

  Blood 20110901

• Synthesis of new 2'-deoxy-2'-fluoro-4'-azido nucleoside analogues as potent anti-HIV agents.

  European journal of medicinal chemistry 20110901

• GIMEMA AIDA 0493 amended protocol for elderly patients with acute promyelocytic leukaemia. Long-term results and prognostic factors.

  British journal of haematology 20110901

• Prognostic implications of the NIH consensus criteria in children with chronic graft-versus-host disease.

  Yonsei medical journal 20110901

• A case of pseudomembranous colitis after voriconazole therapy.

  Yonsei medical journal 20110901

• Astrocytes from familial and sporadic ALS patients are toxic to motor neurons.

  Nature biotechnology 20110901

• What is your diagnosis? Fine-needle aspirate of ulcerative skin lesions in a dog.

  Veterinary clinical pathology 20110901

• Prevention of cytarabine-induced kerato-conjunctivitis by eye rinse in patients receiving high-dose cytarabine and total body irradiation as a conditioning for hematopoietic stem cell transplantation.

  International journal of hematology 20110901

• [An autopsy case of progressive multifocal leukoencephalopathy: comparison of magnetic resonance imaging findings with the pathological findings].

  Brain and nerve = Shinkei kenkyu no shinpo 20110901

• Protection of acute myeloid leukaemia cells from apoptosis induced by front-line chemotherapeutics is mediated by haem oxygenase-1.

  Oncotarget 20110901

• Vaccinia virus protein C6 is a virulence factor that binds TBK-1 adaptor proteins and inhibits activation of IRF3 and IRF7.

  PLoS pathogens 20110901

• [Pulmonary Langerhans histiocytosis and Hodgkin's lymphoma].

  Revue des maladies respiratoires 20110901

• Chronic myeloid leukemia stem cells in the era of targeted therapies: resistance, persistence and long-term dormancy.

  Oncotarget 20110901

• Esculetin inhibits N-methyl-D-aspartate neurotoxicity via glutathione preservation in primary cortical cultures.

  Laboratory animal research 20110901

• Acute lymphoblastic leukemia in elderly patients: a single institution's experience.

  The Korean journal of internal medicine 20110901

• Second primary glioblastoma multiforme following autologous hematopoietic stem cell transplantation in a patient with acute myelogenous leukemia.

  Cancer research and treatment : official journal of Korean Cancer Association 20110901

• Fortuitous detection of esophageal pneumatosis in a neutropenic patient.

  The Korean journal of hematology 20110901

• Recent advances in the path toward the cure for chronic myeloid leukemia.

  The Korean journal of hematology 20110901

• [Mantle cell lymphoma: management in 2011].

  Revue medicale suisse 20110831

• Structure-activity relationship and molecular mechanisms of ethyl 2-amino-6-(3,5-dimethoxyphenyl)-4-(2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (CXL017) and its analogues.

  Journal of medicinal chemistry 20110825

• Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110820

• Acute myeloid leukaemia: optimal management and recent developments.

  Drugs 20110820

• Comparison of high-dose cytarabine and timed-sequential chemotherapy as consolidation for younger adults with AML in first remission: the ALFA-9802 study.

  Blood 20110818

• A special case of acute leukemia in childhood.

  Journal of medicine and life 20110815

• Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML.

  Blood 20110811

• Association of HSV reactivation and pro-inflammatory cytokine levels with the severity of stomatitis after BEAM chemotherapy and autologous SCT.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110801

• Brain perfusion in adult patients with acute myeloblastic leukemia before and after cytosine arabinoside.

  Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging 20110801

• ESHAP chemotherapy regimen associated to lenalidomide induces complete isotopic remission in Hodgkin's lymphoma relapsing after autologous stem cell transplantation.

  Annals of hematology 20110801

• Increasing age at diagnosis and worsening renal function in patients with primary central nervous system lymphoma.

  Journal of neuro-oncology 20110801

• Primary CNS lymphoma in patients younger than 60: can whole-brain radiotherapy be deferred?

  Journal of neuro-oncology 20110801

• Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110801

• Minimally differentiated acute myeloid leukemia (FAB AML-M0): prognostic factors and treatment effects on survival--a retrospective study of 42 adult cases.

  Leukemia research 20110801

• Siblings presenting with progressive congenital aleukemic leukemia cutis.

  Pediatric blood & cancer 20110801

• High acute myeloid leukemia derived VEGFA levels are associated with a specific vascular morphology in the leukemic bone marrow.

  Cellular oncology (Dordrecht) 20110801

• Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-C.

  Leukemia research 20110801

• Treatment and prophylaxis of hematologic malignancy in the central nervous system.

  Current treatment options in neurology 20110801

• An inexpensive way to treat elderly patients with high-risk MDS or AML.

  Leukemia research 20110801

• Delineation of the molecular mechanisms of nucleoside recognition by cytidine deaminase through virtual screening.

  ChemMedChem 20110801

• A class of Trp-Trp-AA-OBzl: Synthesis, in vitro anti-proliferation/in vivo anti-tumor evaluation, intercalation-mechanism investigation and 3D QSAR analysis.

  European journal of medicinal chemistry 20110801

• Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression.

  Experimental hematology 20110801

• Chemotherapeutic-induced apoptosis: a phenotype for pharmacogenomics studies.

  Pharmacogenetics and genomics 20110801

• Retrospective analysis of risk factors for development of liver dysfunction in transient leukemia of Down syndrome.

  Leukemia & lymphoma 20110801

• Use of cytarabine and idarubicin in a newly diagnosed AML patient with a severe wound.

  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20110801

• Mantle cell lymphoma international prognostic index but not pretransplantation induction regimen predicts survival for patients with mantle-cell lymphoma receiving high-dose therapy and autologous stem-cell transplantation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110801

• Proteasome inhibition in myelodysplastic syndromes and acute myelogenous leukemia cell lines.

  Cancer investigation 20110801

• Therapy-related leukemia cutis with histopathologic changes resembling xanthogranuloma.

  Journal of the American Academy of Dermatology 20110801

• Spontaneous acute erythroblastic leukaemia (AML-M6Er) in a dog.

  The Journal of small animal practice 20110801

• Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making?

  Clinical lymphoma, myeloma & leukemia 20110801

• Patterns of molecular response to and relapse after combination of sorafenib, idarubicin, and cytarabine in patients with FLT3 mutant acute myeloid leukemia.

  Clinical lymphoma, myeloma & leukemia 20110801

• Successful treatment of childhood Philadelphia chromosome-positive acute myeloid leukemia.

  Pediatrics international : official journal of the Japan Pediatric Society 20110801

• Homozygosity for the rs9939609T allele of the FTO gene may have protective effect on becoming overweight in survivors of childhood acute lymphoblastic leukaemia.

  Journal of genetics 20110801

• [Significance of intensified conditioning regimen for allogeneic hematopoietic stem cell transplantation for treatment of acute leukemias].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20110801

• Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.

  PLoS pathogens 20110801

• Improving the outcomes of elderly patients with acute myeloid leukemia in a Brazilian University Hospital.

  Clinics (Sao Paulo, Brazil) 20110801

• Development and evaluation of nanostructured lipid carriers of cytarabine for treatment of meningeal leukemia.

  Journal of nanoscience and nanotechnology 20110801

• Prospective Randomization Trial of G-CSF-Primed Induction Regimen versus Standard Regimen in Patients with AML.

  Chonnam medical journal 20110801

• Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies.

  Clinical epigenetics 20110801

• Persistent sonic hedgehog signaling in adult brain determines neural stem cell positional identity.

  Neuron 20110728

• Long-term complete response after treatment with cytarabine, vincristine, and prednisone in an infant with refractory multisystem Langerhans cell histiocytosis.

  Pediatric blood & cancer 20110715

• What's up with down syndrome and leukemia-A lot!

  Pediatric blood & cancer 20110715

• Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study.

  Pediatric blood & cancer 20110715

• Manufacturing decline yields drug shortages.

  Science (New York, N.Y.) 20110708

• Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868.

  Cancer chemotherapy and pharmacology 20110701

• Liposomal cytarabine for central nervous system embryonal tumors in children and young adults.

  Journal of neuro-oncology 20110701

• Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma.

  Journal of neuro-oncology 20110701

• Neurologic complications of intrathecal liposomal cytarabine administered prophylactically to patients with non-Hodgkin lymphoma.

  Journal of neuro-oncology 20110701

• Safety and efficacy of high-dose ranimustine, cytarabine, etoposide and CY (MCVAC) regimen followed by autologous peripheral blood stem cell transplantation for high-risk diffuse large B-cell lymphoma.

  Bone marrow transplantation 20110701

• A Phase I trial: dose escalation of melphalan in the 'BEAM' regimen using amifostine cytoprotection.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110701

• Fludarabine and cytarabine in patients with acute myeloid leukemia refractory to two different courses of front-line chemotherapy.

  Leukemia research 20110701

• Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens.

  Leukemia 20110701

• The addition of arsenic trioxide to low-dose Ara-C in older patients with AML does not improve outcome.

  Leukemia 20110701

• Backtracking to birth of the NUP98-HOXD13 gene fusion in an infant acute myeloid leukemia.

  Leukemia 20110701

• Clinical experience using intrathecal liposomal cytarabine to manage neoplastic meningitis in three patients with acute promyelocytic leukemia.

  Leukemia research 20110701

• Central nervous system remyelination in culture--a tool for multiple sclerosis research.

  Experimental neurology 20110701

• Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.

  Experimental hematology 20110701

• Amonafide: a potential role in treating acute myeloid leukemia.

  Expert opinion on investigational drugs 20110701

• Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110701

• An evidence-based review of a Lentinula edodes mushroom extract as complementary therapy in the surgical oncology patient.

  JPEN. Journal of parenteral and enteral nutrition 20110701

• An effective salvage treatment using ifosfamide, etoposide, cytarabine, dexamethasone, and rituximab (R-IVAD) for patients with relapsed or refractory aggressive B-cell lymphoma.

  International journal of hematology 20110701

• Targeting cancer with peptide aptamers.

  Oncotarget 20110701

• HPLC-MS/MS method for the determination of cytarabine in human plasma.

  Bioanalysis 20110701

• Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemia.

  Blood cancer journal 20110701

• Efforts underway to curb drug shortages.

  Journal of the National Cancer Institute 20110622

• Acute lymphoblastic leukemia in adults.

  Pediatric reports 20110622

• Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.

  Blood 20110609

• Autografting CLL: the game is over!

  Blood 20110609

• Activity of the multikinase inhibitor sorafenib in combination with cytarabine in acute myeloid leukemia.

  Journal of the National Cancer Institute 20110608

• Cytarabine dose for acute myeloid leukemia.

  The New England journal of medicine 20110602

• Cytarabine dose for acute myeloid leukemia.

  The New England journal of medicine 20110602

• Cytarabine dose for acute myeloid leukemia.

  The New England journal of medicine 20110602

• Antiproliferative activity, mechanism of action and oral antitumor activity of CP-4126, a fatty acid derivative of gemcitabine, in in vitro and in vivo tumor models.

  Investigational new drugs 20110601

• LACE-conditioned autologous stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma: treatment outcome and risk factor analysis from a single centre.

  Hematological oncology 20110601

• A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.

  Cancer chemotherapy and pharmacology 20110601

• Long-term follow-up of tandem high-dose therapy with autologous stem cell support for adults with high-risk age-adjusted international prognostic index aggressive non-Hodgkin Lymphomas: a GOELAMS pilot study.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20110601

• The addition of daunorubicin to imatinib mesylate in combination with cytarabine improves the response rate and the survival of patients with myeloid blast crisis chronic myelogenous leukemia (AFR01 study).

  Leukemia research 20110601

• Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia.

  Journal of cancer research and clinical oncology 20110601

• Simultaneous acute myeloid leukaemia and de novo acute hepatitis B: a novel management strategy.

  Leukemia research 20110601

• The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.

  Leukemia research 20110601

• Identification of potential surrogate end points in randomized clinical trials of aggressive and indolent non-Hodgkin's lymphoma: correlation of complete response, time-to-event and overall survival end points.

  Annals of oncology : official journal of the European Society for Medical Oncology 20110601

• Cellular elements of the subarachnoid space promote ALL survival during chemotherapy.

  Leukemia research 20110601

• Successful treatment of acute promyelocytic leukemia in a patient on hemodialysis.

  Clinical and experimental nephrology 20110601

• Treatment with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate results in poor mobilization of peripheral blood stem cells in patients with mantle cell lymphoma.

  Leukemia & lymphoma 20110601

• Disclosing the mysteries of the central nervous system sanctuary for acute lymphoblastic leukemia cells.

  Leukemia research 20110601

• DNA mismatch repair status affects cellular response to Ara-C and other anti-leukemic nucleoside analogs.

  Leukemia 20110601

• A phase I/II study of imatinib plus reinduction therapy for c-kit-positive relapsed/refractory acute myeloid leukemia: inhibition of Akt activation correlates with complete response.

  Leukemia 20110601

• Administration schedule of daunorubicin for elderly patients with acute myelogenous leukemia: a single-institute experience.

  Japanese journal of clinical oncology 20110601

• Prophylactic treatment for cytosine arabinoside-induced keratoconjunctivitis.

  International ophthalmology 20110601

• Immunogenic apoptosis in human acute myeloid leukemia (AML): primary human AML cells expose calreticulin and release heat shock protein (HSP) 70 and HSP90 during apoptosis.

  Oncology reports 20110601

• A genome-wide RNAi screen identifies novel targets of neratinib sensitivity leading to neratinib and paclitaxel combination drug treatments.

  Molecular bioSystems 20110601

• Strategies to optimize collection of hematopoietic stem cells in patients with mantle cell lymphoma receiving hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone combined with cytarabine and methotrexate (Hyper-CVAD) chemotherapy.

  Leukemia & lymphoma 20110601

• Astrocytes are important mediators of Aβ-induced neurotoxicity and tau phosphorylation in primary culture.

  Cell death & disease 20110601

• [Main treatment and preventive measures for hand-foot syndrome, a dermatologic side effect of cancer therapy].

  Magyar onkologia 20110601

• Use of tyrosine kinase inhibitors for chronic myeloid leukemia: management of patients and practical applications for pharmacy practitioners.

  The Annals of pharmacotherapy 20110601

• Targeting mTOR for the treatment of AML. New agents and new directions.

  Oncotarget 20110601

• Numb chin syndrome in acute lymphoblastic leukemia.

  Indian pediatrics 20110601

• The next step for Burkitt lymphoma.

  The Korean journal of hematology 20110601

• Prognostic significance of the FLT3 ITD mutation in patients with normal-karyotype acute myeloid leukemia in relapse.

  The Korean journal of hematology 20110601

• Treatment outcomes in children with Burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institution.

  The Korean journal of hematology 20110601

• Metabolism and brain cancer.

  Clinics (Sao Paulo, Brazil) 20110601

• Chemotherapeutic treatment for leukemia in a bearded dragon (Pogona vitticeps).

  Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 20110601

• Autologous transplantation gives encouraging results for young adults with favorable-risk acute myeloid leukemia, but is not improved with gemtuzumab ozogamicin.

  Blood 20110519

• Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+ /CD38- cells and sensitizes them to antileukemia agents.

  International journal of cancer 20110515

• Contribution of Abcc10 (Mrp7) to in vivo paclitaxel resistance as assessed in Abcc10(-/-) mice.

  Cancer research 20110515

• Topical treatment of cutaneous vaccinia virus infections in immunosuppressed hairless mice with selected antiviral substances.

  Antiviral chemistry & chemotherapy 20110512

• Sensitive DsRed fluorescence-based reporter cell systems for genotoxicity and oxidative stress assessment.

  Mutation research 20110510

• [Standard CHOP immuno-chemotherapy for primary mediastinal lymphomas].

  Orvosi hetilap 20110508

• Myeloid blastic transformation of myeloproliferative neoplasms--a review of 112 cases.

  Leukemia research 20110501

• Hematopoietic stem cell mobilization with the reversible CXCR4 receptor inhibitor plerixafor (AMD3100)-Polish compassionate use experience.

  Annals of hematology 20110501

• Effect of corticosterone and paroxetine on masculine mating behavior: possible involvement of neurogenesis.

  The journal of sexual medicine 20110501

• Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs.

  Mutagenesis 20110501

• Salvage chemotherapy with low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in patients with refractory or relapsed acute myeloid leukemia with translocation (8;21).

  Leukemia research 20110501

• Aminopeptidase inhibition by the novel agent CHR-2797 (tosedostat) for the therapy of acute myeloid leukemia.

  Leukemia research 20110501

• FLT3-internal tandem duplication and age are the major prognostic factors in patients with relapsed acute myeloid leukemia with normal karyotype.

  Haematologica 20110501

• Escalation of daunorubicin and addition of etoposide in the ADE regimen in acute myeloid leukemia patients aged 60 years and older: Cancer and Leukemia Group B Study 9720.

  Leukemia 20110501

• Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response.

  Haematologica 20110501

• A class of novel N-isoquinoline-3-carbonyl-L-amino acid benzylesters: synthesis, anti-tumor evaluation and 3D QSAR analysis.

  European journal of medicinal chemistry 20110501

• Paraplegia and paraparesis from intrathecal methotrexate and cytarabine contaminated with trace amounts of vincristine in China during 2007.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110501

• Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis.

  International journal of hematology 20110501

• Homoharringtonine as a backbone drug for the treatment of newly diagnosed pediatric acute myeloid leukemia: a report from a single institution in China.

  International journal of hematology 20110501

• Patterns and outcome of relapse after autologous stem cell transplantation for mantle cell lymphoma.

  Cancer 20110501

• Novel liver-specific cholic acid-cytarabine conjugates with potent antitumor activities: Synthesis and biological characterization.

  Acta pharmacologica Sinica 20110501

• The α-lipoic acid derivative sodium zinc dihydrolipoylhistidinate reduces chemotherapy-induced alopecia in a rat model: a pilot study.

  Surgery today 20110501

• Genetic variation in genes involved in folate and drug metabolism in a south Indian population.

  Indian journal of human genetics 20110501

• Utility of myeloperoxidase stain in the differential diagnosis of leukemia cutis vs. hystiocitoid Sweet syndrome.

  Dermatology online journal 20110415

• Cellular pharmacology of multi- and duplex drugs consisting of ethynylcytidine and 5-fluoro-2'-deoxyuridine.

  Investigational new drugs 20110401

• Effective clearance of Ara-U the major metabolite of cytosine arabinoside (Ara-C) by hemodialysis in a patient with lymphoma and end-stage renal failure.

  Cancer chemotherapy and pharmacology 20110401

• Recovery of menstruation after long-term chemotherapy and endocrine therapy in pre-menopausal patients with breast cancer.

  Journal of cancer research and clinical oncology 20110401

• Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndrome.

  Leukemia research 20110401

• Human biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathway.

  European journal of nuclear medicine and molecular imaging 20110401

• Differential G-protein-coupled receptor phosphorylation provides evidence for a signaling bar code.

  The Journal of biological chemistry 20110401

• Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation.

  British journal of pharmacology 20110401

• Mad2 haploinsufficiency protects hematopoietic progenitor cells subjected to cell-cycle stress in vivo and to inhibition of redox function of Ape1/Ref-1 in vitro.

  Experimental hematology 20110401

• [Plasmacytoid dendritic cell tumor].

  Actas dermo-sifiliograficas 20110401

• Five Chinese pediatric patients with leukemias possibly arising from immature natural killer cells: clinical features and courses.

  Pediatric hematology and oncology 20110401

• Flt3-ITD alters chemotherapy response in vitro and in vivo in a p53-dependent manner.

  Experimental hematology 20110401

• Characterization of cytarabine-resistant leukemic cell lines established from five different blood cell lineages using gene expression and proteomic analyses.

  International journal of oncology 20110401

• Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.

  Pediatric blood & cancer 20110401

• Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country.

  Pediatric blood & cancer 20110401

• Analysis of efficacy and cost-effectiveness of high-dose arabinoside versus daunorubicin chemotherapy in older adult patients with acute myeloid leukemia by cytogenetic risk profile: retrospective review from China.

  International journal of hematology 20110401

• [Malignant lymphoma: individualized treatment according to biological and clinical risk factors].

  Deutsche medizinische Wochenschrift (1946) 20110401

• Antitumor activity and drug interactions of proteasome inhibitor Bortezomib in human high-risk myelodysplastic syndrome cells.

  International journal of hematology 20110401

• Factors influencing the response to high dose methotrexate-based vincristine and procarbazine combination chemotherapy for primary central nervous system lymphoma.

  Journal of Korean medical science 20110401

• BAG3: a multifaceted protein that regulates major cell pathways.

  Cell death & disease 20110401

• Erythroleukemia relapsing as precursor B-cell lymphoblastic leukemia.

  The Korean journal of laboratory medicine 20110401

• A rare case of microgranular acute promyelocytic leukemia associated with ider(17)(q10)t(15;17) in an old-age patient.

  The Korean journal of laboratory medicine 20110401

• Three-way translocation of MLL/MLLT3, t(1;9;11)(p34.2;p22;q23), in a pediatric case of acute myeloid leukemia.

  The Korean journal of laboratory medicine 20110401

• A point-of-care clinical trial comparing insulin administered using a sliding scale versus a weight-based regimen.

  Clinical trials (London, England) 20110401

• [Neoplastic meningitis].

  Gan to kagaku ryoho. Cancer & chemotherapy 20110401

• KCa2 channels activation prevents [Ca2+]i deregulation and reduces neuronal death following glutamate toxicity and cerebral ischemia.

  Cell death & disease 20110401

• Pharmacological manipulation of the cell cycle and metabolism to protect normal tissues against conventional anticancer drugs.

  Oncotarget 20110401

• Variability in transport and biotransformation of cytarabine is associated with its toxicity in peripheral blood mononuclear cells.

  Pharmacogenomics 20110401

• Induction of ER stress in response to oxygen-glucose deprivation of cortical cultures involves the activation of the PERK and IRE-1 pathways and of caspase-12.

  Cell death & disease 20110401

• Antileukemic activity of the leaf extract of Bischofia javanica blume on human leukemic cell lines.

  Indian journal of pharmacology 20110401

• (90)Y ibritumomab tiuxetan (Zevalin) combined with BEAM (Z -BEAM) conditioning regimen plus autologous stem cell transplantation in relapsed or refractory low-grade CD20-positive B-cell lymphoma. A GELA phase II prospective study.

  Clinical lymphoma, myeloma & leukemia 20110401

• Granulocytic sarcoma of palate. Case report and review of literature.

  The New York state dental journal 20110401

• Beau's lines.

  The Journal of the Association of Physicians of India 20110401

• Atypical teratoid/rhabdoid tumors in adults: a case report and treatment-focused review.

  Journal of clinical medicine research 20110401

• Re-assembled botulinum neurotoxin inhibits CNS functions without systemic toxicity.

  Toxins 20110401

• The use of convection-enhanced delivery with liposomal toxins in neurooncology.

  Toxins 20110401

• Case of relapsed AIDS-related plasmablastic lymphoma treated with autologous stem cell transplantation and highly active antiretroviral therapy.

  Rare tumors 20110330

• Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias.

  Blood 20110324

• Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.

  Blood 20110324

• Cytarabine dose for acute myeloid leukemia.

  The New England journal of medicine 20110317

• A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndrome.

  Cancer 20110315

• Synthesis of n-squalenoyl cytarabine and evaluation of its affinity with phospholipid bilayers and monolayers.

  International journal of pharmaceutics 20110315

• First-in-man study of CPX-351: a liposomal carrier containing cytarabine and daunorubicin in a fixed 5:1 molar ratio for the treatment of relapsed and refractory acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110310

• Blood consult: acute myeloid leukemia and the t(8;21)(q22;22).

  Blood 20110310

• Interpretation of analysis of variance models using principal component analysis to assess the effect of a maternal anticancer treatment on the mineralization of rat bones.

  Analytica chimica acta 20110309

• An evaluation of the factors that affect the health-related quality of life of children following myelosuppressive chemotherapy.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20110301

• Brucellosis: a rare cause of febrile neutropenia in acute myeloblastic leukemia.

  Medical oncology (Northwood, London, England) 20110301

• Risks to health professionals from hazardous drugs in Japan: a pilot study of environmental and biological monitoring of occupational exposure to cyclophosphamide.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20110301

• Spinal cord compression by epidural involvement over 21 vertebral levels in acute lymphoblastic leukemia.

  Journal of pediatric hematology/oncology 20110301

• Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population.

  Annals of hematology 20110301

• High dose cytarabine plus gemtuzumab ozogamicin for patients with relapsed or refractory acute myeloid leukemia: Cancer and Leukemia Group B study 19902.

  Leukemia research 20110301

• Race and intensity of post-remission therapy in acute myeloid leukemia.

  Leukemia research 20110301

• Bafilomycin A1 activates respiration of neuronal cells via uncoupling associated with flickering depolarization of mitochondria.

  Cellular and molecular life sciences : CMLS 20110301

• A pediatric B lineage leukemia with coincident MYC and MLL translocations.

  Journal of pediatric hematology/oncology 20110301

• Early assessment of treatment response in patients with AML using [(18)F]FLT PET imaging.

  Leukemia research 20110301

• Clinical outcome of autologous peripheral blood stem cell transplantation in opticospinal and conventional forms of secondary progressive multiple sclerosis in a Chinese population.

  Annals of hematology 20110301

• Dorsolateral midbrain MRI abnormalities and ocular motor deficits following cytarabine-based chemotherapy for acute myelogenous leukemia.

  Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20110301

• Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine: results of a retrospective comparative study.

  Cancer 20110301

• Convection and retro-convection enhanced delivery: some theoretical considerations related to drug targeting.

  Pharmaceutical research 20110301

• Salvaging AML with CLAG: novel option, or more of the same?

  Leukemia research 20110301

• Salvage chemotherapy regimens for acute myeloid leukemia: Is one better? Efficacy comparison between CLAG and MEC regimens.

  Leukemia research 20110301

• APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.

  European journal of haematology 20110301

• The role of standard-dose cytarabine in children with acute promyelocytic leukemia: a single-center experience.

  Journal of pediatric hematology/oncology 20110301

• Methotrexate- and/or cytarabine-based chemotherapy may be effective and safe in solid-organ transplant recipients with primary central nervous system lymphomas.

  Leukemia & lymphoma 20110301

• The topoisomerase II inhibitor voreloxin causes cell cycle arrest and apoptosis in myeloid leukemia cells and acts in synergy with cytarabine.

  Haematologica 20110301

• Nucleoside analogs induce proteasomal down-regulation of p21 in chronic lymphocytic leukemia cell lines.

  Biochemical pharmacology 20110301

• Acquired protein C deficiency in a child with acute myelogenous leukemia, splenic, renal, and intestinal infarction.

  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110301

• Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.

  The AAPS journal 20110301

• Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells.

  European journal of haematology 20110301

• Prolonged succinylcholine action during electroconvulsive therapy (ECT) after cytarabine, vincristine, and rituximab chemotherapy.

  The journal of ECT 20110301

• The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine.

  Leukemia 20110301

• Ancestry and pharmacogenomics of relapse in acute lymphoblastic leukemia.

  Nature genetics 20110301

• Reactive tonsillar enlargement with strong 18F-FDG uptake after chemotherapy for tonsillar diffuse large B-cell lymphoma.

  Journal of pediatric hematology/oncology 20110301

• Successful management with clofarabine for refractory leukaemia in a young adult with chronic renal failure.

  American journal of hematology 20110301

• Insulin infusion to treat severe hypertriglyceridemia associated with pegaspargase therapy: a case report.

  Journal of pediatric hematology/oncology 20110301

• Clinical relevance of the dose of cytarabine in the upfront treatment of primary CNS lymphomas with methotrexate-cytarabine combination.

  The oncologist 20110301

• Multifaceted chemotherapy for trilateral retinoblastoma.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20110301

• Diffuse infiltrating retinoblastoma with central nervous system metastasis.

  Archives of ophthalmology (Chicago, Ill. : 1960) 20110301

• Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health.

  Oncotarget 20110301

• Identification of predictive markers of cytarabine response in AML by integrative analysis of gene-expression profiles with multiple phenotypes.

  Pharmacogenomics 20110301

• Treatment outcome of all-trans retinoic acid/anthracycline combination chemotherapy and the prognostic impact of FLT3/ITD mutation in acute promyelocytic leukemia patients.

  The Korean journal of hematology 20110301

• Promyelocytic sarcoma of the sternum: a case report and review of the literature.

  The Korean journal of hematology 20110301

• [EBV-associated B-cell lymphoproliferative disorder of the elderly successfully treated with autologous peripheral blood stem cell transplantation and locoregional radiotherapy].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20110301

• [The efficacy and safety of valproic acid in combination with low dose chemotherapy on intermediate and high-risk myelodysplastic syndrome].

  Zhonghua nei ke za zhi 20110301

• A network meta-analysis of randomized controlled trials of induction treatments in acute myeloid leukemia in the elderly.

  Clinical therapeutics 20110301

• Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia.

  Korean journal of pediatrics 20110301

• The treatment of pediatric chronic myelogenous leukemia in the imatinib era.

  Korean journal of pediatrics 20110301

• Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature.

  Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20110301

• Rapid Disruption of Cellular Integrity of Zinc-treated Astroglia Is Regulated by p38 MAPK and Ca-dependent Mechanisms.

  Experimental neurobiology 20110301

• Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 Study.

  Blood 20110224

• A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 Study.

  Blood 20110224

• Too much ara-C? Not enough daunorubicin?

  Blood 20110224

• Modern approaches to treating acute promyelocytic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110210

• BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicity.

  Leukemia research 20110201

• Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma.

  Haematologica 20110201

• Identification of patients with acute myeloblastic leukemia who benefit from the addition of gemtuzumab ozogamicin: results of the MRC AML15 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110201

• Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.

  The oncologist 20110201

• Maculopathy associated with tacrolimus (FK 506).

  Korean journal of ophthalmology : KJO 20110201

• Targeting translation dependence in cancer.

  Oncotarget 20110201

• Large vessel (Takayasu's) arteritis in a patient with myelodysplastic syndrome: is there a common pathogenesis?

  Clinical lymphoma, myeloma & leukemia 20110201

• Azacitidine. Poor-prognosis myelodysplasia: promising, but more data needed.

  Prescrire international 20110201

• Neonatal rat microglia derived from different brain regions have distinct activation responses.

  Neuron glia biology 20110201

• Infusion of HLA-mismatched peripheral blood stem cells improves the outcome of chemotherapy for acute myeloid leukemia in elderly patients.

  Blood 20110120

• Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML.

  Blood 20110120

• Response-guided induction therapy in pediatric acute myeloid leukemia with excellent remission rate.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20110120

• Images in clinical medicine. Palmar-plantar rash with cytarabine therapy.

  The New England journal of medicine 20110120

• Single agent and combination studies of pralatrexate and molecular correlates of sensitivity.

  British journal of cancer 20110118

• Synthesis of 3'-azido-3'-deoxythymidine (AZT)--Cinchona alkaloid conjugates via click chemistry: Toward novel fluorescent markers and cytostatic agents.

  Bioorganic & medicinal chemistry letters 20110115

• Early lymphocyte recovery after intensive timed sequential chemotherapy for acute myelogenous leukemia: peripheral oligoclonal expansion of regulatory T cells.

  Blood 20110113

• BCR-ABL mutation testing to predict response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia.

  PLoS currents 20110111

• The role of FKBP5 in cancer aetiology and chemoresistance.

  British journal of cancer 20110104

• Effectiveness of Traditional Chinese Medicine for Liver Protection and Chemotherapy Completion among Cancer Patients.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Phase I study of preoperative short-course chemoradiation with proton beam therapy and capecitabine for resectable pancreatic ductal adenocarcinoma of the head.

  International journal of radiation oncology, biology, physics 20110101

• Intracranial hypertension following intrathecal administration of liposomal cytarabine.

  Journal of neurology 20110101

• Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative study.

  British journal of haematology 20110101

• Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model.

  Reproductive sciences (Thousand Oaks, Calif.) 20110101

• A novel N-hydroxy-N'-aminoguanidine derivative inhibits ribonucleotide reductase activity: Effects in human HL-60 promyelocytic leukemia cells and synergism with arabinofuranosylcytosine (Ara-C).

  Biochemical pharmacology 20110101

• Targeting Toll-like receptor 7/8 enhances uptake of apoptotic leukemic cells by monocyte-derived dendritic cells but interferes with subsequent cytokine-induced maturation.

  Cancer immunology, immunotherapy : CII 20110101

• Cytogenetic instability in childhood acute lymphoblastic leukemia survivors.

  Journal of biomedicine & biotechnology 20110101

• XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AML.

  Apoptosis : an international journal on programmed cell death 20110101

• The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients.

  Advances in hematology 20110101

• Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis.

  Journal of oncology 20110101

• Cyclophosphamide monotherapy in children with Burkitt lymphoma: a study from the French-African Pediatric Oncology Group (GFAOP).

  Pediatric blood & cancer 20110101

• Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis.

  American journal of hematology 20110101

• Rituximab in combination with CODOX-M/IVAC: a retrospective analysis of 23 cases of non-HIV related B-cell non-Hodgkin lymphoma with proliferation index >95%.

  British journal of haematology 20110101

• Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: results from an Australian population.

  Leukemia & lymphoma 20110101

• Stochastic acquisition of a stem cell-like state and drug tolerance in leukemia cells stressed by radiation.

  International journal of hematology 20110101

• Novel and emerging drugs for acute myeloid leukemia: pharmacology and therapeutic activity.

  Current medicinal chemistry 20110101

• Recurrent neurotropic chloroma: report of a case and review of the literature.

  Advances in hematology 20110101

• Cellular senescence as a target in cancer control.

  Journal of aging research 20110101

• Acute promyelocytic leukemia presenting with central nervous system involvement: a report of 2 cases.

  The Korean journal of laboratory medicine 20110101

• Blood-brain barrier integrity and breast cancer metastasis to the brain.

  Pathology research international 20110101

• In vitro assessment of developmental neurotoxicity: use of microelectrode arrays to measure functional changes in neuronal network ontogeny.

  Frontiers in neuroengineering 20110101

• Functional role of the polymorphic 647 T/C variant of ENT1 (SLC29A1) and its association with alcohol withdrawal seizures.

  PloS one 20110101

• Regional differentiation of retinoic acid-induced human pluripotent embryonic carcinoma stem cell neurons.

  PloS one 20110101

• Squamocin modulates histone H3 phosphorylation levels and induces G1 phase arrest and apoptosis in cancer cells.

  BMC cancer 20110101

• The role of HDACs inhibitors in childhood and adolescence acute leukemias.

  Journal of biomedicine & biotechnology 20110101

• Therapy-related myelodysplastic syndrome/acute myeloid leukemia with del(7)(q22) in a patient with de novo AML.

  Annals of clinical and laboratory science 20110101

• Modulation of Ca²⁺ signals by epigallocatechin-3-gallate(EGCG) in cultured rat hippocampal neurons.

  International journal of molecular sciences 20110101

• Ginkgo biloba extract (EGb761) inhibits mitochondria-dependent caspase pathway and prevents apoptosis in hypoxia-reoxygenated cardiomyocytes.

  Chinese medicine 20110101

• Inhibin B and anti-Müllerian hormone as markers of gonadal function after hematopoietic cell transplantation during childhood.

  BMC pediatrics 20110101

• Androgen-induced cell migration: role of androgen receptor/filamin A association.

  PloS one 20110101

• Inhibition of histone deacetylases 1 and 6 enhances cytarabine-induced apoptosis in pediatric acute myeloid leukemia cells.

  PloS one 20110101

• [Acute myelogenous leukemia developed at the 26th week of gestation].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20110101

• Regulation of retinoid receptors by retinoic acid and axonal contact in Schwann cells.

  PloS one 20110101

• Allogeneic hematopoietic stem cell transplantation for acute leukemia with Gilbert's syndrome.

  Journal of hematology & oncology 20110101

• Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture.

  PloS one 20110101

• IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells.

  PloS one 20110101

• Characterization of a newly identified ETV6-NTRK3 fusion transcript in acute myeloid leukemia.

  Diagnostic pathology 20110101

• [The efficacy and safety of HAA regimen as induction chemotherapy in 150 newly diagnosed acute myeloid leukemia].

  Zhonghua nei ke za zhi 20110101

• Assessment of the consistency and robustness of results from a multicenter trial of remission maintenance therapy for acute myeloid leukemia.

  Trials 20110101

• [FLAG regimen in the treatment of refractory and relapsed acute myeloid leukemia].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20110101

• Serum after autologous transplantation stimulates proliferation and expansion of human hematopoietic progenitor cells.

  PloS one 20110101

• Therapeutics formulated to target cancer stem cells: Is it in our future?

  Cancer cell international 20110101

• Influence of anticancer therapy on oxidation phenotype and acetylation phenotype in patients with acute myeloblastic leukemia.

  Pharmacological reports : PR 20110101

• Proteomic identification of protein targets for 15-deoxy-Δ(12,14)-prostaglandin J2 in neuronal plasma membrane.

  PloS one 20110101

• Enhanced brain targeting of temozolomide in polysorbate-80 coated polybutylcyanoacrylate nanoparticles.

  International journal of nanomedicine 20110101

• Exenatide improves glucocorticoid-induced glucose intolerance in mice.

  Diabetes, metabolic syndrome and obesity : targets and therapy 20110101

• A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project.

  BMC public health 20110101

• Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications.

  Journal of hematology & oncology 20110101

• A patient with splenic marginal zone lymphoma presenting with spastic paraplegia as the initial symptom.

  Case reports in neurology 20110101

• Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome.

  Case reports in oncology 20110101

• An effective personalized approach to a rare tumor: prolonged survival in metastatic pancreatic acinar cell carcinoma based on genetic analysis and cell line development.

  Journal of Cancer 20110101

• Risk of infection in patients with lymphoma receiving rituximab: systematic review and meta-analysis.

  BMC medicine 20110101

• A review on composite liposomal technologies for specialized drug delivery.

  Journal of drug delivery 20110101

• Apoptotic sphingolipid ceramide in cancer therapy.

  Journal of lipids 20110101

• Promising cytotoxic activity profile of fermented wheat germ extract (Avemar®) in human cancer cell lines.

  Journal of experimental & clinical cancer research : CR 20110101

• Review of the management of relapsed small-cell lung cancer with amrubicin hydrochloride.

  Clinical Medicine Insights. Oncology 20110101

• Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib.

  Case reports in oncology 20110101

• Delayed but Complete Response following Oral Temozolomide Treatment in Melanoma Leptomeningeal Carcinomatosis.

  Case reports in oncology 20110101

• Acute myeloid leukemia: leukemia stem cells write a prognostic signature.

  Stem cell research & therapy 20110101

• Pretreatment serum level of 15-kDa granulysin might have a prognostic value in patients with diffuse large B cell lymphoma.

  Acta haematologica 20110101

• Treatment of Akata EBV-positive cells with doxorubicin causes more EBV reactivation than treatment with etoposide.

  Chemotherapy 20110101

• X-Linked Lymphoproliferative Syndrome and Common Variable Immunodeficiency May Not Be Differentiated by SH2D1A and XIAP/BIRC4 Genes Sequence Analysis.

  Case reports in medicine 20110101

• Kaposi's Sarcoma-Associated Herpesvirus-Related Solid Lymphoma Involving the Heart and Brain.

  AIDS research and treatment 20110101

• Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

  PloS one 20110101

• Lights and shadows of cyclophosphamide in the treatment of multiple sclerosis.

  Autoimmune diseases 20110101

• Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia.

  Cancer management and research 20110101

• Detecting differential allelic expression using high-resolution melting curve analysis: application to the breast cancer susceptibility gene CHEK2.

  BMC medical genomics 20110101

• Orbital sporadic Burkitt lymphoma in an adult diabetic African American female and a review of adult orbital cases.

  Clinical ophthalmology (Auckland, N.Z.) 20110101

• Effect of melatonin on the cytotoxicity of chemotherapeutic drugs in human leukemia cells.

  In vivo (Athens, Greece) 20110101

• Red fluorescent protein-aequorin fusions as improved bioluminescent Ca2+ reporters in single cells and mice.

  PloS one 20110101

• Zac1 plays a key role in the development of specific neuronal subsets in the mouse cerebellum.

  Neural development 20110101

• Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34+ acute myeloid leukemia cell lines and primary sorted CD34+ acute myeloid leukemia cells.

  Journal of translational medicine 20110101

• [(99m)Tc-MIBI SPECT in the study of brain lymphoma].

  Revista espanola de medicina nuclear 20110101

• Copy number polymorphisms and anticancer pharmacogenomics.

  Genome biology 20110101

• Disruption of learning processes by chemotherapeutic agents in childhood survivors of acute lymphoblastic leukemia and preclinical models.

  Journal of Cancer 20110101

• Interleukin-11-induced capillary leak syndrome in primary hepatic carcinoma patients with thrombocytopenia.

  BMC cancer 20110101

• Lack of a-disintegrin-and-metalloproteinase ADAM10 leads to intracellular accumulation and loss of shedding of the cellular prion protein in vivo.

  Molecular neurodegeneration 20110101

• Autosomal dominant cerebellar ataxia type I: a review of the phenotypic and genotypic characteristics.

  Orphanet journal of rare diseases 20110101

• 5-azacytidine in chronic myelomonocytic leukemia: case report and review of literature.

  Mediterranean journal of hematology and infectious diseases 20110101

• Interpreting clinical assays for histone deacetylase inhibitors.

  Cancer management and research 20110101

• Development of oral immunomodulatory agents in the management of multiple sclerosis.

  Drug design, development and therapy 20110101

• A highly therapy-resistant case of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma showing strong BCL2 staining, otherwise indistinguishable from Burkitt lymphoma.

  Journal of clinical and experimental hematopathology : JCEH 20110101

• Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.

  Journal of biomedicine & biotechnology 20110101

• Granulocytic sarcoma in a nonleukemic patient: place of radiotherapy and systemic therapies.

  Case reports in medicine 20110101

• Review of cardiotoxicity in pediatric cancer patients: during and after therapy.

  Cardiology research and practice 20110101

• Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence.

  Retrovirology 20110101

• Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma.

  Core evidence 20110101

• P-glycoprotein and breast cancer resistance protein in acute myeloid leukaemia cells treated with the aurora-B kinase inhibitor barasertib-hQPA.

  BMC cancer 20110101

• The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future.

  Advances in hematology 20110101

• Protein kinase D1 (PKD1) activation mediates a compensatory protective response during early stages of oxidative stress-induced neuronal degeneration.

  Molecular neurodegeneration 20110101

• Isolated central nervous system relapse of systemic lymphoma (SCNSL): clinical features and outcome of a retrospective analysis.

  German medical science : GMS e-journal 20110101

• Blastic plasmacytoid dendritic cell neoplasm expressing the CD13 myeloid antigen.

  Acta haematologica 20110101

• Bacterial infection profiles in lung cancer patients with febrile neutropenia.

  BMC infectious diseases 20110101

• Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients.

  European journal of medical research 20110101

• Securinine, a myeloid differentiation agent with therapeutic potential for AML.

  PloS one 20110101

• Transformation of human mesenchymal cells and skin fibroblasts into hematopoietic cells.

  PloS one 20110101

• Atypical Burkitt's lymphoma transforming from follicular lymphoma.

  Diagnostic pathology 20110101

• Mitochondrial pathway mediates the antileukemic effects of Hemidesmus indicus, a promising botanical drug.

  PloS one 20110101

• Genome-wide local ancestry approach identifies genes and variants associated with chemotherapeutic susceptibility in African Americans.

  PloS one 20110101

• Radiotherapy may improve overall survival of patients with T3/T4 transitional cell carcinoma of the renal pelvis or ureter and delay bladder tumour relapse.

  BMC cancer 20110101

• Seed Oil of Brucea javanica Induces Apoptotic Death of Acute Myeloid Leukemia Cells via Both the Death Receptors and the Mitochondrial-Related Pathways.

  Evidence-based complementary and alternative medicine : eCAM 20110101

• Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma.

  Journal of experimental & clinical cancer research : CR 20110101

• Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.

  Journal of biomedicine & biotechnology 20110101

• Can user testing of a clinical trial patient information sheet make it fit-for-purpose?--a randomized controlled trial.

  BMC medicine 20110101

• The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine.

  OncoTargets and therapy 20110101

• Moving on up: Second-Line Agents as Initial Treatment for Newly-Diagnosed Patients with Chronic Phase CML.

  Clinical Medicine Insights. Oncology 20110101

• A possible role for integrin signaling in diffuse axonal injury.

  PloS one 20110101

• Multidisciplinary care in pediatric oncology.

  Journal of multidisciplinary healthcare 20110101

• Hyperbaric oxygen-A new horizon in treating cyclophosphamide-induced hemorrhagic cystitis.

  Indian journal of urology : IJU : journal of the Urological Society of India 20110101

• 17β-Estradiol enhances breast cancer cell motility and invasion via extra-nuclear activation of actin-binding protein ezrin.

  PloS one 20110101

• Holoclone forming cells from pancreatic cancer cells enrich tumor initiating cells and represent a novel model for study of cancer stem cells.

  PloS one 20110101

• Lymphopenia is an important prognostic factor in peripheral T-cell lymphoma (NOS) treated with anthracycline-containing chemotherapy.

  Journal of hematology & oncology 20110101

• A rapidly progressing Pancoast syndrome due to pulmonary mucormycosis: a case report.

  Journal of medical case reports 20110101

• Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons.

  International archives of medicine 20110101

• Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.

  PloS one 20110101

• Mechanisms of resistance to decitabine in the myelodysplastic syndrome.

  PloS one 20110101

• Transient myeloproliferative disorder in a newborn with down syndrome treated with rasburicase for the risk of development of tumor lysis syndrome: A case report.

  Journal of medical case reports 20110101

• Advances in the treatment of chronic myeloid leukemia.

  BMC medicine 20110101

• GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.

  Frontiers in molecular neuroscience 20110101

• Icaritin shows potent anti-leukemia activity on chronic myeloid leukemia in vitro and in vivo by regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT signalings.

  PloS one 20110101

• Fermented wheat germ extract--nutritional supplement or anticancer drug?

  Nutrition journal 20110101

• Treatment of relapsed undifferentiated acute myeloid leukemia (AML-M0) with Ayurvedic therapy.

  International journal of Ayurveda research 20110101

• Challenges in implementing individualized medicine illustrated by antimetabolite therapy of childhood acute lymphoblastic leukemia.

  Clinical proteomics 20110101

• A candidate HIV/AIDS vaccine (MVA-B) lacking vaccinia virus gene C6L enhances memory HIV-1-specific T-cell responses.

  PloS one 20110101

• Acute promyelocytic leukemia: an experience from a tertiary care centre in north India.

  Indian journal of cancer 20110101

• Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan.

  BMC infectious diseases 20110101

• Carcinomatous meningitis: the natural history of successfully treated metastatic bladder cancer.

  Case reports in oncology 20110101

• In vitro assessment of tobacco smoke toxicity at the BBB: do antioxidant supplements have a protective role?

  BMC neuroscience 20110101

• Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis.

  BMC cancer 20110101

• Systematic in-vitro evaluation of the NCI/NIH Developmental Therapeutics Program Approved Oncology Drug Set for the identification of a candidate drug repertoire for MLL-rearranged leukemia.

  OncoTargets and therapy 20110101

• Acute myeloid leukemia of donor origin after allogeneic stem cell transplantation from a sibling who harbors germline XPD and XRCC3 homozygous polymorphisms.

  Journal of hematology & oncology 20110101

• Controlled adhesion and growth of long term glial and neuronal cultures on Parylene-C.

  PloS one 20110101

• A very rapid visual recovery of posterior reversible encephalopathy syndrome.

  Journal of clinical imaging science 20110101

• Improved retroviral suicide gene transfer in colon cancer cell lines after cell synchronization with methotrexate.

  Journal of experimental & clinical cancer research : CR 20110101

• Hypersensitivity reactions to anticancer agents: data mining of the public version of the FDA adverse event reporting system, AERS.

  Journal of experimental & clinical cancer research : CR 20110101

• Long circulating PEGylated PLGA nanoparticles of cytarabine for targeting leukemia.

  Journal of microencapsulation 20110101

• Combination treatment of flag with non-pegylated liposomal doxorubicin (MYOCET(TM)) in elderly patients with acute myeloid leukemia: a single center experience.

  International journal of immunopathology and pharmacology 20110101

• Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway.

  PloS one 20110101

• Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cells.

  PloS one 20110101

• Excitotoxicity triggered by Neurobasal culture medium.

  PloS one 20110101

• GSTP1 DNA methylation and expression status is indicative of 5-aza-2'-deoxycytidine efficacy in human prostate cancer cells.

  PloS one 20110101

• Inhibitory effect of a tyrosine-fructose Maillard reaction product, 2,4-bis(p-hydroxyphenyl)-2-butenal on amyloid-β generation and inflammatory reactions via inhibition of NF-κB and STAT3 activation in cultured astrocytes and microglial BV-2 cells.

  Journal of neuroinflammation 20110101

• Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.

  Molecular cancer 20110101

• Drug sensitivity patterns of HHV8 carrying body cavity lymphoma cell lines.

  BMC cancer 20110101

• Hyperforin inhibits Akt1 kinase activity and promotes caspase-mediated apoptosis involving Bad and Noxa activation in human myeloid tumor cells.

  PloS one 20110101

• Cautionary notes on the use of NF-κB p65 and p50 antibodies for CNS studies.

  Journal of neuroinflammation 20110101

• Safety Evaluation of EXPAREL (DepoFoam Bupivacaine) Administered by Repeated Subcutaneous Injection in Rabbits and Dogs: Species Comparison.

  Journal of drug delivery 20110101

• DIP/WISH deficiency enhances synaptic function and performance in the Barnes maze.

  Molecular brain 20110101

• Response to intrathecal infusions of Depocyt® in secondary diffuse leptomeningeal gliomatosis. A case report.

  In vivo (Athens, Greece) 20110101

• Cyto-morphological features of extramedullary acute megakaryoblastic leukemia on fine needle aspiration and cerebrospinal fluid cytology: A case report.

  CytoJournal 20110101

• Long survival of primary diffuse leptomeningeal gliomatosis following radiotherapy and temozolomide: case report and literature review.

  European journal of medical research 20110101

• Bone marrow mesenchymal stem cells for improving hematopoietic function: an in vitro and in vivo model. Part 2: Effect on bone marrow microenvironment.

  PloS one 20110101

• Disseminated fusariosis and endogenous fungal endophthalmitis in acute lymphoblastic leukemia following platelet transfusion possibly due to transfusion-related immunomodulation.

  BMC ophthalmology 20110101

• Parallel screening of FDA-approved antineoplastic drugs for identifying sensitizers of TRAIL-induced apoptosis in cancer cells.

  BMC cancer 20110101

• Haploidentical hematopoietic stem-cell transplantation in adults.

  Bone marrow research 20110101

• Clinicoradiological changes of brain NK/T cell lymphoma manifesting pure akinesia: a case report.

  BMC neurology 20110101

• HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.

  BMC genomics 20110101

• Miliaria-rash after neutropenic fever and induction chemotherapy for acute myelogenous leukemia.

  Anais brasileiros de dermatologia 20110101

• [Case of peritubular capillary dominant intravascular large B-cell lymphoma (PTC dominant IVLBCL) successfully treated with chemotherapy].

  Nihon Jinzo Gakkai shi 20110101

• De novo acute megakaryoblastic leukemia with p210 BCR/ABL and t(1;16) translocation but not t(9;22) Ph chromosome.

  Journal of hematology & oncology 20110101

• Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma.

  Therapeutics and clinical risk management 20110101

• A meta-analysis of CAG (cytarabine, aclarubicin, G-CSF) regimen for the treatment of 1029 patients with acute myeloid leukemia and myelodysplastic syndrome.

  Journal of hematology & oncology 20110101

• Treatment of Acute Promyelocytic Leukemia with AIDA Based Regimen. Update of a Tunisian Single Center Study.

  Mediterranean journal of hematology and infectious diseases 20110101

• Treatment of acute promyelocytic leukemia with high white cell blood counts.

  Mediterranean journal of hematology and infectious diseases 20110101

• Cauda Equina Enhancing Lesion in an HIV-Infected Patient. Case Report and Literature Review.

  Mediterranean journal of hematology and infectious diseases 20110101

• Relapse of Acute Myeloid Leukemia with t(16;21)(p11;q22) Mimicking Autoimmune Pancreatitis after Second Allogeneic Bone Marrow Transplantation.

  ISRN hematology 20110101

• Astrocyte-secreted factors modulate a gradient of primary dendritic arbors in nucleus laminaris of the avian auditory brainstem.

  PloS one 20110101

• Treatment outcome of adult Burkitt Lymphoma in Japanese patients with modified LMB protocol : a single center retrospective analysis.

  Journal of clinical and experimental hematopathology : JCEH 20110101

• Myeloid sarcoma in a one-month-old infant.

  Case reports in dermatology 20110101

• A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.

  PloS one 20110101

• Epidemiology and treatment of acute promyelocytic leukemia in latin america.

  Mediterranean journal of hematology and infectious diseases 20110101

• Mediastinal choriocarcinoma masquerading as relapsed hodgkin lymphoma.

  Case reports in oncology 20110101

• Scrotal ulceration following all-trans retinoic Acid therapy for acute promyelocytic leukemia.

  Indian journal of dermatology 20110101

• Intravascular lymphoma mimicking cerebral stroke: report of two cases.

  Case reports in neurology 20110101

• Reduced tumor lysis syndrome with low dose chemotherapy for hyperleukocytic acute leukemia prior to induction therapy.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• Mechanisms of neurotoxicity induced in the developing brain of mice and rats by DNA-damaging chemicals.

  The Journal of toxicological sciences 20110101

• Recently confirmed apoptosis-inducing lead compounds isolated from marine sponge of potential relevance in cancer treatment.

  Marine drugs 20110101

• Factors Affecting EWS-FLI1 Activity in Ewing's Sarcoma.

  Sarcoma 20110101

• Clonal hypereosinophilic syndrome: two cases report in black men from sub-saharan Africa and literature reviews.

  ISRN hematology 20110101

• Increased expression of PS1 is sufficient to elevate the level and activity of γ-secretase in vivo.

  PloS one 20110101

• Novel approaches to the treatment of acute myeloid leukemia.

  Hematology. American Society of Hematology. Education Program 20110101

• A rare case of papillary carcinoma of choroids plexus: Its management and review of literature.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101

• Imatinib mesylate: past successes and future challenges in the treatment of gastrointestinal stromal tumors.

  Clinical Medicine Insights. Oncology 20110101

• Oncolytic activities of host defense peptides.

  International journal of molecular sciences 20110101

• Isolated mediastinal myeloid sarcoma successfully treated with chemoradiotherapy followed by unrelated allogeneic stem cell transplantation.

  Internal medicine (Tokyo, Japan) 20110101

• Therapy-resistant, spontaneously remitting generalized neutrophilic eccrine hidradenitis in a healthy patient decreases the expression of dermcidin in affected eccrine glands.

  Case reports in dermatology 20110101

• Aleukemic leukemia cutis manifesting with disseminated nodular eruptions and a plaque preceding acute monocytic leukemia: a case report.

  Case reports in oncology 20110101

• DNA lesion bypass polymerases and 4'-thio-β-Darabinofuranosylcytosine (T-araC).

  International journal of biochemistry and molecular biology 20110101

• Clinical Application of Mesenchymal Stem Cells in the Treatment and Prevention of Graft-versus-Host Disease.

  Advances in hematology 20110101

• Osteoblastic and vascular endothelial niches, their control on normal hematopoietic stem cells, and their consequences on the development of leukemia.

  Stem cells international 20110101

• Brain metastases from ovarian carcinoma.

  ISRN oncology 20110101

• Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting.

  PloS one 20110101

• Changing patterns in the clinical pathological features of hodgkin lymphoma: a report from debrecen, hungary.

  ISRN hematology 20110101

• Blastic plasmacytoid dendritic cell neoplasm on the scalp.

  Case reports in dermatology 20110101

• Acute promyelocytic leukemia: an experience on 95 greek patients treated in the all-trans-retinoic Acid era.

  Mediterranean journal of hematology and infectious diseases 20110101

• Prognostic Significance of NRAS Gene Mutations in Children with Acute Myelogenous Leukemia.

  Mediterranean journal of hematology and infectious diseases 20110101

• The differentiation syndrome in patients with acute promyelocytic leukemia: experience of the pethema group and review of the literature.

  Mediterranean journal of hematology and infectious diseases 20110101

• Clinical features and treatment outcome of acute promyelocytic leukemia patients treated at cairo national cancer institute in egypt.

  Mediterranean journal of hematology and infectious diseases 20110101

• Newly diagnosed acute promyelocytic leukemia.

  Mediterranean journal of hematology and infectious diseases 20110101

• Therapy-related myeloid neoplasm in non-hodgkin lymphoma survivors.

  Mediterranean journal of hematology and infectious diseases 20110101

• Extramedullary disease in acute promyelocytic leukemia: two-in-one disease.

  Mediterranean journal of hematology and infectious diseases 20110101

• History of acute promyelocytic leukemia: a tale of endless revolution.

  Mediterranean journal of hematology and infectious diseases 20110101

• Managing pregnant women with cancer: personal considerations and a review of the literature.

  Ecancermedicalscience 20110101

• The state of research into children with cancer across Europe: new policies for a new decade.

  Ecancermedicalscience 20110101

• An update on the management of peripheral T-cell lymphoma and emerging treatment options.

  Journal of blood medicine 20110101

• Therapeutic effects of combination of paeoniflorin and albiflorin from Paeonia radix on radiation and chemotherapy-induced myelosuppression in mice and rabbits.

  Asian Pacific journal of cancer prevention : APJCP 20110101

• New agents targeting angiogenesis in glioblastoma.

  Chemotherapy research and practice 20110101

• Optimizing Liposomal Cisplatin Efficacy through Membrane Composition Manipulations.

  Chemotherapy research and practice 20110101

• A retrospective audit of clinicopathological attributes and treatment outcomes of adolescent and young adult non-Hodgkin lymphomas from a tertiary care center.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101

• Ataxia telangiectasia: A report of two cousins and review of literature.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20110101

• Arsenic-induced pancreatitis.

  Case reports in gastrointestinal medicine 20110101

• A comparison between zinc sulfate and chlorhexidine gluconate mouthwashes in the prevention of chemotherapy-induced oral mucositis.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

• Proliferation inhibition, cell cycle arrest and apoptosis induced in HL-60 cells by a natural diterpene ester from Daphne mucronata.

  Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 20110101

• Cell death signaling and anticancer therapy.

  Frontiers in oncology 20110101

• Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia.

  Frontiers in oncology 20110101

• Mitochondrial mode of action of a thymidine-based cisplatin analogue breaks resistance in cancer cells.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20101227

• Characteristics and outcome of patients with acute myeloid leukemia refractory to 1 cycle of high-dose cytarabine-based induction chemotherapy.

  Blood 20101223

• Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.

  The New England journal of medicine 20101223

• BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

  Blood 20101216

• Does microgranular variant morphology of acute promyelocytic leukemia independently predict a less favorable outcome compared with classical M3 APL? A joint study of the North American Intergroup and the PETHEMA Group.

  Blood 20101216

• NOTCH1 mutation in a female with myeloid/NK cell precursor acute leukemia.

  Pediatric blood & cancer 20101215

• Chemoenzymatic syntheses and anti-HIV-1 activity of glucose-nucleoside conjugates as prodrugs.

  Bioconjugate chemistry 20101215

• Phenotypic enhancement of thymidylate synthetase pathway inhibitors following ablation of Neil1 DNA glycosylase/lyase.

  Cell cycle (Georgetown, Tex.) 20101215

• Daily palonosetron is superior to ondansetron in the prevention of delayed chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia.

  Cancer 20101215

• Complete remission and early death after intensive chemotherapy in patients aged 60 years or older with acute myeloid leukaemia: a web-based application for prediction of outcomes.

  Lancet (London, England) 20101211

• Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial.

  Lancet (London, England) 20101211

• Translocator protein (TSPO) ligand-Ara-C (cytarabine) conjugates as a strategy to deliver antineoplastic drugs and to enhance drug clinical potential.

  Molecular pharmaceutics 20101206

• Heritable and non-genetic factors as variables of pharmacologic phenotypes in lymphoblastoid cell lines.

  The pharmacogenomics journal 20101201

• Primary hepatic burkitt lymphoma presenting with acute liver failure.

  Journal of gastrointestinal cancer 20101201

• A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia.

  Leukemia research 20101201

• Synthesis and transdermal permeation of novel N4-methoxypoly(ethylene glycol) carbamates of cytarabine.

  Drug development and industrial pharmacy 20101201

• Simultaneous bilateral spontaneous pneumothorax following high-dose chemotherapy and bone marrow transplantation for mantle cell lymphoma without evidence of pulmonary disease.

  International journal of clinical oncology 20101201

• An unusual case of acute myeloid leukemia: late isolated testicular relapse followed by isolated central nervous system relapse.

  Pediatric blood & cancer 20101201

• Extramedullary tumors presenting double vision in patients with t(8;21)(q22;q22) acute myeloid leukemia lacking mutations in the receptor tyrosine kinase genes KIT or FLT3.

  Leukemia research 20101201

• Mesenchymal stem cell as salvage treatment for refractory chronic GVHD.

  Bone marrow transplantation 20101201

• Patient with HIV-associated plasmablastic lymphoma responding to bortezomib alone and in combination with dexamethasone, gemcitabine, oxaliplatin, cytarabine, and pegfilgrastim chemotherapy and lenalidomide alone.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201

• PCR diagnostics and monitoring of adenoviral infections in hematopoietic stem cell transplantation recipients.

  Archives of virology 20101201

• Anterior uveitis associated with high-dose cytosine arabinoside.

  Ocular immunology and inflammation 20101201

• A bioluminescent microbial biosensor for in vitro pretreatment assessment of cytarabine efficacy in leukemia.

  Clinical chemistry 20101201

• Simultaneous quantification of ten cytotoxic drugs by a validated LC-ESI-MS/MS method.

  Analytical and bioanalytical chemistry 20101201

• Prodrugs of aza nucleosides based on proton transfer reaction.

  Journal of computer-aided molecular design 20101201

• Treatment of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia.

  The Journal of antimicrobial chemotherapy 20101201

• Development of cytarabine prodrugs and delivery systems for leukemia treatment.

  Expert opinion on drug delivery 20101201

• Dose intensity of chemotherapy in patients with relapsed Hodgkin's lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20101201

• Evaluation of cytarabine against Ewing sarcoma xenografts by the pediatric preclinical testing program.

  Pediatric blood & cancer 20101201

• Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.

  British journal of haematology 20101201

• Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo.

  Expert opinion on drug delivery 20101201

• Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.

  International journal of hematology 20101201

• New agents in post-remission therapy.

  Best practice & research. Clinical haematology 20101201

• Continuous sequential infusion of fludarabine and cytarabine for elderly patients with acute myeloid leukaemia secondary to a previously diagnosed myelodysplastic syndrome.

  Hematological oncology 20101201

• The DAC system and associations with acute leukemias and myelodysplastic syndromes.

  Investigational new drugs 20101201

• [Lung transplantation for secondary interstitial pneumonitis caused by treatment for primary mediastinal diffuse large B-cell lymphoma].

  Kyobu geka. The Japanese journal of thoracic surgery 20101201

• Structural basis for apoptosis inhibition by Epstein-Barr virus BHRF1.

  PLoS pathogens 20101201

• Growth Inhibition and Apoptosis with H31 Metabolites from Marine Bacillus SW31 in Head and Neck Cancer Cells.

  Clinical and experimental otorhinolaryngology 20101201

• A case of blastic plasmacytoid dendritic cell neoplasm initially mimicking cutaneous lupus erythematosus.

  Cancer research and treatment : official journal of Korean Cancer Association 20101201

• Outcome of childhood acute promyelocytic leukemia treated using a modified AIDA protocol.

  The Korean journal of hematology 20101201

• Additional rituximab-CHOP (R-CHOP) versus involved-field radiotherapy after a brief course of R-CHOP in limited, non-bulky diffuse large B-cell lymphoma: a retrospective analysis.

  The Korean journal of hematology 20101201

• Primary renal aspergillosis and renal stones in both kidneys associated with hematopoietic stem cell transplant.

  The Korean journal of hematology 20101201

• Wernicke's encephalopathy following allogeneic hematopoietic stem cell transplantation.

  The Korean journal of hematology 20101201

• [Chronic myeloid leukemia complicated with cerebellar hemorrhage and acute hydrocephalus successfully treated with imatinib and intensive supportive care].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20101201

• Effects of interior gelation on pharmacokinetics and biodistribution of liposomes encapsulating an anti-cancer drug cytarabine.

  Journal of biomedical nanotechnology 20101201

• Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia.

  Cell death & disease 20101201

• Cytosine-arabinoside stimulates the capability of human marrow stromal cells to support normal hematopoiesis.

  Osaka city medical journal 20101201

• Cytosine methyltransferases as tumor markers.

  Current genomics 20101201

• Aurora-A kinase inhibition enhances the cytosine arabinoside-induced cell death in leukemia cells through apoptosis and mitotic catastrophe.

  Cancer letters 20101128

• Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia.

  Blood 20101125

• Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia: long-term follow-up of a phase 2 study.

  Cancer 20101115

• Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric acute myeloid leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20101115

• Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710.

  Blood 20101111

• The antiparasitic agent ivermectin induces chloride-dependent membrane hyperpolarization and cell death in leukemia cells.

  Blood 20101104

• Clonogenic assays measure leukemia stem cell killing not detectable by chromium release and flow cytometric cytotoxicity assays.

  Cytotherapy 20101101

• Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells.

  Annals of hematology 20101101

• Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin.

  Annals of hematology 20101101

• Progressive multifocal leucoencephalopathy in a patient with Sézary syndrome.

  The British journal of dermatology 20101101

• Prognosis of secondary acute myeloid leukemia is affected by the type of the preceding hematologic disorders and the presence of trisomy 8.

  Japanese journal of clinical oncology 20101101

• Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.

  European journal of cancer (Oxford, England : 1990) 20101101

• Questions regarding frontline therapy of acute myeloid leukemia.

  Cancer 20101101

• Olanzapine increases cell mitotic activity and oligodendrocyte-lineage cells in the hypothalamus.

  Neurochemistry international 20101101

• Leptomeningeal metastasis.

  Current opinion in oncology 20101101

• Sequential cytarabine and alpha-particle immunotherapy with bismuth-213-lintuzumab (HuM195) for acute myeloid leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20101101

• Second-line mitoxantrone, etoposide, and cytarabine for acute myeloid leukemia: a single-center experience.

  American journal of hematology 20101101

• Childhood acute lymphoblastic leukemia in Turkey: factors influencing treatment and outcome: a single center experience.

  Journal of pediatric hematology/oncology 20101101

• Intrathecal liposomal cytarabine in relapsed or refractory infant and pediatric leukemias: the Children's Hospital of Philadelphia experience and review of the literature.

  Journal of pediatric hematology/oncology 20101101

• A nonradiation-containing, intermediate-dose methotrexate regimen for elderly patients with primary central nervous system lymphoma.

  International journal of hematology 20101101

• How important is whole brain radiotherapy for treatment of primary CNS lymphoma?

  The Lancet. Oncology 20101101

• High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.

  The Lancet. Oncology 20101101

• Chemotherapy: Lo and behold, a role for lomustine in acute myeloid leukemia?

  Nature reviews. Clinical oncology 20101101

• Prognostic significance of minimal residual disease detected by a simplified flow cytometric assay during remission induction chemotherapy in children with acute lymphoblastic leukemia.

  Korean journal of pediatrics 20101101

• [Lymphoma-like course in aggressive adult multisystem Langerhans cell histiocytosis and the benefit of PET/CT imaging in evaluation of diffuse metabolic activity of lung parenchyma].

  Vnitrni lekarstvi 20101101

• Refractory chronic lymphocytic leukemia--new therapeutic strategies.

  Oncotarget 20101101

• Homologous recombination repair is essential for repair of vosaroxin-induced DNA double-strand breaks.

  Oncotarget 20101101

• Evaluation of an Actinomycin D/VX-680 aurora kinase inhibitor combination in p53-based cyclotherapy.

  Oncotarget 20101101

• Cytosine arabinoside, vinblastine, diethylstilboestrol and 2-aminoanthracene tested in the in vitro human TK6 cell line micronucleus test (MNvit) at Institut Pasteur de Lille in support of OECD draft test guideline 487.

  Mutation research 20101029

• Cytosine arabinoside, vinblastine, 5-fluorouracil and 2-aminoanthracene testing in the in vitro micronucleus assay with L5178Y mouse lymphoma cells at Sanofi Aventis, with different cytotoxicity measurements, in support of the draft OECD Test Guideline on In Vitro Mammalian Cell Micronucleus Test.

  Mutation research 20101029

• Evaluation of phenolphthalein, diazepam and quinacrine dihydrochloride in the in vitro mammalian cell micronucleus test in Chinese hamster ovary (CHO) and TK6 cells.

  Mutation research 20101029

• 5-Fluorouracil, colchicine, benzo[a]pyrene and cytosine arabinoside tested in the in vitro mammalian cell micronucleus test (MNvit) in Chinese hamster V79 cells at Covance Laboratories, Harrogate, UK in support of OECD draft Test Guideline 487.

  Mutation research 20101029

• 2-Aminoanthracene, 5-fluorouracil, colchicine, benzo[a]pyrene, cadmium chloride and cytosine arabinoside tested in the in vitro mammalian cell micronucleus test (MNvit) in Chinese hamster ovary (CHO) cells at Covance Laboratories, Harrogate UK in support of OECD draft Test Guideline 487.

  Mutation research 20101029

• Comparison of different methods for an accurate assessment of cytotoxicity in the in vitro micronucleus test without cytokinesis block.

  Mutation research 20101029

• Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.

  Blood 20101028

• Combination of sapacitabine and HDAC inhibitors stimulates cell death in AML and other tumour types.

  British journal of cancer 20101026

• Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against T-cell acute lymphoblastic leukemia.

  Cancer research 20101015

• Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.

  British journal of cancer 20101012

• PCR-based methods for CDA K27Q and A70T genotyping: genotypes and alleles distribution in a central Italy population.

  Molecular biology reports 20101001

• Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo.

  Cancer chemotherapy and pharmacology 20101001

• Total body irradiation compared with BEAM: Long-term outcomes of peripheral blood autologous stem cell transplantation for non-Hodgkin's lymphoma.

  International journal of radiation oncology, biology, physics 20101001

• Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors.

  Leukemia research 20101001

• Induction of striatal neurogenesis and generation of region-specific functional mature neurons after ischemia by growth factors. Laboratory investigation.

  Journal of neurosurgery 20101001

• Investigation of microcystin congener-dependent uptake into primary murine neurons.

  Environmental health perspectives 20101001

• Incidence, severity, and etiology of drug-induced acute pancreatitis.

  Digestive diseases and sciences 20101001

• Blood stream infections during chemotherapy-induced neutropenia in adult patients with acute myeloid leukemia: treatment cycle matters.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 20101001

• Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphoma.

  Cancer 20101001

• Anthracycline dose intensification in adult acute lymphoblastic leukemia: lack of benefit in the context of the fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen.

  Cancer 20101001

• Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120.

  Glia 20101001

• Influence of cytidine deaminase on antitumor activity of 2'-deoxycytidine analogs in vitro and in vivo.

  Drug metabolism and disposition: the biological fate of chemicals 20101001

• Juvenile xanthogranuloma with hematological dysfunction treated with 2CDA-AraC.

  Pediatric blood & cancer 20101001

• HPLC method development and validation for simultaneous detection of Arabinoside-C and doxorubicin.

  Toxicology mechanisms and methods 20101001

• Acute intraoperative tumour lysis syndrome.

  Canadian journal of anaesthesia = Journal canadien d'anesthesie 20101001

• Negative regulatory effects of Mnk kinases in the generation of chemotherapy-induced antileukemic responses.

  Molecular pharmacology 20101001

• Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience.

  Pediatric hematology and oncology 20101001

• Synthesis and evaluation of fatty acyl ester derivatives of cytarabine as anti-leukemia agents.

  European journal of medicinal chemistry 20101001

• Renal cell carcinoma and acute promyelocytic leukemia: a nonrandom association?

  American journal of hematology 20101001

• Phase I trial of bortezomib in combination with rituximab-HyperCVAD alternating with rituximab, methotrexate and cytarabine for untreated aggressive mantle cell lymphoma.

  British journal of haematology 20101001

• Acute myeloid leukemia associated with t(10;17)(p13-15;q12-21) and phagocytic activity by leukemic blasts: a clinical study and review of the literature.

  Cancer genetics and cytogenetics 20101001

• Transient abnormal myelopoiesis in a cytogenetically normal neonate.

  International journal of hematology 20101001

• [Leukemia cutis arising at the site of injection of a tetanus vaccine booster].

  Actas dermo-sifiliograficas 20101001

• Anaplastic large-cell lymphoma with atypical chromosomal translocation t(2;5) and hypophyseal tumor.

  Upsala journal of medical sciences 20101001

• Inhibition of GST-pi nuclear transfer increases mantle cell lymphoma sensitivity to cisplatin, cytarabine, gemcitabine, bortezomib and doxorubicin.

  Anticancer research 20101001

• CRIM1 is expressed at higher levels in drug-resistant than in drug-sensitive myeloid leukemia HL60 cells.

  Anticancer research 20101001

• Risk-adapted approaches to therapy for high-risk acute promyelocytic leukemia.

  Clinical lymphoma, myeloma & leukemia 20101001

• Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure.

  Anti-cancer agents in medicinal chemistry 20101001

• An unusual case of capecitabine hyperpigmentation: Is hyperpigmentation a part of hand-foot syndrome or a separate entity?

  Indian journal of pharmacology 20101001

• Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100920

• [Diagnosis, prophylaxis and treatment of central nervous system involvement by non-Hodgkin lymphoma in HIV-infected patients].

  Medicina clinica 20100918

• Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC.

  Blood 20100909

• P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808.

  Blood 20100902

• A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemia.

  Medical oncology (Northwood, London, England) 20100901

• Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation.

  Journal of liposome research 20100901

• Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts.

  Leukemia research 20100901

• Intrathecal liposomal cytarabine for treatment of leptomeningeal involvement in transformed (Richter's syndrome) and non-transformed B-cell chronic lymphocytic leukaemia in Spain: a report of seven cases.

  British journal of haematology 20100901

• Highly regioselective enzymatic synthesis of 5'-O-stearate of 1-beta-D-arabinofuranosylcytosine in binary organic solvent mixtures.

  Applied microbiology and biotechnology 20100901

• Neutropenic enterocolitis in children and young adults with cancer: prognostic value of clinical and image findings.

  Pediatric hematology and oncology 20100901

• Multidrug nanoparticles based on novel random copolymer containing cytarabine and fluorodeoxyuridine.

  Journal of colloid and interface science 20100901

• Ecotoxicity and genotoxicity assessment of cytotoxic antineoplastic drugs and their metabolites.

  Chemosphere 20100901

• Effect of post-remission chemotherapy preceding allogeneic hematopoietic cell transplant in patients with acute myeloid leukemia in first remission.

  Leukemia & lymphoma 20100901

• Day 15 bone marrow driven double induction in young adult patients with acute myeloid leukemia: feasibility, toxicity, and therapeutic results.

  American journal of hematology 20100901

• A class of novel carboline intercalators: Their synthesis, in vitro anti-proliferation, in vivo anti-tumor action, and 3D QSAR analysis.

  Bioorganic & medicinal chemistry 20100901

• Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol.

  Leukemia & lymphoma 20100901

• Modified nanoprecipitation method for preparation of cytarabine-loaded PLGA nanoparticles.

  AAPS PharmSciTech 20100901

• Lectin-aided separation of circulating tumor cells and assay of their response to an anticancer drug in an integrated microfluidic device.

  Electrophoresis 20100901

• Modulation of gemcitabine accumulation by DNA-damaging agents: mechanisms and specificity in an in vitro model.

  Anticancer research 20100901

• Induction of hypoxia-inducible factor-1α inhibits drug-induced apoptosis in the human leukemic cell line HL-60.

  The Korean journal of hematology 20100901

• Long-term survival in a patient with acute promyelocytic leukemia with isolated meningeal relapse.

  The Korean journal of hematology 20100901

• Nitric oxide is an essential mediator for neuronal differentiation of rat primary cortical neuron cells.

  Experimental neurobiology 20100901

• CNS relapse in acute promyeloctyic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100820

• Efficient overcoming of drug resistance to anticancer nucleoside analogs by nanodelivery of active phosphorylated drugs.

  International journal of pharmaceutics 20100816

• Ulcerated plaque under a ruby ring in an immunosuppressed patient.

  Dermatology online journal 20100815

• A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial.

  Blood 20100812

• Induction of striatal neurogenesis enhances functional recovery in an adult animal model of neonatal hypoxic-ischemic brain injury.

  Neuroscience 20100811

• Spurious pleocytosis.

  Blood 20100805

• In vivo evaluation of pH-sensitive polymer-based immunoliposomes targeting the CD33 antigen.

  Molecular pharmaceutics 20100802

• Immunomagnetic selection of CD34(+) cells carried out in cryopreserved cell concentrates from a paediatric patient affected with non-Hodgkin lymphoma.

  Transfusion medicine (Oxford, England) 20100801

• Focal nodular hyperplasia in pediatric allogeneic hematopoietic cell transplant: case series.

  Bone marrow transplantation 20100801

• Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature.

  Leukemia research 20100801

• Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group.

  Haematologica 20100801

• Endoscopic diagnosis of childhood Burkitt's lymphoma of the colon.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100801

• Implication of TAp73 in the p53-independent pathway of Puma induction and Puma-dependent apoptosis in primary cortical neurons.

  Journal of neurochemistry 20100801

• Deoxycytidine kinase is downregulated in Ara-C-resistant acute myeloid leukemia murine cell lines.

  Leukemia 20100801

• Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases.

  Clinical & experimental metastasis 20100801

• Schedule- and dose-dependency of CPX-351, a synergistic fixed ratio cytarabine:daunorubicin formulation, in consolidation treatment against human leukemia xenografts.

  Leukemia & lymphoma 20100801

• Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia.

  Cancer 20100801

• Immunosuppressive treatments in Crohn's disease induce myelodysplasia and leukaemia.

  American journal of hematology 20100801

• Long term follow-up of allogeneic stem cell transplantation in patients with myelodysplastic syndromes using busulfan, cytosine arabinoside, and cyclophosphamide.

  American journal of hematology 20100801

• Secondary adrenal insufficiency in an infant after intrathecal triple chemotherapy.

  Pediatric blood & cancer 20100801

• Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma.

  Journal of pediatric hematology/oncology 20100801

• [Hemiparesis in acute lymphoblastic leukemia].

  Der Radiologe 20100801

• Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.

  American journal of hematology 20100801

• Treatment of acute promyelocytic leukemia with PETHEMA LPA 99 protocol: a Tunisian single center experience.

  Hematology (Amsterdam, Netherlands) 20100801

• Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis.

  Hematology (Amsterdam, Netherlands) 20100801

• Front-line treatment of mantle cell lymphoma.

  Haematologica 20100801

• Corneal perforation with preseptal cellulitis in a patient with acute lymphocytic leukemia.

  Journal of Korean medical science 20100801

• Flows and flaws in primary central nervous system lymphoma.

  Nature reviews. Clinical oncology 20100801

• Rituximab, dexamethasone, cytarabine, and oxaliplatin (R-DHAX) is an effective and safe salvage regimen in relapsed/refractory B-cell non-Hodgkin lymphoma.

  Clinical lymphoma, myeloma & leukemia 20100801

• Peripheral blasts on day 21 of induction chemotherapy in a patient with core binding factor acute myeloid leukemia: more than meets the eye.

  Clinical lymphoma, myeloma & leukemia 20100801

• Bilateral serous retinal detachment as a presenting sign of acute lymphoblastic leukemia.

  Korean journal of ophthalmology : KJO 20100801

• [A case of del(16)(q22) in a patient with acute myeloid leukemia with complex karyotype].

  The Korean journal of laboratory medicine 20100801

• DNA instability at chromosomal fragile sites in cancer.

  Current genomics 20100801

• Magnesium induces neuronal apoptosis by suppressing excitability.

  Cell death & disease 20100801

• VCR/AraC chemotherapy and ND-CNS-LCH.

  Pediatric blood & cancer 20100715

• Efficient synthesis of 5'-O-laurate of 1-beta-D-arabinofuranosylcytosine via highly regioselective enzymatic acylation in binary solvent mixtures.

  Bioorganic & medicinal chemistry letters 20100715

• Simultaneous determination of cytosine arabinoside, daunorubicin and etoposide in human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100715

• Synergistic activity of nilotinib and established chemotherapeutic drugs in imatinib-sensitive and -resistant BCR-ABL-positive cells.

  Cancer chemotherapy and pharmacology 20100701

• Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study.

  Bone marrow transplantation 20100701

• Jumping translocation involving 1q21 during long-term complete remission of acute myeloid leukemia.

  Annals of hematology 20100701

• Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia.

  Leukemia research 20100701

• Monotherapy with methotrexate for primary central nervous lymphoma has single agent activity in the absence of radiotherapy: a single institution cohort.

  Journal of neuro-oncology 20100701

• Complete molecular remission in refractory acute myeloid leukemia with MLL/AF9 treated with gemtuzumab ozogamicin.

  Leukemia research 20100701

• Typhlitis due to mucormycosis after chemotherapy in a patient with acute myeloid leukemia.

  Leukemia research 20100701

• Granulocytic sarcoma of abdomen in acute myeloid leukemia patient with inv(16) and t(6;17) abnormal chromosome: case report and review of literature.

  Leukemia research 20100701

• Cbl-b promotes chemotherapy-induced apoptosis in rat basophilic leukemia cells by suppressing PI3K/Akt activation and enhancing MEK/ERK activation.

  Molecular and cellular biochemistry 20100701

• Sequential flavopiridol, mitoxantrone and cytosine arabinoside for newly diagnosed poor risk acute myeloid leukemia. What to do next?

  Leukemia research 20100701

• Novel effects of glycyrrhetinic acid on the central nervous system tumorigenic progenitor cells: induction of actin disruption and tumor cell-selective toxicity.

  European journal of medicinal chemistry 20100701

• Myeloid leukaemia in children with Down syndrome: report of the registry-based French experience between 1990 and 2003.

  Pediatric blood & cancer 20100701

• CD38 expression, function, and gene resequencing in a human lymphoblastoid cell line-based model system.

  Leukemia & lymphoma 20100701

• Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells.

  Cancer science 20100701

• Inadvertent intrathecal injection of PEG-asparaginase.

  Journal of pediatric hematology/oncology 20100701

• Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia.

  Journal of medical virology 20100701

• Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100701

• Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy.

  Cancer investigation 20100701

• Ten-year follow-up after intense chemoimmunotherapy with Rituximab-HyperCVAD alternating with Rituximab-high dose methotrexate/cytarabine (R-MA) and without stem cell transplantation in patients with untreated aggressive mantle cell lymphoma.

  British journal of haematology 20100701

• Leukaemia cutis at the site of striae distensae: an isotopic response?

  Acta dermato-venereologica 20100701

• Leptomeningeal metastasis.

  Seminars in neurology 20100701

• Vaccinia virus-encoded ribonucleotide reductase subunits are differentially required for replication and pathogenesis.

  PLoS pathogens 20100701

• Diagnosis and individualized therapy of neoplastic meningitis.

  Expert review of anticancer therapy 20100701

• Primary central nervous system lymphoma.

  Current treatment options in neurology 20100701

• Neutropenic enterocolitis: A continuing medical and surgical challenge.

  North American journal of medical sciences 20100701

• New trends in nucleoside biotechnology.

  Acta naturae 20100701

• Photodynamic therapy for multi-resistant cutaneous Langerhans cell histiocytosis.

  Rare tumors 20100630

• AKAP79/150 interacts with AC8 and regulates Ca2+-dependent cAMP synthesis in pancreatic and neuronal systems.

  The Journal of biological chemistry 20100625

• Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome.

  Blood 20100624

• Pegylated arginase I: a potential therapeutic approach in T-ALL.

  Blood 20100624

• Addition of lomustine to idarubicin and cytarabine improves the outcome of elderly patients with de novo acute myeloid leukemia: a report from the GOELAMS.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100620

• Incorporation of gemcitabine and cytarabine into DNA by DNA polymerase beta and ligase III/XRCC1.

  Biochemistry 20100615

• Renal excretion of clofarabine: assessment of dose-linearity and role of renal transport systems on drug excretion.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100614

• Using 18F-fluorodeoxyglucose positron emission tomography to monitor clinical outcomes in patients treated with neoadjuvant chemo-radiotherapy for locally advanced pancreatic cancer.

  American journal of clinical oncology 20100601

• 18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract.

  Annals of hematology 20100601

• Salvage chemotherapy with alternating MINE-ESHAP regimen in relapsed or refractory Hodgkin's lymphoma followed by autologous stem-cell transplantation.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100601

• Efficacy of escalated imatinib combined with cytarabine in newly diagnosed patients with chronic myeloid leukemia.

  Haematologica 20100601

• Daily practice management of myelodysplastic syndromes in France: data from 907 patients in a one-week cross-sectional study by the Groupe Francophone des Myelodysplasies.

  Haematologica 20100601

• An unusual case of pancreatic cancer with leptomeningeal infiltration.

  Journal of gastrointestinal cancer 20100601

• Re-analysis of the outcomes of post-remission therapy for acute myeloid leukemia with core binding factor according to years of patient enrollment.

  Japanese journal of clinical oncology 20100601

• Pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism.

  European journal of clinical pharmacology 20100601

• High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience.

  Multiple sclerosis (Houndmills, Basingstoke, England) 20100601

• Novel benzimidazole-pyrimidine conjugates as potent antitumor agents.

  European journal of medicinal chemistry 20100601

• Hyperperfusion on magnetic resonance imaging in acute chemotherapy-related leukoencephalopathy.

  Journal of child neurology 20100601

• Central line-associated bacteremia caused by drug-resistant Staphylococcus caprae after chemotherapy for acute myelogenous leukemia.

  International journal of hematology 20100601

• Optimal chemotherapy for high-risk early-stage breast cancer.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100601

• Irreversible pulmonary hypertension associated with the use of interferon alpha for chronic hepatitis C.

  Digestive diseases and sciences 20100601

• Treatment approaches for primary CNS lymphomas.

  Expert opinion on pharmacotherapy 20100601

• Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100601

• Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial.

  The Lancet. Oncology 20100601

• Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.

  Leukemia & lymphoma 20100601

• Arsenic Trioxide overcomes cell adhesion-mediated drug resistance through down-regulating the expression of beta(1)-integrin in K562 chronic myelogenous leukemia cell line.

  Leukemia & lymphoma 20100601

• Results of treatment with CMA, a low intermediate regimen, in endemic Burkitt lymphomas in sub-Saharian Africa: experience of Côte d'Ivoire.

  International journal of hematology 20100601

• Development of therapeutic agents for older patients with acute myelogenous leukemia.

  Current opinion in investigational drugs (London, England : 2000) 20100601

• Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-Hodgkin lymphoma.

  Clinical lymphoma, myeloma & leukemia 20100601

• Clinical laboratory identification of liposomal cytarabine in cerebrospinal fluid.

  American journal of hematology 20100601

• High transcript level of FLT3 associated with high risk of relapse in pediatric acute myeloid leukemia.

  Journal of Korean medical science 20100601

• Congenital acute myeloid leukemia with t(8;16) and t(17;19) double translocation: case presentation and literature review.

  Journal of Korean medical science 20100601

• Cerebellar assessment for patients receiving high-dose cytarabine: a standardized approach to nursing assessment and documentation.

  Clinical journal of oncology nursing 20100601

• Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.

  Leukemia & lymphoma 20100601

• The associations of Janus kinase-2 (JAK2) A830G polymorphism and the treatment outcomes in patients with acute myeloid leukemia.

  Leukemia & lymphoma 20100601

• The activity of the lipophilic nucleoside derivatives elacytarabine and CP-4126 in a panel of tumor cell lines resistant to nucleoside analogues.

  Nucleosides, nucleotides & nucleic acids 20100601

• Induction of resistance to the lipophilic cytarabine prodrug elacytarabine (CP-4055) in CEM leukemic cells.

  Nucleosides, nucleotides & nucleic acids 20100601

• Methylation specific PCR to characterize methylation of the promoter of deoxycytidine kinase.

  Nucleosides, nucleotides & nucleic acids 20100601

• A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.

  Hematology (Amsterdam, Netherlands) 20100601

• In-vitro transdermal penetration of cytarabine and its N4-alkylamide derivatives.

  The Journal of pharmacy and pharmacology 20100601

• Differential ex vivo activity of bortezomib in newly diagnosed paediatric acute lymphoblastic and myeloblastic leukaemia.

  Anticancer research 20100601

• Vincristine in high-grade glioma.

  Anticancer research 20100601

• The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.

  Oncotarget 20100601

• Mutations in AML with a normal karyotype: NPM1 and FLT3-ITD, ready to use as a key prognosticator?

  The Korean journal of hematology 20100601

• Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission.

  The Korean journal of hematology 20100601

• Biophysical characterization of a liposomal formulation of cytarabine and daunorubicin.

  International journal of pharmaceutics 20100531

• Interaction between DNA Polymerase lambda and anticancer nucleoside analogs.

  The Journal of biological chemistry 20100528

• Potent antitumor activities of recombinant human PDCD5 protein in combination with chemotherapy drugs in K562 cells.

  Biochemical and biophysical research communications 20100528

• Central nervous system prophylaxis in adults with acute lymphoblastic leukemia: current and emerging therapies.

  Cancer 20100515

• Chronic myeloid leukemia therapy in the era of tyrosine kinase inhibitors--the first molecular targeted treatment.

  Journal of medicine and life 20100515

• Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100510

• The FMCA-GM assays, high throughput non-clonogenic alternatives to CFU-GM in preclinical hematotoxicity testing.

  Toxicology letters 20100504

• Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor for elderly patients with previously untreated acute myeloid leukemia.

  Leukemia research 20100501

• Intrathecal liposomal cytarabine in combination with temozolomide in low-grade oligoastrocytoma with leptomeningeal dissemination.

  Journal of neuro-oncology 20100501

• High-dose chemotherapy and autologous stem cell rescue for atypical teratoid/rhabdoid tumor of the central nervous system.

  Journal of neuro-oncology 20100501

• Primary multiple cerebral invasion in acute promyelocytic leukemia dramatically worsened by all-trans retinoic acid.

  Leukemia research 20100501

• Front-line high-dose chemotherapy with rituximab showed excellent long-term survival in adults with aggressive large b-cell lymphoma: final results of a Phase II GOELAMS Study.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20100501

• [Evaluation of the protocol CMA reinforced in the treatment of endemic Burkitt lymphoma at CHU of Yopougon in Abidjan].

  Bulletin du cancer 20100501

• Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.

  Journal of cellular physiology 20100501

• Early reduction of WT1 transcripts during induction chemotherapy predicts for longer disease free and overall survival in acute myeloid leukemia.

  Haematologica 20100501

• Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20100501

• Late relapses in acute myeloid leukemia: analysis of characteristics and outcome.

  Leukemia & lymphoma 20100501

• Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses.

  British journal of haematology 20100501

• Meisoindigo is a promising agent with in vitro and in vivo activity against human acute myeloid leukemia.

  Leukemia & lymphoma 20100501

• Mosaic Down syndrome-associated acute myeloid leukemia does not require high-dose cytarabine treatment for induction and consolidation therapy.

  International journal of hematology 20100501

• Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan.

  International journal of hematology 20100501

• Adenovirus 36 DNA in adipose tissue of patient with unusual visceral obesity.

  Emerging infectious diseases 20100501

• Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.

  American journal of hematology 20100501

• Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.

  Pediatric hematology and oncology 20100501

• Advances in the management of acute myeloid leukemia in older adult patients.

  Oncology nursing forum 20100501

• Human adenovirus replication in immunocompetent Syrian hamsters can be attenuated with chlorpromazine or cidofovir.

  The journal of gene medicine 20100501

• [Successful selection of chemotherapy based on cell surface antigens in a patient with mixed phenotype acute leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20100501

• [Prognostic factors and therapeutic strategies for acute myeloid leukemia].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20100501

• Brain self-protection: the role of endogenous neural progenitor cells in adult brain after cerebral cortical ischemia.

  Brain research 20100423

• Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis.

  Cancer 20100415

• Neuronal models for evaluation of proliferation in vitro using high content screening.

  Toxicology 20100411

• Phase I/II study of combination therapy with sorafenib, idarubicin, and cytarabine in younger patients with acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100410

• Diffuse leukoencephalopathy and brain edema: unusual presentations of CNS relapse of acute myeloid leukemia.

  Journal of neuroimaging : official journal of the American Society of Neuroimaging 20100401

• Myeloablative hematopoietic stem cell transplantation for myelodysplastic syndrome in patients younger than 55 years: impact of comorbidity and disease burden on the long-term outcome.

  International journal of laboratory hematology 20100401

• Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells.

  Leukemia research 20100401

• Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemia.

  Leukemia research 20100401

• Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.

  Drug development and industrial pharmacy 20100401

• Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA).

  Annals of oncology : official journal of the European Society for Medical Oncology 20100401

• In vitro and in vivo study on the antioxidant activity of dexrazoxane.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100401

• Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses.

  Pediatric blood & cancer 20100401

• Central nervous system involvement at the time of presentation in acute promyelocytic leukemia.

  Pediatric blood & cancer 20100401

• Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.

  Pediatric blood & cancer 20100401

• Exploiting cellular pathways to develop new treatment strategies for AML.

  Cancer treatment reviews 20100401

• Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy.

  British journal of haematology 20100401

• Epithelial uptake of [18F]1-(2'-deoxy-2'-arabinofuranosyl) cytosine indicates intestinal inflammation in mice.

  Gastroenterology 20100401

• Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C.

  British journal of haematology 20100401

• Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100401

• Dose-intensified treatment of Burkitt lymphoma and B-cell lymphoma unclassifiable, (with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma) in young adults (<50 years): a comparison of two adapted BFM protocols.

  American journal of hematology 20100401

• Final analysis of the UKLG LY02 trial comparing 6-8 cycles of CHOP with 3 cycles of CHOP followed by a BEAM autograft in patients <65 years with poor prognosis histologically aggressive NHL.

  British journal of haematology 20100401

• Synthesis, X-ray crystal structure study and antitumoral evaluations of 5,6-disubstituted pyrimidine derivatives.

  Bioorganic & medicinal chemistry 20100401

• PACdb: a database for cell-based pharmacogenomics.

  Pharmacogenetics and genomics 20100401

• Hepatosplenic alphabeta T cell lymphoma.

  International journal of clinical oncology 20100401

• Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.

  Leukemia & lymphoma 20100401

• Cytomegalovirus ventriculoencephalitis after unrelated double cord blood stem cell transplantation with an alemtuzumab-containing preparative regimen for Philadelphia-positive acute lymphoblastic leukemia.

  Journal of Korean medical science 20100401

• Solitary intradural extramedullary lymphoma of the cervical spine.

  Journal of neurosurgery. Spine 20100401

• ESHAP versus rituximab-ESHAP in frail patients with refractory diffuse large B-cell lymphoma.

  Clinical lymphoma, myeloma & leukemia 20100401

• Orbital mass as a presenting sign of acute leukemia.

  Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 20100401

• Simultaneous detection of MDR1 and WT1 gene expression to predict the prognosis of adult acute lymphoblastic leukemia.

  Hematology (Amsterdam, Netherlands) 20100401

• [Curative effect of low dose cytarabine and aclarubin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on patients with the intermediate and high-risk myelodysplastic syndrome].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20100401

• Leukemia cutis limited to the needle puncture sites.

  The Journal of dermatology 20100401

• CXCL12 inhibits expression of the NMDA receptor's NR2B subunit through a histone deacetylase-dependent pathway contributing to neuronal survival.

  Cell death & disease 20100401

• Transport characteristics of mouse concentrative nucleoside transporter 1.

  International journal of pharmaceutics 20100330

• The freeze-thawed and freeze-dried stability of cytarabine-encapsulated multivesicular liposomes.

  International journal of pharmaceutics 20100315

• Phase 2 study of intrathecal, long-acting liposomal cytarabine in the prophylaxis of lymphomatous meningitis in human immunodeficiency virus-related non-Hodgkin lymphoma.

  Cancer 20100315

• Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.

  Bioorganic & medicinal chemistry letters 20100315

• Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.

  Cancer research 20100315

• Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German CML Study IV.

  Blood 20100311

• Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience.

  Blood 20100304

• Can homeopathy bring additional benefits to thalassemic patients on hydroxyurea therapy? Encouraging results of a preliminary study.

  Evidence-based complementary and alternative medicine : eCAM 20100301

• Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : report on one case and review of other uses in acute leukemias.

  Medical oncology (Northwood, London, England) 20100301

• Dermatomyositis associated with acute myelocytic leukemia.

  Rheumatology international 20100301

• Acute myeloid leukemia and Langerhans' cell histiocytosis: multiple theories for an unusual presentation.

  Leukemia research 20100301

• Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy.

  Journal of neuro-oncology 20100301

• Rituximab retherapy in patients with relapsed aggressive B cell and mantle cell lymphoma.

  Annals of hematology 20100301

• Apoptosis- and necrosis-induced changes in light attenuation measured by optical coherence tomography.

  Lasers in medical science 20100301

• Molecular identification of phaeohyphomycosis due to Alternaria infectoria in a patient with acute myeloid leukemia--a case report.

  Diagnostic microbiology and infectious disease 20100301

• Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.

  Pediatric blood & cancer 20100301

• The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.

  European journal of haematology 20100301

• Primary human acute myelogenous leukemia cells release matrix metalloproteases and their inhibitors: release profile and pharmacological modulation.

  European journal of haematology 20100301

• R-DHAP is effective in fludarabine-refractory chronic lymphocytic leukemia.

  Leukemia 20100301

• High rate and prolonged duration of complete remissions induced by rituximab, methotrexate, doxorubicin, cyclophosphamide, vincristine, ifosfamide, etoposide, cytarabine, and thalidomide (R-MACLO-IVAM-T), a modification of the National Cancer Institute 89-C-41 regimen, in patients with newly diagnosed mantle cell lymphoma.

  Leukemia & lymphoma 20100301

• Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.

  Leukemia & lymphoma 20100301

• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia: the JALSG AML95 study.

  International journal of hematology 20100301

• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia: results of the JALSG AML97 study.

  International journal of hematology 20100301

• Intrathecal chemotherapy and meningeal relapses in myelomonocytic AML. A single institution experience.

  American journal of hematology 20100301

• Induction therapy in acute myeloid leukemia: intensifying and targeting the approach.

  Current opinion in hematology 20100301

• Advantage of MIDAM protocol in treatment of elderly patients with refractory and relapsing acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100301

• Celastrol and an EGCG pro-drug exhibit potent chemosensitizing activity in human leukemia cells.

  International journal of molecular medicine 20100301

• Laromustine (cloretazine).

  Expert opinion on pharmacotherapy 20100301

• Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.

  Chinese journal of cancer 20100301

• Toxic shock syndrome caused by hospital-acquired methicillin-resistant Staphylococcus aureus in a patient with pancytopenia.

  Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 20100301

• Transdermal penetration of cytarabine and its 5'-O alkyl ester derivatives.

  Medicinal chemistry (Shariqah (United Arab Emirates)) 20100301

• [Successful treatment with hyper-CVAD and highly active anti-retroviral therapy (HAART) for AIDS-related Burkitt lymphoma].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20100301

• Juvenile myelomonocytic leukemia with PTPN11 mutation in a 23-month-old girl.

  Collegium antropologicum 20100301

• Fatal hepatitis B reactivation in an immune patient after anti-leukemic chemotherapy.

  The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100301

• Prognostic significance of nucleophosmin mutations and FLT3 internal tandem duplication in adult patients with cytogenetically normal acute myeloid leukemia.

  The Korean journal of hematology 20100301

• Synchronous development of KIT positive acute myeloid leukemia in a patient with gastrointestinal stromal tumor.

  The Korean journal of hematology 20100301

• A case of donor-derived granulocytic sarcoma after allogeneic hematopoietic stem cell transplantation.

  The Korean journal of hematology 20100301

• Mees lines and Beau lines after chemotherapy.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20100223

• Single cycle of arsenic trioxide-based consolidation chemotherapy spares anthracycline exposure in the primary management of acute promyelocytic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100220

• Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial.

  British journal of cancer 20100216

• Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100210

• The impact on outcome of the addition of all-trans retinoic acid to intensive chemotherapy in younger patients with nonacute promyelocytic acute myeloid leukemia: overall results and results in genotypic subgroups defined by mutations in NPM1, FLT3, and CEBPA.

  Blood 20100204

• Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG).

  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 20100201

• Brazilian experience with two conditioning regimens in patients with multiple sclerosis: BEAM/horse ATG and CY/rabbit ATG.

  Bone marrow transplantation 20100201

• Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemia.

  Molecular pharmaceutics 20100201

• Synthesis and in vitro cytostatic activity of new beta-D-arabino furan[1',2':4,5]oxazolo- and arabino-pyrimidinone derivatives.

  European journal of medicinal chemistry 20100201

• Beta-catenin signaling increases in proliferating NG2+ progenitors and astrocytes during post-traumatic gliogenesis in the adult brain.

  Stem cells (Dayton, Ohio) 20100201

• [Acute lower limb ischemia revealing acute leukemia. Case report and review of the literature].

  Journal des maladies vasculaires 20100201

• 'I am older, not elderly,' said the patient with acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201

• Attempts to optimize induction and consolidation treatment in acute myeloid leukemia: results of the MRC AML12 trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20100201

• Treatment with rituximab, dexamethasone, high-dose cytarabine, and oxaliplatin (R-DHAOx) produces a strong long-term antitumor effect in previously treated patients with follicular non-Hodgkin's lymphoma.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100201

• Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology.

  American journal of hematology 20100201

• Subacute methotrexate neurotoxicity and cerebral venous sinus thrombosis in a 12-year-old with acute lymphoblastic leukemia and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: homocysteine-mediated methotrexate neurotoxicity via direct endothelial injury.

  Pediatric hematology and oncology 20100201

• DEGRO Practical Guidelines for palliative radiotherapy of breast cancer patients: brain metastases and leptomeningeal carcinomatosis.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20100201

• Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation.

  Hematology (Amsterdam, Netherlands) 20100201

• [Efficiency of GHA priming therapy on patients with acute monocytic leukemia and its mechanism].

  Zhongguo shi yan xue ye xue za zhi 20100201

• [Neoplastic meningitis. Diagnosis and individualised therapy].

  Der Nervenarzt 20100201

• AS-1411, a guanosine-rich oligonucleotide aptamer targeting nucleolin for the potential treatment of cancer, including acute myeloid leukemia.

  Current opinion in molecular therapeutics 20100201

• [Neuron differential attachment purification and its influence factor].

  Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery 20100201

• Long-term survival with favorable cognitive outcome after chemotherapy in primary central nervous system lymphoma.

  Annals of neurology 20100201

• Efficacy and safety of modified rituximab-ESHAP therapy for relapsed/refractory B-cell lymphoma.

  Journal of chemotherapy (Florence, Italy) 20100201

• [Distribution of WHO subtypes, initial treatment outcomes and prognosis study of 623 unselected adult patients with acute myeloid leukaemia in Shanghai.].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20100201

• [Effectiveness of remission induction with high-dose cytarabine for relapsed or refractory pediatric acute leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20100201

• [Intravascular large B-cell lymphoma with pontine involvement successfully treated with R-hyper-CVAD/R-MTX-Ara-C regimen].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20100201

• Updates on the treatment of acute promyelocytic leukemia.

  Clinical advances in hematology & oncology : H&O 20100201

• Clofarabine in leukemia.

  Expert review of hematology 20100201

• Application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to different amine-containing drugs.

  Journal of medicinal chemistry 20100128

• Clinical case of acute myeloblastic leukemia with t(8;21)(q22;q22) in a patient with Klinefelter's syndrome.

  Hematology reports 20100126

• Toxicity of laromustine plus high-dose cytarabine in patients with relapsed acute myeloid leukemia.

  Blood 20100114

• De novo neurogenesis in adult hypothalamus as a compensatory mechanism to regulate energy balance.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20100113

• Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.

  Journal of the National Cancer Institute 20100106

• A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC.

  British journal of cancer 20100105

• Homoharringtonine in combination with cytarabine and aclarubicin as induction therapy improves remission and survival of patients with higher risk myelodysplastic syndromes.

  Chinese medical journal 20100105

• Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction.

  The Journal of clinical investigation 20100104

• Cytogenetic insights into DNA damage and repair of lesions induced by a monomethylated trivalent arsenical.

  Mutation research 20100101

• Failure of three novel regimens to improve outcome for patients with relapsed or refractory acute myeloid leukaemia: a report from the Eastern Cooperative Oncology Group.

  British journal of haematology 20100101

• Use of lectins to enrich mouse ES-derived retinal progenitor cells for the purpose of transplantation therapy.

  Cell transplantation 20100101

• Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.

  British journal of haematology 20100101

• Assessment of in vivo genotoxicity of the rodent carcinogen furan: evaluation of DNA damage and induction of micronuclei in mouse splenocytes.

  Mutagenesis 20100101

• Successful treatment of Hodgkin lymphoma and acute leukemia.

  Leukemia & lymphoma 20100101

• Cytoprotective effect of imatinib mesylate in non-BCR-ABL-expressing cells along with autophagosome formation.

  Biochemical and biophysical research communications 20100101

• Histiocytic sarcoma in the brain of a cat.

  The Journal of veterinary medical science 20100101

• Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.

  Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20100101

• Cell cycle effects of fatty acid derivatives of cytarabine, CP-4055, and of gemcitabine, CP-4126, as basis for the interaction with oxaliplatin and docetaxel.

  International journal of oncology 20100101

• Report of a phase 1/2 study of a combination of azacitidine and cytarabine in acute myelogenous leukemia and high-risk myelodysplastic syndromes.

  Leukemia & lymphoma 20100101

• Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20100101

• Gangrenous cheilitis associated with all-trans retinoic acid therapy for acute promyelocytic leukemia.

  International journal of hematology 20100101

• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group.

  International journal of hematology 20100101

• Idarubicin plus behenoyl cytarabine and 6-thioguanine compares favorably with idarubicin plus cytarabine-based regimen for children with previously untreated acute myeloid leukemia: 10-year retrospective, multicenter study in Korea.

  Journal of Korean medical science 20100101

• Repeated spontaneous pregnancies and successful deliveries after repeated autologous stem cell transplantation and GnRH-agonist treatment.

  The oncologist 20100101

• The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemia.

  Molecular cancer 20100101

• A comparison of azacitidine and decitabine activities in acute myeloid leukemia cell lines.

  PloS one 20100101

• [Clinical study of sequential high-dose chemotherapy with in vivo rituximab-purged stem cell autografting for mantle cell lymphoma].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20100101

• Microglial responses around intrinsic CNS neurons are correlated with axonal regeneration.

  BMC neuroscience 20100101

• Downstream EWS/FLI1 - upstream Ewing's sarcoma.

  Genome medicine 20100101

• Potential and perspectives of cyclonucleosides.

  Current medicinal chemistry 20100101

• [Patients older than 80 years with de novo acute myeloid leukemias without erythroblastic and/or megakaryocytic dysplasia achieve complete remission and longer survival after classical chemotherapy 3 + 7].

  Vnitrni lekarstvi 20100101

• Comprehensive survey of SNPs in the Affymetrix exon array using the 1000 Genomes dataset.

  PloS one 20100101

• Summary of 615 patients of chronic myeloid leukemia in Shanghai from 2001 to 2006.

  Journal of experimental & clinical cancer research : CR 20100101

• Derivation of primary choroid plexus epithelial cells from the mouse.

  Methods in molecular biology (Clifton, N.J.) 20100101

• Pancratistatin induces apoptosis in clinical leukemia samples with minimal effect on non-cancerous peripheral blood mononuclear cells.

  Cancer cell international 20100101

• Extracellular signal-regulated kinase 1/2 plays a pro-life role in experimental brain stem death via MAPK signal-interacting kinase at rostral ventrolateral medulla.

  Journal of biomedical science 20100101

• Successful treatment of Cisplatin overdose with plasma exchange.

  Case reports in medicine 20100101

• Therapy of acute myelogenous leukemia in adults.

  Cancer treatment and research 20100101

• Cytosine-arabinoside-induced keratopathy: a model of corneal proliferation kinetics.

  Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde 20100101

• Promyelocytic sarcoma of the spine: a case report and review of the literature.

  Advances in hematology 20100101

• A case of acute colitis with severe rectal bleeding in a patient with chronic myeloid leukemia after dasatinib use.

  Acta haematologica 20100101

• New liposomal cytarabine formulation in CSF.

  Clinical laboratory 20100101

• Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury.

  Journal of neuroinflammation 20100101

• Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases.

  Journal of cardiothoracic surgery 20100101

• Cyclodepsipeptides from marine sponges: natural agents for drug research.

  Marine drugs 20100101

• Novel agents and regimens for acute myeloid leukemia: 2009 ASH annual meeting highlights.

  Journal of hematology & oncology 20100101

• Voreloxin is an anticancer quinolone derivative that intercalates DNA and poisons topoisomerase II.

  PloS one 20100101

• Tumor tissue-derived formaldehyde and acidic microenvironment synergistically induce bone cancer pain.

  PloS one 20100101

• Polysaccharopeptides derived from Coriolus versicolor potentiate the S-phase specific cytotoxicity of Camptothecin (CPT) on human leukemia HL-60 cells.

  Chinese medicine 20100101

• Fludarabine-induced bradycardia in a patient with refractory leukemia.

  Annals of Saudi medicine 20100101

• Primary Burkitt's lymphoma of the ovary.

  African journal of paediatric surgery : AJPS 20100101

• Successful treatment of a granulocytic sarcoma of the uterine cervix in complete remission at six-year follow-up.

  Journal of oncology 20100101

• Analyses of ERG in a patient with intraocular lymphoma.

  Clinical ophthalmology (Auckland, N.Z.) 20100101

• Gemcitabine and treatment of diffuse large B-cell lymphoma in relapsed or refractory elderly patients: a prospective randomized trial in Algeria.

  Journal of cancer research and therapeutics 20100101

• Treatment outcome of acute promyelocytic leukemia with modified aida protocol.

  Advances in hematology 20100101

• Nucleoside drugs induce cellular differentiation by caspase-dependent degradation of stem cell factors.

  PloS one 20100101

• Attenuation of vaccinia virus by the expression of human Flt3 ligand.

  Virology journal 20100101

• Vascular endothelial growth factor-related pathways in hemato-lymphoid malignancies.

  Journal of oncology 20100101

• Inhibition of ABCB1 (MDR1) expression by an siRNA nanoparticulate delivery system to overcome drug resistance in osteosarcoma.

  PloS one 20100101

• Prevention of catheter-related bacteremia with a daily ethanol lock in patients with tunnelled catheters: a randomized, placebo-controlled trial.

  PloS one 20100101

• Copy number variation and cytidine analogue cytotoxicity: a genome-wide association approach.

  BMC genomics 20100101

• Acral erythema with bullous formation: a side effect of chemotherapy in a child with acute lymphoblastic leukemia.

  The Turkish journal of pediatrics 20100101

• Clinical trials with anti-angiogenic agents in hematological malignancies.

  Journal of angiogenesis research 20100101

• Lentinan: hematopoietic, immunological, and efficacy studies in a syngeneic model of acute myeloid leukemia.

  Nutrition and cancer 20100101

• [Acute myeloid leukemia in adults: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán from 2003 to 2008].

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20100101

• A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2.

  Acta haematologica 20100101

• Insertion of vaccinia virus C7L host range gene into NYVAC-B genome potentiates immune responses against HIV-1 antigens.

  PloS one 20100101

• An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes.

  OncoTargets and therapy 20100101

• Granulocytic sarcoma of the pancreas: a case report and review of the literatures.

  BMC gastroenterology 20100101

• Nigella sativa L. seed extract modulates the neurotransmitter amino acids release in cultured neurons in vitro.

  Journal of biomedicine & biotechnology 20100101

• Challenges in treating older patients with acute myeloid leukemia.

  Journal of oncology 20100101

• Use of clofarabine for acute childhood leukemia.

  Biologics : targets & therapy 20100101

• Systemic mastocytosis associated with acute myeloid leukaemia.

  Pathology 20100101

• Modified outpatient dexamethazone, cytarabine and cisplatin regimen may lead to high response rates and low toxicity in lymphoma.

  Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20100101

• Expression profile and specific network features of the apoptotic machinery explain relapse of acute myeloid leukemia after chemotherapy.

  BMC cancer 20100101

• Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines.

  Chinese medicine 20100101

• Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients.

  BMC cancer 20100101

• Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.

  Journal of oncology 20100101

• Adhesion-induced drug resistance in leukemia stem cells.

  Pharmacology 20100101

• Scope of nanotechnology in ovarian cancer therapeutics.

  Journal of ovarian research 20100101

• Dynamics of Kv1 channel transport in axons.

  PloS one 20100101

• Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment concept.

  BMC cancer 20100101

• Basic mechanisms of arsenic trioxide (ATO)-induced apoptosis in human leukemia (HL-60) cells.

  Journal of hematology & oncology 20100101

• Recent advances in the treatment of acute myeloid leukemia.

  F1000 medicine reports 20100101

• Mechanistic insights on the inhibition of c5 DNA methyltransferases by zebularine.

  PloS one 20100101

• Distinct patterns of DNA damage response and apoptosis correlate with Jak/Stat and PI3kinase response profiles in human acute myelogenous leukemia.

  PloS one 20100101

• Successful allogeneic hematopoietic stem cell transplantation for aggressive NK cell leukemia.

  Internal medicine (Tokyo, Japan) 20100101

• Membranous nephropathy and lupus-like syndrome after hematopoietic cell transplantation: a case report.

  Journal of medical case reports 20100101

• Clinical study of adjuvant capecitabine monotherapy in Chinese elderly patients (aged 55-70) with stage IIa breast cancer.

  Onkologie 20100101

• Dedifferentiation and proliferation of mammalian cardiomyocytes.

  PloS one 20100101

• Vitamin D in combination cancer treatment.

  Journal of Cancer 20100101

• [Toxicity of different treatment protocols for acute myeloid leukemias in adults: the results of four Russian multicenter studies].

  Terapevticheskii arkhiv 20100101

• [Recurrences of acute promyelocytic leukemia in children: experience with arsenic trioxide therapy and autologous hematopoietic cell transplantation].

  Terapevticheskii arkhiv 20100101

• Epigenetic approaches in the treatment of myelodysplastic syndromes: clinical utility of azacitidine.

  OncoTargets and therapy 20100101

• Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma.

  OncoTargets and therapy 20100101

• Current and emerging therapies for the treatment of pancreatic cancer.

  OncoTargets and therapy 20100101

• The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire.

  Advances in hematology 20100101

• Self-contained gene-set analysis of expression data: an evaluation of existing and novel methods.

  PloS one 20100101

• Protease activated receptors 1 and 4 sensitize TRPV1 in nociceptive neurones.

  Molecular pain 20100101

• Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity.

  PloS one 20100101

• Hairless expression attenuates apoptosis in a mouse model and the COS cell line; involvement of p53.

  PloS one 20100101

• Effect of genetic alterations of cytarabine- metabolizing enzymes in childhood acute lymphoblastic leukemia.

  Hematology/oncology and stem cell therapy 20100101

• Progressive multifocal leukoencephalopathy in a patient without apparent immunosuppression.

  Virology journal 20100101

• A novel spliced fusion of MLL with CT45A2 in a pediatric biphenotypic acute leukemia.

  BMC cancer 20100101

• Bilateral posterior RION after concomitant radiochemotherapy with temozolomide in a patient with glioblastoma multiforme: a case report.

  BMC cancer 20100101

• Non-small cell lung carcinoma presenting as carcinomatous meningitis.

  Lung India : official organ of Indian Chest Society 20100101

• Hydronephrosis Resulting from Bilateral Ureteral Stenosis: A Late Complication of Polyoma BK Virus Cystitis?

  Journal of transplantation 20100101

• Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses.

  PloS one 20100101

• The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells.

  BMC cancer 20100101

• Safety and efficacy of azacitidine in myelodysplastic syndromes.

  Drug design, development and therapy 20100101

• Comparison of mitotic cell death by chromosome fragmentation to premature chromosome condensation.

  Molecular cytogenetics 20100101

• Identification and structural analysis of C-terminally truncated collapsin response mediator protein-2 in a murine model of prion diseases.

  Proteome science 20100101

• Primary bilateral adrenal diffuse large B-cell lymphoma demonstrating adrenal failure.

  Internal medicine (Tokyo, Japan) 20100101

• The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective.

  ASN neuro 20100101

• Context-dependent cell cycle checkpoint abrogation by a novel kinase inhibitor.

  PloS one 20100101

• Influence of wild-type MLL on glucocorticoid sensitivity and response to DNA-damage in pediatric acute lymphoblastic leukemia.

  Molecular cancer 20100101

• The effect of differentiating and apoptotic agents on notch signalling pathway in hepatoblastoma.

  Hepato-gastroenterology 20100101

• Bilateral proptosis and bitemporal swelling: A rare manifestation of acute myeloid leukemia.

  Journal of pediatric neurosciences 20100101

• Enhanced engraftment of a very low-dose cord blood unit in an adult haemopoietic transplant by addition of six mismatched viable cord units.

  Stem cells international 20100101

• Functional characterization of FLT3 receptor signaling deregulation in acute myeloid leukemia by single cell network profiling (SCNP).

  PloS one 20100101

• Acute myelogenous leukemia patients are at low risk for invasive fungal infections after high-dose cytarabine consolidations and thus do not require prophylaxis.

  Acta haematologica 20100101

• Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.

  Oncology 20100101

• The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation.

  Radiation oncology (London, England) 20100101

• Molecular measurement of BCR-ABL transcript variations in chronic myeloid leukemia patients in cytogenetic remission.

  BMC blood disorders 20100101

• A hereditary spastic paraplegia mutation in kinesin-1A/KIF5A disrupts neurofilament transport.

  Molecular neurodegeneration 20100101

• Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen.

  BMC cancer 20100101

• The gene-reduction effect of chromosomal losses detected in gastric cancers.

  BMC gastroenterology 20100101

• Targeted therapy in lymphoma.

  Journal of hematology & oncology 20100101

• The use of chemotherapy regimens carrying a moderate or high risk of febrile neutropenia and the corresponding management of febrile neutropenia: an expert survey in breast cancer and non-Hodgkin's lymphoma.

  BMC cancer 20100101

• First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib.

  Journal of hematology & oncology 20100101

• Antiviral lead compounds from marine sponges.

  Marine drugs 20100101

• Marine benthic cyanobacteria contain apoptosis-inducing activity synergizing with daunorubicin to kill leukemia cells, but not cardiomyocytes.

  Marine drugs 20100101

• Marine antitumor drugs: status, shortfalls and strategies.

  Marine drugs 20100101

• Unilateral optic nerve infiltration as an initial site of relapse of acute lymphoblastic leukemia in remission.

  Oman journal of ophthalmology 20100101

• The pharmacogenetics of imanitib.

  Genome medicine 20100101

• Cell cycle-dependent priming action of granulocyte colony-stimulating factor (G-CSF) enhances in vitro apoptosis induction by cytarabine and etoposide in leukemia cell lines.

  Journal of clinical and experimental hematopathology : JCEH 20100101

• Outpatient management of acute myeloid leukemia after intensive consolidation chemotherapy is feasible and reduces hospital treatment costs.

  Onkologie 20100101

• Gemcitabine functions epigenetically by inhibiting repair mediated DNA demethylation.

  PloS one 20100101

• Simple and rapid enzymatic method for the synthesis of single-strand oligonucleotides containing trifluorothymidine.

  Nucleosides, nucleotides & nucleic acids 20100101

• Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.

  Journal of neuroinflammation 20100101

• The insulin-like growth factor-1 receptor kinase inhibitor, NVP-ADW742, suppresses survival and resistance to chemotherapy in acute myeloid leukemia cells.

  Oncology research 20100101

• Idiopathic hyperammonemia after chemotherapy with vinorelbine, topotecan, and cisplatin in a patient with acute lymphocytic leukemia.

  Hematology/oncology and stem cell therapy 20100101

• Nelarabine in the treatment of refractory T-cell malignancies.

  Clinical Medicine Insights. Oncology 20100101

• pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.

  PloS one 20100101

• Effects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placement.

  PloS one 20100101

• Monitoring treatment response of childhood acute lymphocytic leukemia with certain molecular and biochemical markers.

  Journal of biochemical and molecular toxicology 20100101

• Temsirolimus in the treatment of relapsed and/or refractory mantle cell lymphoma.

  Cancer management and research 20100101

• Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation.

  PloS one 20100101

• An update in management of noncutaneous T-cell lymphomas.

  Advances in hematology 20100101

• Combined effect of olfactory ensheathing cell (OEC) transplantation and glial cell line-derived neurotrophic factor (GDNF) intravitreal injection on optic nerve injury in rats.

  Molecular vision 20100101

• Hyperleukocytosis in a neonate: A diagnostic dilemma.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20100101

• Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase.

  Biologics : targets & therapy 20100101

• Early Detection of t(8;21) Chromosomal Translocations During Treatment of PML-RARA Positive Acute Promyelocytic Leukemia: A Case Study.

  Clinical Medicine Insights. Oncology 20100101

• Peripheral T-cell lymphoma: review and updates of current management strategies.

  Advances in hematology 20100101

• New trends in the standard of care for initial therapy of acute myeloid leukemia.

  Hematology. American Society of Hematology. Education Program 20100101

• Impact of autologous and allogeneic stem cell transplantation in peripheral T-cell lymphomas.

  Advances in hematology 20100101

• The spectrum of use of rituximab in chronic lymphocytic leukemia.

  OncoTargets and therapy 20100101

• Genetic polymorphisms of ATP-binding cassette (ABC) proteins, overall survival and drug toxicity in patients with Acute Myeloid Leukemia.

  International journal of molecular epidemiology and genetics 20100101

• [Long-term observations of children with acute lymphoblastic leukemia and high leukocytosis treated according to modified 'New York' protocols (1987-2003)].

  Przeglad lekarski 20100101

• XPD DNA nucleotide excision repair gene polymorphisms associated with DNA repair deficiency predict better treatment outcomes in secondary acute myeloid leukemia.

  International journal of molecular epidemiology and genetics 20100101

• Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients.

  Mediterranean journal of hematology and infectious diseases 20100101

• Allogeneic hematopoietic cell transplantation in the treatment of chronic lymphocytic leukemia: why and when?

  Mediterranean journal of hematology and infectious diseases 20100101

• Role and timing of hematopoietic cell transplantation for myelodysplastic syndrome.

  Mediterranean journal of hematology and infectious diseases 20100101

• Clinical analysis and optimization of postremission therapy for acute myeloid leukemia patients with minimal residual disease as determined by flow cytometry.

  Mediterranean journal of hematology and infectious diseases 20100101

• Allogeneic transplantation for chronic lymphocytic leukemia.

  Mediterranean journal of hematology and infectious diseases 20100101

• Treatment of cancer in the older aged person.

  Mediterranean journal of hematology and infectious diseases 20100101

• Membrane-Bound Catechol-O-Methyl Transferase in Cortical Neurons and Glial Cells is Intracellularly Oriented.

  Frontiers in psychiatry 20100101

• [Therapeutic impact of alpha interferon in chronic myelogenous leukaemia].

  Le Mali medical 20100101

• [A case of the association of acute lymphoblastic lymphoma with active tuberculosis in the child: a Malian case].

  Le Mali medical 20100101

• Apoptosis photoinduction by C60 fullerene in human leukemic T cells.

  Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20100101

• Auricular oedema and dyshidrotic eczema in a patient with acute myeloid leukaemia treated with cytarabine.

  Case reports in oncology 20100101

• Herbo-mineral ayurvedic treatment in a high risk acute promyelocytic leukemia patient with second relapse: 12 years follow up.

  Journal of Ayurveda and integrative medicine 20100101

• Autologous blood stem cell transplantation for Hodgkin and non-Hodgkin lymphoma: complications and outcome.

  The National medical journal of India 20100101

• Dual-Positive (CD4+/CD8+) Acute Adult T-Cell Leukemia/Lymphoma Associated with Complex Karyotype and Refractory Hypercalcemia: Case Report and Literature Review.

  Case reports in oncology 20100101

• Rituximab in the treatment of B-cell non-Hodgkin lymphoma, focus on outcomes and comparative effectiveness.

  ClinicoEconomics and outcomes research : CEOR 20100101

• The protein kinase C agonist PEP005 (ingenol 3-angelate) in the treatment of human cancer: a balance between efficacy and toxicity.

  Toxins 20100101

• Nanomedicine formulations for combination therapies.

  Nano reviews 20100101

• Treatment of acute myelogenous leukemia in a Mexican pediatric hospital.

  Proceedings of the Western Pharmacology Society 20100101

• Adverse drug effects in hospitalized elderly: data from the healthcare cost and utilization project.

  Clinical pharmacology : advances and applications 20100101

• Prevention and management of antineoplastic therapy induced oral mucositis.

  National journal of maxillofacial surgery 20100101

• Chemotherapy-induced oesophageal stricture in a child with osteosarcoma: a case report.

  Chemotherapy research and practice 20100101

• Neurogenesis and astrogenesis contribution to recovery of vestibular functions in the adult cat following unilateral vestibular neurectomy: cellular and behavioral evidence.

  Neuroscience 20091229

• Anthracycline dose intensification in acute myeloid leukemia.

  The New England journal of medicine 20091224

• Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091220

• FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.

  Biochemical and biophysical research communications 20091218

• Epidemiologic study on survival of chronic myeloid leukemia and Ph(+) acute lymphoblastic leukemia patients with BCR-ABL T315I mutation.

  Blood 20091217

• Pulmonary tuberculosis presenting as fever without source in a pediatric patient with acute lymphoblastic leukemia.

  Pediatric blood & cancer 20091215

• Citrulline as a marker for chemotherapy induced mucosal barrier injury in pediatric patients.

  Pediatric blood & cancer 20091215

• Weight patterns in children with higher risk ALL: A report from the Children's Oncology Group (COG) for CCG 1961.

  Pediatric blood & cancer 20091215

• Atomic force microscope study of tumor cell membranes following treatment with anti-cancer drugs.

  Biosensors & bioelectronics 20091215

• Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group.

  Pediatric blood & cancer 20091215

• Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091210

• Interneurons produced in adulthood are required for the normal functioning of the olfactory bulb network and for the execution of selected olfactory behaviors.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20091202

• Fludarabine, amsacrine, high-dose cytarabine and 12 Gy total body irradiation followed by allogeneic hematopoietic stem cell transplantation is effective in patients with relapsed or high-risk acute lymphoblastic leukemia.

  Bone marrow transplantation 20091201

• DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study.

  European journal of haematology 20091201

• High rates of durable response are achieved with imatinib after treatment with interferon alpha plus cytarabine: results from the International Randomized Study of Interferon and STI571 (IRIS) trial.

  Haematologica 20091201

• Successful bortezomib-based treatment in POEMS syndrome.

  European journal of haematology 20091201

• Hyperleukocytotic secondary acute myeloid leukemia (AML) with sole monosomy 7 as sequela of Philadelphia-chromosome positive chronic myeloid leukemia (CML).

  European journal of haematology 20091201

• A new pattern of cytosine-arabinoside-induced lung toxicity.

  British journal of haematology 20091201

• Leptomeningeal metastasis.

  Current opinion in neurology 20091201

• High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG.

  Leukemia 20091201

• Treatment of children with acute promyelocytic leukemia: results of the first North American Intergroup trial INT0129.

  Pediatric blood & cancer 20091201

• Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia.

  American journal of hematology 20091201

• Disease status at autologous stem cell transplantation and the cell of origin phenotype are important predictors of outcome in patients with neurologic (central nervous system) relapse of diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.

  Leukemia & lymphoma 20091201

• Topoisomerase IIalpha expression in acute myeloid leukaemia cells that survive after exposure to daunorubicin or ara-C.

  Oncology reports 20091201

• Clofarabine-based salvage chemotherapy for relapsed or refractory acute leukemia before allogeneic stem cell transplantation: results from a case series.

  Leukemia & lymphoma 20091201

• Last exit clofarabine?

  Leukemia & lymphoma 20091201

• [FLAG regimen as consolidation therapy for patients with acute myeloid leukemia].

  Zhongguo shi yan xue ye xue za zhi 20091201

• Neoplastic meningitis from breast cancer: feasibility and activity of long-term intrathecal liposomal Ara-C combined with dose-dense temozolomide.

  Anticancer research 20091201

• Molecular responses during chemotherapy in acute myeloid leukemias in predicting poor-response to standard chemotherapy.

  The Malaysian journal of pathology 20091201

• Serum potassium, calcium and magnesium in patients receiving ESHAP chemotherapy for relapsed lymphomas.

  The journal of the Royal College of Physicians of Edinburgh 20091201

• The Prognostic Impact of K-RAS Mutations in Adult Acute Myeloid Leukemia Patients Treated with High Dose Cytarabine.

  Journal of the Egyptian National Cancer Institute 20091201

• Outcome and haemato-toxicity of two chemotherapy regimens for childhood non-Hodgkin's lymphoma in a Kenyan hospital.

  East African medical journal 20091201

• WU Polyomavirus (WUPyV): A Recently Detected Virus Causing Respiratory Disease?

  Viruses 20091201

• Identification of the amino acid-AZT-phosphoramidase by affinity T7 phage display selection.

  Bioorganic & medicinal chemistry letters 20091115

• Constitutive activation of the DNA damage signaling pathway in acute myeloid leukemia with complex karyotype: potential importance for checkpoint targeting therapy.

  Cancer research 20091115

• Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091110

• Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse.

  Blood 20091105

• pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells.

  International journal of pharmaceutics 20091103

• JS-K, an arylating nitric oxide (NO) donor, has synergistic anti-leukemic activity with cytarabine (ARA-C).

  Leukemia research 20091101

• Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.

  Annals of hematology 20091101

• Treatment outcome of adult patients with Burkitt lymphoma: results using the LMB protocol in Korea.

  Annals of hematology 20091101

• Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.

  Annals of hematology 20091101

• Intermediate dose gemcitabine-cisplatin combination chemotherapy without treatment delay for cytopenia followed by autografting--a new standard of care in relapsed or refractory Hodgkin lymphoma?

  Annals of hematology 20091101

• Separation of diastereoisomers of Ara-C phosphotriesters using solid phase extraction and HPLC for the study of their decomposition kinetic in cell extracts.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091101

• Successful treatment of congenital acute myeloid leukemia (AML-M6) in a premature infant.

  Journal of pediatric hematology/oncology 20091101

• Severe anterior uveitis as a complication of high-dose cytosine-arabinoside.

  Acta ophthalmologica 20091101

• Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.

  American journal of hematology 20091101

• Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101

• Quantifying the survival benefit for allogeneic hematopoietic stem cell transplantation in relapsed acute myelogenous leukemia.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20091101

• A phase I study of the mammalian target of rapamycin inhibitor sirolimus and MEC chemotherapy in relapsed and refractory acute myelogenous leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20091101

• Mitoxantrone and etoposide in patients with newly diagnosed acute myeloid leukemia with persistent leukemia after a course of therapy with cytarabine and idarubicin.

  Leukemia & lymphoma 20091101

• Positron emission tomography guided therapy of aggressive non-Hodgkin lymphomas--the PETAL trial.

  Leukemia & lymphoma 20091101

• Mast cell leukemia with rapidly progressing portal hypertension.

  Pathology international 20091101

• Heparin and suramin alter plitidepsin uptake via inhibition of GPCR coupled signaling.

  Journal of chemotherapy (Florence, Italy) 20091101

• 7.0-Tesla Tesla magnetic resonance imaging of granulomatous meningoencephalitis in a Maltese dog: a comparison with 0.2 and 1.5-Tesla.

  The Journal of veterinary medical science 20091101

• Multiple hepatocellular carcinomas developed 15 months after commencement of chemotherapy for elderly acute myelogenous leukemia.

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20091101

• Successful treatment with autologous peripheral blood stem cell transplantation for acquired immunodeficiency syndrome (AIDS)-related malignant lymphoma.

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20091101

• The cytotoxic effects of gemtuzumab ozogamicin (mylotarg) in combination with conventional antileukemic agents by isobologram analysis in vitro.

  Anticancer research 20091101

• [Inhibitive effect of artesunate on human lymphoblastic leukemia/lymphoma cells].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20091101

• High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

  Lancet (London, England) 20091031

• Progress in primary CNS lymphoma.

  Lancet (London, England) 20091031

• [Therapeutic management of central nervous system lymphomas in a single hematological institute].

  Orvosi hetilap 20091018

• Expression of eukaryotic initiation factor 4E predicts clinical outcome in patients with mantle cell lymphoma treated with hyper-CVAD and rituximab, alternating with rituximab, high-dose methotrexate, and cytarabine.

  Cancer 20091015

• Structure-activity relationship and molecular mechanisms of ethyl 2-amino-4-(2-ethoxy-2-oxoethyl)-6-phenyl-4h-chromene-3-carboxylate (sha 14-1) and its analogues.

  Journal of medicinal chemistry 20091008

• Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children.

  Leukemia research 20091001

• Self-reported experience of mucositis in cancer patients who underwent conditioning regimen and stem cell transplantation.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20091001

• Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers.

  Cancer chemotherapy and pharmacology 20091001

• Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma.

  Cancer chemotherapy and pharmacology 20091001

• Intrathecal liposomal cytarabine in children under 4 years with malignant brain tumors.

  Journal of neuro-oncology 20091001

• SNP analyses in cytarabine metabolizing enzymes in AML patients and their impact on treatment response and patient survival: identification of CDA SNP C-451T as an independent prognostic parameter for survival.

  Leukemia 20091001

• Chemotherapy-induced palmoplantar erythrodysesthesia in a child with Burkitt lymphoma.

  Pediatric blood & cancer 20091001

• Novel N-(3-carboxyl-9-benzyl-beta-carboline-1-yl)ethylamino acids: synthesis, anti-tumor evaluation, intercalating determination, 3D QSAR analysis and docking investigation.

  European journal of medicinal chemistry 20091001

• Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells.

  Blood 20091001

• Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study.

  Anti-cancer drugs 20091001

• Glyceraldehyde 3-phosphate dehydrogenase depletion induces cell cycle arrest and resistance to antimetabolites in human carcinoma cell lines.

  The Journal of pharmacology and experimental therapeutics 20091001

• Incidence and outcome of patients with diffuse large B cell lymphoma with marrow involvement and preliminary experience of an adult acute lymphoblastic leukemia protocol (NEALL VI) in cyclophosphamide, doxorubicin, vincristine, and prednisolone--rituximab refractory patients.

  Leukemia & lymphoma 20091001

• Phase I/II trial of AEG35156 X-linked inhibitor of apoptosis protein antisense oligonucleotide combined with idarubicin and cytarabine in patients with relapsed or primary refractory acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20091001

• A 51-year-old male CML patient with progressive hearing loss, confusion, ataxia, and aphasia during imatinib treatment.

  American journal of hematology 20091001

• The effect of active hexose correlated compound in modulating cytosine arabinoside-induced hair loss, and 6-mercaptopurine- and methotrexate-induced liver injury in rodents.

  Cancer epidemiology 20091001

• FLAIE (fludarabine, cytarabine, idarubicin, and etoposide), a four drug induction chemotherapy for adult acute myeloid leukemia: A single center experience.

  American journal of hematology 20091001

• A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.

  Acta pharmacologica Sinica 20091001

• Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs.

  International journal of hematology 20091001

• Fulminant fatal cardiotoxicity following cyclophosphamide therapy.

  Journal of cardiology 20091001

• Toxicity and efficacy of 5-fluorouracil and capecitabine in a patient with TYMS gene polymorphism: A challenge or a dilemma?

  Clinical colorectal cancer 20091001

• [Effect of FLAG consolidation therapy on mobilization of autologous peripheral blood stem cells in patients with acute myelogenous leukemia].

  Zhongguo shi yan xue ye xue za zhi 20091001

• [Clinical study on regimen cyclophosphamide, Ara-C and topotecan (CAT) in treatment of patients with refractory or relapsed acute myelogenous leukemia].

  Zhongguo shi yan xue ye xue za zhi 20091001

• Genetic factors influencing cytarabine therapy.

  Pharmacogenomics 20091001

• Outpatient consolidation chemotherapy in pediatric acute myeloid leukemia: a retrospective analysis.

  Hematology (Amsterdam, Netherlands) 20091001

• Rapid induction of P-glycoprotein mRNA and protein expression by cytarabine in HL-60 cells.

  Anticancer research 20091001

• [History, current status, and future prospects in clinical study of myeloid leukemia].

  Nihon rinsho. Japanese journal of clinical medicine 20091001

• [Combination chemotherapy for acute myeloid leukemia].

  Nihon rinsho. Japanese journal of clinical medicine 20091001

• [Characteristics of elderly patients with acute myelogenous leukemia].

  Nihon rinsho. Japanese journal of clinical medicine 20091001

• [Management of diffuse large B-cell lymphoma in the rituximab era].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20091001

• [Standard therapies for acute myeloid leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20091001

• [Prognosis and chromosomal abnormalities in 79 children with t (8;21) acute myeloid leukemia].

  Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20091001

• Neurofilament isoform alterations in the rat cerebellum following cytosine arabinoside administration.

  Toxicology letters 20090928

• RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.

  Blood 20090924

• High-dose daunorubicin in older patients with acute myeloid leukemia.

  The New England journal of medicine 20090924

• Anthracycline dose intensification in acute myeloid leukemia.

  The New England journal of medicine 20090924

• Chronic myeloid leukemia (CML) with P190 BCR-ABL: analysis of characteristics, outcomes, and prognostic significance.

  Blood 20090910

• Discovery of a new template for anticancer agents: 2'-deoxy-2'-fluoro-4'-selenoarabinofuranosyl-cytosine (2'-F-4'-seleno-ara-C).

  Journal of medicinal chemistry 20090910

• FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt.

  Cancer cell 20090908

• Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.

  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20090901

• Auto-SCT for AML in second remission: CALGB study 9620.

  Bone marrow transplantation 20090901

• Synthesis and evaluation of anti-tumor activities of N4 fatty acyl amino acid derivatives of 1-beta-arabinofuranosylcytosine.

  European journal of medicinal chemistry 20090901

• Improved outcome for Chinese children with acute promyelocytic leukemia: a comparison of two protocols.

  Pediatric blood & cancer 20090901

• H(2)O(2)-mediated modulation of cytosolic signaling and organelle function in rat hippocampus.

  Pflugers Archiv : European journal of physiology 20090901

• Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2.

  International journal of cancer 20090901

• Pin1 affects Tau phosphorylation in response to Abeta oligomers.

  Molecular and cellular neurosciences 20090901

• Gfi-1B promoter remains associated with active chromatin marks throughout erythroid differentiation of human primary progenitor cells.

  Stem cells (Dayton, Ohio) 20090901

• Tailoring treatment strategy for acute promyelocytic leukemia in low-income countries.

  Pediatric blood & cancer 20090901

• Inhibition of MEK signaling enhances the ability of cytarabine to induce growth arrest and apoptosis of acute myelogenous leukemia cells.

  Apoptosis : an international journal on programmed cell death 20090901

• Rapamycin, the mTOR kinase inhibitor, sensitizes acute myeloid leukemia cells, HL-60 cells, to the cytotoxic effect of arabinozide cytarabine.

  Anti-cancer drugs 20090901

• Primary central nervous system lymphoma: recent progress, many remaining questions.

  Current opinion in oncology 20090901

• Myeloid/natural killer cell precursor acute leukemia with multiple subcutaneous nodules as the initial presentation: a case report and literature review.

  International journal of hematology 20090901

• Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.

  Leukemia & lymphoma 20090901

• Special feature of mixed phosphotriester derivatives of cytarabine.

  Bioorganic & medicinal chemistry 20090901

• New agents in acute myeloid leukemia: beyond cytarabine and anthracyclines.

  Current oncology reports 20090901

• Imatinib mesylate pharmacokinetics before and after sleeve gastrectomy in a morbidly obese patient with chronic myeloid leukemia.

  Pharmacotherapy 20090901

• [Blastic plasmacytoid dendritic cell neoplasm - a rare differential diagnosis of neoplastic skin infiltrations associated with systemic symptoms].

  Deutsche medizinische Wochenschrift (1946) 20090901

• Long-term outcomes of de novo acute myeloid leukemia in Thai patients.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090901

• Haploidentical hematopoietic stem-cell transplantation for non-Hodgkin lymphoma with bone marrow involvement.

  Leukemia & lymphoma 20090901

• Outcomes of CAG regimen for refractory biphenotypic acute leukemia patients.

  Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih 20090901

• I-Tositumomab in lymphoma.

  Current oncology (Toronto, Ont.) 20090901

• Retinoblastoma CSF metastasis cured by multimodality chemotherapy without radiation.

  Ophthalmic genetics 20090901

• Synthesis and conformational analysis of locked carbocyclic analogues of 1,3-diazepinone riboside, a high-affinity cytidine deaminase inhibitor.

  The Journal of organic chemistry 20090821

• Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090820

• Synthesis of radiolabeled cytarabine conjugates.

  Bioorganic & medicinal chemistry letters 20090815

• The FLT3 inhibitor tandutinib (formerly MLN518) has sequence-independent synergistic effects with cytarabine and daunorubicin.

  Cell cycle (Georgetown, Tex.) 20090815

• Synthesis, DNA intercalation and 3D QSAR analysis of cis-2,4,5-trisubstituted-1,3-dithiolanes as a novel class of antitumor agents.

  Bioorganic & medicinal chemistry 20090815

• Imatinib-induced pseudoporphyria.

  Clinical and experimental dermatology 20090801

• A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.

  Leukemia research 20090801

• Impact on survival of different treatments for myelodysplastic syndromes (MDS).

  Leukemia research 20090801

• Twice daily fludarabine/Ara-C associated to idarubicin, G-CSF and ATRA is an effective salvage regimen in non-promyelocytic acute myeloid leukemia.

  Leukemia research 20090801

• Continuous 24-h monitoring of electrocardiogram during anthracycline-based therapy in acute leukemia.

  Leukemia research 20090801

• Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial.

  Leukemia 20090801

• Is survival enough for myelodysplastic syndromes?

  Leukemia research 20090801

• Effect of cloretazine (VNP40101M) on acute myeloid leukaemia blast cells in vitro as a single agent and combined with cytarabine and daunorubicin.

  Leukemia research 20090801

• Laromustine: the return of alkylators to non-myeloablative therapy of AML.

  Leukemia research 20090801

• Cerebral non-Langerhans cell histiocytosis in a 17-year-old patient with a headache: case report.

  Journal of neurology 20090801

• Results of risk-adapted therapy in acute myeloid leukaemia. A long-term population-based follow-up study.

  European journal of haematology 20090801

• Vaccinia-induced epidermal growth factor receptor-MEK signalling and the anti-apoptotic protein F1L synergize to suppress cell death during infection.

  Cellular microbiology 20090801

• Low dose cytarabine in patients with relapsed or refractory Ewing sarcoma.

  Pediatric blood & cancer 20090801

• pY-STAT3 and p53 expression predict outcome for poor prognosis diffuse large B-cell lymphoma treated with high dose chemotherapy and autologous stem cell transplantation.

  Leukemia & lymphoma 20090801

• Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?

  Leukemia & lymphoma 20090801

• Autologous and allogeneic stem cell transplantation: rising therapeutic promise for mantle cell lymphoma.

  Leukemia & lymphoma 20090801

• In vitro effect of carboplatin, cytarabine, paclitaxel, vincristine, and low-power laser irradiation on murine mesenchymal stem cells.

  Lasers in surgery and medicine 20090801

• A modified haploidentical nonmyeloablative transplantation without T cell depletion for high-risk acute leukemia: successful engraftment and mild GVHD.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090801

• Cytosolic 5'-nucleotidase III (NT5C3): gene sequence variation and functional genomics.

  Pharmacogenetics and genomics 20090801

• A non-apoptotic function of caspase-3 in pharmacologically-induced differentiation of K562 cells.

  British journal of pharmacology 20090801

• [A case of primary gastric mantle cell lymphoma].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20090801

• Nidogen plays a role in the regenerative axon growth of adult sensory neurons through Schwann cells.

  Journal of Korean medical science 20090801

• SKP2 siRNA inhibits the degradation of P27kip1 and down-regulates the expression of MRP in HL-60/A cells.

  Acta biochimica et biophysica Sinica 20090801

• Central nervous system disease in hematologic malignancies: historical perspective and practical applications.

  Seminars in oncology 20090801

• MRSA-pyomyositis in a patient with acute myelogenous leukemia after intensive chemotherapy.

  Anticancer research 20090801

• Influence of late treatment on how chronic myeloid leukemia responds to imatinib.

  Clinics (Sao Paulo, Brazil) 20090801

• Effectiveness of allogeneic NK cells in haploidentical bone marrow transplantation for leukemic mice.

  Zhongguo shi yan xue ye xue za zhi 20090801

• [Clinical research of modified CAG regimen for the treatment of relapsed acute myeloid leukemia].

  Zhongguo shi yan xue ye xue za zhi 20090801

• Regulation of host translational machinery by African swine fever virus.

  PLoS pathogens 20090801

• Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.

  Clinical lymphoma & myeloma 20090801

• Therapy-related acute myeloid leukemia following HIV-associated lymphoma.

  Clinical lymphoma & myeloma 20090801

• [Acute myeloid leukemia trials by Japan Adult Leukemia Study Group (JALSG)].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20090801

• [Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20090801

• [Multicenter report of nonmyeloablative allogeneic stem cell transplantation for hematologic diseases].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090801

• Survival is poorer in patients with secondary core-binding factor acute myelogenous leukemia compared with de novo core-binding factor leukemia.

  Cancer 20090715

• Stable interference of EWS-FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target.

  British journal of cancer 20090707

• [One hundred fifty autologous peripheral haemopoietic stem cell transplantations and their lessons].

  Orvosi hetilap 20090705

• Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.

  Cancer chemotherapy and pharmacology 20090701

• Pharmacokinetics of CPX-351 (cytarabine/daunorubicin HCl) liposome injection in the mouse.

  Journal of pharmaceutical sciences 20090701

• Efficacy of continuous venovenous hemofiltration with chemotherapy in patients with Burkitt lymphoma and leukemia at high risk of tumor lysis syndrome.

  Annals of hematology 20090701

• Pseudohypopyon: Extramedullary relapse of acute myelogenous leukemia with poor prognosis.

  Pediatric blood & cancer 20090701

• Shortened and intensified MJMA: an effective salvage therapy for relapsed and refractory lymphomas and a strong mobilizer of PBSCs.

  Bone marrow transplantation 20090701

• Allo-SCT conditioning for myelodysplastic syndrome and acute myeloid leukemia with clofarabine, cytarabine and ATG.

  Bone marrow transplantation 20090701

• Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.

  European journal of haematology 20090701

• Idiopathic hyperammonemia (IHA) after dose-dense induction chemotherapy for acute myeloid leukemia: Case report and review of the literature.

  Leukemia research 20090701

• Molecular targeting of MLL-rearranged leukemia cell lines with the synthetic peptide PFWT synergistically enhances the cytotoxic effect of established chemotherapeutic agents.

  Leukemia research 20090701

• GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.

  Pediatric blood & cancer 20090701

• An uncommon cause of small bowel obstruction: isolated primary granulocytic sarcoma.

  QJM : monthly journal of the Association of Physicians 20090701

• Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia.

  American journal of hematology 20090701

• Reappearance of acute myeloid leukemia after almost 23 years of continuous complete remission.

  American journal of hematology 20090701

• Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090701

• A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma.

  Leukemia & lymphoma 20090701

• ASCT in follicular lymphoma.

  Nature reviews. Clinical oncology 20090701

• [Prophylaxis and treatment of modified BFM-90 regimen for lymphoblastic lymphoma in children and adolescents accompanied with infection].

  Ai zheng = Aizheng = Chinese journal of cancer 20090701

• Apoptosis of t(14;18)-positive lymphoma cells by a Bcl-2 interacting small molecule.

  Journal of hematopathology 20090701

• Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism.

  British journal of cancer 20090616

• Retraction notice to: 'Simultaneous micellar electrokinetic chromatography and liquid chromatography of adriblastina and tarabine PFS: Their application to some biological fluids' [Talanta 66 (2005) 253-260].

  Talanta 20090615

• Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.

  Biochemical pharmacology 20090615

• Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100.

  Blood 20090611

• The management of prolonged, isolated hyperbilirubinemia following cytarabine-based chemotherapy for acute myeloid leukaemia.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20090601

• A multicenter phase II trial of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin for patients with primary refractory/relapsed aggressive non-Hodgkin's lymphoma.

  Cancer chemotherapy and pharmacology 20090601

• Variability in responsiveness to lovastatin of the primitive CD34+ AML subfraction compared to normal CD34+ cells.

  Annals of hematology 20090601

• Liposomal cytarabine in cerebrospinal fluid.

  British journal of haematology 20090601

• Inappropriate antidiuretic hormone production by leukaemic blasts in acute myeloid leukaemia.

  British journal of haematology 20090601

• [Klinefelter syndrome and acute myeloblastic leukaemia].

  Presse medicale (Paris, France : 1983) 20090601

• Effective treatment of advanced-stage childhood lymphoblastic lymphoma without prophylactic cranial irradiation: results of St Jude NHL13 study.

  Leukemia 20090601

• The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells.

  Leukemia 20090601

• Neoplastic meningitis from breast carcinoma with complete response to liposomal cytarabine: case report.

  Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20090601

• Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia.

  Leukemia 20090601

• A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels.

  Pharmaceutical research 20090601

• Langerhans cell histiocytosis of the sternum.

  Upsala journal of medical sciences 20090601

• Tumour necrosis factor alpha activates nuclear factor kappaB signalling to reduce N-type voltage-gated Ca2+ current in postganglionic sympathetic neurons.

  The Journal of physiology 20090601

• Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090601

• Acute myelogenous leukemia.

  Experimental hematology 20090601

• The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.

  Cancer research 20090601

• Bortezomib in treatment of extramedullary plasmacytoma of the pancreas.

  Hepatobiliary & pancreatic diseases international : HBPD INT 20090601

• Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.

  Puerto Rico health sciences journal 20090601

• The clinical outcome of FLAG chemotherapy without idarubicin in patients with relapsed or refractory acute myeloid leukemia.

  Journal of Korean medical science 20090601

• [Allogeneic hematopoietic stem cell transplantation in 6 patients with myelodysplastic syndrome].

  Zhongguo shi yan xue ye xue za zhi 20090601

• [Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming in 50 patients with relapsed acute myeloid leukemia].

  Zhongguo shi yan xue ye xue za zhi 20090601

• [Clinical study on fludarabine combined with cytarabine regimen in the treatment of patients with refractory and relapsed acute myeloid leukemia].

  Zhongguo shi yan xue ye xue za zhi 20090601

• Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy.

  Chinese journal of integrative medicine 20090601

• Regimen containing perarubicin for the treatment of newly diagnosed young patients with acute myeloid leukemia.

  Ai zheng = Aizheng = Chinese journal of cancer 20090601

• Treatment of meningoencephalitis of unknown origin in a dog.

  The Veterinary record 20090516

• Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy.

  Cancer 20090515

• The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine.

  Journal of medicinal chemistry 20090514

• Chemotherapy and dasatinib induce long-term hematologic and molecular remission in systemic mastocytosis with acute myeloid leukemia with KIT D816V.

  Leukemia research 20090501

• Intractable epilepsy in patients treated for childhood acute lymphocytic leukemia.

  Seizure 20090501

• Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.

  Bone marrow transplantation 20090501

• The effect of cantharidins on leukemic stem cells.

  International journal of cancer 20090501

• Acute myelogenous leukemia presenting as acute infectious meningitis in a 7-year-old boy.

  Clinical pediatrics 20090501

• Treatment-subgroup interaction: an example from a published, phase II clinical trial.

  Contemporary clinical trials 20090501

• Efficacy and safety of liposomal cytarabine in lymphoma patients with central nervous system involvement from lymphoma.

  Cancer 20090501

• Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells.

  Cancer science 20090501

• The impact of dose escalation and resistance modulation in older patients with acute myeloid leukaemia and high risk myelodysplastic syndrome: the results of the LRF AML14 trial.

  British journal of haematology 20090501

• Cytarabine-associated lymphoid dyscrasia with atypical T CD30+ infiltrate in a patient suffering from acute nonlymphoblastic leukaemia.

  The British journal of dermatology 20090501

• Role of the AraC-XylS family regulator YdeO in multi-drug resistance of Escherichia coli.

  The Journal of antibiotics 20090501

• R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome.

  Haematologica 20090501

• Synthesis of potent antitumor and antiviral benzofuran derivatives.

  Bioorganic & medicinal chemistry letters 20090501

• A novel regimen combining high dose cytarabine and bortezomib has activity in multiply relapsed and refractory mantle cell lymphoma - long-term results of a multicenter observation study.

  Leukemia & lymphoma 20090501

• Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.

  Cancer research 20090501

• [Stem cell therapy in multiple sclerosis: a clinical update].

  Zeitschrift fur Rheumatologie 20090501

• Delayed recognition of intrathecal methotrexate overdose.

  Journal of pediatric hematology/oncology 20090501

• Sinusal bradycardia after receiving intermediate or high dose cytarabine: four cases from a single institution.

  European journal of cancer care 20090501

• Efficacy and feasibility of IDEA therapy for refractory or relapsed non-Hodgkin's lymphoma.

  Anticancer research 20090501

• Viral sequestration of antigen subverts cross presentation to CD8(+) T cells.

  PLoS pathogens 20090501

• [Efficacy of modified B-NHL-BFM-90 protocol on anaplastic T-cell lymphoma in children and adolescents].

  Ai zheng = Aizheng = Chinese journal of cancer 20090501

• A successful treatment of relapsed primary CNS lymphoma patient with intraventricular rituximab followed by high-dose chemotherapy with autologous stem cell rescue.

  Yonsei medical journal 20090430

• Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCG.

  Blood 20090423

• A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy.

  Journal of medicinal chemistry 20090423

• Mucoepidermoid carcinoma of the submandibular gland after chemotherapy in a child.

  Auris, nasus, larynx 20090401

• A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.

  Cancer chemotherapy and pharmacology 20090401

• Favorable outcome with chemo-immunotherapy in Burkitt lymphoma and leukemia.

  Leukemia research 20090401

• Single-dose mitoxantrone in combination with continuous infusion intermediate-dose cytarabine plus etoposide for treatment of refractory or early relapsed acute myeloid leukemia.

  Leukemia research 20090401

• Induction of excision repairable DNA lesions in lymphocytes exposed to lead and ALA in vitro.

  Biological trace element research 20090401

• Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.

  Bone marrow transplantation 20090401

• Central and peripheral nervous system toxicity of common chemotherapeutic agents.

  Cancer chemotherapy and pharmacology 20090401

• Chemotherapy induced esophageal stricture.

  Pediatric blood & cancer 20090401

• A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.

  Leukemia 20090401

• Changes in acetylcholinesterase (AchE) activity in lymphocytes and whole blood in acute lymphoblastic leukemia patients.

  Clinica chimica acta; international journal of clinical chemistry 20090401

• Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature.

  Transplant infectious disease : an official journal of the Transplantation Society 20090401

• Yttrium-90 ibritumomab tiuxetan doses calculated to deliver up to 15 Gy to critical organs may be safely combined with high-dose BEAM and autologous transplantation in relapsed or refractory B-cell non-Hodgkin's lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090401

• The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.

  American journal of hematology 20090401

• miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche.

  Nature neuroscience 20090401

• Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells.

  International journal of oncology 20090401

• [Biventricular hypertrophic non-obstructive cardiomyopathy as a symptom of transient myeloproliferative disorder in a newborn with Down syndrome].

  Zeitschrift fur Geburtshilfe und Neonatologie 20090401

• Severe Henoch-Schönlein purpura induced by cytarabine.

  The Annals of pharmacotherapy 20090401

• Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage.

  Molecular cancer therapeutics 20090401

• Characterisation of extramedullary relapse in patients with chronic myeloid leukemia in advanced disease after allogeneic stem cell transplantation.

  Leukemia & lymphoma 20090401

• [Expression and function of Ahi-1 gene in Jurkat cells].

  Zhongguo shi yan xue ye xue za zhi 20090401

• [Efficacy of induction chemotherapy for patients with high-risk myelodysplastic syndrome (MDS) or MDS-transformed acute myeloid leukemia with CHG regimen and its comparison with regimen GAG and HA].

  Zhongguo shi yan xue ye xue za zhi 20090401

• [IDA-FLAG regimen in treatment of patients with refractory or relapsed acute leukemia].

  Zhongguo shi yan xue ye xue za zhi 20090401

• Improvement of induction remission rate by modifying the dose of idarubicin for relapsed childhood acute lymphoblastic leukemia.

  Journal of Korean medical science 20090401

• [Bacillus cereus sepsis and subarachnoid hemorrhage following consolidation chemotherapy for acute myelogenous leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20090401

• Successful use of full-dose dexamethasone, high-dose cytarabine, and cisplatin as part of initial therapy in non-hodgkin and hodgkin lymphoma with severe hepatic dysfunction.

  Clinical lymphoma & myeloma 20090401

• Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.

  Blood 20090305

• Intracerebroventricular infusion of cytosine-arabinoside causes prepulse inhibition disruption.

  Neuroreport 20090304

• Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.

  Cancer immunology, immunotherapy : CII 20090301

• Evaluation of osmolality and pH of various concentrations of methotrexate, cytarabine, and thiotepa prepared in normal saline, sterile water for injection, and lactated Ringer's solution for intrathecal administration.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20090301

• Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: final results of Children's Cancer Group Study 5941.

  Pediatric blood & cancer 20090301

• Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia.

  Leukemia 20090301

• Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group.

  Pediatric blood & cancer 20090301

• Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities.

  Annals of hematology 20090301

• CTLA-4 genotype and relapse incidence in patients with acute myeloid leukemia in first complete remission after induction chemotherapy.

  Leukemia 20090301

• Micafungin-induced immune hemolysis attacks.

  International journal of hematology 20090301

• Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine.

  Cancer 20090301

• Mass selection of ions from beams using waveform isolation in radiofrequency quadrupoles.

  Analytical chemistry 20090301

• Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: a prospective, multicenter phase II study.

  American journal of hematology 20090301

• Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20090301

• Avemar, a nontoxic fermented wheat germ extract, attenuates the growth of sensitive and 5-FdUrd/Ara-C cross-resistant H9 human lymphoma cells through induction of apoptosis.

  Oncology reports 20090301

• Preclinical studies of vorinostat (suberoylanilide hydroxamic acid) combined with cytosine arabinoside and etoposide for treatment of acute leukemias.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090301

• Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survival.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20090301

• Glycine transporter blockade ameliorates motor ataxia in a mouse model of spinocerebellar atrophy.

  Journal of pharmacological sciences 20090301

• Gemcitabine, etoposide, cisplatin, and dexamethasone in patients with refractory or relapsed non-Hodgkin's lymphoma.

  The Korean journal of internal medicine 20090301

• Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of the Polish Acute Leukemia Group.

  Leukemia & lymphoma 20090301

• [Effect of valproic acid on the expression of P27(Kip1) and P170 and drug resistance of HL-60/HT cells].

  Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20090301

• Biphenotypic acute leukemia treated with acute myeloid leukemia regimens: a case series.

  Journal of the National Medical Association 20090301

• Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma.

  Leukemia & lymphoma 20090301

• Development of cell-cycle inhibitors for cancer therapy.

  Current oncology (Toronto, Ont.) 20090301

• Concomitant renal cell carcinoma and chronic myelogenous leukemia: use of a targeted approach.

  Current oncology (Toronto, Ont.) 20090301

• Myeloid disease.

  Current opinion in hematology 20090301

• Core binding factor acute myeloid leukemia (CBF-AML): is high-dose Ara-C (HDAC) consolidation as effective as you think?

  Current opinion in hematology 20090301

• [Effect of berberine on the differentiation and apoptosis of K562 cell line].

  Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials 20090301

• Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia.

  Journal of hematopathology 20090301

• ['Squalenoylation': a new approach to the design of anticancer and antiviral nanomedicines].

  Bulletin de l'Academie nationale de medecine 20090301

• Effect of occupational exposure to cytostatics and nucleotide excision repair polymorphism on chromosomal aberrations frequency.

  Interdisciplinary toxicology 20090301

• Radiolytic activation of a cytarabine prodrug possessing a 2-oxoalkyl group: one-electron reduction and cytotoxicity characteristics.

  Organic & biomolecular chemistry 20090221

• Cytosine arabinoside-induced cytogenotoxicity in bone marrow and spermatogonial cells of mice and its potential transmission through the male germline.

  Mutation research 20090219

• Extending thymidine kinase activity to the catalytic repertoire of human deoxycytidine kinase.

  Biochemistry 20090217

• Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses.

  Bioorganic & medicinal chemistry letters 20090215

• Challenge of high polarity and low concentrations in analysis of cytostatics and metabolites in wastewater by hydrophilic interaction chromatography/tandem mass spectrometry.

  Journal of chromatography. A 20090213

• Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy.

  British journal of cancer 20090210

• Detection of excision repaired DNA damage in the comet assay by using Ara-C and hydroxyurea in three different cell types.

  Cell biology and toxicology 20090201

• Synthesis of glycose carbamides and evaluation of the induction of erythroid differentiation of human erythroleukemic K562 cells.

  European journal of medicinal chemistry 20090201

• Ligand-induced Flt3-downregulation modulates cell death associated proteins and enhances chemosensitivity to idarubicin in THP-1 acute myeloid leukemia cells.

  Leukemia research 20090201

• Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells.

  Leukemia research 20090201

• Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients.

  Annals of hematology 20090201

• Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C.

  Journal of neuro-oncology 20090201

• Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treatment: results of a phase II study.

  Journal of neuro-oncology 20090201

• Cytidine deaminase genotype and toxicity of cytosine arabinoside therapy in children with acute myeloid leukemia.

  British journal of haematology 20090201

• High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients.

  British journal of haematology 20090201

• Pseudo-bowel obstruction due to varicella zoster virus infection after autologous stem cell transplantation.

  American journal of hematology 20090201

• Prognostic significance of beta-catenin and topoisomerase IIalpha in de novo acute myeloid leukemia.

  American journal of hematology 20090201

• Lymphomatous meningitis: early diagnosis and treatment.

  Clinical journal of oncology nursing 20090201

• Small hairpin RNA targeting at Bcl-2 increases cytarabine-induced apoptosis in Raji cells.

  Acta biochimica et biophysica Sinica 20090201

• Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML.

  Onkologie 20090201

• Alemtuzumab and DHAP (A-DHAP) is effective for relapsed peripheral T-cell lymphoma, unspecified: interim results of a phase II prospective study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20090201

• Registry of Hospital das Clínicas of the University of São Paulo Medical School: first official solid organ and tissue transplantation report - 2008.

  Clinics (Sao Paulo, Brazil) 20090201

• Successful administration of cytarabine in a 16-month-old girl with acute myelogenous leukemia and cytarabine syndrome.

  Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 20090201

• [Effects of human ERMAP-siRNA on erythroid differentiation of K562 cells induced by Ara-C].

  Zhongguo shi yan xue ye xue za zhi 20090201

• [Standard-dose of idarubicin in combination with continuous infusion of cytarabine as induction therapy in patients with acute myeloid leukaemia].

  Zhongguo shi yan xue ye xue za zhi 20090201

• [Relapsed acute myeloid leukemia with Down syndrome showing long disease-free survival after bone marrow transplantation].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20090201

• [Interdigitating dendritic cell sarcoma of lower extremities resistant to high dose chemotherapy BEAM with peripheral blood stem cell transplantation].

  Vnitrni lekarstvi 20090201

• [The action of donor-derived NK cell in leukemic mice MHC haplotype-mismatched bone marrow transplantation].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090201

• Anticancer Chemotherapy and it's Anaesthetic Implications (Current Concepts).

  Indian journal of anaesthesia 20090201

• Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.

  Blood 20090122

• Identification of a novel point mutation in ENT1 that confers resistance to Ara-C in human T cell leukemia CCRF-CEM cells.

  FEBS letters 20090122

• Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines.

  Blood 20090115

• Complex t(2;21;8)(p12;q22;q22): a variant t(8;21) in a patient with acute myeloid leukemia (AML-M2).

  Cancer genetics and cytogenetics 20090115

• The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine.

  Journal of medicinal chemistry 20090108

• New uracil dimers showing erythroid differentiation inducing activities.

  Journal of medicinal chemistry 20090108

• Treatment of therapy-related acute myeloid leukemia occurring in elderly non-Hodgkin lymphoma patients with low-dose cytarabine, aclarubicin and granulocyte colony-stimulating factor.

  Leukemia research 20090101

• Rituximab-induced acute thrombocytopenia: a case report and review of the literature.

  Medical oncology (Northwood, London, England) 20090101

• Intravenous administration of CP-4055 (ELACYT) in patients with solid tumours. A Phase I study.

  Acta oncologica (Stockholm, Sweden) 20090101

• Dic(9;20)(p13;q11) in childhood acute lymphoblastic leukaemia is related to low cellular resistance to asparaginase, cytarabine and corticosteroids.

  Leukemia 20090101

• In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy.

  Leukemia research 20090101

• Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.

  Human pathology 20090101

• The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.

  Bone marrow transplantation 20090101

• Increased risk for invasive aspergillosis in patients with lymphoproliferative diseases after autologous hematopoietic SCT.

  Bone marrow transplantation 20090101

• Chitosan-based thermosensitive hydrogel containing liposomes for sustained delivery of cytarabine.

  Drug development and industrial pharmacy 20090101

• Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.

  Blood 20090101

• The key role of stem cell factor/KIT signaling in the proliferation of blast cells from Down syndrome-related leukemia.

  Leukemia 20090101

• Clinical management of primary non-acute promyelocytic leukemia acute myeloid leukemia: Practice Guidelines by the Italian Society of Hematology, the Italian Society of Experimental Hematology, and the Italian Group for Bone Marrow Transplantation.

  Haematologica 20090101

• M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit.

  Veterinary research 20090101

• Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20090101

• CP-4055 and CP-4126 are active in ara-C and gemcitabine-resistant lymphoma cell lines.

  British journal of haematology 20090101

• TRAIL-induced apoptosis of HL60 leukemia cells: two distinct phenotypes of acquired TRAIL resistance that are accompanied with resistance to TNFalpha but not to idarubicin and cytarabine.

  Blood cells, molecules & diseases 20090101

• Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimens.

  Cancer 20090101

• Synthesis, transport and pharmacokinetics of 5'-amino acid ester prodrugs of 1-beta-D-arabinofuranosylcytosine.

  Molecular pharmaceutics 20090101

• Carnosol delays chemotherapy-induced DNA fragmentation and morphological changes associated with apoptosis in leukemic cells.

  Nutrition and cancer 20090101

• Human multidrug resistance protein 7 (ABCC10) is a resistance factor for nucleoside analogues and epothilone B.

  Cancer research 20090101

• Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.

  Journal of pediatric hematology/oncology 20090101

• Granulocytic sarcoma of the breast without development of bone marrow involvement: a case report.

  Diagnostic pathology 20090101

• Impact of age, leukocyte count and day 21-bone marrow response to chemotherapy on the long-term outcome of children with philadelphia chromosome-positive acute lymphoblastic leukemia in the pre-imatinib era: results of the FRALLE 93 study.

  BMC cancer 20090101

• Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role.

  Journal of ovarian research 20090101

• Autologous stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of three cases.

  Internal medicine (Tokyo, Japan) 20090101

• A genetic strategy for stochastic gene activation with regulated sparseness (STARS).

  PloS one 20090101

• An unusual radiologic pattern of cryptogenic organizing pneumonia: diffuse pulmonary nodules in a leukemia patient.

  Korean journal of radiology 20090101

• Human T cell leukemia virus reactivation with progression of adult T-cell leukemia-lymphoma.

  PloS one 20090101

• Post-translational regulation of Oct4 transcriptional activity.

  PloS one 20090101

• Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress.

  BMC neuroscience 20090101

• Persistent hiccups as an adverse event to FLAG-IDA regimen for leukemia.

  Acta oncologica (Stockholm, Sweden) 20090101

• New dosing schedules of dasatinib for CML and adverse event management.

  Journal of hematology & oncology 20090101

• Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.

  Breast cancer research : BCR 20090101

• ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.

  Journal of hematology & oncology 20090101

• A second case of secondary acute myeloblastic leukemia associated with the MLL-KIAA0284 fusion gene.

  Blood cells, molecules & diseases 20090101

• Engineering the vaccinia virus L1 protein for increased neutralizing antibody response after DNA immunization.

  Virology journal 20090101

• Successfully conservative treatment of large cervical choriocarcinoma with profuse vaginal bleeding.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20090101

• Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemia.

  BMC cancer 20090101

• [A clinical trial for homoharringtonine and low-dose cytosine arabinoside combined with G-CSF or GM-CSF to treat the relapsed or refractory acute myeloid leukemia (AML), geriatric AML and advanced myelodysplastic syndromes].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20090101

• Intensive chemotherapy for a patient with primary cutaneous diffuse large B-cell lymphoma with Burkitt-like morphology.

  Internal medicine (Tokyo, Japan) 20090101

• Cytarabine conjugates with biologically active molecules and their potential anticancer activity.

  Neoplasma 20090101

• Imatinib is a substrate for various multidrug resistance proteins.

  Neoplasma 20090101

• Radiosynthesis of F-18 labeled cytidine analog 2'-fluoro-5-iodo-l-beta-d-arabinofuranosylcytosine ([(18)F]FIAC).

  Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 20090101

• Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia.

  Anti-cancer drugs 20090101

• HIV-associated multicentric Castleman disease.

  Current opinion in HIV and AIDS 20090101

• Protective effect of vitamin A on ARA-C induced intestinal damage in mice.

  Tumori 20090101

• CHK1 inhibition as a strategy for targeting Fanconi Anemia (FA) DNA repair pathway deficient tumors.

  Molecular cancer 20090101

• Altering chemosensitivity by modulating translation elongation.

  PloS one 20090101

• Magnetic nanoparticle of Fe3O4 and 5-bromotetrandrin interact synergistically to induce apoptosis by daunorubicin in leukemia cells.

  International journal of nanomedicine 20090101

• Delta-ALA-D activity is a reliable marker for oxidative stress in bone marrow transplant patients.

  BMC cancer 20090101

• Fludarabine in the treatment of chronic lymphocytic leukemia: a review.

  Therapeutics and clinical risk management 20090101

• Unique aspects of transcriptional regulation in neurons--nuances in NFkappaB and Sp1-related factors.

  Journal of neuroinflammation 20090101

• Temozolomide and cisplatin in relapsed/refractory acute leukemia.

  Journal of hematology & oncology 20090101

• Adenylyl cyclases 1 and 8 initiate a presynaptic homeostatic response to ethanol treatment.

  PloS one 20090101

• Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.

  Clinical pharmacokinetics 20090101

• Targeted treatment of acute myeloid leukemia in older adults: role of gemtuzumab ozogamicin.

  Clinical interventions in aging 20090101

• Anthracycline extravasation injuries: management with dexrazoxane.

  Therapeutics and clinical risk management 20090101

• Adult B lymphoblastic leukaemia/lymphoma with hypodiploidy (-9) and a novel chromosomal translocation t(7;12)(q22;p13) presenting with severe eosinophilia - case report and review of literature.

  Journal of hematology & oncology 20090101

• P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patients.

  BMC cancer 20090101

• [Efficacy of IA regimen followed by FLAG regimen in the treatment of acute myeloid leukaemia].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20090101

• Inflammatory cytokines IL-1β and TNF-α regulate p75NTR expression in CNS neurons and astrocytes by distinct cell-type-specific signalling mechanisms.

  ASN neuro 20090101

• Vorinostat in solid and hematologic malignancies.

  Journal of hematology & oncology 20090101

• A homoharringtonine-based induction regimen for the treatment of elderly patients with acute myeloid leukemia: a single center experience from China.

  Journal of hematology & oncology 20090101

• ABT-869, a promising multi-targeted tyrosine kinase inhibitor: from bench to bedside.

  Journal of hematology & oncology 20090101

• Comparison of two regimens for the treatment of meningoencephalomyelitis of unknown etiology.

  Journal of veterinary internal medicine 20090101

• Mantle cell lymphoma of the gastrointestinal tract presenting with multiple intussusceptions--case report and review of literature.

  World journal of surgical oncology 20090101

• Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology.

  Molecular pain 20090101

• Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival.

  Molecular brain 20090101

• The changing roles of neurons in the cortical subplate.

  Frontiers in neuroanatomy 20090101

• Prognosis of acute myeloid leukemia in the general population: data from southern Switzerland.

  Tumori 20090101

• Natalizumab in the treatment of multiple sclerosis.

  Therapeutics and clinical risk management 20090101

• [Toxicity estimation of unspecific medicinal antiviral agents for prophylaxis and therapy of hazard and especially hazard viral infections].

  Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic] 20090101

• Utilization of genomic signatures to identify phenotype-specific drugs.

  PloS one 20090101

• Increased ATP generation in the host cell is required for efficient vaccinia virus production.

  Journal of biomedical science 20090101

• [Chronic myeloid leukemia in the 21st century: biology and treatment].

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20090101

• Pure erythroid leukemia with hemophagocytosis.

  Internal medicine (Tokyo, Japan) 20090101

• Evaluation of nine children with reversible posterior encephalopathy syndrome.

  Neurology India 20090101

• Glutamate uptake triggers transporter-mediated GABA release from astrocytes.

  PloS one 20090101

• Langerhans cell histiocytosis, a case of Letterer Siwe disease.

  The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 20090101

• Chemoresistance acquisition induces a global shift of expression of aniogenesis-associated genes and increased pro-angogenic activity in neuroblastoma cells.

  Molecular cancer 20090101

• Peripheral T-cell lymphoma of the eyelid.

  Clinical ophthalmology (Auckland, N.Z.) 20090101

• Drugs associated with more suicidal ideations are also associated with more suicide attempts.

  PloS one 20090101

• Role of hydroxycarbamide in prevention of complications in patients with sickle cell disease.

  Therapeutics and clinical risk management 20090101

• NSC23925, identified in a high-throughput cell-based screen, reverses multidrug resistance.

  PloS one 20090101

• Clinical presentation and endoscopic features of primary gastric Burkitt lymphoma in childhood, presenting as a protein-losing enteropathy: a case report.

  Journal of medical case reports 20090101

• BMP signaling mediates effects of exercise on hippocampal neurogenesis and cognition in mice.

  PloS one 20090101

• Converting redox signaling to apoptotic activities by stress-responsive regulators HSF1 and NRF2 in fenretinide treated cancer cells.

  PloS one 20090101

• [Neurolymphomatosis: diagnosis of extension and assessment of response to treatment with PET-CT].

  Revista espanola de medicina nuclear 20090101

• Role of the Wnt receptor Frizzled-1 in presynaptic differentiation and function.

  Neural development 20090101

• Differential deployment of REST and CoREST promotes glial subtype specification and oligodendrocyte lineage maturation.

  PloS one 20090101

• Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in Taiwan.

  PharmacoEconomics 20090101

• Oncogenic RAS enables DNA damage- and p53-dependent differentiation of acute myeloid leukemia cells in response to chemotherapy.

  PloS one 20090101

• Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers.

  PloS one 20090101

• Doxorubicin loaded Polymeric Nanoparticulate Delivery System to overcome drug resistance in osteosarcoma.

  BMC cancer 20090101

• Non-specific interstitial pneumonia as the initial presentation of biphenotypic acute leukemia: a case report.

  Cases journal 20090101

• Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib.

  Drug design, development and therapy 20090101

• Routine use of ancillary investigations in staging diffuse large B-cell lymphoma improves the International Prognostic Index (IPI).

  Journal of hematology & oncology 20090101

• A Case of Chronic Conjunctivitis following Rituximab Therapy.

  Advances in hematology 20090101

• Acute myelogenous leukemia switch lineage upon relapse to acute lymphoblastic leukemia: a case report.

  Cases journal 20090101

• Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles.

  PloS one 20090101

• Vitamin e and N-acetylcysteine as antioxidant adjuvant therapy in children with acute lymphoblastic leukemia.

  Advances in hematology 20090101

• Managing myelodysplastic symptoms in elderly patients.

  Clinical interventions in aging 20090101

• Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemia.

  PloS one 20090101

• Comparative effects of heterologous TRPV1 and TRPM8 expression in rat hippocampal neurons.

  PloS one 20090101

• Optimal induction and post-remission therapy for AML in first remission.

  Hematology. American Society of Hematology. Education Program 20090101

• Standard therapy of advanced Hodgkin lymphoma.

  Hematology. American Society of Hematology. Education Program 20090101

• An evidence-based review of natalizumab therapy in the management of Crohn's disease.

  Therapeutics and clinical risk management 20090101

• Global demethylation of rat chondrosarcoma cells after treatment with 5-aza-2'-deoxycytidine results in increased tumorigenicity.

  PloS one 20090101

• Chemotherapy in canine acute megakaryoblastic leukemia: a case report and review of the literature.

  In vivo (Athens, Greece) 20090101

• Ethnic differences of two non-synonymous single nucleotide polymorphisms in CDA gene.

  Drug metabolism and pharmacokinetics 20090101

• Metallothionein induction reduces caspase-3 activity and TNFalpha levels with preservation of cognitive function and intact hippocampal neurons in carmustine-treated rats.

  Oxidative medicine and cellular longevity 20090101

• Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

  Journal of oncology 20090101

• Development of fludarabine formulations in the treatment of chronic lymphocytic leukemia.

  Drug design, development and therapy 20090101

• Changing therapy from Glivecto a 'copy' imatinib results in a worsening of chronic myeloid leukemia disease status: two case reports.

  Cases journal 20090101

• Enhanced Expression of Radiation-induced Leukocyte CDKN1A mRNA in Multiple Primary Breast Cancer Patients: Potential New Marker of Cancer Susceptibility.

  Biomarker insights 20090101

• Current and emerging therapies for acute myeloid leukemia.

  Clinical therapeutics 20090101

• Hand-foot syndrome due to capecitabine.

  Indian journal of dermatology 20090101

• A docking model of human ribonucleotide reductase with flavin and phenosafranine.

  Bioinformation 20090101

• Specific factors influence the success of autologous and allogeneic hematopoietic stem cell transplantation.

  Oxidative medicine and cellular longevity 20090101

• Progressive multifocal leukoencephalopathy developing in a fludarabine naïve patient with chronic lymphocytic leukemia.

  International journal of general medicine 20090101

• Targeted treatment of chronic myeloid leukemia: role of imatinib.

  OncoTargets and therapy 20090101

• Role of trabectedin in the treatment of soft tissue sarcoma.

  OncoTargets and therapy 20090101

• Update on the rational use of Y-ibritumomab tiuxetan in the treatment of follicular lymphoma.

  OncoTargets and therapy 20090101

• Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia.

  OncoTargets and therapy 20090101

• Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin's lymphoma.

  OncoTargets and therapy 20090101

• Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review.

  Core evidence 20090101

• Persistent hypokalemia in an acute lymphoblastic leukemia patient.

  Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology 20090101

• Recent advances in the treatment of B-cell lymphoma.

  F1000 medicine reports 20090101

• Palonosetron for the prevention of chemotherapy-induced nausea and vomiting: approval and efficacy.

  Cancer management and research 20090101

• Thalassaemia intermedia: an update.

  Mediterranean journal of hematology and infectious diseases 20090101

• Combined Modality Treatment Including Methotrexate-Based Chemotherapy For Primary CENTRAL Nervous System Lymphoma: A Single Institution Experience.

  Mediterranean journal of hematology and infectious diseases 20090101

• Clinical aspects and therapy of sporadic burkitt lymphoma.

  Mediterranean journal of hematology and infectious diseases 20090101

• MLL leukemia-associated rearrangements in peripheral blood lymphocytes from healthy individuals.

  Genetics and molecular biology 20090101

• Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?

  BMJ case reports 20090101

• Comparison between types of cancer chemotherapies used in a private and a government-based hospital in Mexico.

  Proceedings of the Western Pharmacology Society 20090101

• Chapter 2 cytarabine.

  Profiles of drug substances, excipients, and related methodology 20090101

• Cytoplasmic inclusions of Htt exon1 containing an expanded polyglutamine tract suppress execution of apoptosis in sympathetic neurons.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20081231

• Early versus late intensification for patients with high-risk Hodgkin lymphoma-3 cycles of intensive chemotherapy plus low-dose lymph node radiation therapy versus 4 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine plus myeloablative chemotherapy with autologous stem cell transplantation: five-year results of a randomized trial on behalf of the GOELAMS Group.

  Cancer 20081215

• Spurious elevation of the cerebrospinous fluid white cell counts in three patients receiving liposomal cytarabine as part of post-remission therapy.

  Leukemia 20081201

• Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (Gleevec) in relapsed/refractory AML.

  Leukemia research 20081201

• Gemtuzumab-ozogamicin in combination with fludarabine, cytarabine, idarubicin (FLAI-GO) as induction therapy in CD33-positive AML patients younger than 65 years.

  Leukemia research 20081201

• Neurological complications after intrathecal liposomal cytarabine application in patients after allogeneic haematopoietic stem cell transplantation.

  Annals of hematology 20081201

• Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia.

  Leukemia 20081201

• Differential allelic expression in leukoblast from patients with acute myeloid leukemia suggests genetic regulation of CDA, DCK, NT5C2, NT5C3, and TP53.

  Drug metabolism and disposition: the biological fate of chemicals 20081201

• Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.

  Experimental hematology 20081201

• Treatment of core-binding-factor in acute myelogenous leukemia with fludarabine, cytarabine, and granulocyte colony-stimulating factor results in improved event-free survival.

  Cancer 20081201

• R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study.

  Haematologica 20081201

• Liposomal daunorubicin versus standard daunorubicin: long term follow-up of the GIMEMA GSI 103 AMLE randomized trial in patients older than 60 years with acute myelogenous leukaemia.

  British journal of haematology 20081201

• Efficacy of mouth rinse in preventing oral mucositis in patients receiving high-dose cytarabine for allogeneic hematopoietic stem cell transplantation.

  International journal of hematology 20081201

• Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: the hunter becomes the hunted.

  American journal of hematology 20081201

• Human leukocyte antigen-DR negative de novo acute myeloid leukemia with Philadelphia chromosome.

  International journal of hematology 20081201

• Resistance to cytarabine induces the up-regulation of NKG2D ligands and enhances natural killer cell lysis of leukemic cells.

  Neoplasia (New York, N.Y.) 20081201

• Outcome of high-dose cytarabine-based induction therapy followed by hematopoietic stem cell transplantation in acute myeloid leukemia: influence of karyotype.

  Leukemia & lymphoma 20081201

• Small-molecule Bcl-2 antagonists as targeted therapy in oncology.

  Current oncology (Toronto, Ont.) 20081201

• [Mechanism of CAG regimen eliminating T-cell acute lymphoblastic leukemia A3 cell line].

  Zhongguo shi yan xue ye xue za zhi 20081201

• Autologous stem cell transplantation for diffuse large B-cell lymphoma with residual extranodal involvement.

  The Korean journal of internal medicine 20081201

• A novel mutation in the GATA1 gene associated with acute megakaryoblastic leukemia in a Korean Down syndrome patient.

  Journal of Korean medical science 20081201

• Successful salvage chemotherapy for isolated central nervous system (CNS) relapse in Burkitt lymphoma: monocentric experience of 3 pediatric patients.

  Journal of pediatric hematology/oncology 20081201

• Fifth International Workshop on the CCN Family of Genes: Abstracts and Posters October 18-22, 2008.

  Journal of cell communication and signaling 20081201

• [A retrospective analysis of clinical outcomes in 225 childhood with acute lymphoblastic leukemia].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20081201

• Treatment of lymphomatous and leukemic meningitis with liposomal encapsulated cytarabine.

  International journal of nanomedicine 20081201

• Imatinib: a second look. Longer follow-up in chronic myeloid leukaemia: clear advantages.

  Prescrire international 20081201

• Rituximab in the treatment of non-Hodgkin's lymphoma.

  Biologics : targets & therapy 20081201

• Bevacizumab in the treatment of HER2-negative breast cancer.

  Biologics : targets & therapy 20081201

• Allium compounds, dipropyl and dimethyl thiosulfinates as antiproliferative and differentiating agents of human acute myeloid leukemia cell lines.

  Biologics : targets & therapy 20081201

• Adult Burkitt lymphoma: advances in diagnosis and treatment.

  Oncology (Williston Park, N.Y.) 20081130

• Cytosine arabinoside treatment impairs the remote spatial memory function and induces dendritic retraction in the anterior cingulate cortex of rats.

  Brain research bulletin 20081125

• Phase 2 trial of rituximab plus hyper-CVAD alternating with rituximab plus methotrexate-cytarabine for relapsed or refractory aggressive mantle cell lymphoma.

  Cancer 20081115

• Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration.

  The Journal of biological chemistry 20081114

• Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

  Journal of medicinal chemistry 20081113

• High-dose yttrium-90-ibritumomab tiuxetan with tandem stem-cell reinfusion: an outpatient preparative regimen for autologous hematopoietic cell transplantation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110

• Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081110

• Successful combination therapy with infusion of allogenetic bone marrow mesenchymal stem cells and CAG regimen in hypoplastic relapsed acute myelogenous leukemia.

  Leukemia research 20081101

• Induction therapy for elderly patients with acute myeloid leukemia.

  Blood reviews 20081101

• The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia.

  Leukemia research 20081101

• Neuroophthalmological side effects following intrathecal administration of liposomal cytarabine for central nervous system prophylaxis in three adolescents with acute myeloid leukaemia.

  Annals of hematology 20081101

• Significant cytotoxic activity in vitro of the EGFR tyrosine kinase inhibitor gefitinib in acute myeloblastic leukaemia.

  European journal of haematology 20081101

• Liposomal cytarabine given concomitantly with radiotherapy in a patient with leptomeningeal metastasis from breast cancer.

  Journal of neurology 20081101

• Temporal profiling of changes in phosphatidylinositol 4,5-bisphosphate, inositol 1,4,5-trisphosphate and diacylglycerol allows comprehensive analysis of phospholipase C-initiated signalling in single neurons.

  Journal of neurochemistry 20081101

• Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma.

  Bone marrow transplantation 20081101

• Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate.

  European journal of haematology 20081101

• Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy.

  Blood 20081101

• Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.

  American journal of hematology 20081101

• Efficacy of fractionated gemtuzumab ozogamicin combined with cytarabine in advanced childhood myeloid leukaemia.

  British journal of haematology 20081101

• Oral mucositis in acute lymphoblastic leukaemia: analysis of 169 paediatric patients.

  Oral diseases 20081101

• Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.

  Cancer 20081101

• Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.

  Cancer 20081101

• AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.

  International journal of hematology 20081101

• Marked increase of normal blast morphologically mimicking leukemic clone in acute lymphoblastic leukemia patient following G-CSF therapy.

  International journal of hematology 20081101

• Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma.

  International journal of hematology 20081101

• Progressive multifocal leukoencephalopathy in a patient with B-cell lymphoma during rituximab-containing chemotherapy: case report and review of the literature.

  International journal of hematology 20081101

• Autologous stem cell transplantation with PCR-negative graft would be associated with a favorable outcome in core-binding factor acute myeloid leukemia.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20081101

• Leflunomide-associated progressive multifocal leukoencephalopathy.

  Archives of neurology 20081101

• Granulocytic sarcoma of the right humerus in a non-leukaemia patient.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20081101

• [Granulocytic sarcoma of the prostate presenting with urinary obstruction which progressed to acute myeloid leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20081101

• [FIP1L1/PDGFRalpha fusion gene-negative chronic eosinophilic leukemia with t(5;12)(q31;p13): a case report and review of literatures].

  Zhonghua nei ke za zhi 20081101

• [A case of stage IV breast cancer in which a long-term no change state (NC) was attained by a combination of S-1 and TAM following AC-T as a primary systemic therapy (PST)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20081101

• Life-threatening conjunctival presentation of myeloid sarcoma.

  Clinical & experimental ophthalmology 20081101

• Existing and emerging therapeutic options for the treatment of acute myeloid leukemia.

  Clinical advances in hematology & oncology : H&O 20081101

• Future research directions for the treatment of AML.

  Clinical advances in hematology & oncology : H&O 20081101

• [Culture and purification of human fetal OB olfactory ensheathing cells in vitro with different methods].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20081101

• Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081020

• Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia.

  Cancer 20081015

• Clofarabine combinations as acute myeloid leukemia salvage therapy.

  Cancer 20081015

• Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin's lymphoma in Spain.

  Medicina clinica 20081011

• Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study.

  Medicina clinica 20081004

• Synergy of Irofulven in combination with various anti-metabolites, enzyme inhibitors, and miscellaneous agents in MV522 lung carcinoma cells: marked interaction with gemcitabine and 5-fluorouracil.

  Investigational new drugs 20081001

• Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001

• Patients with acute myeloid leukemia and RAS mutations benefit most from postremission high-dose cytarabine: a Cancer and Leukemia Group B study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20081001

• Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group.

  Blood 20081001

• Molecular and biologic characterization and drug sensitivity of pan-histone deacetylase inhibitor-resistant acute myeloid leukemia cells.

  Blood 20081001

• Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.

  British journal of haematology 20081001

• The impact of histopathologic diagnosis on the proper management of testis neoplasms.

  Nature clinical practice. Oncology 20081001

• Low dose interleukin-2 following intensification therapy with high dose cytarabine for acute myelogenous leukemia in first complete remission.

  American journal of hematology 20081001

• Rapid complete response using intrathecal rituximab in a patient with leptomeningeal lymphomatosis due to mantle cell lymphoma.

  Anti-cancer drugs 20081001

• Substituted ajoenes as novel anti-cancer agents.

  Bioorganic & medicinal chemistry letters 20081001

• A 50-year-old man with burkitt lymphoma.

  Brain pathology (Zurich, Switzerland) 20081001

• Vaccinia virus protein C16 acts intracellularly to modulate the host response and promote virulence.

  The Journal of general virology 20081001

• Biochemical effects of piceatannol in human HL-60 promyelocytic leukemia cells--synergism with Ara-C.

  International journal of oncology 20081001

• Integrin agonists as adjuvants in chemotherapy for melanoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20081001

• ATM and the Mre11-Rad50-Nbs1 complex respond to nucleoside analogue-induced stalled replication forks and contribute to drug resistance.

  Cancer research 20081001

• Effects of transplanting olfactory ensheathing cells on recovery of olfactory epithelium after olfactory nerve transection in rats.

  Medical science monitor : international medical journal of experimental and clinical research 20081001

• An 'eruptive' variant of juvenile xanthogranuloma associated with langerhans cell histiocytosis.

  Journal of cutaneous pathology 20081001

• Polymeric nanogels containing the triphosphate form of cytotoxic nucleoside analogues show antitumor activity against breast and colorectal cancer cell lines.

  Molecular cancer therapeutics 20081001

• [Efficiency of GHA priming chemotherapy on patients with refractory acute myeloid leukemia and myelodysplastic syndrome and its relationship with expression of costimulatory molecule B7.1].

  Zhongguo shi yan xue ye xue za zhi 20081001

• High-dose chemotherapy with BEAM or Busulphan/Melphalan and Thiotepa followed by hematopoietic cell transplantation in malignant lymphoma.

  Leukemia & lymphoma 20081001

• Low frequency and variability of FLT3 mutations in Korean patients with acute myeloid leukemia.

  Journal of Korean medical science 20081001

• Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.

  Neurosurgery 20081001

• Clinical pharmacology.

  Indian journal of pharmacology 20081001

• Survival from adult leukaemia in England and Wales up to 2001.

  British journal of cancer 20080923

• Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.

  Chinese medical journal 20080920

• A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial).

  Blood 20080915

• Myeloid sarcoma is associated with superior event-free survival and overall survival compared with acute myeloid leukemia.

  Cancer 20080915

• Synthesis, biological active molecular design, and molecular docking study of novel deazaflavin-cholestane hybrid compounds.

  Bioorganic & medicinal chemistry 20080915

• Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?

  British journal of cancer 20080902

• Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.

  Leukemia research 20080901

• Invasive infections with a coagulase-negative staphylococcus in an immunocompromised patient: case report and review of the literature.

  Annals of hematology 20080901

• Intracranial myeloid sarcoma.

  British journal of haematology 20080901

• Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan.

  International journal of hematology 20080901

• Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study.

  Bone marrow transplantation 20080901

• A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome.

  Blood 20080901

• Extremely slow methotrexate elimination in a patient with t(9;22) positive acute lymphoblastic leukemia treated with imatinib.

  American journal of hematology 20080901

• [Autologous hematopoietic stem cell transplantation followed by oral bexarotene in a patient with advanced mycosis fungoides].

  Actas dermo-sifiliograficas 20080901

• Infiltration of the spinal cord in a patient with multiple myeloma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080901

• Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.

  Cancer research 20080901

• Trilateral retinoblastoma with pituitary-hypothalamic dysfunction.

  Ophthalmic genetics 20080901

• hKSR-2, a vitamin D-regulated gene, inhibits apoptosis in arabinocytosine-treated HL60 leukemia cells.

  Molecular cancer therapeutics 20080901

• Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells.

  International journal of nanomedicine 20080901

• Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?

  Current opinion in oncology 20080901

• Brain endothelial cell-cell junctions: how to 'open' the blood brain barrier.

  Current neuropharmacology 20080901

• Tipifarnib in the treatment of newly diagnosed acute myelogenous leukemia.

  Biologics : targets & therapy 20080901

• Primary systemic anaplastic large cell lymphoma in Korean adults: 11 years' experience at Asan Medical Center.

  Yonsei medical journal 20080830

• Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080820

• Combination of dexamethasone, high-dose cytarabine, and carboplatin is effective for advanced large-cell non-Hodgkin lymphoma of childhood.

  Cancer 20080815

• [Imatinib therapy in chronic myeloid leukemia].

  Orvosi hetilap 20080810

• Resistance to chemotherapy: new treatments and novel insights into an old problem.

  British journal of cancer 20080805

• Plasma pharmacokinetics and oral bioavailability of 3,4,5,6-tetrahydrouridine, a cytidine deaminase inhibitor, in mice.

  Cancer chemotherapy and pharmacology 20080801

• Cytosine arabinoside affects the heat and capsaicin receptor TRPV1 localisation and sensitivity in human sensory neurons.

  Journal of neuro-oncology 20080801

• Retrospective analysis of 65 Chinese children with acute promyelocytic leukemia: a single center experience.

  Pediatric blood & cancer 20080801

• Unexpected CNS localization in M2 acute myeloid leukemia: a link with past heroin addiction?

  American journal of hematology 20080801

• Suppression of p38-stress kinase sensitizes quiescent leukemic cells to anti-mitotic drugs by inducing proliferative responses in them.

  Cancer biology & therapy 20080801

• Acyclovir bioavailability in patients with acute myelogenous leukemia treated with daunorubicin and cytarabine.

  Journal of clinical pharmacology 20080801

• Reduced efficacy of topical corticosteroid in preventing cytarabine-induced kerato-conjunctivitis in patients receiving high-dose cytarabine and total body irradiation for allogeneic hematopoietic stem cell transplantation.

  Bone marrow transplantation 20080801

• Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia.

  Haematologica 20080801

• Pure motor lumbosacral radiculopathy after intrathecal chemotherapy.

  European journal of neurology 20080801

• Therapy-related acute promyelocytic leukemia caused by hormonal therapy and radiation in a patient with recurrent breast cancer.

  Japanese journal of clinical oncology 20080801

• Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor.

  Journal of the American Academy of Dermatology 20080801

• Azacitidine and the beginnings of therapeutic epigenetic modulation.

  Expert opinion on pharmacotherapy 20080801

• Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080801

• Value of frontline autologous stem-cell transplantation in peripheral T-cell lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080801

• Transient myeloproliferative disorder in a newborn with Down syndrome.

  Advances in neonatal care : official journal of the National Association of Neonatal Nurses 20080801

• [Renal tubular acidosis as an initial manifestation in children with malignant lymphoma].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20080801

• Efficacy and safety of trabeculectomy with mitomycin C for childhood glaucoma: a study of results with long-term follow-up.

  Clinics (Sao Paulo, Brazil) 20080801

• Sjögren's syndrome associated with multiple myeloma.

  Singapore medical journal 20080801

• Intrathecal liposomal cytarabine: more friend than foe?

  Leukemia & lymphoma 20080801

• Efficacy and safety of intrathecal liposomal cytarabine for the treatment of meningeal relapse in acute lymphoblastic leukemia: experience of two pediatric institutions.

  Leukemia & lymphoma 20080801

• [Loeys-Dietz syndrome with acute myeloid leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20080801

• Long-term Activation of c-Jun N-terminal Kinase through Receptor Interacting Protein is Associated with DNA Damage-induced Cell Death.

  The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 20080801

• Macrophage inflammatory protein-3alpha influences growth of K562 leukemia cells in co-culture with anticancer drug-pretreated HS-5 stromal cells.

  Toxicology 20080730

• Clinical factors associated with fatigue over time in paediatric oncology patients receiving chemotherapy.

  British journal of cancer 20080708

• Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs.

  Cancer chemotherapy and pharmacology 20080701

• Antitumor studies -- part 2: structure-activity relationship study for flavin analogs including investigations on their in vitro antitumor assay and docking simulation into protein tyrosine kinase.

  European journal of medicinal chemistry 20080701

• Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.

  Leukemia research 20080701

• All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.

  Pediatric blood & cancer 20080701

• Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080701

• The expression of DeltaNTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity.

  British journal of haematology 20080701

• Acute myeloid leukemia in the elderly: conventional and novel treatment approaches.

  Blood reviews 20080701

• Rituximab improves the efficacy of high-dose chemotherapy with autograft for high-risk follicular and diffuse large B-cell lymphoma: a multicenter Gruppo Italiano Terapie Innnovative nei linfomi survey.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080701

• Germinal center B (GCB) and non-GCB cell-like diffuse large B cell lymphomas have similar outcomes following autologous haematopoietic stem cell transplantation.

  British journal of haematology 20080701

• Resistance to FLT3 inhibition in an in vitro model of primary AML cells with a stem cell phenotype in a defined microenvironment.

  Leukemia 20080701

• Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080701

• High-performance liquid chromatography/tandem mass spectrometry method for the simultaneous determination of cytarabine and its valyl prodrug valcytarabine in rat plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20080701

• In hot water: global warming takes a toll on coral reefs.

  Environmental health perspectives 20080701

• Granulocytic sarcoma in a patient with myelodysplastic syndrome.

  Oncology (Williston Park, N.Y.) 20080701

• Arsenic and old lace: novel approaches in elderly patients with acute myeloid leukemia.

  Seminars in hematology 20080701

• The expanding role of arsenic in acute promyelocytic leukemia.

  Seminars in hematology 20080701

• Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.

  Journal of pediatric hematology/oncology 20080701

• [Study on the relationship between human cytidine deaminase gene polymorphisms and Ara-C sensitivity].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080701

• Conventional and diffusion-weighted MRI findings of methotrexate related sub-acute neurotoxicity.

  Journal of the neurological sciences 20080615

• Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080615

• Acute myeloid leukaemia presenting as recurrent generalized urticaria in infancy.

  European journal of pediatrics 20080601

• Treatment of B-cell lymphoma with LMB modified protocols in Africa--report of the French-African Pediatric Oncology Group (GFAOP).

  Pediatric blood & cancer 20080601

• Phase I study of the ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone (3-AP) in combination with high dose cytarabine in patients with advanced myeloid leukemia.

  Investigational new drugs 20080601

• Two cases of post-liver transplant acute myeloid leukemia in Korean adults: review of bibliographies and comparison with post-renal transplant acute myeloid leukemia.

  Annals of hematology 20080601

• Results of the first randomized multicentre trial on childhood acute lymphoblastic leukaemia in Russia.

  Leukemia 20080601

• Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study.

  British journal of haematology 20080601

• Increase sensitivity to chemotherapeutical agents and cytoplasmatic interaction between NPM leukemic mutant and NF-kappaB in AML carrying NPM1 mutations.

  Leukemia 20080601

• Chronic kidney disease after liver, cardiac, lung, heart-lung, and hematopoietic stem cell transplant.

  Pediatric nephrology (Berlin, Germany) 20080601

• ESHAP therapy effective in a patient with Langerhans cell sarcoma.

  International journal of hematology 20080601

• Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells.

  Anti-cancer drugs 20080601

• A rare case of co-existent aggressive natural killer cell and acute monocytic leukemia with cytomegalovirus infection.

  International journal of hematology 20080601

• R-DHAP: a good small step, but not the journey's end.

  Leukemia & lymphoma 20080601

• Primary hepatic Burkitt lymphoma.

  Pediatric hematology and oncology 20080601

• Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20080601

• CI-994 (N-acetyl-dinaline) in combination with conventional anti-cancer agents is effective against acute myeloid leukemia in vitro and in vivo.

  Oncology reports 20080601

• Management of adult patients receiving intraventricular chemotherapy for the treatment of leptomeningeal metastasis.

  Clinical journal of oncology nursing 20080601

• Drug delivery in acute myeloid leukemia.

  Expert opinion on drug delivery 20080601

• Epigenetic treatment of myelodysplastic syndromes and acute myeloid leukemias.

  Current medicinal chemistry 20080601

• [Up-regulation of CD86 and cytokine expression in acute leukemia cells by Ara-C].

  Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20080601

• [Combined effect of TNF-related apoptosis induced ligand and Ara-C in inducing apoptosis of HL-60 cells and its mechanism].

  Zhongguo shi yan xue ye xue za zhi 20080601

• [Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children].

  Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 20080601

• Predictors for successful mobilization of peripheral blood progenitor cells with ESHAP + G-CSF in patients with pretreated non-Hodgkin's lymphoma.

  Journal of the Chinese Medical Association : JCMA 20080601

• Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group.

  Leukemia & lymphoma 20080601

• Treatment outcomes with CHOP chemotherapy in adult patients with hemophagocytic lymphohistiocytosis.

  Journal of Korean medical science 20080601

• Newly developed multiple myeloma in a patient with primary T-cell lymphoma of bone.

  Journal of Korean medical science 20080601

• Immunocytochemical detection of hENT1 and hCNT1 in normal tissues, lung cancer cell lines, and NSCLC patient samples.

  Nucleosides, nucleotides & nucleic acids 20080601

• A dog with acute myelomonocytic leukemia.

  The Journal of veterinary medical science 20080601

• [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].

  Gan to kagaku ryoho. Cancer & chemotherapy 20080601

• Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy.

  Clinical therapeutics 20080601

• Predictive factors of all-trans-retinoic acid related complications during induction therapy for acute promyelocytic leukemia.

  Hematology (Amsterdam, Netherlands) 20080601

• Cytosine arabinoside in addition to VCAA-based protocols for the treatment of canine lymphoma with bone marrow involvement: does it make the difference?

  Veterinary and comparative oncology 20080601

• Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080520

• Repair of 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine-induced DNA single-strand breaks by transcription-coupled nucleotide excision repair.

  Cancer research 20080515

• Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080510

• Aberrant phenotype of plasmacytoid monocytes in acute myeloid leukemia.

  American journal of hematology 20080501

• Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome--Polish Adult Leukemia Group (PALG) pilot study.

  Annals of hematology 20080501

• Ex vivo induction of mRNA in human whole blood as a new platform of drug and dietary supplement development.

  Pharmaceutical research 20080501

• Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience.

  Journal of neuro-oncology 20080501

• Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome.

  European journal of haematology 20080501

• Preclinical toxicology (subacute and acute) and efficacy of a new squalenoyl gemcitabine anticancer nanomedicine.

  The Journal of pharmacology and experimental therapeutics 20080501

• Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.

  Blood 20080501

• Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080501

• Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1.

  Placenta 20080501

• Mutated and non-mutated TP53 as targets in the treatment of leukaemia.

  British journal of haematology 20080501

• Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.

  British journal of haematology 20080501

• Facile synthesis of novel mutual derivatives of nucleosides and pyrimidines by regioselectively chemo-enzymatic protocol.

  Bioorganic & medicinal chemistry 20080501

• Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia.

  British journal of haematology 20080501

• Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling.

  British journal of haematology 20080501

• Structural studies of nucleoside analog and feedback inhibitor binding to Drosophila melanogaster multisubstrate deoxyribonucleoside kinase.

  The FEBS journal 20080501

• [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases].

  Actas dermo-sifiliograficas 20080501

• Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells.

  Leukemia 20080501

• Acute myeloid leukemia presenting as one-and-a-half syndrome.

  The American journal of emergency medicine 20080501

• Fludarabine/intermediate-dose cytarabine with or without allogeneic hematopoietic stem cell transplantation in poor-risk leukemia: a single center experience.

  International journal of hematology 20080501

• Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.

  Cancer investigation 20080501

• Improved outcome of children with acute myeloid leukemia treated on 2 consecutive protocols.

  Saudi medical journal 20080501

• Sequential oral hydroxyurea and intravenous cytosine arabinoside in refractory childhood acute leukemia: a pediatric oncology group phase 1 study.

  Journal of pediatric hematology/oncology 20080501

• Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema.

  Journal of pediatric hematology/oncology 20080501

• Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia.

  Current cancer drug targets 20080501

• Neoplastic meningitis.

  Current neurology and neuroscience reports 20080501

• Progressive multifocal leukoencephalopathy.

  Current treatment options in neurology 20080501

• Prophylaxis of central nervous system leukemia: a case of chronic myeloid leukemia with lymphoid blast crisis treated with imatinib mesylate.

  World journal of pediatrics : WJP 20080501

• [Clinical features of pure erythroid leukemia--case report and review of literature].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080501

• The effect of HIF-1alpha siRNA on growth and chemosensitivity of MIA-paca cell line.

  Yonsei medical journal 20080430

• Comparison of the results of the treatment of adolescents and young adults with standard-risk acute lymphoblastic leukemia with the Programa Español de Tratamiento en Hematología pediatric-based protocol ALL-96.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080410

• Cyclopentenyl cytosine increases gemcitabine radiosensitisation in human pancreatic cancer cells.

  British journal of cancer 20080408

• Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma.

  Cancer chemotherapy and pharmacology 20080401

• Granulocytic sarcoma with massive scalp involvement.

  American journal of hematology 20080401

• Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen.

  American journal of hematology 20080401

• Lipomembranous panniculitis in a patient with acute leukemia induced by chemotherapy.

  Leukemia research 20080401

• Association of 3q21q26 syndrome and late-appearing Philadelphia chromosome in acute myeloid leukemia.

  Leukemia 20080401

• Potential of dendritic-cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole-limpet-hemocyanin-pulsed, donor-derived dendritic-cell vaccine for acute myeloid leukemia.

  American journal of hematology 20080401

• Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway.

  Leukemia 20080401

• Ex vivo simulation of the action of antileukemia drugs by measuring apoptosis-related mRNA in blood.

  Clinical chemistry 20080401

• Effect of frequently used chemotherapeutic drugs on cytotoxic activity of human cytotoxic T-lymphocytes.

  Journal of immunotherapy (Hagerstown, Md. : 1997) 20080401

• Outcome of BEAM-autologous and BEAM-alemtuzumab allogeneic transplantation in relapsed advanced stage follicular lymphoma.

  British journal of haematology 20080401

• Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting as a bladder neoplasm.

  Pathology international 20080401

• Sub-acute demyelinating neuropathy associated with an NK/T cell lymphoma.

  Journal of neurology, neurosurgery, and psychiatry 20080401

• Alleviation of the drug-resistant phenotype in idarubicin and cytosine arabinoside double-resistant acute myeloid leukemia cells by indomethacin.

  International journal of oncology 20080401

• Risk factors for post-treatment hypogonadism in testicular cancer patients.

  European journal of endocrinology 20080401

• Relapse and death during first remission in acute myeloid leukemia.

  Haematologica 20080401

• Radioimmunotherapy-based conditioning regimens for stem cell transplantation.

  Seminars in hematology 20080401

• Two distinct molecular mechanisms underlying cytarabine resistance in human leukemic cells.

  Cancer research 20080401

• Outcome of childhood B-cell non-Hodgkin lymphoma and B-cell acute lymphoblastic leukemia treated with the Tokyo Children's Cancer Study Group NHL B9604 protocol.

  Leukemia & lymphoma 20080401

• Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells.

  Leukemia & lymphoma 20080401

• [Efficacy of DACE regimen on relapsed and refractory non-Hodgkin's lymphoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20080401

• Difficulty of peripheral blood stem cell collection after multiple consolidation therapy in acute myeloid leukemia.

  Journal of clinical and experimental hematopathology : JCEH 20080401

• Outcomes of a modified CALGB 19802 regimen in adult acute lymphoblastic leukemia.

  Journal of Korean medical science 20080401

• Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia.

  Anti-cancer drugs 20080401

• An approach to the management of chronic myeloid leukemia in British Columbia.

  Current oncology (Toronto, Ont.) 20080401

• [The assay of intracelluar cytidine deaminase activity and its clinical significance in patient with acute leukemia].

  Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20080401

• A case of primary hepatic Burkitt's lymphoma.

  The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 20080401

• Acute monoblastic leukemia with t(10;11)(p12;q23) presenting with pulmonary involvement: a case report and literature review.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080401

• Modified IDARAM chemotherapy regimen for primary central nervous system lymphoma: experience of three cases.

  Hematology (Amsterdam, Netherlands) 20080401

• Treating refractory leukemias in childhood, role of clofarabine.

  Therapeutics and clinical risk management 20080401

• [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20080401

• Synthesis and evaluation of macromolecule-bound derivatives of a peptidyl-1-beta-D-arabinofuranosylcytosine prodrug.

  Drug metabolism letters 20080401

• Thrombotic microangiopathy with severe renal failure in adenocarcinoma.

  Indian journal of nephrology 20080401

• Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080320

• Parotid acinar cell carcinoma in a long-term survivor of childhood acute lymphoblastic leukemia.

  Pediatric blood & cancer 20080301

• Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.

  Pediatric blood & cancer 20080301

• Acute myelogenous leukemia associated with Ollier disease.

  Pediatric blood & cancer 20080301

• EBV+ lymphoproliferative disease following prolonged chemotherapy for refractory LCH.

  Pediatric blood & cancer 20080301

• Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.

  Pediatric blood & cancer 20080301

• Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2).

  Pediatric blood & cancer 20080301

• Triple intrathecal therapy without cranial irradiation for central nervous system preventive therapy in childhood acute lymphoblastic leukemia.

  Pediatric blood & cancer 20080301

• Amsacrine containing induction therapy in elderly AML patients: comparison to standard induction regimens in a matched-pair analysis.

  Leukemia research 20080301

• Amonafide, a topoisomerase II inhibitor, is unaffected by P-glycoprotein-mediated efflux.

  Leukemia research 20080301

• Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literature.

  Annals of hematology 20080301

• The prognostic significance of leukemic cells clearance kinetics evaluation during the initial course of induction therapy with HAD (homoharringtonine, cytosine arabinoside, daunorubicin) in patients with de novo acute myeloid leukemia.

  American journal of hematology 20080301

• Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia.

  American journal of hematology 20080301

• Absent immunoglobulins in HIV-related Burkitt lymphoma/leukaemia.

  Annals of hematology 20080301

• Continuous drip infusion of low dose cytarabine and etoposide with granulocyte colony-stimulating factor for elderly patients with acute myeloid leukaemia ineligible for intensive chemotherapy.

  Hematological oncology 20080301

• Adenosine receptor ligands protect against a combination of apoptotic and necrotic cell death in cerebellar granule neurons.

  Experimental brain research 20080301

• Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.

  European journal of haematology 20080301

• The role of the proto-oncogene ETS2 in acute megakaryocytic leukemia biology and therapy.

  Leukemia 20080301

• Dose-finding study of imatinib in combination with intravenous cytarabine: feasibility in newly diagnosed patients with chronic myeloid leukemia.

  Blood 20080301

• The value of oral cytarabine ocfosfate and etoposide in the treatment of refractory and elderly AML patients.

  International journal of hematology 20080301

• A phase 2 pilot study of pegfilgrastim and filgrastim for mobilizing peripheral blood progenitor cells in patients with non-Hodgkin's lymphoma receiving chemotherapy.

  Haematologica 20080301

• Enhancement of the anti-tumor efficacy of a GM-CSF-secreting tumor cell immunotherapy in preclinical models by cytosine arabinoside.

  Experimental hematology 20080301

• Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds.

  Oncology reports 20080301

• Polysaccharopeptide enhances the anticancer activity of doxorubicin and etoposide on human breast cancer cells ZR-75-30.

  International journal of oncology 20080301

• Therapeutic experience of adult acute myeloid leukemia in a single institution of China and its relationship with chromosome karyotype.

  Leukemia & lymphoma 20080301

• Acute promyelocytic leukemia: from highly fatal to highly curable.

  Blood 20080301

• Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.

  Haematologica 20080301

• Drug-induced hypersensitivity syndrome with rapid hematopoietic reconstitution during treatment for acute myeloid leukemia.

  Haematologica 20080301

• Phase I and pharmacokinetic study of bortezomib in combination with idarubicin and cytarabine in patients with acute myelogenous leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20080301

• Consolidation therapy: what should be the standard of care?

  Best practice & research. Clinical haematology 20080301

• Preclinical modeling of cytosine arabinoside response in Mll-Enl translocator mouse leukemias.

  Molecular cancer therapeutics 20080301

• Epstein-Barr virus-positivity in tumor has no correlation with the clinical outcomes of patients with angioimmunoblastic T-cell lymphoma.

  The Korean journal of internal medicine 20080301

• [Therapeutic effect of priming induction regimen of CAG for newly diagnosed acute myeloid leukemia in elderly patients].

  Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20080301

• First-Line management of CML: a state of the art review.

  Journal of the National Comprehensive Cancer Network : JNCCN 20080301

• Tumor targeting using liposomal antineoplastic drugs.

  International journal of nanomedicine 20080301

• Multivariate analysis of febrile neutropenia occurrence in patients with non-Hodgkin lymphoma: data from the INC-EU Prospective Observational European Neutropenia Study.

  British journal of haematology 20080301

• Pharmacodynamics of memantine: an update.

  Current neuropharmacology 20080301

• Pitfalls, prevention, and treatment of hyperuricemia during tumor lysis syndrome in the era of rasburicase (recombinant urate oxidase).

  Biologics : targets & therapy 20080301

• The hen's egg test for micronucleus induction (HET-MN): novel analyses with a series of well-characterized substances support the further evaluation of the test system.

  Mutation research 20080227

• Irreversible paraplegia following one time prophylactic intrathecal chemotherapy in an adult patient with acute lymphoblastic leukemia.

  Yonsei medical journal 20080227

• Treatment of 11 dogs with meningoencephalomyelitis of unknown origin with a combination of prednisolone and cytosine arabinoside.

  The Veterinary record 20080223

• A long-term durable remission with high-dose therapy and autologous stem cell transplant for stage IVB HIV-associated Hodgkins disease.

  AIDS (London, England) 20080219

• Clinical pharmacology of cancer therapies in older adults.

  British journal of cancer 20080212

• Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines.

  Toxicology in vitro : an international journal published in association with BIBRA 20080201

• CAG regimen enables relapsed or refractory T-cell acute lymphocytic leukemia patients to achieve complete remission: a report of six cases.

  American journal of hematology 20080201

• Images in haematology. Bilateral adrenal chloromas.

  British journal of haematology 20080201

• Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia.

  Leukemia 20080201

• Treatment of newly diagnosed acute promyelocytic leukemia (APL): a comparison of French-Belgian-Swiss and PETHEMA results.

  Blood 20080201

• An ATM- and Rad3-related (ATR) signaling pathway and a phosphorylation-acetylation cascade are involved in activation of p53/p21Waf1/Cip1 in response to 5-aza-2'-deoxycytidine treatment.

  The Journal of biological chemistry 20080201

• Outcomes in CCG-2961, a children's oncology group phase 3 trial for untreated pediatric acute myeloid leukemia: a report from the children's oncology group.

  Blood 20080201

• DNA repair polymorphisms and outcome of chemotherapy for acute myelogenous leukemia: a report from the Children's Oncology Group.

  Leukemia 20080201

• Significance of age in acute myeloid leukemia patients younger than 30 years: a common analysis of the pediatric trials AML-BFM 93/98 and the adult trials AMLCG 92/99 and AMLSG HD93/98A.

  Cancer 20080201

• Cladribine combined with high doses of arabinoside cytosine, mitoxantrone, and G-CSF (CLAG-M) is a highly effective salvage regimen in patients with refractory and relapsed acute myeloid leukemia of the poor risk: a final report of the Polish Adult Leukemia Group.

  European journal of haematology 20080201

• A phase II clinical trial of intensive chemotherapy followed by consolidative stem cell transplant: long-term follow-up in newly diagnosed mantle cell lymphoma.

  British journal of haematology 20080201

• A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149).

  Journal of neuro-oncology 20080201

• Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments.

  Expert opinion on pharmacotherapy 20080201

• DNA methylation and sensitivity to antimetabolites in cancer cell lines.

  Oncology reports 20080201

• Hypomethylation and apoptosis in 5-azacytidine-treated myeloid cells.

  Experimental hematology 20080201

• Statins induce lethal effects in acute myeloblastic leukemia [corrected] cells within 72 hours.

  Leukemia & lymphoma 20080201

• Acute myeloid leukemia.

  Pediatric clinics of North America 20080201

• Gastroparesis associated with high-dose cytosine arabinoside.

  Internal medicine journal 20080201

• [Leukoencephalopathy caused by antineoplastic drugs].

  Brain and nerve = Shinkei kenkyu no shinpo 20080201

• [Allogeneic peripheral blood hematopoietic stem cell transplantation for post-operatively treating acute non-lymphocytic leukemia patient complicated with renal cell carcinoma: one case report].

  Zhongguo shi yan xue ye xue za zhi 20080201

• [A rare complication of immunosuppression: digestive aspergillosis].

  Gastroenterologie clinique et biologique 20080201

• [The efficacy of high-dose cytarabine for patients with t(8;21) AML and with normal karyotype AML].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080201

• Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec, Gleevectrade mark).

  Therapeutics and clinical risk management 20080201

• 2'-deoxy-4'-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2'-alpha-hydroxyl groups.

  The Journal of biological chemistry 20080125

• Synthesis and characterization of poly(2-ethyl 2-oxazoline)-conjugates with proteins and drugs: suitable alternatives to PEG-conjugates?

  Journal of controlled release : official journal of the Controlled Release Society 20080122

• Rituximab improves the treatment results of DHAP-VIM-DHAP and ASCT in relapsed/progressive aggressive CD20+ NHL: a prospective randomized HOVON trial.

  Blood 20080115

• Specific clones of spontaneously evolving karyotypes generate individuality of cancers.

  Cancer genetics and cytogenetics 20080115

• Phase I-II study of oxaliplatin, fludarabine, cytarabine, and rituximab combination therapy in patients with Richter's syndrome or fludarabine-refractory chronic lymphocytic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110

• High-dose therapy and autologous stem-cell transplantation in angioimmunoblastic lymphoma: complete remission at transplantation is the major determinant of Outcome-Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110

• Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110

• Drug incorporation and release of water soluble drugs from novel functionalized poly(glycerol adipate) nanoparticles.

  Journal of controlled release : official journal of the Controlled Release Society 20080104

• Predictors of response to reinduction chemotherapy for patients with acute myeloid leukemia who do not achieve complete remission with frontline induction chemotherapy.

  American journal of hematology 20080101

• In vitro cross-resistance to nucleoside analogues and inhibitors of topoisomerase 1 and 2 in acute myeloid leukemia.

  Annals of hematology 20080101

• BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity.

  Annals of hematology 20080101

• Gemtuzumab ozogamicin, cytosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia.

  Annals of oncology : official journal of the European Society for Medical Oncology 20080101

• Unmanipulated HLA 2-3 antigen-mismatched (haploidentical) bone marrow transplantation using only pharmacological GVHD prophylaxis.

  Experimental hematology 20080101

• Chemotherapeutic treatment of bone marrow stromal cells strongly affects their protective effect on acute myeloid leukemia cell survival.

  Leukemia & lymphoma 20080101

• Synergistic antileukemic effects between ABT-869 and chemotherapy involve downregulation of cell cycle-regulated genes and c-Mos-mediated MAPK pathway.

  Leukemia 20080101

• High mobility group protein B1 is an activator of apoptotic response to antimetabolite drugs.

  Molecular pharmacology 20080101

• Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.

  Cancer science 20080101

• Phase II trial of a transplantation regimen of yttrium-90 ibritumomab tiuxetan and high-dose chemotherapy in patients with non-Hodgkin's lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080101

• The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.

  Haematologica 20080101

• Thalidomide in induction treatment increases the very good partial response rate before and after high-dose therapy in previously untreated multiple myeloma.

  Haematologica 20080101

• Tandutinib, an oral, small-molecule inhibitor of FLT3 for the treatment of AML and other cancer indications.

  IDrugs : the investigational drugs journal 20080101

• Ondansetron-associated hypokalemia in a 2-year-old with pre-B-cell ALL.

  Journal of pediatric hematology/oncology 20080101

• Workflow to improve patient recruitment for clinical trials within hospital information systems - a case-study.

  Trials 20080101

• Ataxia-telangiectasia and Rad3-related and DNA-dependent protein kinase cooperate in G2 checkpoint activation by the DNA strand-breaking nucleoside analogue 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine.

  Molecular cancer therapeutics 20080101

• Src-family kinases in the development and therapy of Philadelphia chromosome-positive chronic myeloid leukemia and acute lymphoblastic leukemia.

  Leukemia & lymphoma 20080101

• Dicholine salt of succinic acid, a neuronal insulin sensitizer, ameliorates cognitive deficits in rodent models of normal aging, chronic cerebral hypoperfusion, and beta-amyloid peptide-(25-35)-induced amnesia.

  BMC pharmacology 20080101

• Evans syndrome in a patient with Langerhans cell histiocytosis: possible pathogenesis of autoimmunity in LCH.

  International journal of hematology 20080101

• Wound healing in patients with cancer.

  Eplasty 20080101

• Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML).

  BMC cancer 20080101

• [Discrepant results of ABO type of red cells and serum in a patient with acute myelogenous leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20080101

• Monocyte deactivation in neutropenic acute respiratory distress syndrome patients treated with granulocyte colony-stimulating factor.

  Critical care (London, England) 20080101

• NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols.

  Journal of translational medicine 20080101

• The combination of clofarabine and cytarabine in pediatric relapsed acute lymphoblastic leukemia: a case report.

  Chemotherapy 20080101

• Gene expression-based screening for inhibitors of PDGFR signaling.

  Genome biology 20080101

• Radiation recall dermatitis: case report and review of the literature.

  Current oncology (Toronto, Ont.) 20080101

• [Clinical report of posterior leukoencephalopathy syndrome].

  Georgian medical news 20080101

• Sensitivity of mesenchymal stem cells and their progeny to medicines used for the treatment of hematoproliferative diseases.

  Acta haematologica 20080101

• Lineage tracing of cardiac explant derived cells.

  PloS one 20080101

• EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma.

  PloS one 20080101

• Updated estimates of survival and cost effectiveness for imatinib versus interferon-alpha plus low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukaemia.

  PharmacoEconomics 20080101

• NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissue.

  PloS one 20080101

• Chemotherapy-induced acral erythema in a pediatric patient with acute monoblastic leukemia.

  Pediatric hematology and oncology 20080101

• How chemotherapy damages the central nervous system.

  Journal of biology 20080101

• Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer.

  BMC cancer 20080101

• Isolation and characterization of cidofovir resistant vaccinia viruses.

  Virology journal 20080101

• Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion.

  PloS one 20080101

• [HAA regimen as induction chemotherapy for newly diagnosed acute myelogenous leukemia].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20080101

• Adenosine transporter ENT4 is a direct target of EWS/WT1 translocation product and is highly expressed in desmoplastic small round cell tumor.

  PloS one 20080101

• Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity.

  PloS one 20080101

• Antibody complementarity-determining regions (CDRs) can display differential antimicrobial, antiviral and antitumor activities.

  PloS one 20080101

• HDAC inhibitors act with 5-aza-2'-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells.

  PloS one 20080101

• Localized small-bowel infarction caused by Aspergillus during chemotherapy for acute myeloid leukemia: report of a case.

  Surgery today 20080101

• Relapse of acute myeloid leukemia as isolated bilateral testicular granulocytic sarcoma in an adult.

  Urology journal 20080101

• Sex-specific expression of the X-linked histone demethylase gene Jarid1c in brain.

  PloS one 20080101

• A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-to-intermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 trial.

  BMC cancer 20080101

• Prognostic impact of combined fludarabine, treosulfan and mitoxantrone resistance profile in childhood acute myeloid leukemia.

  Anticancer research 20080101

• The micronucleus assay determination of chromosomal level DNA damage.

  Methods in molecular biology (Clifton, N.J.) 20080101

• Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma.

  Neoplasma 20080101

• [Somatic maturation and sensorimotor development of C57BL/6 mice prenatally exposed to cytosine arabinoside].

  Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 20080101

• High-throughput gene expression profiling of memory differentiation in primary human T cells.

  BMC immunology 20080101

• Progressive paresthesia and weakness after intrathecal chemotherapy.

  The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 20080101

• Riluzole increases the amount of latent HSF1 for an amplified heat shock response and cytoprotection.

  PloS one 20080101

• Zoledronic acid increases docetaxel cytotoxicity through pMEK and Mcl-1 inhibition in a hormone-sensitive prostate carcinoma cell line.

  Journal of translational medicine 20080101

• Successful outcome of Langerhans cell histiocytosis complicated by therapy-related myelodysplasia and acute myeloid leukemia: a case report.

  Cases journal 20080101

• [Adult acute lymphoblastic leukemia with central nervous system involvement: an overview].

  Bulletin du cancer 20080101

• Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation.

  Journal of neuroinflammation 20080101

• [A case of unclassified B-cell lymphosarcoma].

  Terapevticheskii arkhiv 20080101

• Synthesis and antitumor activity of 1-beta-4-selenoarabinofuranosyl cytosine (4'-seleno-ara-C).

  Nucleic acids symposium series (2004) 20080101

• Systemic lupus erythematosus and multiple myeloma: an uncommon association. Two cases and literature review.

  Clinical and experimental rheumatology 20080101

• Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway.

  Journal of neuroinflammation 20080101

• Ascending sensory motor polyradiculoneuropathy with cranial nerve involvement following administration of intrathecal methotrexate and intravenous cytarabine in a patient with acute myelogenous leukemia: a case report*.

  Cases journal 20080101

• The prince and the pauper. A tale of anticancer targeted agents.

  Molecular cancer 20080101

• Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK).

  Drug metabolism and pharmacokinetics 20080101

• Role of drug transporters and drug accumulation in the temporal acquisition of drug resistance.

  BMC cancer 20080101

• [Novel possibilities of development and therapeutical application of liposomes].

  Acta pharmaceutica Hungarica 20080101

• Fatal acute tumor lysis syndrome following intrathecal chemotherapy for acute lymphoblastic leukemia with meningeal involvement.

  Internal medicine (Tokyo, Japan) 20080101

• Effect of differentiating agents (all-trans retinoic acid and phorbol 12-myristate 13-acetate) on drug sensitivity of HL60 and NB4 cells in vitro.

  Folia histochemica et cytobiologica 20080101

• Curative strategies in acute promyelocytic leukemia.

  Hematology. American Society of Hematology. Education Program 20080101

• Acute myeloid leukemia-targeted toxin activates both apoptotic and necroptotic death mechanisms.

  PloS one 20080101

• [Adolescents with de novo acute lymphoblastic leukemia: efficacy and safety of a pediatric vs adult treatment protocol].

  Gaceta medica de Mexico 20080101

• Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment.

  PloS one 20080101

• Current status of haploidentical stem cell transplantation for leukemia.

  Journal of hematology & oncology 20080101

• Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.

  La Clinica terapeutica 20080101

• Chemotherapy-induced diffuse melanonychia.

  Acta clinica Belgica 20080101

• [Evaluation of selected endocrine complications in patients treated with auto- and allo-haematopoietic stem cell transplantation].

  Medycyna wieku rozwojowego 20080101

• [Analysis of therapy results and prognostic factors in children with acute lymphoblastic leukaemia in Warmia and Mazury region: 17-years experience].

  Medycyna wieku rozwojowego 20080101

• Chemotherapy induced nail changes.

  Indian journal of dermatology 20080101

• Development and targeted use of nilotinib in chronic myeloid leukemia.

  Drug design, development and therapy 20080101

• Hand-foot syndrome due to capecitabine.

  Indian journal of dermatology 20080101

• Changes of serum growth factors (IGF-I & IGFBP-2) and prediction of response to chemotherapy in patients with acute myeloid leukemia.

  The Egyptian journal of immunology 20080101

• Acute thrombosis in superior mesenteric artery as first symptom in a AML patient.

  International journal of general medicine 20080101

• Liver involvement with acute myeloid leukemia.

  Case reports in gastroenterology 20080101

• Therapeutic comparison of chemotherapy and surgery for early stage diffuse large B-cell gastric lymphoma.

  Yonsei medical journal 20071231

• A case of successful intrapleural chemotherapy with Cisplatin plus cytarabine for intractable malignant pleural effusion.

  Yonsei medical journal 20071231

• Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071220

• Targeted chronic myeloid leukemia therapy: Seeking a cure.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071215

• Two cases of isolated symptomatic myocarditis induced by all-trans retinoic acid (ATRA).

  Annals of hematology 20071201

• Modulation of cell apoptosis by AIR.

  Leukemia 20071201

• Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).

  American journal of hematology 20071201

• Successful treatment of adult T-cell leukemia with unrelated cord blood transplantation.

  American journal of hematology 20071201

• Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.

  Leukemia 20071201

• Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance.

  Hematology (Amsterdam, Netherlands) 20071201

• Pharmacogenetics of deoxycytidine kinase: identification and characterization of novel genetic variants.

  The Journal of pharmacology and experimental therapeutics 20071201

• The regulation of M1 muscarinic acetylcholine receptor desensitization by synaptic activity in cultured hippocampal neurons.

  Journal of neurochemistry 20071201

• Development of an intestinal cell culture model to obtain smooth muscle cells and myenteric neurones.

  Journal of anatomy 20071201

• In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.

  British journal of pharmacology 20071201

• Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.

  International journal of laboratory hematology 20071201

• Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.

  American journal of ophthalmology 20071201

• Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071201

• A randomized comparison of immediate versus delayed application of G-CSF in induction therapy for patients with acute myeloid leukemia unfit for intensive chemotherapy.

  Haematologica 20071201

• Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20071201

• [Single-nucleotide polymorphisms of the cytidine deaminase gene in childhood with acute leukemia and normal Chinese children].

  Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 20071201

• [Efficacy of thalidomide combined dexamethasone on newly diagnosed multiple myeloma].

  Ai zheng = Aizheng = Chinese journal of cancer 20071201

• [Mitochondrial membrane potential at HL-60 cell apoptosis induced by cytarabine].

  Zhongguo shi yan xue ye xue za zhi 20071201

• [Effects of FLAG protocol in treatment of the first time induced non-remission acute myeloid leukemia].

  Zhongguo shi yan xue ye xue za zhi 20071201

• [Analysis on prognosis and correlative factors of acute nonlymphocytic leukemia].

  Zhongguo shi yan xue ye xue za zhi 20071201

• Early acute myeloblastic leukemia treatment for childhood myelodysplastic syndrome with t(3;5) (NPM/MLF1).

  Journal of pediatric hematology/oncology 20071201

• Myeloid sarcoma presenting in muscle-tissue of the lower limb: unusual origin of a compartment-syndrome.

  American journal of clinical oncology 20071201

• A case of gastric adenocarcinoma presenting as meningeal carcinomatosis.

  The Korean journal of internal medicine 20071201

• Personalized genomic medicine with a patchwork, partially owned genome.

  The Yale journal of biology and medicine 20071201

• Role of nelarabine in the treatment of T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma.

  Therapeutics and clinical risk management 20071201

• Tipifarnib in the treatment of acute myeloid leukemia.

  Biologics : targets & therapy 20071201

• Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.

  Biologics : targets & therapy 20071201

• Acute myeloid leukemia presenting as obstructive jaundice caused by granulocytic sarcoma.

  Gut and liver 20071201

• Shenfu injection attenuates neurotoxicity of bupivacaine in cultured mouse spinal cord neurons.

  Chinese medical journal 20071120

• Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species.

  Cancer research 20071115

• Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.

  Leukemia research 20071101

• Infections with viridans group streptococci in children with cancer.

  Pediatric blood & cancer 20071101

• Optimal control of treatment in a mathematical model of chronic myelogenous leukemia.

  Mathematical biosciences 20071101

• TNF-alpha inhibitor etanercept and hematologic malignancies: report of a case and review of the literature.

  American journal of hematology 20071101

• N-hydroxy-N'-(3,4,5-trimethoxyphenyl)-3,4,5-trimethoxy-benzamidine, a novel resveratrol analog, inhibits ribonucleotide reductase in HL-60 human promyelocytic leukemia cells: synergistic antitumor activity with arabinofuranosylcytosine.

  International journal of oncology 20071101

• Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.

  Leukemia & lymphoma 20071101

• Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071101

• Resistance to Ara-C up-regulates the activation of NF-kappaB, telomerase activity and Fas expression in NALM-6 cells.

  Biological & pharmaceutical bulletin 20071101

• Frequency, severity and risk factors for oral mucositis after BEAM conditioning and autologous peripheral blood stem cell transplantation: a single center analysis and review of the literature.

  Leukemia & lymphoma 20071101

• Primary testicular lymphoma.

  Journal of the National Medical Association 20071101

• [A short duration treatment with intensive consolidation therapy for patients with acute myelogenous leukemia--13 year experience in a single institute].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071101

• [Phase I study of intrathecal chemotherapy with NS-101 for leptomeningeal carcinomatosis in Japan].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071101

• Phase I trial of FLAGM with high doses of cytosine arabinoside for relapsed, refractory acute myeloid leukemia: study of the Japan Adult Leukemia Study Group (JALSG).

  International journal of hematology 20071101

• Gemcitabine-induced reversible posterior leukoencephalopathy syndrome: a case report and review of the literature.

  The oncologist 20071101

• Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20071020

• Non-hematopoietic stem cell transplantation treatment of juvenile myelomonocytic leukemia: a retrospective analysis and definition of response criteria.

  Pediatric blood & cancer 20071015

• Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study.

  Blood 20071015

• Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.

  British journal of cancer 20071008

• Clinical significance of high-Km 5'-nucleotidase (cN-II) mRNA expression in high-risk myelodysplastic syndrome.

  Leukemia research 20071001

• Synergistic interactions between 12-0-tetradecanoylphorbol-13-acetate (TPA) and imatinib in patients with chronic myeloid leukemia in blastic phase that is resistant to standard-dose imatinib.

  Leukemia research 20071001

• Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia.

  Leukemia research 20071001

• What does over-expression of cN-II enzyme signify in haematological malignancies?

  Leukemia research 20071001

• What is the best salvage therapy for treatment of isolated CNS relapse in elderly patients with imatinib-responsive Ph(+) ALL?

  Leukemia research 20071001

• Essential role of p53 in trophoblastic apoptosis induced in the developing rodent placenta by treatment with a DNA-damaging agent.

  Apoptosis : an international journal on programmed cell death 20071001

• Thalidomide for the treatment of histiocytic sarcoma after hematopoietic stem cell transplant.

  American journal of hematology 20071001

• Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.

  Bone marrow transplantation 20071001

• Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.

  American journal of hematology 20071001

• Cellular localization and functional characterization of the equilibrative nucleoside transporters of antitumor nucleosides.

  Cancer science 20071001

• Liposomal cytarabine for treatment of myeloid central nervous system relapse in chronic myeloid leukaemia occurring during imatinib therapy.

  European journal of clinical investigation 20071001

• Trisomy 21 as a sole acquired abnormality in an adult Omani patient with CD7- and CD9-positive acute myeloid leukemia.

  Archives of medical research 20071001

• The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement.

  Journal of pediatric hematology/oncology 20071001

• Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.

  Expert opinion on investigational drugs 20071001

• [Efficacy and safety of induction chemotherapy consisting of anthracycline for 3 days and cytarabine for 7 days in elderly patients with acute myeloid leukemia].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071001

• [Comparison of salvage chemotherapy regimen ACES with ESHAP for refractory or relapsed malignant lymphoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20071001

• Autologous stem cell transplantation for chronic lymphocytic leukemia.

  Seminars in hematology 20071001

• Effect of dose regimen on the toxicity of 2'-deoxy-2'-methylidenecytidine (DMDC) in monkeys.

  The Journal of toxicological sciences 20071001

• Targeted chronic myeloid leukemia therapy: seeking a cure.

  Journal of managed care pharmacy : JMCP 20071001

• Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.

  Haematologica 20071001

• [Strategy for chemical biology using affinity magnetic nanobeads].

  Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme 20071001

• Oblimersen for the treatment of patients with chronic lymphocytic leukemia.

  Therapeutics and clinical risk management 20071001

• Pharmacology of intracellular cytosine-arabinoside-5'-triphosphate in malignant cells of pediatric patients with initial or relapsed leukemia and in normal lymphocytes.

  Cancer chemotherapy and pharmacology 20070901

• Reduced supportive capacity of bone marrow stroma upon chemotherapy is mediated via changes in glycosaminoglycan profile.

  Matrix biology : journal of the International Society for Matrix Biology 20070901

• Motor and perceptual timing deficits among survivors of childhood leukemia.

  Journal of pediatric psychology 20070901

• Granular acute lymphoblastic leukemia: a case report and literature review.

  American journal of hematology 20070901

• Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea.

  American journal of hematology 20070901

• Drosophila deoxyribonucleoside kinase mutants with enhanced ability to phosphorylate purine analogs.

  Gene therapy 20070901

• Autocrine insulin-like growth factor-I signaling promotes growth and survival of human acute myeloid leukemia cells via the phosphoinositide 3-kinase/Akt pathway.

  Leukemia 20070901

• Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning.

  Bone marrow transplantation 20070901

• Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials.

  Leukemia 20070901

• Phase II study of chemotherapy and stem cell transplantation for adult acute lymphoblastic leukemia or lymphoblastic lymphoma: Japan Clinical Oncology Group Study 9004.

  Cancer science 20070901

• Striking response to intrathecal liposomal cytarabine in a patient with meningeal myelomatosis.

  British journal of haematology 20070901

• Re: Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

  Blood 20070901

• Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients.

  Haematologica 20070901

• A critical role for the co-repressor N-CoR in erythroid differentiation and heme synthesis.

  Cell research 20070901

• Toward optimal use of intrathecal liposomal cytarabine.

  Leukemia & lymphoma 20070901

• Intrathecal liposomal cytarabine for prevention of meningeal disease in patients with acute lymphocytic leukemia and high-grade lymphoma.

  Leukemia & lymphoma 20070901

• All-trans retinoic acid syndrome: another cause of drug-induced respiratory failure.

  Southern medical journal 20070901

• Marked elevation in homocysteine and homocysteine sulfinic acid in the cerebrospinal fluid of lymphoma patients receiving intensive treatment with methotrexate.

  International journal of clinical pharmacology and therapeutics 20070901

• Primary meningeal lymphoma of T-cell origin: a rare presentation of primary central nervous system lymphomas.

  Clinical lymphoma & myeloma 20070901

• Management of acute myeloid leukaemia--5 years experience at Armed Forces Bone Marrow Transplant Centre, Rawalpindi.

  JPMA. The Journal of the Pakistan Medical Association 20070901

• Diagnosis and management of primary intraocular lymphoma: an update.

  Clinical ophthalmology (Auckland, N.Z.) 20070901

• Antiproliferative effects of sapacitabine (CYC682), a novel 2'-deoxycytidine-derivative, in human cancer cells.

  British journal of cancer 20070828

• FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia.

  Blood 20070815

• [Drug-induced leukoencephalopathy].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20070810

• Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.

  Pediatric blood & cancer 20070801

• Prognostic significance of WT1 gene expression in pediatric acute myeloid leukemia.

  Pediatric blood & cancer 20070801

• Central nervous system blastic crisis in chronic myeloid leukemia on imatinib mesylate therapy: a case report.

  Journal of neuro-oncology 20070801

• Spontaneous pregnancy and normal delivery after repeated autologous bone marrow transplantation and GnRH agonist treatment.

  Human reproduction (Oxford, England) 20070801

• Therapeutic strategy of untreated de novo acute myeloid leukemia in the elderly: the efficacy of continuous drip infusion with low dose cytarabine and etoposide.

  Journal of cancer research and clinical oncology 20070801

• Paraneoplastic Sweet's syndrome and the pathergy phenomenon.

  Annals of hematology 20070801

• Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi).

  Leukemia 20070801

• Male pheromone-stimulated neurogenesis in the adult female brain: possible role in mating behavior.

  Nature neuroscience 20070801

• Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase.

  The Journal of general virology 20070801

• A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20070801

• Rituximab-ESHAP as a mobilization regimen for relapsed or refractory B-cell lymphomas: a comparison with ESHAP.

  Transfusion 20070801

• Gemtuzumab therapy for isolated extramedullary AML relapse following allogeneic stem-cell transplant.

  Nature clinical practice. Oncology 20070801

• Modeling of in vitro drug activity and prediction of clinical outcome in acute myeloid leukemia.

  Journal of clinical pharmacology 20070801

• Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070801

• A novel FLT3 inhibitor FI-700 selectively suppresses the growth of leukemia cells with FLT3 mutations.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070801

• The criteria for bone marrow recovery post-myelosuppressive therapy for acute myelogenous leukemia: a quantitative study.

  Archives of pathology & laboratory medicine 20070801

• Cyclopentenyl cytosine (CPEC): an overview of its in vitro and in vivo activity.

  Current cancer drug targets 20070801

• Expansion of regulatory T cells in patients with Langerhans cell histiocytosis.

  PLoS medicine 20070801

• [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].

  Deutsche medizinische Wochenschrift (1946) 20070801

• The effectiveness of intravenous 5-fluorouracil-containing chemotherapy after curative resection for gastric carcinoma: A systematic review of published randomized controlled trials.

  Journal of chemotherapy (Florence, Italy) 20070801

• The phosphoinositide 3-kinase pathway in human cancer: genetic alterations and therapeutic implications.

  Current genomics 20070801

• A step forward in therapy for ALL in infants.

  Lancet (London, England) 20070721

• A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

  Lancet (London, England) 20070721

• Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?

  British journal of cancer 20070716

• Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes.

  Cancer 20070715

• Effect of cytarabine and decitabine in combination in human leukemic cell lines.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20070715

• Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.

  Cancer chemotherapy and pharmacology 20070701

• Gene expression analysis identifies a genetic signature potentially associated with response to alpha-IFN in chronic phase CML patients.

  Leukemia research 20070701

• Successful treatment of intracranial ependymoma with leptomeningeal spread with systemic chemotherapy and intrathecal liposomal cytarabine in a two-year-old child.

  Journal of neuro-oncology 20070701

• Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.

  European journal of oncology nursing : the official journal of European Oncology Nursing Society 20070701

• The effect of short-term intensive chemotherapy on reactivation of tuberculosis.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070701

• A mixed-mode liquid chromatography-tandem mass spectrometric method for the determination of cytarabine in mouse plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070701

• Characteristics of pediatric chemotherapy medication errors in a national error reporting database.

  Cancer 20070701

• Vaccinia virus gene F3L encodes an intracellular protein that affects the innate immune response.

  The Journal of general virology 20070701

• [Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir].

  La Revue de medecine interne 20070701

• Leptomeningeal neoplasms.

  Current treatment options in neurology 20070701

• Gallium imaging in a patient with tumor lysis syndrome.

  Clinical nuclear medicine 20070701

• A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients.

  Experimental hematology 20070701

• Fatal hypersensitivity reaction to gemtuzumab ozogamicin associated with platelet transfusion.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070701

• Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non-M3 acute myeloid leukaemia: results of a prospective, pilot, multi-centre trial and comparison with a historical cohort of patients.

  British journal of haematology 20070701

• Biphenotypic acute leukaemia: a case series.

  British journal of haematology 20070701

• A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia.

  British journal of haematology 20070701

• Vincristine-induced acute neurotoxicity versus Guillain-Barré syndrome: a diagnostic dilemma.

  European journal of neurology 20070701

• Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.

  American journal of ophthalmology 20070701

• Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.

  Leukemia & lymphoma 20070701

• Salvage immuno-chemotherapy with a combination of rituximab, high-dose cytarabine, mitoxantrone and dexamethasone for patients with primary CNS lymphoma: a preliminary study.

  Leukemia & lymphoma 20070701

• Disseminated intravascular coagulation in acute leukemia at presentation and during induction therapy.

  Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20070701

• [Results of dose-intense, dose-impact weekly combination chemotherapy with rituximab for patients with CD 20-positive B-cell non-Hodgkin's lymphoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070701

• Results of compassionate therapy with intrathecal depot liposomal cytarabine in acute myeloid leukemia meningeosis.

  International journal of hematology 20070701

• [Primary culture and identification of olfactory ensheathing cells from adult rat].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20070701

• Chemotherapy for myeloid malignancy in children with Fanconi anemia.

  Pediatric blood & cancer 20070615

• Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes.

  Biochemical and biophysical research communications 20070615

• Genotoxicity (mitotic recombination) of the cancer chemotherapeutic agents cisplatin and cytosine arabinoside in Aspergillus nidulans.

  Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 20070601

• Gemtuzumab ozogamicin with cytarabine and mitoxantrone as a third-line treatment in a poor prognosis group of adult acute myeloid leukemia patients: a single-center experience.

  Annals of hematology 20070601

• Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.

  British journal of haematology 20070601

• Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling.

  Mutation research 20070601

• The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factors.

  Leukemia 20070601

• Long-term outcome of intensive chemotherapy for adults with de novo acute myeloid leukaemia (AML): the nationwide AML-92 study by the Finnish Leukaemia Group.

  European journal of haematology 20070601

• Cytogenetic study of the induction mechanism of chromosome-type aberrations by 1-beta-D-arabinofuranosylcytosine.

  Mutation research 20070601

• Camelpox virus encodes a schlafen-like protein that affects orthopoxvirus virulence.

  The Journal of general virology 20070601

• Functional evidence for GABA as modulator of the contractility of the longitudinal muscle in mouse duodenum: role of GABA(A) and GABA(C) receptors.

  Neuropharmacology 20070601

• Intensified PEG-L-asparaginase and antimetabolite-based therapy for treatment of higher risk precursor-B acute lymphoblastic leukemia: a report from the Children's Oncology Group.

  Journal of pediatric hematology/oncology 20070601

• Complete remission induced by gemtuzumab ozogamicin in a Jehovah's Witness patient with acute myelogenous leukemia.

  International journal of hematology 20070601

• Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: a case report.

  Leukemia & lymphoma 20070601

• Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells.

  Acta medica Okayama 20070601

• Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.

  Pediatric hematology and oncology 20070601

• Hand-foot syndrome with scleroderma-like change induced by the oral capecitabine: a case report.

  The Korean journal of internal medicine 20070601

• Nanoparticulate carriers for the treatment of coronary restenosis.

  International journal of nanomedicine 20070601

• Skin relapse of acute myeloid leukemia associated with trisomy 8.

  Acta dermatovenerologica Alpina, Pannonica, et Adriatica 20070601

• Reappraisal of the use of procarbazine in the treatment of lymphomas and brain tumors.

  Therapeutics and clinical risk management 20070601

• An overview of the clinical use of ondansetron in preschool age children.

  Therapeutics and clinical risk management 20070601

• Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST).

  Therapeutics and clinical risk management 20070601

• Radioimmunotherapy with tositumomab and iodine-131 tositumomab for non-Hodgkin's lymphoma.

  Biologics : targets & therapy 20070601

• Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance.

  Biologics : targets & therapy 20070601

• Imatinib and tyrosine kinase inhibition, in the management of BCR-ABL negative myeloproliferative disorders.

  Biologics : targets & therapy 20070601

• Solitary preleukemic granulocytic sarcoma as a cause of small bowel obstruction.

  Gut and liver 20070601

• The synergistic interaction of gemcitabine and cytosine arabinoside with the ribonucleotide reductase inhibitor triapine is schedule dependent.

  Biochemical pharmacology 20070515

• Supercritical fluid chromatography and high-performance liquid chromatography/tandem mass spectrometric methods for the determination of cytarabine in mouse plasma.

  Analytical chemistry 20070515

• Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor.

  Cancer research 20070515

• [Results of the SHOP LNHB98 (LMB89) trial in pediatric patients with B-cell non-Hodgkin's lymphoma].

  Medicina clinica 20070505

• In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.

  Journal of medicinal chemistry 20070503

• High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.

  Cancer chemotherapy and pharmacology 20070501

• A microarray study of altered gene expression after cytarabine resistance in acute myeloid leukemia.

  Leukemia 20070501

• Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell lines.

  Leukemia 20070501

• Imexon-based combination chemotherapy in A375 human melanoma and RPMI 8226 human myeloma cell lines.

  Cancer chemotherapy and pharmacology 20070501

• CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.

  Annals of hematology 20070501

• The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion.

  Leukemia 20070501

• The incidence and impact of thrombocytopenia in myelodysplastic syndromes.

  Cancer 20070501

• Isolated granulocytic sarcoma of the orbit.

  European journal of haematology 20070501

• Atrial fibrillation induced by gemcitabine treatment in a 65-year-old man.

  Onkologie 20070501

• Acute tumour lysis syndrome in a dog with B-Cell multicentric lymphoma.

  Australian veterinary journal 20070501

• Disseminated cutaneous Fusarium moniliforme infections in a leukemic child.

  International journal of dermatology 20070501

• In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: relevance to stem cell transplantation.

  International journal of hematology 20070501

• Dormant tumor cells develop cross-resistance to apoptosis induced by CTLs or imatinib mesylate via methylation of suppressor of cytokine signaling 1.

  Cancer research 20070501

• A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft.

  Leukemia & lymphoma 20070501

• Mobilization of peripheral blood progenitor cells after DHAP regimen with or without rituximab: a large multicenter comparative study in patients with malignant lymphoma.

  Leukemia & lymphoma 20070501

• Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow.

  Haematologica 20070501

• Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC).

  Haematologica 20070501

• [The standard treatments for patients with hematological malignancies in Japan].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070501

• [Three cases of necrotizing pneumonia by pseudomonas aeruginosa infection in hematological malignancy, including dead and alive cases].

  Gan to kagaku ryoho. Cancer & chemotherapy 20070501

• [Acute myelogenous leukemia with multilineage myelodysplasia, positive direct Coombs test, and elevated levels of platelet-associated IgG].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20070501

• Efficacy and safety of rituximab combined with ESHAP chemotherapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.

  Clinical lymphoma & myeloma 20070501

• The p53 codon 72 proline allele is endowed with enhanced cell-death inducing potential in cancer cells exposed to hypoxia.

  British journal of cancer 20070423

• Mechanisms of ischemic stroke in HIV-infected patients.

  Neurology 20070417

• Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.

  Blood 20070415

• Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

  Blood 20070415

• Novel selective human mitochondrial kinase inhibitors: design, synthesis and enzymatic activity.

  Bioorganic & medicinal chemistry 20070415

• Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.

  Cancer 20070415

• [Current therapeutic strategies in the management of acute myeloid leukemia].

  Medizinische Klinik (Munich, Germany : 1983) 20070415

• The cytokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), can deliver Bcl-XL as an extracellular fusion protein to protect cells from apoptosis and retain differentiation induction.

  The Journal of biological chemistry 20070413

• Anaplastic large cell lymphoma of bone--is it a bad tumor?

  Pediatric blood & cancer 20070401

• Pediatric primary leptomeningeal lymphoma treated without cranial radiotherapy.

  Pediatric blood & cancer 20070401

• Extramedullary infiltration at diagnosis and prognosis in children with acute myelogenous leukemia.

  Pediatric blood & cancer 20070401

• Cytotoxic activity of the third-generation bisphosphonate zoledronic acid in acute myeloid leukemia.

  Leukemia research 20070401

• Reversible posterior leukoencephalopathy syndrome after repeat intermediate-dose cytarabine chemotherapy in a patient with acute myeloid leukemia.

  American journal of hematology 20070401

• Inhalation and dermal exposure to eight antineoplastic drugs in an industrial laundry facility.

  International archives of occupational and environmental health 20070401

• Neutrophilic eccrine hidradenitis masquerading as facial cellulitis.

  Journal of the American Academy of Dermatology 20070401

• Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.

  Blood 20070401

• Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AML by the addition of pravastatin to idarubicin + high-dose Ara-C: a phase 1 study.

  Blood 20070401

• Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.

  Annals of hematology 20070401

• Yttrium-90-ibritumomab tiuxetan (Zevalin) combined with high-dose BEAM chemotherapy and autologous stem cell transplantation for chemo-refractory aggressive non-Hodgkin's lymphoma.

  Experimental hematology 20070401

• In vitro cytotoxicity of nelarabine, clofarabine and flavopiridol in paediatric acute lymphoblastic leukaemia.

  British journal of haematology 20070401

• Feasibility and toxicity of intrathecal liposomal cytarabine in 5 children and young adults with refractory neoplastic meningitis.

  Journal of pediatric hematology/oncology 20070401

• 'Flushing out' cytosine arabinoside from CSF to reverse neurotoxicity.

  Journal of pediatric hematology/oncology 20070401

• Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.

  PLoS medicine 20070401

• [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].

  Ai zheng = Aizheng = Chinese journal of cancer 20070401

• Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

  Hematology (Amsterdam, Netherlands) 20070401

• Diffuse alveolar damage and hemorrhage in acute myelogenous leukemia treated with corticosteroids.

  Connecticut medicine 20070401

• [Alveolar rhabdomyosarcoma of unknown origin mimicking acute leukemia at the initial presentation].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20070401

• [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20070401

• [Effect of daunorubicin and cytarabine on cell line NB4].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20070401

• Relationship between in vitro chemosensitivity assessed with MTT assay and clinical outcomes in 103 patients with acute leukemia.

  The Korean journal of laboratory medicine 20070401

• A case of lineage switch from acute lymphoblastic leukemia to acute myeloid leukemia.

  The Korean journal of laboratory medicine 20070401

• Gingival hyperplasia as an early diagnostic oral manifestation in acute monocytic leukemia: a case report.

  European journal of dentistry 20070401

• Temozolomide as salvage treatment in primary brain lymphomas.

  British journal of cancer 20070326

• Anti-Cripto Mab inhibit tumour growth and overcome MDR in a human leukaemia MDR cell line by inhibition of Akt and activation of JNK/SAPK and bad death pathways.

  British journal of cancer 20070326

• Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.

  Chinese medical journal 20070320

• Therapy for elderly patients with acute myeloid leukemia: a problem in search of solutions.

  Cancer 20070315

• A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment.

  Cancer 20070315

• Perturbed gap-filling synthesis in nucleotide excision repair causes histone H2AX phosphorylation in human quiescent cells.

  Journal of cell science 20070315

• T-cell acute lymphoblastic leukemia relapsing as acute myelogenous leukemia.

  Pediatric blood & cancer 20070301

• Adolescents with acute lymphoblastic leukaemia: outcome on UK national paediatric (ALL97) and adult (UKALLXII/E2993) trials.

  Pediatric blood & cancer 20070301

• Improved outcome in childhood acute myeloid leukemia in Singapore with the MRC AML 10 protocol.

  Pediatric blood & cancer 20070301

• MR imaging of therapy-induced changes of bone marrow.

  European radiology 20070301

• Progressive multifocal leukoencephalopathy mimicking cerebral vasculitis in systemic granulomatosis.

  The Journal of infection 20070301

• The role of intrathecal chemotherapy prophylaxis in patients with diffuse large B-cell lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070301

• Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.

  Leukemia 20070301

• Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.

  Leukemia 20070301

• Effect of priming with granulocyte-macrophage colony-stimulating factor in younger adults with newly diagnosed acute myeloid leukemia: a trial by the Acute Leukemia French Association (ALFA) Group.

  Leukemia 20070301

• Sequence-dependent synergy of the proteasome inhibitor bortezomib and cytarabine in mantle cell lymphoma.

  Leukemia 20070301

• Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib.

  Cancer 20070301

• Improved outcome from substituting methotrexate with epirubicin: results from a randomised comparison of CMF versus CEF in patients with primary breast cancer.

  European journal of cancer (Oxford, England : 1990) 20070301

• Invasive aspergillosis localised to the colon presenting as toxic megacolon.

  European journal of haematology 20070301

• Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.

  Expert review of anticancer therapy 20070301

• Treatment of acute myeloid leukemia in older patients.

  Expert review of anticancer therapy 20070301

• Absence of prognostic impact of CD13 and/or CD33 antigen expression in adult acute lymphoblastic leukemia. Results of the GIMEMA ALL 0496 trial.

  Haematologica 20070301

• Autologous stem cell transplantation after complete remission and first consolidation in acute myeloid leukemia patients aged 61-70 years: results of the prospective EORTC-GIMEMA AML-13 study.

  Haematologica 20070301

• Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched/haploidentical T-cell-replete hematopoietic stem cell transplantation.

  Haematologica 20070301

• The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells.

  British journal of haematology 20070301

• Palifermin and palmar-plantar erythrodysesthesia.

  British journal of haematology 20070301

• High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.

  Bone marrow transplantation 20070301

• Acute encephalopathy and cerebral vasospasm after multiagent chemotherapy including PEG-asparaginase and intrathecal cytarabine for the treatment of acute lymphoblastic leukemia.

  Journal of pediatric hematology/oncology 20070301

• [A case of meningeal carcinomatosis from lung cancer successfully treated with aggressive multimodal therapy].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20070301

• Acute promyelocytic leukemia: a novel PML/RARalpha fusion that generates a frameshift in the RARalpha transcript and ATRA resistance.

  Leukemia & lymphoma 20070301

• CODOX-M/IVAC (NCI 89-C-41) in children and adolescents with Burkitt's leukemia/lymphoma and large B-cell lymphomas: a 15-year monocentric experience.

  Leukemia & lymphoma 20070301

• Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma.

  Leukemia & lymphoma 20070301

• Almost normal cognitive function in patients during therapy for childhood acute lymphoblastic leukemia without cranial irradiation according to ALL-BFM 95 and COALL 06-97 protocols: results of an Austrian-German multicenter longitudinal study and implications for follow-up.

  Pediatric hematology and oncology 20070301

• Protective effect ofBacopa monniera L. on cytarabine induced biochemical changes in chick embryo.

  Indian journal of clinical biochemistry : IJCB 20070301

• Long-term outcome after prophylactic lamivudine treatment on hepatitis B virus reactivation in non-Hodgkin's lymphoma.

  Yonsei medical journal 20070227

• The role of the VEGF-C/VEGFR-3 axis in cancer progression.

  British journal of cancer 20070226

• Small-molecule Bcl-2 inhibitors sensitise tumour cells to immune-mediated destruction.

  British journal of cancer 20070226

• HPLC separation of some purine and pyrimidine derivatives on Chromolith Performance Si monolithic column.

  Journal of biochemical and biophysical methods 20070223

• Imatinib combined with induction or consolidation chemotherapy in patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study.

  Blood 20070215

• Posterior reversible encephalopathy syndrome in children with cancer.

  Pediatric blood & cancer 20070201

• Cytotoxic effects of histone deacetylase inhibitor FK228 (depsipeptide, formally named FR901228) in combination with conventional anti-leukemia/lymphoma agents against human leukemia/lymphoma cell lines.

  Investigational new drugs 20070201

• Tandem high-dose chemotherapy and autologous stem cell transplantation in refractory/relapsed Hodgkin's lymphoma: a monocenter prospective study.

  American journal of hematology 20070201

• High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study.

  Annals of hematology 20070201

• Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.

  European journal of haematology 20070201

• Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.

  Clinica chimica acta; international journal of clinical chemistry 20070201

• Mitoxantrone-related acute myeloblastic leukaemia in a patient with metastatic hormone-refractory prostate cancer.

  Anti-cancer drugs 20070201

• Primary cultures of human vestibular schwannoma: selective growth of schwannoma cells.

  Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20070201

• Age and high-dose methotrexate are associated to clinical acute encephalopathy in FRALLE 93 trial for acute lymphoblastic leukemia in children.

  Leukemia 20070201

• Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.

  Clinical radiology 20070201

• Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.

  Bone marrow transplantation 20070201

• The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.

  British journal of haematology 20070201

• Pharmacokinetic characteristics of L-valyl-ara-C and its implication on the oral delivery of ara-C.

  Acta pharmacologica Sinica 20070201

• [Mandibular chloroma].

  Revue de stomatologie et de chirurgie maxillo-faciale 20070201

• Anticipatory nausea: the role of individual differences related to sensory perception and autonomic reactivity.

  Annals of behavioral medicine : a publication of the Society of Behavioral Medicine 20070201

• Factors influencing engraftment in autologous peripheral hematopoetic stem cell transplantation (PBSCT).

  Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 20070201

• Depolarization and CaM kinase IV modulate NMDA receptor splicing through two essential RNA elements.

  PLoS biology 20070201

• Transverse myelopathy following intrathecal administration of chemotherapy.

  Singapore medical journal 20070201

• Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.

  European journal of haematology 20070201

• [Neuropathology of progressive multifocal leukoencephalopathy].

  No to shinkei = Brain and nerve 20070201

• [Progressive multifocal leukoencephalopathy--epidemiology, clinical pictures, diagnosis and therapy].

  No to shinkei = Brain and nerve 20070201

• A new inhibitor of apoptosis from vaccinia virus and eukaryotes.

  PLoS pathogens 20070201

• Fludarabine-mediated circumvention of cytarabine resistance is associated with fludarabine triphosphate accumulation in cytarabine-resistant leukemic cells.

  International journal of hematology 20070201

• A pilot study of imatinib, low-dose cytarabine and idarubicin for patients with chronic myeloid leukemia in myeloid blast phase.

  Leukemia & lymphoma 20070201

• Dexa-BEAM as salvage therapy in patients with primary refractory aggressive non-Hodgkin lymphoma.

  Leukemia & lymphoma 20070201

• A phase I/II trial of pixantrone (BBR2778), methylprednisolone, cisplatin, and cytosine arabinoside (PSHAP) in relapsed/refractory aggressive non-Hodgkin's lymphoma.

  Leukemia & lymphoma 20070201

• Timed-sequential chemotherapy as induction and/or consolidation regimen for younger adults with acute myelogenous leukemia.

  Hematology (Amsterdam, Netherlands) 20070201

• Expression of multidrug resistance (MDR) proteins and in vitro drug resistance in acute leukemias.

  Hematology (Amsterdam, Netherlands) 20070201

• Cloning and characterization of an alternative splicing transcript of the gene coding for human cytidine deaminase.

  Biochemistry and cell biology = Biochimie et biologie cellulaire 20070201

• [Effect of nimodipine on mechanisms of HL-60 cell apoptosis induced by cytarabine].

  Zhongguo shi yan xue ye xue za zhi 20070201

• Occult subcutaneous panniculitis-like T-cell lymphoma with initial presentations of cellulitis-like skin lesion and fulminant hemophagocytosis.

  Journal of the Formosan Medical Association = Taiwan yi zhi 20070201

• [Treatment for acute myeloid leukemia: introduction].

  Nihon rinsho. Japanese journal of clinical medicine 20070128

• [What is your diagnosis? Neutropenic colitis (neutropenic typhlitis)].

  Praxis 20070124

• [Guideline 'Leptomeningeal metastases of solid tumours'].

  Nederlands tijdschrift voor geneeskunde 20070113

• Effects of interferon gamma on native human acute myelogenous leukaemia cells.

  Cancer immunology, immunotherapy : CII 20070101

• Retroperitoneal fibrosis after chemotherapy.

  European urology 20070101

• The mitotic manipulation of cytotrophoblast differentiation in vitro.

  Placenta 20070101

• A pharmacokinetic study of intra-CSF administered encapsulated cytarabine (DepoCyt) for the treatment of neoplastic meningitis in patients with leukemia, lymphoma, or solid tumors as part of a phase III study.

  Journal of neuro-oncology 20070101

• Acute myeloid leukemia with T-cell receptor gamma gene rearrangement occurring in a patient with chronic lymphocytic leukemia: a case report.

  American journal of hematology 20070101

• Effects of AraC treatment on motor coordination and cerebellar cytoarchitecture in the adult rat. A possible protective role of NAC.

  Neurotoxicology 20070101

• Predictable prognostic factor of CD56 expression in patients with acute myeloid leukemia with t(8:21) after high dose cytarabine or allogeneic hematopoietic stem cell transplantation.

  American journal of hematology 20070101

• In silico prediction of pregnane X receptor activators by machine learning approaches.

  Molecular pharmacology 20070101

• Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL).

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas--results of a randomized comparison by the German Low-Grade Lymphoma Study Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20070101

• Differential expression of drug-resistance-related genes between sensitive and resistant blasts in acute myeloid leukemia.

  Acta haematologica 20070101

• LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre.

  Bone marrow transplantation 20070101

• Significance of additional high-dose cytarabine in combination with cyclophosphamide plus total body irradiation regimen for allogeneic stem cell transplantation.

  Bone marrow transplantation 20070101

• Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.

  British journal of haematology 20070101

• Late relapses in acute promyelocytic leukaemia.

  Acta haematologica 20070101

• Pilot remission induction therapy with idarubicin, plus an intensified dose of ara-C and priming with granulocyte colony-stimulating factor for acute myeloid leukemia.

  Acta haematologica 20070101

• Cytosine beta-D-arabinofuranoside used as a paradigm modifier to increase production of tau aggregates in a cellular model of tauopathy.

  Neurochemical research 20070101

• Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling.

  Experimental hematology 20070101

• In vitro and in vivo antileukemic effect of novel dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.

  Neoplasma 20070101

• Juvenile Ewing sarcoma presenting as a pelvic mass.

  Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20070101

• Re: Henschler R, Brennscheidt U, Mertelsmann R, and Herrmann F (1991). Induction of c-jun expression in the myeloid leukemia cell line KG-1 by 1-beta-D-arabinofuranosylcytosine.

  Molecular pharmacology 20070101

• Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells.

  Molecular cancer 20070101

• An ion-pairing liquid chromatography/tandem mass spectrometric method for the determination of cytarabine in mouse plasma.

  Rapid communications in mass spectrometry : RCM 20070101

• Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography.

  Cardiovascular ultrasound 20070101

• A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents.

  Molecular cancer research : MCR 20070101

• Improved outcome after relapse in children with acute myeloid leukaemia.

  British journal of haematology 20070101

• Porous graphitic carbon chromatography/tandem mass spectrometric determination of cytarabine in mouse plasma.

  Rapid communications in mass spectrometry : RCM 20070101

• Imatinib: a review of its use in chronic myeloid leukaemia.

  Drugs 20070101

• Chronic Myeloid Leukaemia in The 21st Century.

  The Ulster medical journal 20070101

• Multiple complete remissions over a period of 6 years in a patient with acute myeloid leukemia after intensive chemotherapy.

  Leukemia & lymphoma 20070101

• Ligand bound beta1 integrins inhibit procaspase-8 for mediating cell adhesion-mediated drug and radiation resistance in human leukemia cells.

  PloS one 20070101

• Biodiversity, traditional medicine and public health: where do they meet?

  Journal of ethnobiology and ethnomedicine 20070101

• An unusual cause of unilateral pleural effusion in the setting of aortic stenosis: acute myeloid leukemia.

  Internal medicine (Tokyo, Japan) 20070101

• Pilot study of gemtuzumab ozogamicin (GO), fludarabine, cytarabine and idarubicin combined regimen (GO-FLAI) as first-line induction therapy plus GO alone as consolidation therapy for elderly acute myeloid leukemia patients.

  Acta haematologica 20070101

• Two successful pregnancies in a chronic myeloid leukemia patient treated with imatinib.

  Haematologica 20070101

• High-dose therapy and autologous stem cell transplantation for Hodgkin's lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis.

  La Tunisie medicale 20070101

• Flavonoids potentiate the efficacy of cytarabine through modulation of drug-induced apoptosis.

  Neoplasma 20070101

• Comparison between molecularly defined and conventional therapeutics in a conditional BCR-ABL cell culture model.

  Oligonucleotides 20070101

• [Detection of novel rearrangement of the JC virus gene in a case of progressive multifocal leukoencephalopathy with adult T-cell leukemia].

  Rinsho shinkeigaku = Clinical neurology 20070101

• Resolution of disseminated fusariosis in a child with acute leukemia treated with combined antifungal therapy: a case report.

  BMC infectious diseases 20070101

• Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratios.

  BMC cardiovascular disorders 20070101

• Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.

  Molecular cancer 20070101

• Null effect of antidepressants on the astrocytes-mediated proliferation of hippocampal progenitor cells in vitro.

  Molecular pain 20070101

• Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukaemia: a multicentre, phase II study.

  Drugs & aging 20070101

• [Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20070101

• Protein kinase D regulates several aspects of development in Drosophila melanogaster.

  BMC developmental biology 20070101

• Glia protects neurons against extracellular human neuromelanin.

  Neuro-degenerative diseases 20070101

• Synergistic activity of troxacitabine (Troxatyl) and gemcitabine in pancreatic cancer.

  BMC cancer 20070101

• Vascular endothelium: target or victim of cytostatic therapy?

  Canadian journal of physiology and pharmacology 20070101

• [Comparison of the present and previously used protocol of risk stratification in children with acute lymphoblastic leukemia].

  Medycyna wieku rozwojowego 20070101

• Non-hodgkin lymphoma presenting with tetraparesis in a 3-year-old child.

  Pediatric neurosurgery 20070101

• All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients.

  American journal of therapeutics 20070101

• Characterization of vaccinia virus A12L protein proteolysis and its participation in virus assembly.

  Virology journal 20070101

• [Rationale for the use of liposomal cytarabine in meningeal carcinomatosis].

  Tumori 20070101

• [Efficacy of liposomal cytarabine in neoplastic meningitis].

  Tumori 20070101

• [Experience with the intrathecal use of liposomal cytarabine at the Besta Institute].

  Tumori 20070101

• [Intrathecal chemotherapy treatment of neoplastic meningitis from solid tumors using liposomal cytarabine: experience at the Istituto Regina Elena di Roma].

  Tumori 20070101

• Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome.

  Anticancer research 20070101

• [Toxic effects of medications on the cornea].

  Bulletin de la Societe belge d'ophtalmologie 20070101

• Composite multifocal basal cell carcinoma and precursor B acute lymphoblastic leukemia: case report.

  Diagnostic pathology 20070101

• [The results of a multicenter trial of acute lymphoblastic leukemia treatment on ALL-MB 91/ALL-BFM 90m in children: analysis of efficacy and toxicity].

  Terapevticheskii arkhiv 20070101

• [Gemcitabine: from preclinic to clinic passing by pharmacokinetics].

  Bulletin du cancer 20070101

• Mitochondrial respiratory chain is involved in insulin-stimulated hydrogen peroxide production and plays an integral role in insulin receptor autophosphorylation in neurons.

  BMC neuroscience 20070101

• Microglial cells in astroglial cultures: a cautionary note.

  Journal of neuroinflammation 20070101

• Impact of imatinib on the pharmacokinetics and in vivo efficacy of etoposide and/or ifosfamide.

  BMC pharmacology 20070101

• Infections caused by mycobacterium tuberculosis in patients with hematological disorders and in recipients of hematopoietic stem cell transplant, a twelve year retrospective study.

  Annals of clinical microbiology and antimicrobials 20070101

• Prognostic factors in elderly patients with AML and the implications for treatment.

  Hematology. American Society of Hematology. Education Program 20070101

• Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.

  Acta haematologica 20070101

• Squalestatin alters the intracellular trafficking of a neurotoxic prion peptide.

  BMC neuroscience 20070101

• Brucella bacteremia in patients with acute leukemia: a case series.

  Journal of medical case reports 20070101

• Novel marine-derived anti-cancer agents.

  Current pharmaceutical design 20070101

• Aplidine: a paradigm of how to handle the activity and toxicity of a novel marine anticancer poison.

  Current pharmaceutical design 20070101

• Acute lymphoblastic leukemia in a patient with chronic cyanoacrylate exposure.

  Acta haematologica 20070101

• Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway.

  PloS one 20070101

• Comparison of COAP and UW-19 protocols for dogs with multicentric lymphoma.

  Journal of veterinary internal medicine 20070101

• Neutropenic enterocolitis: is there a right timing for surgery? Assessment of a clinical case.

  Tumori 20070101

• Cell cycle, melanin contents and apoptosis processes in B16 and Cloudman S91 mouse melanoma cells after exposure to cytostatic drugs.

  Acta poloniae pharmaceutica 20070101

• Neglected respiratory toxicity caused by cancer therapy.

  The open respiratory medicine journal 20070101

• NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitor.

  Analytical chemistry insights 20070101

• High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma.

  German medical science : GMS e-journal 20070101

• The pK(a) Distribution of Drugs: Application to Drug Discovery.

  Perspectives in medicinal chemistry 20070101

• Pneumonia caused by Moraxella catarrhalis in haematopoietic stem cell transplant patients. Report of two cases and review of the literature.

  The Libyan journal of medicine 20070101

• Targeting receptors, transporters and site of absorption to improve oral drug delivery.

  Drug target insights 20070101

• Synthesis and characterization of a novel liver-targeted prodrug of cytosine-1-beta-D-arabinofuranoside monophosphate for the treatment of hepatocellular carcinoma.

  Journal of medicinal chemistry 20061228

• Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20061220

• Body mass index does not influence pharmacokinetics or outcome of treatment in children with acute lymphoblastic leukemia.

  Blood 20061215

• Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.

  The New England journal of medicine 20061207

• Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines.

  British journal of cancer 20061204

• Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML) cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90.

  Leukemia research 20061201

• A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine.

  Toxicology in vitro : an international journal published in association with BIBRA 20061201

• Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.

  Pediatric hematology and oncology 20061201

• Intestinal mucosal dysfunction and infection during remission-induction therapy for acute myeloid leukaemia.

  Leukemia 20061201

• Chronic myeloid leukemia: standard treatment options.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20061201

• t(8;21) acute myeloid leukaemia cells are dependent on vascular endothelial growth factor (VEGF)/VEGF receptor type2 pathway and phosphorylation of Akt.

  British journal of haematology 20061201

• Increased mortality with FLA compared with ADE chemotherapy in high-risk AML.

  Blood 20061201

• Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20061201

• Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.

  Journal of pediatric hematology/oncology 20061201

• What is the role of rituximab in salvage treatment for patients with diffuse large B-cell lymphoma?

  Leukemia & lymphoma 20061201

• DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis.

  Leukemia & lymphoma 20061201

• Growth inhibition and induction of apoptosis in acute myeloid leukemia cells by new indolinone derivatives targeting fibroblast growth factor, platelet-derived growth factor, and vascular endothelial growth factor receptors.

  Molecular cancer therapeutics 20061201

• Studying the right cell in acute myelogenous leukemia: dynamic changes of apoptosis and signal transduction pathway protein expression in chemotherapy resistant ex-vivo selected 'survivor cells'.

  Cell cycle (Georgetown, Tex.) 20061201

• Primitive, quiescent and difficult to kill: the role of non-proliferating stem cells in chronic myeloid leukemia.

  Cell cycle (Georgetown, Tex.) 20061201

• 5-FdUrd-araC heterodinucleoside re-establishes sensitivity in 5-FdUrd- and AraC-resistant MCF-7 breast cancer cells overexpressing ErbB2.

  Differentiation; research in biological diversity 20061201

• Multiple granulocytic sarcomas in essential thrombocythemia.

  International journal of hematology 20061201

• Childhood CD4+/CD56+ hematodermic neoplasm: case report and review of the literature.

  Haematologica 20061201

• Long-term follow-up of autologous peripheral blood stem cell transplantation in the treatment of a patient with acute panmyelosis with myelofibrosis.

  Haematologica 20061201

• PET-imaging as a useful tool for early detection of the relapse site in the management of primary myeloid sarcoma.

  Haematologica 20061201

• [Superior sagittal sinus thrombosis during remission induction therapy for acute lymphoblastic leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20061201

• [Myelodysplastic syndrome with cyclosporine A-induced encephalopathy presenting with a mass effect on the right basal ganglia after cord blood transplantation].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20061201

• Antileukemic activity of sulfonamide conjugates of arabinosylcytosine.

  Experimental oncology 20061201

• New methods for direct delivery of chemotherapy for treating brain tumors.

  The Yale journal of biology and medicine 20061201

• Azacytidine (Vidaza(R)) in the treatment of myelodysplastic syndromes.

  Therapeutics and clinical risk management 20061201

• Recommendations of the canadian consensus group on the management of chronic myeloid leukemia.

  Current oncology (Toronto, Ont.) 20061201

• Characterization of a late gene, ORF60 from Bombyx mori nucleopolyhedrovirus.

  Journal of biochemistry and molecular biology 20061130

• Maculopapular skin rashes associated with high-dose chemotherapy: prevalence and risk factors.

  Oncology nursing forum 20061127

• Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis.

  Chinese medical journal 20061120

• The effects of lestaurtinib (CEP701) and PKC412 on primary AML blasts: the induction of cytotoxicity varies with dependence on FLT3 signaling in both FLT3-mutated and wild-type cases.

  Blood 20061115

• Chemotherapy for primary central nervous system lymphoma.

  Neurosurgical focus 20061115

• Lymphomatous meningitis in primary central nervous system lymphoma.

  Neurosurgical focus 20061115

• Low incidence of sepsis due to viridans streptococci in a ten-year retrospective study of pediatric acute myeloid leukemia.

  Pediatric blood & cancer 20061101

• Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells.

  Leukemia research 20061101

• Evaluation of early DNA damage in healthcare workers handling antineoplastic drugs.

  International archives of occupational and environmental health 20061101

• Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model.

  Blood 20061101

• Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin's lymphoma.

  Annals of hematology 20061101

• Sivelestat relieves respiratory distress refractory to dexamethasone in all-trans retinoic acid syndrome: a report of two cases.

  European journal of haematology 20061101

• A new mechanism of methotrexate action revealed by target screening with affinity beads.

  Molecular pharmacology 20061101

• A new, simple method for quantifying gemcitabine triphosphate in cancer cells using isocratic high-performance liquid chromatography.

  Cancer science 20061101

• Effect of gemtuzumab ozogamicin on acute myeloid leukemia blast cells in vitro, as a single agent and combined with other cytotoxic cells.

  British journal of haematology 20061101

• Treatment of Burkitt's lymphoma during pregnancy.

  The Annals of pharmacotherapy 20061101

• Virchow's node, jaundice, and weight loss--lymphoma mimicking gastrointestinal malignancy.

  Nature clinical practice. Gastroenterology & hepatology 20061101

• Nongenotoxic p53 activation protects cells against S-phase-specific chemotherapy.

  Cancer research 20061101

• Acute myeloid leukemia with severe aplastic anemia following immunosuppressive therapy.

  Indian journal of pediatrics 20061101

• Cytosine arabinoside-metabolizing enzyme genes are underexpressed in children with MLL gene-rearranged acute lymphoblastic leukemia.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20061101

• [Complete remission of acute promyelocytic leukemia resisting all-trans retinoic acid of one case treated by tanshinone II A].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20061101

• [Therapeutic results with apl 93 protocol in acute promyelocytic leukemia (34 cases)].

  La Tunisie medicale 20061101

• The P2Y₄ receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells.

  Purinergic signalling 20061101

• Recent advances in structure and function of cytosolic IMP-GMP specific 5'-nucleotidase II (cN-II).

  Purinergic signalling 20061101

• High dose chemotherapy and autologous stem cell transplantation in non-Hodgkin's lymphoma: an eight-year experience.

  Yonsei medical journal 20061031

• TIMP-1 gene deficiency increases tumour cell sensitivity to chemotherapy-induced apoptosis.

  British journal of cancer 20061023

• Results of a phase II trial testing interferon-alpha 2b and cytarabine in children and adolescents with chronic myelogenous leukemia.

  Pediatric blood & cancer 20061015

• Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.

  British journal of cancer 20061009

• ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia.

  British journal of cancer 20061009

• Primary central nervous system non-Hodgkin lymphoma in childhood presenting as bilateral optic neuritis.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20061001

• Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma.

  Annals of hematology 20061001

• Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG).

  Annals of hematology 20061001

• A case of relapsed meningeal Burkitt's leukemia/lymphoma treated with intraventricular rituximab combined with high-dose cytarabine.

  American journal of hematology 20061001

• Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.

  European journal of haematology 20061001

• Results of CHOP chemotherapy for diffuse large B-cell lymphoma.

  Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20061001

• Induction of remission of relapsed acute myeloid leukemia after unrelated donor cord blood transplantation by concomitant low-dose cytarabine and calcitriol in adults.

  European journal of haematology 20061001

• Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial.

  Leukemia 20061001

• Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial.

  Leukemia 20061001

• Cytotoxic and biochemical effects of 3,3',4,4',5,5'-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells.

  Experimental hematology 20061001

• JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.

  Experimental hematology 20061001

• Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.

  Cancer investigation 20061001

• Abnormal expansion of naïve B lymphocytes after unrelated cord blood transplantation--a case report.

  Clinical and laboratory haematology 20061001

• Etoposide pharmacokinetics in children treated for acute myeloid leukemia.

  Anti-cancer drugs 20061001

• Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs.

  The Journal of small animal practice 20061001

• Autologous peripheral blood stem cell transplantation for severe multiple sclerosis.

  International journal of hematology 20061001

• Treatment of acute myeloid leukemia patients aged more than 75 years: results of the E-AML-01 trial of the Japanese Elderly Leukemia and Lymphoma Study Group (JELLSG).

  Leukemia & lymphoma 20061001

• CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.

  Leukemia & lymphoma 20061001

• Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.

  Leukemia & lymphoma 20061001

• Aclarubicin plus behenoyl cytarabine and prednisolone for previously treated acute myeloid leukemia patients.

  Leukemia & lymphoma 20061001

• [Bulky lymphadenopathy in acute myeloid leukemia with inv (16) (p13q22): a case report].

  Zhongguo shi yan xue ye xue za zhi 20061001

• [Preparation of cytarabine nanoparticle and study on the drug releasing mechanism].

  Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi 20061001

• Severe pneumonia and human bocavirus in adult.

  Emerging infectious diseases 20061001

• Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060920

• Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial.

  British journal of cancer 20060918

• The thalidomide analogue, CC-4047, induces apoptosis signaling and growth arrest in childhood acute lymphoblastic leukemia cells in vitro and in vivo.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060915

• Dephosphorylation of Rb (Thr-821) in response to cell stress.

  Experimental cell research 20060910

• Higher incidence of chemotherapy induced oral mucositis in females: a supplement of multivariate analysis to a randomized multicentre study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060901

• Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials.

  Blood 20060901

• Maintenance rituximab following induction chemoimmunotherapy may prolong progression-free survival in mantle cell lymphoma: a pilot study from the Wisconsin Oncology Network.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060901

• Multicapillary electrophoresis analysis of single-nucleotide sequence variations in the deoxycytidine kinase gene.

  Clinical chemistry 20060901

• Efficacy of single dose pegfilgrastim in enhancing the mobilization of CD34+ peripheral blood stem cells in aggressive lymphoma patients treated with cisplatin-aracytin-containing regimens.

  Bone marrow transplantation 20060901

• Treatment options in relapsed or refractory Hodgkin disease patients: the mini-BEAM regimen does exist too.

  British journal of haematology 20060901

• Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis.

  Journal of neurology, neurosurgery, and psychiatry 20060901

• High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.

  Bone marrow transplantation 20060901

• Prolonged remission in a case of Richter's transformation of B-cell chronic lymphocytic leukaemia following adoptive immunotherapy.

  Bone marrow transplantation 20060901

• [Twenty years of treating childhood acute lymphoblastic leukemia].

  Anales de pediatria (Barcelona, Spain : 2003) 20060901

• Antiangiogenic activity of 4'-thio-beta-D-arabinofuranosylcytosine.

  Molecular cancer therapeutics 20060901

• ESHAP salvage therapy for refractory and relapsed non-Hodgkin's lymphoma: a single center experience.

  The Korean journal of internal medicine 20060901

• Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF) supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy.

  Leukemia & lymphoma 20060901

• AIDS-associated Burkitt or Burkitt-like lymphoma: short intensive polychemotherapy is feasible and effective.

  Leukemia & lymphoma 20060901

• Is cytarabine required in the treatment of acute promyelocytic leukemia? Updated experience and review of the literature.

  Clinical advances in hematology & oncology : H&O 20060901

• [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20060901

• Glutathione S-transferase GSTM1 and GSTT1 polymorphisms in adult acute myeloid leukemia; its impact on toxicity and response to chemotherapy.

  Journal of the Egyptian National Cancer Institute 20060901

• Asparaginase (native ASNase or pegylated ASNase) in the treatment of acute lymphoblastic leukemia.

  International journal of nanomedicine 20060901

• Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.

  International journal of nanomedicine 20060901

• Cancer treatment-induced mucositis pain: strategies for assessment and management.

  Therapeutics and clinical risk management 20060901

• Treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia with imatinib in combination with chemotherapy.

  Current hematologic malignancy reports 20060901

• Chemopotentiating effects of a novel NAD biosynthesis inhibitor, FK866, in combination with antineoplastic agents.

  European journal of medical research 20060830

• Cytidine is a novel substrate for wild-type concentrative nucleoside transporter 2.

  Biochemical and biophysical research communications 20060825

• High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060820

• Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060820

• Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.

  Blood 20060815

• A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia.

  British journal of cancer 20060807

• In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients.

  British journal of cancer 20060807

• SFTG international collaborative study on in vitro micronucleus test II. Using human lymphocytes.

  Mutation research 20060804

• SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells.

  Mutation research 20060804

• SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells.

  Mutation research 20060804

• SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study.

  Mutation research 20060804

• Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia.

  Leukemia research 20060801

• Long-term survival in refractory acute myeloid leukemia after sequential treatment with chemotherapy and reduced-intensity conditioning for allogeneic stem cell transplantation.

  Blood 20060801

• Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia.

  Leukemia 20060801

• Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.

  Cancer 20060801

• Central line-related bacteraemia due to Roseomonas mucosa in a neutropenic patient with acute myeloid leukaemia in Piraeus, Greece.

  Journal of medical microbiology 20060801

• Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.

  European journal of haematology 20060801

• Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C.

  Experimental hematology 20060801

• Progressive hepatic lymphoma successfully treated with regional chemotherapy through a hepatic artery catheter.

  Internal medicine journal 20060801

• American Society of Clinical Oncology--42nd annual meeting. Poster presentations on leukemia and cytotoxic chemotherapy. 2-6 June 2006, Atlanta, GA, USA.

  IDrugs : the investigational drugs journal 20060801

• Leukemic infiltration of the knee.

  The Journal of rheumatology 20060801

• Primary systemic anaplastic large cell lymphoma in a single Korean institution: clinical characteristics and treatment outcome.

  Journal of Korean medical science 20060801

• Nonleukemic granulocytic sarcoma in the bile duct: a case report.

  Journal of Korean medical science 20060801

• Secondary central nervous system lymphoma.

  International journal of hematology 20060801

• Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.

  Transfusion 20060801

• Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation.

  Leukemia & lymphoma 20060801

• De novo acute myeloid leukemia in adults younger than 60 years of age: socioeconomic aspects and treatment results in a Brazilian university center.

  Leukemia & lymphoma 20060801

• [Successful treatment with voriconazole for disseminated cutaneous and visceral infection by Fusarium solani in a patient with acute myeloid leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20060801

• [Acute monoblastic leukemia with tetrasomy 8].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20060801

• t(8;21) (q22;q22) acute myelogenous leukemia in Mexico: a single institution experience.

  Hematology (Amsterdam, Netherlands) 20060801

• Markedly improving Novozym 435-mediated regioselective acylation of 1-beta-D-arabinofuranosylcytosine by using co-solvent mixtures as the reaction media.

  Journal of biotechnology 20060725

• Markedly enhancing lipase-catalyzed synthesis of nucleoside drugs' ester by using a mixture system containing organic solvents and ionic liquid.

  Bioorganic & medicinal chemistry letters 20060715

• Bortezomib interactions with chemotherapy agents in acute leukemia in vitro.

  Cancer chemotherapy and pharmacology 20060701

• Clofarabine and cytarabine combination as induction therapy for acute myeloid leukemia (AML) in patients 50 years of age or older.

  Blood 20060701

• Phase II trial of subcutaneous recombinant human interleukin 11 with subcutaneous recombinant human granulocyte-macrophage colony stimulating factor in patients with acute myeloid leukemia (AML) receiving high-dose cytarabine during induction: ECOG 3997.

  Leukemia research 20060701

• Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome.

  Leukemia research 20060701

• Developmental clinical trials: building one step at a time.

  Leukemia research 20060701

• Cord blood transplantation for acute myelogenous leukemia using a conditioning regimen consisting of granulocyte colony-stimulating factor-combined high-dose cytarabine, fludarabine, and total body irradiation.

  European journal of haematology 20060701

• The role of human nucleoside transporters in cellular uptake of 4'-thio-beta-D-arabinofuranosylcytosine and beta-D-arabinosylcytosine.

  Molecular pharmacology 20060701

• An antecedent diagnosis of refractory anemia with excess blasts has no prognostic relevance in acute myeloid leukemia of older adult patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060701

• High-dose cytosine arabinoside in the treatment of acute myeloid leukemia: Review of three randomized trials.

  Cancer 20060701

• Increased expression of insulin-like growth factor i is associated with Ara-C resistance in leukemia.

  The Tohoku journal of experimental medicine 20060701

• Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study.

  British journal of haematology 20060701

• Enhanced cellular uptake of Ara-C via a peptidomimetic prodrug, L-valyl-ara-C in Caco-2 cells.

  The Journal of pharmacy and pharmacology 20060701

• Ara-C induces apoptosis in resting B-CLL cells independent on cell proliferation, but involving Ara-CTP formation and inhibition of RNA synthesis.

  Haematologica 20060701

• The mechanisms of Ara-C-induced apoptosis of resting B-chronic lymphocytic leukemia cells.

  Haematologica 20060701

• Multifocal necrotizing leukoencephalopathy: An unusual complication of acute leukemia.

  Archives of neurology 20060701

• Neoplastic meningitis.

  The neurologist 20060701

• [Chronic myelogenous leukemia].

  Nihon rinsho. Japanese journal of clinical medicine 20060701

• Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.

  Molecular cancer therapeutics 20060701

• Imatinib activity in vitro in tumor cells from patients with chronic myeloid leukemia in chronic phase and blast crisis.

  Anti-cancer drugs 20060701

• Rituximab-CHOP-ESHAP vs CHOP-ESHAP-high-dose therapy vs conventional CHOP chemotherapy in high-intermediate and high-risk aggressive non-Hodgkin's lymphoma.

  Leukemia & lymphoma 20060701

• Arsenic trioxide-responsive leukemia cutis in a patient with acute promyelocytic leukemia after ATRA treatment.

  Leukemia & lymphoma 20060701

• Viridans group streptococcal infections among children with cancer and the importance of emerging antibiotic resistance.

  Seminars in pediatric infectious diseases 20060701

• Leukemias and lymphomas: treatment and prophylaxis of the central nervous system.

  Current treatment options in neurology 20060701

• AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL.

  British journal of cancer 20060619

• Cancer-associated carbohydrate identification in Hodgkin's lymphoma by carbohydrate array profiling.

  International journal of cancer 20060615

• Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma.

  Blood 20060615

• Fludarabine and cytosine are less effective than standard ADE chemotherapy in high-risk acute myeloid leukemia, and addition of G-CSF and ATRA are not beneficial: results of the MRC AML-HR randomized trial.

  Blood 20060615

• Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.

  Cancer 20060615

• Long intracellular retention of 4'-thio-arabinofuranosylcytosine 5'-triphosphate as a critical factor for the anti-solid tumor activity of 4'-thio-arabinofuranosylcytosine.

  Cancer chemotherapy and pharmacology 20060601

• Palmar-plantar erythrodysesthesia due to docetaxel-capecitabine therapy is treated with vitamin E without dose reduction.

  Breast (Edinburgh, Scotland) 20060601

• Modified Magrath IVAC regimen as second-line therapy for relapsed or refractory aggressive non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil.

  Leukemia research 20060601

• Gene expression profiles of two accelerations in a CML patient.

  Leukemia research 20060601

• Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG).

  Annals of hematology 20060601

• Enhancement of chemosensitivity toward peplomycin by calpastatin-stabilized NF-kappaB p65 in esophageal carcinoma cells: possible involvement of Fas/Fas-L synergism.

  Apoptosis : an international journal on programmed cell death 20060601

• A case of hepatosplenic gamma-delta T-cell lymphoma with a transient response to fludarabine and alemtuzumab.

  European journal of haematology 20060601

• Standard induction chemotherapy followed by attenuated consolidation in elderly patients with acute myeloid leukemia.

  Annals of hematology 20060601

• Excretion of cytosine arabinoside in saliva after its administration at high doses.

  Anti-cancer drugs 20060601

• Timing of autologous stem cell transplantation from last chemotherapy affects lymphocyte collection and survival in non-Hodgkin lymphoma.

  British journal of haematology 20060601

• Long-term results of an ultra low-dose cytarabine-based regimen for the treatment of acute megakaryoblastic leukaemia in children with Down syndrome.

  British journal of haematology 20060601

• Translocation between chromosome 5q35 and chromosome 11q13-- an unusual cytogenetic finding in a primary refractory acute myeloid leukemia.

  Clinical and laboratory haematology 20060601

• Propofol-induced bradycardia in a pediatric patient undergoing chemotherapy with the known cardiotoxic agent cytarabin.

  Paediatric anaesthesia 20060601

• Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060601

• Isochromosome 1q in a myelodysplastic syndrome after treatment for acute promyelocytic leukemia.

  Cancer genetics and cytogenetics 20060601

• Myeloid sarcoma of the urinary bladder and epididymis as a primary manifestation of acute myeloid leukemia with inv(16).

  Archives of pathology & laboratory medicine 20060601

• Palifermin for oral mucositis in the high-dose chemotherapy and stem cell transplant setting: the Royal Adelaide Hospital Cancer Centre experience.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20060601

• Pulmonary complications after hematopoietic stem cell transplantation.

  Journal of Korean medical science 20060601

• Isolated biliary granulocytic sarcoma followed by acute myelogeneous leukemia with multilineage dysplasia: a case report and literature review.

  Journal of Korean medical science 20060601

• Molecular analysis of chronic eosinophilic leukemia with t(4;10) showing good response to imatinib mesylate.

  International journal of hematology 20060601

• Successful treatment of refractory peripheral T-cell lymphoma with a combination of fludarabine and cyclophosphamide.

  International journal of hematology 20060601

• Peripheral neuropathy caused by high-dose cytosine arabinoside treatment in a patient with acute myeloid leukemia.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20060601

• [An abdominal Burkitt's lymphoma in acute phase. Case report].

  Minerva pediatrica 20060601

• Cross-resistance to cytosine arabinoside in human acute myeloid leukemia cells selected for resistance to vincristine.

  Experimental oncology 20060601

• Transcription factor GATA-1 and Down syndrome leukemogenesis.

  Leukemia & lymphoma 20060601

• Ex vivo activity of thalidomide in childhood acute leukemia.

  Leukemia & lymphoma 20060601

• Anti-clastogenic effect of beta-glucan extracted from barley towards chemically induced DNA damage in rodent cells.

  Human & experimental toxicology 20060601

• Successful reduced-intensity stem cell transplantation in a patient with myelodysplastic syndrome combined with Sweet's syndrome.

  Hematology (Amsterdam, Netherlands) 20060601

• t(8;16) AML developed subsequent to breast cancer therapy.

  Hematology (Amsterdam, Netherlands) 20060601

• Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia.

  The Malaysian journal of pathology 20060601

• Chemotherapy for patients with acute myeloid leukemia in first remission.

  Current hematologic malignancy reports 20060601

• Is cytarabine required in the treatment of acute promyelocytic leukemia?

  Current hematologic malignancy reports 20060601

• Alemtuzumab as consolidation after a response to fludarabine is effective in purging residual disease in patients with chronic lymphocytic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20060520

• Neuronal apoptosis and gray matter heterotopia in microcephaly produced by cytosine arabinoside in mice.

  Brain research 20060517

• An inhibitor of DNA recombination blocks memory consolidation, but not reconsolidation, in context fear conditioning.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20060517

• MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas.

  Neurology 20060509

• WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder.

  Leukemia research 20060501

• Shifting to outpatient management of acute myeloid leukemia: a prospective experience.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Optimal treatment intensity in children with Down syndrome and myeloid leukaemia: data from 56 children treated on NOPHO-AML protocols and a review of the literature.

  Annals of hematology 20060501

• Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR project.

  Cancer 20060501

• Remission induction chemotherapy induces in vivo caspase-dependent apoptosis in bone marrow acute myeloid leukemia blast cells and spares lymphocytes.

  Cytometry. Part B, Clinical cytometry 20060501

• Quantitative real-time RT-PCR monitoring of BCR-ABL in chronic myelogenous leukemia shows lack of agreement in blood and bone marrow samples.

  International journal of oncology 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Functional single nucleotide polymorphism haplotypes in the human equilibrative nucleoside transporter 1.

  Pharmacogenetics and genomics 20060501

• Donor cell leukemia in a patient developing 11 months after an allogeneic bone marrow transplantation for chronic myeloid leukemia.

  American journal of hematology 20060501

• Neurologic toxicities of cancer therapies.

  Current neurology and neuroscience reports 20060501

• [Pelvic Burkitt lymphoma mimicking an ovarian tumor].

  Journal de gynecologie, obstetrique et biologie de la reproduction 20060501

• Randomised phase III study of R-ICE versus R-DHAP in relapsed patients with CD20 diffuse large B-cell lymphoma (DLBCL) followed by high-dose therapy and a second randomisation to maintenance treatment with rituximab or not: an update of the CORAL study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Expression of trophinin and bystin identifies distinct cell types in the germinal zones of adult rat brain.

  The European journal of neuroscience 20060501

• [Neurological complications during and after the treatment of acute lymphocytic leukemia].

  No to hattatsu = Brain and development 20060501

• Core binding factor acute myeloid leukemia.

  Clinical advances in hematology & oncology : H&O 20060501

• Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning.

  International journal of hematology 20060501

• Cellular pharmacology of gemcitabine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060501

• Treatment of relapsed acute myeloid leukaemia.

  Reviews on recent clinical trials 20060501

• Isolation and characterization of a scFv antibody specific for tumor endothelial marker 1 (TEM1), a new reagent for targeted tumor therapy.

  Cancer letters 20060428

• Competition of cytarabine and aspirin in binding to serum albumin in multidrug therapy.

  Biopolymers 20060415

• The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe.

  Blood 20060415

• Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.

  Journal of controlled release : official journal of the Controlled Release Society 20060410

• Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia.

  Leukemia research 20060401

• Pleural tumors as sole primary manifestation of acute promyelocytic leukemia.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060401

• Non-anthracycline based remission induction therapy for newly diagnosed patients with acute myeloid leukemia aged 60 or older.

  Leukemia research 20060401

• Addition of cyclosporin-A to chemotherapy in secondary (post-MDS) AML in the elderly. A multicenter randomized trial of the Leukemia Working Group of the Hellenic Society of Hematology.

  Annals of hematology 20060401

• The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).

  Annals of oncology : official journal of the European Society for Medical Oncology 20060401

• Identification of functional single nucleotide polymorphism haplotypes in the cytidine deaminase promoter.

  Human genetics 20060401

• Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.

  Leukemia 20060401

• Role of cytokines in the treatment of acute leukemias: a review.

  Leukemia 20060401

• Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.

  Cancer 20060401

• Unrelated cord blood transplantation after myeloablative conditioning in patients with acute leukemia aged between 50 and 55 years.

  Bone marrow transplantation 20060401

• Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.

  Haematologica 20060401

• Long-term outcome of autologous transplantation of peripheral blood progenitor cells as postremission management of patients > or =60 years with acute myelogenous leukemia.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20060401

• Cytosine arabinoside induces programmed endothelial cell death through the caspase-3 pathway.

  Biological research for nursing 20060401

• Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060401

• Current trends of infectious complications following hematopoietic stem cell transplantation in a single center.

  Journal of Korean medical science 20060401

• Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia.

  Journal of Korean medical science 20060401

• General approach to, and perspectives on clinical research in, older patients with newly diagnosed acute myeloid leukemia.

  Seminars in hematology 20060401

• Richter's transformation in chronic lymphocytic leukemia.

  Seminars in oncology 20060401

• [IEMAD (modified MIME) therapy for refractory or relapsed non-Hodgkin's lymphoma].

  Zhongguo shi yan xue ye xue za zhi 20060401

• Mycotic aneurysm of the distal aortic arch caused by Aspergillus.

  The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi 20060401

• [Tyrosine kinase inhibitors for the treatment of CML].

  Therapeutische Umschau. Revue therapeutique 20060401

• The efficacy of unrelated cord blood transplantation for adult myelodysplastic syndrome.

  Leukemia & lymphoma 20060401

• The role of post-remission chemotherapy for older patients with acute myelogenous leukemia.

  Leukemia & lymphoma 20060401

• Sequential response-adapted induction and consolidation regimens idarubicin/cytarabine and mitoxantrone/etoposide in adult acute myelogenous leukemia: 10 year follow-up of a study by the Canadian Leukemia Studies Group.

  Leukemia & lymphoma 20060401

• Treatment of acute myeloid leukemia in older adults: time to reflect?

  Leukemia & lymphoma 20060401

• Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

  Blood 20060315

• JWA, a novel signaling molecule, involved in the induction of differentiation of human myeloid leukemia cells.

  Biochemical and biophysical research communications 20060310

• Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.

  Leukemia research 20060301

• Bilateral ear Sweet's syndrome in a case with relapse acute myeloblastic leukemia.

  Leukemia research 20060301

• APE chemotherapy for children with relapsed Hodgkin disease: a Pediatric Oncology Group trial.

  Pediatric blood & cancer 20060301

• Development of a cavum septi pellucidi after Ommaya reservoir placement: report of an unusual complication.

  Acta neurochirurgica 20060301

• Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period.

  Annals of hematology 20060301

• Long-term follow-up of high-dose mitoxantrone-based induction therapy for patients with newly-diagnosed acute myelogenous leukemia. Twelve year results from a single institution.

  Leukemia & lymphoma 20060301

• Long-term follow-up results of the combination of topotecan and cytarabine and other intensive chemotherapy regimens in myelodysplastic syndrome.

  Cancer 20060301

• Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.

  British journal of haematology 20060301

• Live attenuated influenza vaccine is safe and immunogenic in immunocompromised ferrets.

  The Journal of infectious diseases 20060301

• Catalase activity in Candida albicans exposed to antineoplastic drugs.

  Journal of medical microbiology 20060301

• The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons.

  Journal of neurochemistry 20060301

• Role of the C-terminal actin binding domain in BCR/ABL-mediated survival and drug resistance.

  British journal of haematology 20060301

• Induction of neutral endopeptidase activity in PC-3 cells by an aqueous extract of Epilobium angustifolium L. and oenothein B.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20060301

• Roles of protein C, protein S, and antithrombin III in acute leukemia.

  American journal of hematology 20060301

• Cloretazine for the treatment of acute myeloid leukemia.

  Expert review of anticancer therapy 20060301

• Non-Hodgkin's lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals.

  Expert review of anticancer therapy 20060301

• Ultraviolet recall phenomenon associated with methotrexate and cytarabine.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20060301

• A new description of cellular quiescence.

  PLoS biology 20060301

• Molecular response in two children with relapsed acute myeloid leukemia treated with a combination of gemtuzumab ozogamicin and cytarabine.

  Haematologica 20060301

• Rituximab and DHAP followed by intensive therapy with autologous stem-cell transplantation as first-line therapy for mantle cell lymphoma.

  Haematologica 20060301

• Compassionate use of intrathecal depot liposomal cytarabine as treatment of central nervous system involvement in acute leukemia: report of 6 cases.

  Haematologica 20060301

• Analysis of mechanisms contributing to AraC-mediated chemoresistance and re-establishment of drug sensitivity by the novel heterodinucleoside phosphate 5-FdUrd-araC.

  Apoptosis : an international journal on programmed cell death 20060301

• Semisynthetic homoharringtonine induces apoptosis via inhibition of protein synthesis and triggers rapid myeloid cell leukemia-1 down-regulation in myeloid leukemia cells.

  Molecular cancer therapeutics 20060301

• Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.

  Blood 20060215

• Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421.

  Blood 20060215

• Mitoxantrone, carboplatin, cytosine arabinoside, and methylprednisolone followed by autologous peripheral blood stem cell transplantation: a salvage regimen for patients with refractory or recurrent non-Hodgkin lymphoma.

  Cancer 20060215

• Continuous infusion intermediate-dose cytarabine, mitoxantrone, plus etoposide for refractory or early relapsed acute myelogenous leukemia.

  Leukemia research 20060201

• Successful autologous peripheral blood stem cell harvest and transplant in a patient with cold agglutinins.

  Bone marrow transplantation 20060201

• Growth hormone deficiency after chemotherapy for acute lymphoblastic leukemia in children who have not received cranial radiation.

  Pediatric blood & cancer 20060201

• Acute myelogenous leukemia in elderly patients not eligible for intensive chemotherapy: the dark side of the moon.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060201

• ESHAP + fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients.

  Bone marrow transplantation 20060201

• Immunological characterization and antibacterial function of persisting granulocytes in leukemic patients receiving pulse cytosine arabinoside-consolidation chemotherapy on days 1, 3, and 5.

  Journal of immunology (Baltimore, Md. : 1950) 20060201

• Topical prophylaxis of conjunctivitis induced by high-dose cytosine arabinoside.

  Haematologica 20060201

• The schedule-dependent effects of the novel antifolate pralatrexate and gemcitabine are superior to methotrexate and cytarabine in models of human non-Hodgkin's lymphoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20060201

• Adult acute myeloid leukemia.

  Mayo Clinic proceedings 20060201

• Subacute anthracycline cardiotoxicity.

  Heart, lung & circulation 20060201

• [High-dose chemotherapy with autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in complete response as consolidation therapy, second report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060201

• Liposomal cytarabine: new drug. Lymphomatous meningitis: no better than standard cytarabine.

  Prescrire international 20060201

• A case of infectious eccrine hidradenitis.

  The Journal of dermatology 20060201

• [Acute airway obstruction during chemotherapy-induced agranulocytosis with fever].

  Revue de pneumologie clinique 20060201

• Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity.

  Neoplasia (New York, N.Y.) 20060201

• Increased risk of venous thromboembolism in patients with acute leukaemia.

  British journal of cancer 20060130

• Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes.

  Journal of neuroscience methods 20060115

• Similar response rates and superior early progression-free survival with gemcitabine, dexamethasone, and cisplatin salvage therapy compared with carmustine, etoposide, cytarabine, and melphalan salvage therapy prior to autologous stem cell transplantation for recurrent or refractory Hodgkin lymphoma.

  Cancer 20060115

• Sequential administration of irinotecan and cytarabine in the treatment of relapsed and refractory acute myeloid leukemia.

  Cancer chemotherapy and pharmacology 20060101

• Alternative medicine remedies might stimulate viability of leukemic cells.

  Pediatric blood & cancer 20060101

• Flavopiridol and histone deacetylase inhibitors promote mitochondrial injury and cell death in human leukemia cells that overexpress Bcl-2.

  Molecular pharmacology 20060101

• Another case of PORN (bilateral progressive outer retinal necrosis) after allogeneic stem cell transplantation.

  Bone marrow transplantation 20060101

• Feasibility of FLAG-IDA regimen in cases with relapsed/refractory acute leukemia cases.

  Annals of hematology 20060101

• Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20060101

• Trial of amifostine in autologous stem cell transplant.

  Bone marrow transplantation 20060101

• Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL.

  Bone marrow transplantation 20060101

• Improved treatment results for childhood acute myeloid leukemia in Taiwan.

  Leukemia 20060101

• Nfl gene inactivation in acute myeloid leukemia cells confers cytarabine resistance through MAPK and mTOR pathways.

  Leukemia 20060101

• MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia.

  Leukemia 20060101

• Concomitant hairy cell and acute myeloid leukemia.

  European journal of haematology 20060101

• Practical threshold for micronucleated reticulocyte induction observed for low doses of mitomycin C, Ara-C and colchicine.

  Mutagenesis 20060101

• Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: case report and review of the literature.

  American journal of hematology 20060101

• Granulocytic sarcoma of the gingiva with trisomy 21.

  American journal of hematology 20060101

• Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients.

  American journal of hematology 20060101

• Non-transplant therapy for older adults with acute myeloid leukemia.

  Journal of the National Comprehensive Cancer Network : JNCCN 20060101

• [Two cases of malignant lymphoma with high fever and C-reactive protein (CRP) elevation after treatment with granulocyte colony-stimulating factor (G-CSF)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20060101

• Melanoma, a tumor based on a mutant stem cell?

  The Journal of investigative dermatology 20060101

• Evidence for a functional role of GABA receptors in the rat mature hippocampus.

  The European journal of neuroscience 20060101

• Weekly induction intraperitoneal chemotherapy after primary surgical cytoreduction in patients with advanced epithelial ovarian cancer.

  World journal of surgical oncology 20060101

• In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia.

  Haematologica 20060101

• Structural adaptation in adult rabbit ventricular myocytes: influence of dynamic physical interaction with fibroblasts.

  Cell biochemistry and biophysics 20060101

• [Chemotherapy for biliary tract cancers: general remarks].

  Nihon rinsho. Japanese journal of clinical medicine 20060101

• A cat with acute myeloblastic leukemia without maturation (M1) treated with combination chemotherapy.

  The Journal of veterinary medical science 20060101

• [The pharmacokinetic study on cytarabine nanoparticle lyophilization injection in rabbits].

  Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition 20060101

• Evaluation of chemosensitivity of human bone marrow stromal cells--differences between common chemotherapeutic drugs.

  Anticancer research 20060101

• Pulmonary arterial hypertension after childhood cancer therapy and bone marrow transplantation.

  Cardiology 20060101

• Burkitt's lymphoma presenting as oculomotor palsy in an hiv-positive patient.

  European journal of ophthalmology 20060101

• Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer.

  International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 20060101

• Safety assessment of 4'-thio-beta-D-arabinofuranosylcytosine in the beagle dog suggests a drug-induced centrally mediated effect on the hypothalamic-pituitary-adrenal axis.

  International journal of toxicology 20060101

• Antisense p53 oligonucleotides inhibit proliferation and induce chemosensitivity in follicular thyroid cancer cells.

  Anticancer research 20060101

• Primary pancreatic lymphoma--pancreatic tumours that are potentially curable without resection, a retrospective review of four cases.

  BMC cancer 20060101

• Clinical review: specific aspects of acute renal failure in cancer patients.

  Critical care (London, England) 20060101

• Cancer and kinases: reports from the front line.

  Genome biology 20060101

• Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT)--phase I/II trial: study protocol.

  BMC cancer 20060101

• Outcome for young high-risk aggressive B-cell lymphoma patients treated with CHOEP-14 and rituximab (R-CHOEP-14).

  Medical oncology (Northwood, London, England) 20060101

• The relation between deoxycytidine kinase activity and the radiosensitising effect of gemcitabine in eight different human tumour cell lines.

  BMC cancer 20060101

• Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments.

  BMC cancer 20060101

• Skin involvement in Hodgkin's disease.

  Cancer investigation 20060101

• Donor cell leukemia developing after hematopoietic stem cell transplantation for multiple myeloma.

  Acta clinica Belgica 20060101

• Hospital in the home (HITH) care following autologous stem cell transplantation for lymphoma and multiple myeloma.

  The Australian journal of advanced nursing : a quarterly publication of the Royal Australian Nursing Federation 20060101

• Efficacy and tolerability of gemtuzumab ozogamicin (anti-CD33 monoclonal antibody, CMA-676, Mylotarg) in children with relapsed/refractory myeloid leukemia.

  BMC cancer 20060101

• Acute myeloblastic leukemia in a patient with hereditary protein C deficiency.

  Internal medicine (Tokyo, Japan) 20060101

• Transient expression of Drosophila melanogaster deoxynucleoside kinase gene enhances cytotoxicity of nucleoside analogs.

  Nucleosides, nucleotides & nucleic acids 20060101

• Myeloid leukaemia treatment and survival--the South Australian experience, 1977 to 2002.

  Asian Pacific journal of cancer prevention : APJCP 20060101

• Invasive pulmonary aspergillosis: role of early diagnosis and surgical treatment in patients with acute leukemia.

  Annals of clinical microbiology and antimicrobials 20060101

• [Acute lymphoblastic leukemia in children with initial leucocytosis above 50,000/mm3: summary of treatment results of Polish Pediatric Leukemia/Lymphoma Study Group].

  Przeglad lekarski 20060101

• Down syndrome with myelodysplasia of megakaryoblastic lineage.

  Clinical laboratory science : journal of the American Society for Medical Technology 20060101

• Zygomycosis in the immunocompromised patient: a case report.

  Acta bio-medica : Atenei Parmensis 20060101

• AmBisome treatment of fungal sinusitis in severe immunocompromised patient with acute lymphoblastic leukemia relapsed after autologous peripheral blood transplantation.

  Acta bio-medica : Atenei Parmensis 20060101

• Successful management of cerebral and pulmonary mucormycosis with liposomal amphotericin B in a 28-year-old woman with acute lymphoblastic leukemia.

  Acta bio-medica : Atenei Parmensis 20060101

• A case of fusariosis in an immunocompromised patient successfully treated with liposomal amphotericin B.

  Acta bio-medica : Atenei Parmensis 20060101

• New agents for intrathecal administration.

  Cancer investigation 20060101

• [Effect of cytarabine on expression of cell adhesion molecules and on endothelium-leukocyte interaction in vitro].

  Terapevticheskii arkhiv 20060101

• Extensive myocardial infiltration by hemopoietic precursors in a patient with myelodysplastic syndrome.

  BMC blood disorders 20060101

• Induction of cell cycle changes and modulation of apoptogenic/anti-apoptotic and extracellular signaling regulatory protein expression by water extracts of I'm-Yunity (PSP).

  BMC complementary and alternative medicine 20060101

• [Limphomatous meningitis as recurrence site in Hodgkin's disease].

  Medicina 20060101

• IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.

  American journal of therapeutics 20060101

• [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].

  Otolaryngologia polska = The Polish otolaryngology 20060101

• High-risk fludarabine-pretreated B-cell chronic lymphocytic leukemia's high response rate following sequential DHAP and alemtuzumab administration though in absence of molecular remission.

  Medical oncology (Northwood, London, England) 20060101

• [Modulating effect of antileukemia drugs on the cellular susceptibility in chronic myeloid leukemia to cytotoxic lymphocytes].

  Voprosy onkologii 20060101

• Thalidomide increases in vitro sensitivity of childhood acute lymphoblastic leukemia cells to prednisolone and cytarabine.

  Archivum immunologiae et therapiae experimentalis 20060101

• Glioblastoma multiforme with oligodendroglial component (GBMO): favorable outcome after post-operative radiotherapy and chemotherapy with nimustine (ACNU) and teniposide (VM26).

  BMC cancer 20060101

• Dexamethasone, melphalan, actinomycin D, cytosine arabinoside (DMAC) protocol for dogs with relapsed lymphoma.

  Journal of veterinary internal medicine 20060101

• Micro-array analysis of resistance for gemcitabine results in increased expression of ribonucleotide reductase subunits.

  Nucleosides, nucleotides & nucleic acids 20060101

• Antitumor effects of 3,3',4,4',5,5'-hexahydroxystilbene in HL-60 human promyelocytic leukemia cells.

  Nucleosides, nucleotides & nucleic acids 20060101

• Resveratrol, an ingredient of wine, acts synergistically with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.

  Nucleosides, nucleotides & nucleic acids 20060101

• Acute ascending motoric paraplegia following intrathecal chemotherapy for treatment of acute lymphoblastic leukemia in children: case reports and review of the literature.

  Klinische Padiatrie 20060101

• Inhibition of poly (ADP-ribose) polymerase as a protective effect of nicaraven in ionizing radiation- and ara-C-induced cell death.

  Anticancer research 20060101

• Cytotoxic drug sensitivity of Epstein-Barr virus transformed lymphoblastoid B-cells.

  BMC cancer 20060101

• Pharmacology of drugs formulated with DepoFoam: a sustained release drug delivery system for parenteral administration using multivesicular liposome technology.

  Clinical pharmacokinetics 20060101

• Topotecan, Ara-C, cisplatin and prednisolone (Toposhap) for patients with refractory and relapsing lymphomas: Results of a phase II trial.

  Acta haematologica 20060101

• CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo.

  Journal of biology 20060101

• Bullous variant of acral erythema due to methotrexate.

  Indian journal of dermatology, venereology and leprology 20060101

• Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage.

  Critical care (London, England) 20060101

• Choroid plexus epithelial monolayers--a cell culture model from porcine brain.

  Cerebrospinal fluid research 20060101

• Activity of bortezomib in glioblastoma.

  Anticancer research 20060101

• [Reults of treatment with protocols BFM 90 and BFM 95].

  Medicinski arhiv 20060101

• [Auditory evoked potentials in patients after acute children's lymphoblastic leukemia treatment].

  Przeglad lekarski 20060101

• Pseudomembranous necrotizing tracheobronchitis caused by Aspergillus spp--contribution of one case with acute myeloid leukemia.

  Folia medica 20060101

• A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan Adult Leukemia Study Group AML 97 Study.

  Cancer 20051215

• The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.

  British journal of cancer 20051212

• In vitro studies of the genotoxicity of ionizing radiation in human G(0) T lymphocytes.

  Environmental and molecular mutagenesis 20051201

• Micronucleated erythrocyte frequencies in old and new world primates: measurement of micronucleated erythrocyte frequencies in peripheral blood of Callithrix jacchus as a model for evaluating genotoxicity in primates.

  Environmental and molecular mutagenesis 20051201

• Twenty years of Polish experience with three consecutive protocols for treatment of childhood acute myelogenous leukemia.

  Leukemia 20051201

• Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols.

  Leukemia 20051201

• Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit--multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group.

  Leukemia 20051201

• Gemcitabine-induced activation of checkpoint signaling pathways that affect tumor cell survival.

  Molecular pharmacology 20051201

• Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000.

  Leukemia 20051201

• Identification of novel insertion sites in the Ad5 genome that utilize the Ad splicing machinery for therapeutic gene expression.

  Molecular therapy : the journal of the American Society of Gene Therapy 20051201

• Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells.

  Leukemia 20051201

• Very acute cardiac toxicity during BEAC chemotherapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.

  Bone marrow transplantation 20051201

• Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum.

  Bone marrow transplantation 20051201

• TLS/FUS-ERG fusion gene in acute lymphoblastic leukemia with t(16;21)(p11;q22) and monitoring of minimal residual disease.

  Leukemia & lymphoma 20051201

• Burkitt lymphoma in adults: a prospective study of 72 patients treated with an adapted pediatric LMB protocol.

  Annals of oncology : official journal of the European Society for Medical Oncology 20051201

• Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells.

  Leukemia 20051201

• Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.

  Hematology (Amsterdam, Netherlands) 20051201

• Phase I and pharmacokinetic study of flavopiridol followed by 1-beta-D-arabinofuranosylcytosine and mitoxantrone in relapsed and refractory adult acute leukemias.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051201

• The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.

  Haematologica 20051201

• The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia.

  Haematologica 20051201

• Amsacrine combined with etoposide and high-dose methylprednisolone as salvage therapy in acute lymphoblastic leukemia in children.

  Haematologica 20051201

• Myeloid/natural killer cell precursor acute leukemia with tetraploidy.

  Cancer genetics and cytogenetics 20051201

• p16 inactivation associated with aggressive clinical course and fatal outcome in TEL/AML1-positive acute lymphoblastic leukemia.

  Journal of pediatric hematology/oncology 20051201

• [Autologous hematopoietic stem cell transplantation for aggressive B-cell non-Hodgkin's lymphoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051201

• [Improved quality of life in a patient with carcinomatous meningitis from invasive lobular carcinoma treated with intrathecal MTX and Ara-C in combination with systemic docetaxel].

  Gan to kagaku ryoho. Cancer & chemotherapy 20051201

• Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patients.

  Transplantation proceedings 20051201

• Acute leukaemia presenting as vulvar ulcers in an adolescent girl.

  The Australian & New Zealand journal of obstetrics & gynaecology 20051201

• [Effects of RhG-CSF on apoptosis of HL-60 cell induced by cytarabine].

  Zhongguo shi yan xue ye xue za zhi 20051201

• Successful treatment of rhinocerebral zygomycosis with a combination of caspofungin and liposomal amphotericin B.

  Haematologica 20051201

• Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation.

  International journal of hematology 20051201

• [Effectiveness analysis of HA based triple-drug regimen as induction chemotherapy in the treatment of acute myeloid leukemia and its relationship with karyotype].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20051201

• In vitro Evaluation of Cytarabin Induced Apoptosis in Leukemic Blasts.

  Iranian journal of allergy, asthma, and immunology 20051201

• In vitro profiling of the sensitivity of pediatric leukemia cells to tipifarnib: identification of T-cell ALL and FAB M5 AML as the most sensitive subsets.

  Blood 20051115

• Abrogation of heat shock protein 70 induction as a strategy to increase antileukemia activity of heat shock protein 90 inhibitor 17-allylamino-demethoxy geldanamycin.

  Cancer research 20051115

• Evaluation of genotoxic effects induced by exposure to antineoplastic drugs in lymphocytes and exfoliated buccal cells of oncology nurses and pharmacy employees.

  Mutation research 20051110

• [What was the cause of fever, neck pain and arm paresis? Normal blood picture led to error].

  MMW Fortschritte der Medizin 20051110

• The t(8;9)(p22;p24) translocation in atypical chronic myeloid leukaemia yields a new PCM1-JAK2 fusion gene.

  Oncogene 20051103

• Increase in Ara-C cytotoxicity in the presence of valproate, a histone deacetylase inhibitor, is associated with the concurrent expression of cyclin D1 and p27(Kip 1) in acute myeloblastic leukemia cells.

  Leukemia research 20051101

• MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.

  Blood 20051101

• FLAG-IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia.

  Annals of hematology 20051101

• Primary lacrimal sac non-Hodgkin's lymphoma in a child.

  International journal of pediatric otorhinolaryngology 20051101

• Oncogenic potential of the transcription factor LYL1 in acute myeloblastic leukemia.

  Leukemia 20051101

• Inflammatory neurodegeneration induced by lipoteichoic acid from Staphylococcus aureus is mediated by glia activation, nitrosative and oxidative stress, and caspase activation.

  Journal of neurochemistry 20051101

• Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia: final results of a randomized phase III study (06903) of the EORTC Leukemia Cooperative Group.

  Leukemia 20051101

• The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy.

  Journal of neurochemistry 20051101

• Treatment of older patients with AML.

  Critical reviews in oncology/hematology 20051101

• Drug therapy for the treatment of Langerhans cell histiocytosis.

  Expert opinion on pharmacotherapy 20051101

• The N-terminal tetrapeptide of neutrophil proteinase 3 causes S-phase arrest in granulopoietic progenitors.

  Experimental hematology 20051101

• Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate.

  Haematologica 20051101

• Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.

  Haematologica 20051101

• Membranous glomerulopathy in children given allogeneic hematopoietic stem cell transplantation.

  Haematologica 20051101

• Mobilization of autologous hematopoietic progenitors and subsequent transplantation is a safe and feasible procedure in chronic phase chronic myelogenous leukemia patients with cytogenetic resistance to imatinib.

  Haematologica 20051101

• CD79a expression in acute myeloid leukemia t(8;21) and the importance of cytogenetics in the diagnosis of leukemias with immunophenotypic ambiguity.

  Cancer genetics and cytogenetics 20051101

• Hemolytic uremic syndrome after bone marrow transplantation: clinical characteristics and outcome in children.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20051101

• Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051101

• Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction.

  European journal of cancer (Oxford, England : 1990) 20051101

• Chronic myelogenous leukemia.

  Journal of the National Comprehensive Cancer Network : JNCCN 20051101

• A case of bleomycin-induced acral erythema (AE) with eccrine squamous syringometaplasia (ESS) and summary of reports of AE with ESS in the literature.

  The Journal of dermatology 20051101

• [A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].

  Nihon Hinyokika Gakkai zasshi. The japanese journal of urology 20051101

• [Prognostic value of serum markers for liver fibrosis in transient abnormal myelopoiesis (TAM)].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20051101

• [Oral administration of arsenic trioxide induced molecular remission in relapsed acute promyelocytic leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20051101

• Successful treatment of retinoic acid syndrome with dexamethasone: a case report.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20051101

• Three cases of diffuse large B-cell lymphoma presenting as primary splenic lymphoma.

  Yonsei medical journal 20051031

• Neurogenesis in the hypothalamus of adult mice: potential role in energy balance.

  Science (New York, N.Y.) 20051028

• The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis.

  Blood 20051015

• Modeling the pharmacodynamics of highly schedule-dependent agents: exemplified by cytarabine-based regimens in acute myeloid leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20051015

• [Standards and new developments in the chemotherapy of glioblastomas].

  Deutsche medizinische Wochenschrift (1946) 20051007

• High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantation.

  Annals of hematology 20051001

• Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.

  Oncology reports 20051001

• High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20051001

• First-line autologous stem cell transplantation in primary CNS lymphoma.

  European journal of haematology 20051001

• Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.

  Japanese journal of clinical oncology 20051001

• The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence.

  British journal of haematology 20051001

• High activity and incomplete cross resistance of nucleoside analogues cladribine and fludarabine versus Ara-C on leukemic cells from patients with AML.

  Therapeutic drug monitoring 20051001

• CML clonal evolution with resistance to single agent imatinib therapy.

  Clinical and laboratory haematology 20051001

• Antineoplastic agents for pediatric anaplastic large cell lymphoma: Vinblastine is the most effective in vitro.

  Leukemia & lymphoma 20051001

• Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients.

  British journal of haematology 20051001

• Potentiation of in vitro ara-C cytotoxicity by ribonucleotide reductase inhibitors, cyclin-dependent kinase modulators and the DNA repair inhibitor aphidicolin in paediatric acute myeloid leukaemia.

  British journal of haematology 20051001

• The application of molecular analyses for primary granulocytic sarcoma with a specific chromosomal translocation.

  International journal of hematology 20051001

• Leukemic and lymphomatous meningitis: incidence, prognosis and treatment.

  Journal of neuro-oncology 20051001

• Brain white matter changes during treatment of a child for acute lymphoblastic leukemia.

  Journal of Nippon Medical School = Nippon Ika Daigaku zasshi 20051001

• [JWA gene in regulating committed differentiation of HL-60 cells induced by ATRA, Ara-C and TPA].

  Zhongguo shi yan xue ye xue za zhi 20051001

• Acute monocytic leukaemia in a cat.

  The Veterinary record 20050917

• Controllable selective synthesis of a polymerizable prodrug of cytarabine by enzymatic and chemical methods.

  Bioorganic & medicinal chemistry letters 20050915

• Current treatment approaches for mantle-cell lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050910

• Myelodysplastic syndrome of donor origin subsequent to successful treatment of myeloid/NK-cell precursor leukaemia with allogeneic PBSCT: two very rare conditions in one patient.

  Annals of hematology 20050901

• A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia Group.

  Annals of hematology 20050901

• Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.

  Leukemia research 20050901

• Quantitation of synergism of arabinosylcytosine and cladribine against the growth of arabinosylcytosine-resistant human lymphoid cells.

  Journal of cancer research and clinical oncology 20050901

• Leukemic transformation of polycythemia vera: a single center study of 23 patients.

  Cancer 20050901

• Effect of notch ligands on in vitro sensitivity to chemo-therapeutic drugs in leukemia and lymphoma cells.

  Oncology reports 20050901

• Drug-induced pancreatitis: an update.

  Journal of clinical gastroenterology 20050901

• Dramatic improvement in non-AIDS related progressive multifocal leucoencephalopathy.

  Journal of neurology, neurosurgery, and psychiatry 20050901

• Are MTT assays the right tool to analyze drug resistance caused by ABC-transporters in patient samples?

  Leukemia & lymphoma 20050901

• A prospective randomized study to compare the molecular response rates between central lymphatic irradiation and intensive alternating triple chemotherapy in the treatment of stage I-III follicular lymphoma.

  International journal of radiation oncology, biology, physics 20050901

• Medical ethics collides with public policy: LVAD for a patient with leukemia.

  The Annals of thoracic surgery 20050901

• Methotrexate-induced status epilepticus.

  American journal of hematology 20050901

• Phase I evaluation of a 40-kDa branched-chain long-acting pegylated IFN-alpha-2a with and without cytarabine in patients with chronic myelogenous leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050901

• Purine nucleoside analogues for the treatment of hematological malignancies: pharmacology and clinical applications.

  Current cancer drug targets 20050901

• Loss of Gli3 enhances the viability of embryonic telencephalic cells in vitro.

  The European journal of neuroscience 20050901

• Leptomeningeal metastases: current concepts and management guidelines.

  Journal of the National Comprehensive Cancer Network : JNCCN 20050901

• [Development of animal model with JC virus infection and the therapeutic study].

  [Hokkaido igaku zasshi] The Hokkaido journal of medical science 20050901

• Preparation and in vivo evaluation of PEGylated spherulite formulations.

  Biochimica et biophysica acta 20050830

• Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles.

  British journal of cancer 20050822

• Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820

• Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050820

• [Treatment of refractory and relapsed acute lymphocytic leukemia in adults].

  Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20050818

• Drug therapy for acute myeloid leukemia.

  Blood 20050815

• Identification of an AraC-like regulator gene required for induction of the 78-kDa ferrioxamine B receptor in Vibrio vulnificus.

  FEMS microbiology letters 20050815

• Fluvastatin synergistically enhances the antiproliferative effect of gemcitabine in human pancreatic cancer MIAPaCa-2 cells.

  British journal of cancer 20050808

• Autologous tandem transplantation in patients with primary progressive or relapsed/refractory lymphoma.

  Annals of hematology 20050801

• Use of MLL/GRAF fusion mRNA for measurement of minimal residual disease during chemotherapy in an infant with acute monoblastic leukemia (AML-M5).

  Genes, chromosomes & cancer 20050801

• Acute megakaryoblastic leukemia in children and adolescents, excluding Down's syndrome: improved outcome with intensified induction treatment.

  Leukemia 20050801

• AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.

  Leukemia 20050801

• High-dose sequential chemotherapy followed by autologous stem cell transplantation in relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a multicenter phase II study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050801

• Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.

  Biochemical pharmacology 20050801

• Pretreatment prognostic factors and treatment outcome in elderly patients with de novo acute myeloid leukemia.

  Annals of oncology : official journal of the European Society for Medical Oncology 20050801

• Hyperfractionated cyclophosphamide with high-doses of arabinosylcytosine and methotrexate (HyperCHiDAM Verona 897).

  Cancer 20050801

• Outcome of patients with acute myelogenous leukemia after second salvage therapy.

  Cancer 20050801

• 2-Chlorodeoxyadenosine and cytarabine combination therapy for idiopathic hypereosinophilic syndrome.

  Cancer 20050801

• Liposomal encapsulated anti-cancer drugs.

  Anti-cancer drugs 20050801

• Cytarabine-induced lung injury: case report.

  Anti-cancer drugs 20050801

• Successful bone marrow transplantation for life threatening xanthogranuloma disseminatum in neurofibromatosis type-1.

  Pediatric transplantation 20050801

• Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.

  Cancer research 20050801

• Clonogenic growth patterns correlate with chemotherapy response in acute myeloid leukaemia.

  Hematology (Amsterdam, Netherlands) 20050801

• [Study on the expression of human ERMAP gene in erythropoietic and macrophage differentiation of K562 cells].

  Zhongguo shi yan xue ye xue za zhi 20050801

• [Study on mechanism of apoptosis of HL-60 cells induced by cytarabine].

  Zhongguo shi yan xue ye xue za zhi 20050801

• Induction of impaired membrane phospholipid asymmetry in mature erythrocytes after chemotherapy.

  International journal of hematology 20050801

• [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].

  Zhonghua wai ke za zhi [Chinese journal of surgery] 20050801

• Treatment of acute myeloid leukemia during the second and third trimesters of pregnancy.

  Pharmacotherapy 20050801

• [Response rates following neoadjuvant chemotherapy and breast preserving treatment in patients with locally advanced breast cancer].

  Magyar sebeszet 20050801

• Studies on radiation-induced apoptosis in G0 human lymphocytes.

  International journal of radiation biology 20050801

• [Studies of treatment strategy and prognosis on acute myeloid leukemia with chromosome 8 and 21 translocation].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20050801

• Progressive multifocal leukoencephalopathy in a patient treated with natalizumab.

  The New England journal of medicine 20050728

• Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.

  British journal of cancer 20050711

• Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).

  Annals of hematology 20050701

• Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine.

  Blood 20050701

• A novel phospholipid gemcitabine conjugate is able to bypass three drug-resistance mechanisms.

  Cancer chemotherapy and pharmacology 20050701

• The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study.

  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20050701

• Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.

  Bioorganic & medicinal chemistry 20050701

• BAVC regimen and autologous bone marrow transplantation for APL patients in second molecular remission: updated results.

  Bone marrow transplantation 20050701

• Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro.

  Leukemia 20050701

• Pleiotrophin mediates the neurotrophic effect of cyclic AMP on dopaminergic neurons: analysis of suppression-subtracted cDNA libraries and confirmation in vitro.

  Experimental neurology 20050701

• Cytotoxic effects of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine in cross-resistant H9 human lymphoma cells.

  Leukemia research 20050701

• In vitro activity of imatinib in cells from patients with adult acute lymphoblastic leukemia.

  Anti-cancer drugs 20050701

• Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro.

  Neuroscience letters 20050701

• Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.

  Bone marrow transplantation 20050701

• Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells.

  Oncology reports 20050701

• Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: results of a phase III study.

  British journal of clinical pharmacology 20050701

• Mini-BEAM and autologous hematopoietic stem-cell transplant for treatment of post-transplant lymphoproliferative disorders.

  American journal of hematology 20050701

• Veno-occlusive disease of the liver associated with chronic myelomonocytic leukemia treated with vincristine and standard doses of cytarabine.

  American journal of hematology 20050701

• A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20050701

• Acetaminophen-induced anion gap metabolic acidosis and 5-oxoprolinuria (pyroglutamic aciduria) acquired in hospital.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20050701

• Hydatid disease in acute leukemia: effect of anticancer treatment on echinococcosis.

  Microbes and infection 20050701

• Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.

  Haematologica 20050701

• Regarding the alleged radiosensitization of intrathecal cytarabine.

  Journal of pediatric hematology/oncology 20050701

• Ara-C fever and infections after high-dose ara-C treatment in pediatric lymphoid malignancies.

  Journal of pediatric hematology/oncology 20050701

• Pharmacology of 5-Aza-2'-deoxycytidine (decitabine).

  Seminars in hematology 20050701

• Autologous or allogeneic stem cell transplantation as post-remission therapy in refractory or relapsed acute myeloid leukemia after highly intensive chemotherapy.

  Leukemia & lymphoma 20050701

• Successful mobilization of peripheral blood stem cells with the DHAP regimen (dexamethasone, cytarabine, cisplatinum) plus granulocyte colony-stimulating factor in patients with relapsed Hodgkin's disease.

  Leukemia & lymphoma 20050701

• Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation in two Japanese girls.

  Leukemia & lymphoma 20050701

• Granulocytic sarcoma of the heart: extramedullary relapse of acute myeloblastic leukemia after allogeneic stem cell transplantation successfully treated by chemotherapy alone.

  Leukemia & lymphoma 20050701

• Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome.

  Leukemia & lymphoma 20050701

• Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines.

  Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20050701

• Aclarubicin and low-dose Cytosine arabinoside in combination with granulocyte colony-stimulating factor in treating acute myeloid leukemia patients with relapsed or refractory disease and myelodysplastic syndrome: a multicenter study of 112 Chinese patients.

  International journal of hematology 20050701

• Primary intracranial dural lymphoma of mucosa-associated lymphoid tissue (MALT) type: report of one case and review of the literature.

  Bulletin du cancer 20050701

• Liposomal cytarabine (DepoCyte) for the treatment of neoplastic meningitis.

  Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20050701

• Phase III randomized multicenter study of a humanized anti-CD33 monoclonal antibody, lintuzumab, in combination with chemotherapy, versus chemotherapy alone in patients with refractory or first-relapsed acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050620

• Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.

  Blood 20050615

• A sensitive new method for clinically monitoring cytarabine concentrations at the DNA level in leukemic cells.

  Biochemical pharmacology 20050615

• Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).

  Annals of hematology 20050601

• The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells.

  Blood 20050601

• Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial.

  Annals of hematology 20050601

• Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050601

• High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia.

  Leukemia 20050601

• Trying to improve clinical outcome in AML: lessons from negative trials.

  Leukemia research 20050601

• Curing acute myelogenous leukemia: still a major challenge.

  Leukemia research 20050601

• High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experience.

  Leukemia research 20050601

• Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes.

  Leukemia research 20050601

• Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway.

  British journal of haematology 20050601

• Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).

  American journal of hematology 20050601

• Fludarabine and cytarabine as continuous sequential infusion for elderly patients with acute myeloid leukemia.

  Haematologica 20050601

• Management of leptomeningeal malignancy.

  Expert opinion on pharmacotherapy 20050601

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• [Effects of FLAG regimen in treatment of refractory or relapsed acute myeloid leukemia].

  Zhongguo shi yan xue ye xue za zhi 20050601

• A randomized phase III study of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin as salvage chemotherapy followed by posttransplantation rituximab maintenance therapy versus observation for treatment of aggressive B-Cell and T-Cell non-Hodgkin's lymphoma.

  Clinical lymphoma 20050601

• The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia.

  Leukemia & lymphoma 20050601

• Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia.

  Leukemia & lymphoma 20050601

• Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantation.

  Leukemia & lymphoma 20050601

• Transplant-finalized salvage of adult acute lymphoblastic leukemia: results of a mitoxantrone- and methotrexate-based regimen in 36 patients.

  Leukemia & lymphoma 20050601

• [A case of progressive multifocal leukoencephalopathy presenting white matter MRI lesions extending over the cerebral cortex and a marked decrease in cerebral blood flow on SPECT, and associated with HTLV-I infection].

  Rinsho shinkeigaku = Clinical neurology 20050601

• FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study.

  JPMA. The Journal of the Pakistan Medical Association 20050601

• Gateways to clinical trials.

  Methods and findings in experimental and clinical pharmacology 20050601

• Resistance to 9-beta-D-arabinofuranosyl-2-fluoroadenine due to reduced incorporation into DNA from competition by excess deoxyadenosine triphosphate: implications for different sensitivities to nucleoside analogues.

  International journal of hematology 20050601

• Unrelated cord blood transplantation after myeloablative conditioning for adult patients with refractory anemia.

  International journal of hematology 20050601

• Complex karyotypic abnormalities in a case of acute myeloid leukaemia--M4Eo.

  The Malaysian journal of pathology 20050601

• Neoplastic meningitis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050520

• Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells.

  Blood 20050515

• The role of clofarabine in hematologic and solid malignancies--development of a next-generation nucleoside analog.

  Cancer 20050515

• Disease biology rather than age is the most important determinant of survival of patients > or = 60 years with acute myeloid leukemia treated with uniform intensive therapy.

  Cancer 20050515

• Conditioned medium of the primary culture of rat choroid plexus epithelial (modified ependymal) cells enhances neurite outgrowth and survival of hippocampal neurons.

  Neuroscience letters 20050513

• [Therapeutic effects of chemotherapeutic regimens containing pirarubicin on the treatment of high-risk or refractory and relapsed acute leukemia in adults].

  Zhonghua yi xue za zhi 20050511

• Anti-tumor efficacy of the nucleoside analog 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl) cytosine (4'-thio-FAC) in human pancreatic and ovarian tumor xenograft models.

  International journal of cancer 20050510

• Sequential multiagent chemotherapy is not superior to high-dose cytarabine alone as postremission intensification therapy for acute myeloid leukemia in adults under 60 years of age: Cancer and Leukemia Group B Study 9222.

  Blood 20050501

• One versus two high-dose cytarabine-based consolidation before autologous stem cell transplantation for young acute myeloblastic leukaemia patients in first complete remission.

  British journal of haematology 20050501

• Activation of the RAS pathway is predictive for a chemosensitive phenotype of acute myelogenous leukemia blasts.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050501

• Sensitivity to gemcitabine and its metabolizing enzymes in neuroblastoma.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20050501

• Knee arthritis as a rare inaugural manifestation of adult leukemia.

  Rheumatology international 20050501

• Myelopathy due to intrathecal chemotherapy: report of six cases.

  Journal of pediatric hematology/oncology 20050501

• Vincristine-induced urinary bladder paralysis.

  Journal of pediatric hematology/oncology 20050501

• TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.

  Haematologica 20050501

• Limited value of FLT3 mRNA expression in the bone marrow for prognosis and monitoring of patients with acute myeloid leukemia.

  Haematologica 20050501

• [Suppressive effect of high-dose chemotherapy (HDC) on the clonal growth of grafted peripheral blood granulocyte progenitors is reduced 72 hours after completion of HDC].

  Polskie Archiwum Medycyny Wewnetrznej 20050501

• Gemcitabine, cisplatin and methylprednisolone (GEM-P) is an effective salvage regimen in patients with relapsed and refractory lymphoma.

  British journal of cancer 20050425

• Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study.

  Blood 20050415

• Gene repair in mammalian cells is stimulated by the elongation of S phase and transient stalling of replication forks.

  DNA repair 20050404

• Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry.

  Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 20050401

• Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C.

  The Biochemical journal 20050401

• Cerebrospinal fluid-disseminated meningioma.

  Cancer 20050401

• PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways.

  Leukemia 20050401

• Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSF.

  Leukemia 20050401

• Biochemical modulation of cytarabine triphosphate by clofarabine.

  Cancer chemotherapy and pharmacology 20050401

• Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.

  Leukemia 20050401

• Proteome-based identification of molecular markers predicting chemosensitivity to each category of anticancer agents in human gliomas.

  International journal of oncology 20050401

• Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.

  European journal of haematology 20050401

• Concurrent administration of high-dose rituximab before and after autologous stem-cell transplantation for relapsed aggressive B-cell non-Hodgkin's lymphomas.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050401

• Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.

  British journal of haematology 20050401

• [Clinical randomized comparative trial of ProMACE-CytaBOM regimen and CHOP regimen in treating non-Hodgkin's lymphoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20050401

• [Sensitivity of survivin-positive primary leukemia cells to chemotherapy].

  Zhongguo shi yan xue ye xue za zhi 20050401

• [Influence of anti-CXCR4 monoclonal antibody 12G5 on killing effect of cytosine arabinoside to HL-60 cell].

  Zhongguo shi yan xue ye xue za zhi 20050401

• Simultaneous separation and determination of Tarabine PFS and Adriblastine using micellar electrokinetic chromatography and high performance liquid chromatography. Application to some biological fluids.

  Journal of separation science 20050401

• GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDS.

  Oncology (Williston Park, N.Y.) 20050401

• Spinal paraparesis due to leukemic meningitis in early-stage chronic lymphocytic leukemia.

  Leukemia & lymphoma 20050401

• Simultaneous micellar electrokinetic chromatography and liquid chromatography of adriblastina and tarabine PFS Their application to some biological fluids.

  Talanta 20050331

• Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.

  Blood 20050315

• Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I study.

  British journal of cancer 20050314

• An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital.

  British journal of cancer 20050314

• Substrate cycles and drug resistance to 1-beta-D-arabinofuranosylcytosine (araC).

  Leukemia & lymphoma 20050301

• Prognostic features for response and survival in elderly patients with de novo acute myeloid leukemia treated with mitoxantrone and intermediate dose cytarabine.

  Leukemia & lymphoma 20050301

• Acute myeloid leukemia in the elderly: etoposide when anthracyclins are contraindicated.

  Leukemia & lymphoma 20050301

• ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin's lymphoma: comparison with high-dose cyclophosphamide plus G-CSF.

  Bone marrow transplantation 20050301

• A phase I and pharmacologic study of idarubicin, cytarabine, etoposide, and the multidrug resistance protein (MDR1/Pgp) inhibitor PSC-833 in patients with refractory leukemia.

  Leukemia research 20050301

• Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.

  Cancer 20050301

• In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia.

  Anti-cancer drugs 20050301

• Synergistic action of resveratrol, an ingredient of wine, with Ara-C and tiazofurin in HL-60 human promyelocytic leukemia cells.

  Experimental hematology 20050301

• Prediction of individual response to chemotherapy in patients with acute myeloid leukaemia using the chemosensitivity index Ci.

  British journal of haematology 20050301

• Chronic myeloid leukemia: current application of cytogenetics and molecular testing for diagnosis and treatment.

  Mayo Clinic proceedings 20050301

• High leukaemia cure rate in Down's syndrome explained.

  The Lancet. Oncology 20050301

• [Case of central nervous system lymphoma metastasized to breast after remission by methotrexate chemotherapy].

  No shinkei geka. Neurological surgery 20050301

• [Current and new therapeutic strategies in acute myeloid leukemia].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050301

• The development and application of imatinib.

  Expert opinion on drug safety 20050301

• [Metabolism, mechanism of action and resistance to cytotoxic nucleoside analogues].

  Bulletin du cancer 20050301

• [Disseminated cutaneous and visceral fusariosis in an aplastic patient: an unusual digestive entry].

  Annales de dermatologie et de venereologie 20050301

• [Adams-Stokes attack due to complete atrioventricular block in a patient with acute promyelocytic leukemia during remission induction therapy using all-trans retinoic acid].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20050301

• Microbial growth tests in anti-neoplastic injectable solutions.

  Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20050301

• Interaction between gemcitabine and topotecan in human non-small-cell lung cancer cells: effects on cell survival, cell cycle and pharmacogenetic profile.

  British journal of cancer 20050227

• Adenomatous polyposis coli influences micronuclei induction by PhIP and acrylamide in mouse erythrocytes.

  Mutation research 20050207

• GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.

  Journal of the National Cancer Institute 20050202

• Liver-targeted drug delivery using HepDirect prodrugs.

  The Journal of pharmacology and experimental therapeutics 20050201

• Mechanistic role of heat shock protein 70 in Bcr-Abl-mediated resistance to apoptosis in human acute leukemia cells.

  Blood 20050201

• Results of a phase 1-2 study of clofarabine in combination with cytarabine (ara-C) in relapsed and refractory acute leukemias.

  Blood 20050201

• Combination of imatinib and cytarabine for the treatment of Philadelphia chromosome positive acute lymphoblastic leukemia.

  Leukemia & lymphoma 20050201

• Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells.

  Genes to cells : devoted to molecular & cellular mechanisms 20050201

• Anti-CD33 monoclonal antibodies enhance the cytotoxic effects of cytosine arabinoside and idarubicin on acute myeloid leukemia cells through similarities in their signaling pathways.

  Experimental hematology 20050201

• Administration of low-dose cytarabine results in immediate S-phase arrest and subsequent activation of cell cycling in murine stem cells.

  Experimental hematology 20050201

• Second induction in pediatric patients with recurrent acute lymphoid leukemia using DFCI-ALL protocols.

  Journal of pediatric hematology/oncology 20050201

• Acute pancreatitis during all-trans-retinoic acid treatment for acute promyelocytic leukemia in a patient without overt hypertriglyceridemia.

  Japanese journal of clinical oncology 20050201

• [Treatment of childhood Burkitt lymphoma according to LMB89 protocol in Casablanca].

  Bulletin du cancer 20050201

• Cognitive changes in children treated for acute lymphoblastic leukemia with chemotherapy only according to the Pediatric Oncology Group 9605 protocol.

  Journal of child neurology 20050201

• '3+7' therapy for the treatment of acute myeloid leukemia. PRO.

  Clinical advances in hematology & oncology : H&O 20050201

• Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050120

• Phase I trial of iodine-131 tositumomab with high-dose chemotherapy and autologous stem-cell transplantation for relapsed non-Hodgkin's lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050120

• Advanced-stage large-cell lymphoma in children and adolescents: results of a randomized trial incorporating intermediate-dose methotrexate and high-dose cytarabine in the maintenance phase of the APO regimen: a Pediatric Oncology Group phase III trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20050120

• A randomized trial of high-versus conventional-dose cytarabine in consolidation chemotherapy for adult de novo acute myeloid leukemia in first remission after induction therapy containing high-dose cytarabine.

  Blood 20050115

• Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells.

  Blood 20050115

• [Treatment results with ALL-BFM-95 protocol in children with acute lymphoblastic leukemia in Hungary].

  Orvosi hetilap 20050109

• Down syndrome, drug metabolism and chromosome 21.

  Pediatric blood & cancer 20050101

• Venous thromboembolism after high-dose chemotherapy in a patient with Hodgkin's lymphoma receiving the new oral contraceptive ethinylestradiol and drospirenone ('Yasmine').

  Bone marrow transplantation 20050101

• Acute myeloid leukemia and Down syndrome evolution of modern therapy--state of the art review.

  Pediatric blood & cancer 20050101

• Chk1 is essential for tumor cell viability following activation of the replication checkpoint.

  Cell cycle (Georgetown, Tex.) 20050101

• Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).

  Leukemia research 20050101

• Neurotrophins protect against cytosine arabinoside-induced apoptosis of immature rat cerebellar neurons.

  Neurochemistry international 20050101

• Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).

  Annals of oncology : official journal of the European Society for Medical Oncology 20050101

• Conditioning with targeted busulfan for autologous peripheral blood stem cells transplantation for acute myelogenous leukemia in an XYY male.

  American journal of hematology 20050101

• Hypereosinophilic syndrome: long-term remission following allogeneic stem cell transplant in spite of transient eosinophilia post-transplant.

  American journal of hematology 20050101

• Induction chemotherapy for acute myelogenous leukemia.

  Current hematology reports 20050101

• Cytarabine-induced fever complicating the clinical course of leukemia.

  Anti-cancer drugs 20050101

• Genetic effects caused by potent antileukemic steroidal esters of chlorambucil's active metabolite.

  Anti-cancer drugs 20050101

• The effect of antitumor drugs on oxidative stress in B16 and S91 melanoma cells in vitro.

  Medical science monitor : international medical journal of experimental and clinical research 20050101

• Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995).

  Leukemia & lymphoma 20050101

• Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.

  Clinical pharmacokinetics 20050101

• Images in haematology. Combined central retinal artery and vein occlusions as the presenting signs of ocular relapse in acute lymphoblastic leukaemia.

  British journal of haematology 20050101

• Intrathecal chemotherapy for patients with meningeal carcinomatosis.

  Surgical neurology 20050101

• Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.

  Haematologica 20050101

• Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells.

  BMC cancer 20050101

• [Acute myelomonocytic leukemia complicated with multiple lower intestinal ulcers induced by nonsteroidal anti-inflammatory drugs].

  Gan to kagaku ryoho. Cancer & chemotherapy 20050101

• ESHAP for primary cutaneous T-cell lymphomas: efficacy and tolerance in 11 patients.

  The hematology journal : the official journal of the European Haematology Association 20050101

• Natural killer T-cell lymphoma of the tongue.

  The Annals of otology, rhinology, and laryngology 20050101

• Lipophilic arabinofuranosyl cytosine derivatives in liposomes.

  Methods in enzymology 20050101

• In vitro sensitivity of leukemic cells to nucleoside derivatives in childhood acute leukemias: good activity in leukemic relapses.

  Neoplasma 20050101

• Low dose docosahexaenoic acid protects normal colonic epithelial cells from araC toxicity.

  BMC pharmacology 20050101

• Heterodinucleoside phosphates of 5-fluorodeoxyuridine and arabinofuranosylcytosine--new drugs in cancer chemotherapy?

  In vivo (Athens, Greece) 20050101

• Contribution of chitosan and its derivatives to cancer chemotherapy.

  In vivo (Athens, Greece) 20050101

• Leptomeningeal metastasis.

  Cancer investigation 20050101

• Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.

  Anticancer research 20050101

• Hsp27 and axonal growth in adult sensory neurons in vitro.

  BMC neuroscience 20050101

• Outcome of acute myeloid leukaemia in adults: a retrospective analysis.

  The National medical journal of India 20050101

• Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma.

  BMC cancer 20050101

• Role of early plasma membrane events in chemotherapy-induced cell death.

  Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy 20050101

• Determination of caspase-3 activation fails to predict chemosensitivity in primary acute myeloid leukemia blasts.

  BMC cancer 20050101

• Cardiotoxicity of cancer chemotherapy: implications for children.

  Paediatric drugs 20050101

• Induction of caspase 3 activity, bcl-2 bax and p65 gene expression modulation in human acute promyelocytic leukemia HL-60 cells by doxorubicin with amifostine.

  Pharmacological reports : PR 20050101

• Experiencing neutropenia: quality of life interviews with adult cancer patients.

  BMC nursing 20050101

• [Dosage of drugs for cerebrospinal administration].

  Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20050101

• Cancer cell adaptation to chemotherapy.

  BMC cancer 20050101

• Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein.

  Virology journal 20050101

• Genetic factors influencing pyrimidine-antagonist chemotherapy.

  The pharmacogenomics journal 20050101

• Induction of fetal haemoglobin expression in erythroid cells--a model based on iron availability signalling.

  Medical hypotheses 20050101

• Successful treatment of a patient with synchronous advanced non-small cell lung cancer and acute myeloid leukemia by a combination of gefitinib, low-dose cytarabine and aclarubicin.

  Anticancer research 20050101

• In B-CLL, the codon 72 polymorphic variants of p53 are not related to drug resistance and disease prognosis.

  BMC cancer 20050101

• A Case of Burkitt's Lymphoma Involving Both Breasts.

  Breast cancer (Tokyo, Japan) 20050101

• Description of a PCR-based technique for DNA splicing and mutagenesis by producing 5' overhangs with run through stop DNA synthesis utilizing Ara-C.

  BMC biotechnology 20050101

• Chemotherapy for acute myeloid leukemias with cytosine arabinoside, daunorubicin, etoposide, and mitoxantrone may cause permanent oligoasthenozoospermia or amenorrhea in middle-aged patients.

  Neoplasma 20050101

• Acute myeloid leukemia treatment in patients over 60 years of age. Comparison of symptomatic, palliative, and aggressive therapy.

  Neoplasma 20050101

• The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.

  Neoplasma 20050101

• Stem cell transplantation as consolidation therapy for children in first-remission AML: a single-center report.

  Pediatric hematology and oncology 20050101

• Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.

  Journal of drugs in dermatology : JDD 20050101

• Usefulness of PKH fluorescent labelling to study leukemic cell proliferation with various cytostatic drugs or acetyl tetrapeptide--AcSDKP.

  BMC cancer 20050101

• Treatment of acute promyelocytic leukemia: a single institution experience.

  Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 20050101

• A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.

  Biotechnology annual review 20050101

• Long-term disease-free survival in advanced melanomas treated with nitrosoureas: mechanisms and new perspectives.

  BMC cancer 20050101

• New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agents.

  Hematology. American Society of Hematology. Education Program 20050101

• Management of early stage disease.

  Hematology. American Society of Hematology. Education Program 20050101

• Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.

  Klinische Padiatrie 20050101

• First-line therapy with gemcitabine and paclitaxel in locally, recurrent or metastatic breast cancer: a phase II study.

  BMC cancer 20050101

• Rituximab, Ara-C, dexamethasone and oxaliplatin is safe and active in heavily pretreated patients with diffuse large B-cell lymphoma.

  Oncology 20050101

• Control of acute myeloid leukemia morbidity in northwest Iran.

  Asian Pacific journal of cancer prevention : APJCP 20050101

• Synthetic approaches to a mononucleotide prodrug of cytarabine.

  Nucleosides, nucleotides & nucleic acids 20050101

• A long-term follow-up analysis in adult acute myeloid leukemia patients after hematopoietic stem cell transplantation.

  Tumori 20050101

• [Meningeal carcinomatosis in cancer patients].

  Tumori 20050101

• [Drug sensitivity of tumor cells in varieties of acute childhood leukemia].

  Voprosy onkologii 20050101

• Influence of long-term treatment with cytosine arabinoside on telomere length in human HL60 cells.

  Nucleic acids symposium series (2004) 20050101

• Granulomatous meningoencephalomyelitis in dogs: A review.

  Irish veterinary journal 20050101

• Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia.

  Core evidence 20050101

• Platinated DNA adducts enhance poisoning of DNA topoisomerase I by camptothecin.

  The Journal of biological chemistry 20041224

• Synergistic effect of SU11248 with cytarabine or daunorubicin on FLT3 ITD-positive leukemic cells.

  Blood 20041215

• Polymerization of the triphosphates of AraC, 2',2'-difluorodeoxycytidine (dFdC) and OSI-7836 (T-araC) by human DNA polymerase alpha and DNA primase.

  Biochemical pharmacology 20041215

• Unusual sites of metastatic malignancy: case 3. Acute leukemia presenting as bilateral proptosis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041215

• Coexistence of treatment-related MLL cleavage and rearrangement in a child with haemophagocytic lymphohistiocytosis.

  British journal of cancer 20041213

• [Treatment of primary mediastinal large B-cell lymphomas].

  Orvosi hetilap 20041212

• Signal transduction of c-Kit receptor tyrosine kinase in CHRF myeloid leukemia cells.

  Journal of cancer research and clinical oncology 20041201

• Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma.

  Bone marrow transplantation 20041201

• Long-term survival estimates for imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.

  Cancer 20041201

• Cost-effectiveness of imatinib versus interferon-alpha plus low-dose cytarabine for patients with newly diagnosed chronic-phase chronic myeloid leukemia.

  Cancer 20041201

• Immunobiologic therapies for myelodysplastic syndrome.

  Best practice & research. Clinical haematology 20041201

• VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia.

  European journal of haematology 20041201

• Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.

  European journal of haematology 20041201

• Drug-induced corneal complications.

  Current opinion in ophthalmology 20041201

• The effect of G-CSF on the in vitro cytotoxicity of cytarabine and fludarabine in the FLAG combination in pediatric acute myeloid leukemia.

  International journal of oncology 20041201

• Interferon-alpha-2b and oral cytarabine ocfosfate for newly diagnosed chronic myeloid leukaemia.

  Annals of oncology : official journal of the European Society for Medical Oncology 20041201

• Cytarabine-induced neurotoxicity responding to methyl prednisolone.

  American journal of hematology 20041201

• Primary central nervous system lymphoma report of 32 cases and review of the literature.

  Clinical neurology and neurosurgery 20041201

• Complex t(8;14;21)(q22;q13;q22), a variant of t(8;21), with t(15;21)(q15;p11) in a patient with acute myelogenous leukemia (M1).

  Cancer genetics and cytogenetics 20041201

• The -omics era and its impact.

  Archives of pathology & laboratory medicine 20041201

• Cytosine arabinoside substitution decreases transcription factor-DNA binding element complex formation.

  Archives of pathology & laboratory medicine 20041201

• Pharmacokinetic studies in children with cancer.

  Critical reviews in oncology/hematology 20041201

• Breast cancer resistance protein and P-glycoprotein in 149 adult acute myeloid leukemias.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20041201

• [Efficacy of modified BFM-90 regimen on children and adolescents with T cell lymphoblastic lymphoma: a report of 20 cases].

  Ai zheng = Aizheng = Chinese journal of cancer 20041201

• Role of liposomal daunorubicin, fludarabine and cytarabine (FLAD) in the salvage therapy of adult acute lymphoblastic leukemia.

  Leukemia & lymphoma 20041201

• [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C].

  Zhongguo shi yan xue ye xue za zhi 20041201

• Neoplastic meningitis.

  Seminars in neurology 20041201

• Phase I study for poor-prognosis lymphoma: augmentation of the 'BEAM' regimen with escalating dose melphalan using amifostine cytoprotection and autologous hematopoietic stem cell transplantation--a preliminary report.

  Seminars in oncology 20041201

• Angiotropic B-cell lymphoma with telangiectasia, accompanied by panniculitic formation.

  The Journal of dermatology 20041201

• Isolated central nervous system blast crisis in chronic myeloid leukemia.

  Hematological oncology 20041201

• Increased expression of N-acetylglucosaminyltransferase-V in human hepatoma cells by retinoic acid and 1alpha,25-dihydroxyvitamin D3.

  The international journal of biochemistry & cell biology 20041101

• Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia.

  Annals of hematology 20041101

• A new approach to treatment of acute myelogenous leukemia using targeted therapy in combination with standard chemotherapy.

  Leukemia research 20041101

• A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia.

  Leukemia research 20041101

• The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia.

  Leukemia research 20041101

• Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia.

  Leukemia 20041101

• Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents.

  British journal of haematology 20041101

• Impact of cytidine deaminase activity on intrinsic resistance to cytarabine in carcinoma cells.

  Oncology reports 20041101

• Management of patients with systemic mastocytosis: review of M. D. Anderson Cancer Center experience.

  American journal of hematology 20041101

• Growth factor priming in therapy of acute myelogenous leukemia.

  Current hematology reports 20041101

• Teaching cases from the Royal Marsden and St Mary's Hospitals case 28: a patient with acute leukemia with rare leukemic cells of unusual morphology.

  Leukemia & lymphoma 20041101

• Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Group B Study 9621.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101

• Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041101

• Butyrate increases apoptosis induced by different antineoplastic drugs in monocytic leukemia cells.

  Chemotherapy 20041101

• Clinical and molecular complete remission in a case of variant hairy cell leukemia treated with DHAP followed by high-dose chemotherapy plus rituximab.

  Haematologica 20041101

• An in vitro study on the mechanisms of coagulation activation in acute myelogenous leukemia (AML): role of tissue factor regulation by cytotoxic drugs and GM-CSF.

  Thrombosis and haemostasis 20041101

• Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients.

  Pharmacogenetics 20041101

• [Primary study of relationship between serum level of VEGF and non-Hodgkin's lymphoma in children and adolescent patients].

  Ai zheng = Aizheng = Chinese journal of cancer 20041101

• [Infection control in neutropenia induced by high-dose cytarabine chemotherapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20041101

• [Successful treatment of acute myelomonocytic leukemia developed from essential thrombocythemia with cytarabine plus etoposide].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20041101

• Gene-expression profiling reveals down-regulation of equilibrative nucleoside transporter 1 (ENT1) in Ara-C-resistant CCRF-CEM-derived cells.

  Journal of biochemistry 20041101

• Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation.

  British journal of cancer 20041018

• Translocation t(12;21) is related to in vitro cellular drug sensitivity to doxorubicin and etoposide in childhood acute lymphoblastic leukemia.

  Blood 20041015

• Synthesis and antiviral activities of 1'-carbon-substituted 4'-thiothymidines.

  Bioorganic & medicinal chemistry 20041015

• Possible modulating actions of plant extracts on the chromosome breaking activity of MMC and Ara-C in human lymphocytes in vitro.

  Toxicology in vitro : an international journal published in association with BIBRA 20041001

• High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.

  Bone marrow transplantation 20041001

• A long-term follow-up of 33 patients with non-Hodgkin's lymphoma who received the BEAM high-dose intensification regimen with cytokine support only and no transplant.

  Leukemia 20041001

• Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study.

  Bone marrow transplantation 20041001

• Antileukemic and long-term effects of two regimens with or without TBI in allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia.

  Bone marrow transplantation 20041001

• Toxicity and efficacy of intensive chemotherapy for children with acute lymphoblastic leukemia (ALL) after first bone marrow or extramedullary relapse.

  Pediatric blood & cancer 20041001

• Outcome of children with B cell lymphoma in Venezuela with the LMB-89 protocol.

  Pediatric blood & cancer 20041001

• Essential thrombocythemia terminating in pure erythroleukemia.

  American journal of hematology 20041001

• Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20041001

• Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.

  British journal of haematology 20041001

• Sequential chemotherapy regimens followed by high-dose therapy with stem cell transplantation in mantle cell lymphoma: an update of a prospective study.

  Haematologica 20041001

• [Clinical and microbiological characteristics of neutropenic enterocolitis in adults with blood cancer in the National Cancer Institute of Bogota D.C. (Colombia)].

  Enfermedades infecciosas y microbiologia clinica 20041001

• Visual recovery after radiation therapy for bilateral subfoveal acute myelogenous leukemia (AML).

  American journal of ophthalmology 20041001

• Glomerular dysfunction, independent of tubular dysfunction, induced by antineoplastic chemotherapy in children.

  Pediatrics international : official journal of the Japan Pediatric Society 20041001

• Unexpected response of hormone-refractory prostate cancer to treatment with an antileukemic chemotherapy regimen.

  Urology 20041001

• Testicular granulocytic sarcoma, a source of diagnostic confusion.

  Urology 20041001

• [Pseudomonas sepsis with ecthyma gangrenosum in an acute myeloid leukemia patient].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20041001

• Immunocytochemical detection of deoxycytidine kinase in pediatric malignancies in relation to in vitro cytarabine sensitivity.

  Nucleosides, nucleotides & nucleic acids 20041001

• Clofarabine in adult acute leukemias: clinical success and pharmacokinetics.

  Nucleosides, nucleotides & nucleic acids 20041001

• Cytotoxic and apoptotic effects of novel heterodinucleoside phosphates consisting of 5-fluorodeoxyuridine and Ara-C in human cancer cell lines.

  Nucleosides, nucleotides & nucleic acids 20041001

• Modulation of cytarabine induced cytotoxicity using novel deoxynucleoside analogs in the HL60 cell line.

  Nucleosides, nucleotides & nucleic acids 20041001

• Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinosylcytosine (ara-C) in leukemia and solid tumor cell lines.

  Nucleosides, nucleotides & nucleic acids 20041001

• Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.

  Nucleosides, nucleotides & nucleic acids 20041001

• A thoracic-epidural granulocytic sarcoma case that was diagnosed preceding the onset of and that recurred co-incidental to acute promyelocytic leukemia, which developed after surgical treatment.

  Acta medica Okayama 20041001

• Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells.

  Blood 20040915

• Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia.

  Cancer 20040915

• Pressure-induced bullae and sweat gland necrosis following chemotherapy induction.

  The American journal of medicine 20040915

• Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides.

  British journal of cancer 20040913

• Susceptibility to cytosine arabinoside (Ara-C)-induced cytotoxicity in human leukemia cell lines.

  Toxicology letters 20040910

• Gonadal function in patients treated for leukemia in childhood.

  Leukemia & lymphoma 20040901

• First experience with gemtuzumab ozogamicin plus cytarabine as continuous infusion for elderly acute myeloid leukaemia patients.

  Leukemia research 20040901

• Treatment intensity significantly influencing fibrosis in bone marrow independently of the cytogenetic response: meta-analysis of the long-term results from two prospective controlled trials on chronic myeloid leukemia.

  Leukemia 20040901

• Intraventricular cytarabine in a case of idiopathic hypertrophic pachymeningitis.

  Journal of neurology, neurosurgery, and psychiatry 20040901

• Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas.

  British journal of haematology 20040901

• Successful allogeneic bone marrow transplantation for acute myelogenous leukemia after drug-induced cardiomyopathy.

  The Tohoku journal of experimental medicine 20040901

• The treatment of neoplastic meningitis.

  Expert opinion on pharmacotherapy 20040901

• Methotrexate and cytarabine inhibit progression of human lymphoma in NOD/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene.

  Molecular therapy : the journal of the American Society of Gene Therapy 20040901

• Assessment of drug resistance in acute myeloid leukemia.

  Expert review of molecular diagnostics 20040901

• Treating childhood acute myeloid leukaemia with the AML-BFM-83 protocol: experience in a developing country.

  British journal of haematology 20040901

• High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitt's lymphoma in adults.

  British journal of haematology 20040901

• Aggressive systemic mastocytosis mimicking sclerosing cholangitis.

  Haematologica 20040901

• [Acute myeloid leukemia with Aspergillus tracheobronchitis after allogeneic peripheral blood stem cell transplant].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20040901

• [Acute myeloid leukemia presenting with obstructive jaundice and granulocytic sarcoma of the common bile duct].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20040901

• Chemotherapy-induced and/or radiation therapy-induced oral mucositis--complicating the treatment of cancer.

  Neoplasia (New York, N.Y.) 20040901

• A single-center, retrospective study of management and outcome of 45 elderly AML patients, diagnosed in 2001.

  Journal of experimental & clinical cancer research : CR 20040901

• The effects of IL-2, IL-6 and IL-10 levels on prognosis in patients with aggressive Non-Hodgkin's Lymphoma (NHL).

  Journal of experimental & clinical cancer research : CR 20040901

• Determinants of survival in Nigerians with Burkitt's lymphoma.

  African journal of medicine and medical sciences 20040901

• In vitro studies of a FLT3 inhibitor combined with chemotherapy: sequence of administration is important to achieve synergistic cytotoxic effects.

  Blood 20040815

• Characterization of a gemcitabine-resistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040815

• Overexpression of DcR1 and survivin in genetically modified cells with pleiotropic drug resistance.

  Cancer letters 20040810

• Jun N-terminal kinase promotes proliferation of immature erythroid cells and erythropoietin-dependent cell lines.

  Blood 20040801

• In vitro assessment of nucleoside analogs in multiple myeloma.

  Cancer chemotherapy and pharmacology 20040801

• Intensive chemotherapy with idarubicin, cytarabine, etoposide, and G-CSF priming in patients with advanced myelodysplastic syndrome and high-risk acute myeloid leukemia.

  Annals of hematology 20040801

• Electrophysiological characterization of a recombinant human Na+-coupled nucleoside transporter (hCNT1) produced in Xenopus oocytes.

  The Journal of physiology 20040801

• High-dose cytosine arabinoside and etoposide with total body irradiation as a preparatory regimen for allogeneic hematopoietic stem-cell transplantation in patients with acute lymphoblastic leukemia.

  Bone marrow transplantation 20040801

• Low-dose ARAC, donor cells, and GM-CSF for treatment of recurrent acute myeloid leukemia after allogeneic stem cell transplantation.

  Leukemia 20040801

• Hepatotoxicity due to a possible interaction between cytosine arabinoside and dipyridamole: a case report.

  European journal of clinical pharmacology 20040801

• In vitro and in vivo antitumor activity of novel amphiphilic dimers consisting of 5-fluorodeoxyuridine and arabinofuranosylcytosine.

  International journal of oncology 20040801

• Functional analysis of apoptosis induction in acute myeloid leukaemia-relevance of karyotype and clinical treatment response.

  British journal of haematology 20040801

• Histiocyte-rich dermatoses in two patients with acute lymphocytic leukaemia treated with cytarabine.

  Histopathology 20040801

• Fatal peripheral neuropathy following FLA chemotherapy.

  Clinical and laboratory haematology 20040801

• Increasing dose intensity of anthracycline antibiotics improves outcome in patients with acute myelogenous leukemia.

  American journal of hematology 20040801

• Prolonged fever of unknown origin and hemophagocytosis evolving into acute lymphoblastic leukemia.

  American journal of hematology 20040801

• Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway.

  British journal of haematology 20040801

• Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells.

  British journal of haematology 20040801

• Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.

  Haematologica 20040801

• Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups.

  Haematologica 20040801

• Low dose Ara-C for myelodysplastic syndromes: is it still a current therapy?

  Leukemia & lymphoma 20040801

• Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy.

  Leukemia & lymphoma 20040801

• DNA methylation as a therapeutic target in hematologic disorders: recent results in older patients with myelodysplasia and acute myeloid leukemia.

  International journal of hematology 20040801

• Peripheral blood stem cell collection after intermediate-dose cytarabine in adult patients with acute myeloblastic leukemia undergoing autologous blood stem cell transplantation in first complete remission.

  International journal of hematology 20040801

• [Mobilization of peripheral blood stem cells with mitoxantrone and high-dose cytarabine chemotherapy and rhG-CSF in patients with hematopoietic malignancies].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20040801

• Spontaneous DNA repair in human peripheral blood mononuclear cells.

  Biochemical and biophysical research communications 20040723

• Corticotropin releasing factor enhances survival of cultured GABAergic cerebellar neurons after exposure to a neurotoxin.

  Brain research. Developmental brain research 20040719

• Value of positron emission tomography scan in staging cancers, and an unusual presentation of acute myeloid leukemia. Case 1. Demonstration of CNS lymphoma by positron emission tomography scan affects management.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040715

• Clonal evolution as pathogenetic mechanism in relapse of primary CNS lymphoma.

  Neurology 20040713

• Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer.

  British journal of cancer 20040705

• Fatal hemorrhagic pneumonia caused by infection due to Kytococcus sedentarius--a pathogen or passenger?

  Annals of hematology 20040701

• Altered prepulse inhibition in rats treated prenatally with the antimitotic Ara-C: an animal model for sensorimotor gating deficits in schizophrenia.

  Psychopharmacology 20040701

• Valproic acid inhibits proliferation and induces apoptosis in acute myeloid leukemia cells expressing P-gp and MRP1.

  Leukemia 20040701

• Life-threatening complications of transient abnormal myelopoiesis in neonates with Down syndrome.

  European journal of pediatrics 20040701

• Cytosine arabinoside induces costimulatory molecule expression in acute myeloid leukemia cells.

  Leukemia 20040701

• Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy.

  Leukemia research 20040701

• Stromal cell protection of B-lineage acute lymphoblastic leukemic cells during chemotherapy requires active Akt.

  Leukemia research 20040701

• A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma.

  Bone marrow transplantation 20040701

• An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.

  Biochemical pharmacology 20040701

• Sweet's syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment.

  American journal of hematology 20040701

• Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside.

  American journal of hematology 20040701

• Intensive therapy for aggressive lymphoma.

  The New England journal of medicine 20040701

• Clinical effects and P-glycoprotein inhibition in patients with acute myeloid leukemia treated with zosuquidar trihydrochloride, daunorubicin and cytarabine.

  Haematologica 20040701

• Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.

  Haematologica 20040701

• Polyethylene glycol interferon-alpha2b alone or in combination with low-dose Ara-C in patients newly diagnosed with chronic myeloid leukemia.

  Haematologica 20040701

• [Protective effects of minocycline against hair follicle damage induced by cytosine arabinoside in vitro].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20040701

• [Five cases of de novo acute myeloid leukemia with trilineage myelodysplasia (AML/TMDS) achieved CR with the continuous drip infusion of low-dose etoposide and low-dose cytosine arabinoside combined with mitoxantrone (MEtA)].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040701

• [Imatinib therapy for patients with chronic myelogenous leukemia].

  Nihon rinsho. Japanese journal of clinical medicine 20040701

• [Significance of C-reaction protein for differential diagnosis of fever after chemotherapy on children with acute lymphoblastic leukemia].

  Zhonghua er ke za zhi = Chinese journal of pediatrics 20040701

• No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response?

  Leukemia & lymphoma 20040701

• Outcome of elderly patients with aggressive Non-Hodgkin's lymphoma refractory to or relapsing after first-line CHOP or CHOP-like chemotherapy: a low probability of cure.

  Leukemia & lymphoma 20040701

• Presentation of extramedullary acute myelogenous leukemia as bilateral testicular masses: response to non-myeloablative allogeneic transplantation.

  Leukemia & lymphoma 20040701

• Effect of DCEP mobilizing regimen in in vivo purging of PBSC harvests in multiple myeloma.

  Leukemia & lymphoma 20040701

• [Mantle cell lymphoma markedly infiltrated into adrenal glands with adrenal insufficiency].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20040701

• Repair of cytokine-induced DNA damage in cultured rat islets of Langerhans.

  Free radical research 20040701

• Ex vivo therapeutic index by drug sensitivity assay using fresh human normal and tumor cells.

  Journal of experimental therapeutics & oncology 20040701

• Reduced expression of Bax in ceramide-resistant HL-60 subline.

  Biochemical and biophysical research communications 20040618

• A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia.

  Blood 20040615

• Competition of drugs to serum albumin in combination therapy.

  Biopolymers 20040615

• Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantation.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040615

• A novel effective and safe consolidation for patients over 60 years with acute myeloid leukemia: intermediate dose cytarabine (2 x 1 g/m2 on days 1, 3, and 5).

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040615

• Distinct functions for WRN and TP53 in a shared pathway of cellular response to 1-beta-D-arabinofuranosylcytosine and bleomycin.

  Experimental cell research 20040610

• Effects of naringin on cytosine arabinoside (Ara-C)-induced cytotoxicity and apoptosis in P388 cells.

  Life sciences 20040604

• Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced trophoblastic cell apoptosis and impaired proliferation in rat placenta.

  Biology of reproduction 20040601

• Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial.

  Annals of hematology 20040601

• Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells.

  Bone marrow transplantation 20040601

• A phase II study of timed sequential therapy of acute myelogenous leukemia (AML) for patients over the age of 60: two cycle timed sequential therapy with topotecan, ara-C and mitoxantrone in adults with poor-risk AML.

  Leukemia research 20040601

• A G-quadruplex-interactive agent, telomestatin (SOT-095), induces telomere shortening with apoptosis and enhances chemosensitivity in acute myeloid leukemia.

  International journal of oncology 20040601

• Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.

  Cancer chemotherapy and pharmacology 20040601

• Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.

  International journal of radiation oncology, biology, physics 20040601

• Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy.

  British journal of haematology 20040601

• Growth hormone releasing peptide (ghrelin) is synthesized and secreted by cardiomyocytes.

  Cardiovascular research 20040601

• Successful treatment of congenital systemic juvenile xanthogranuloma with Langerhans cell histiocytosis-based chemotherapy.

  Journal of pediatric hematology/oncology 20040601

• Abrogation of Chk1-mediated S/G2 checkpoint by UCN-01 enhances ara-C-induced cytotoxicity in human colon cancer cells.

  Acta pharmacologica Sinica 20040601

• Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias: therapy with sequential 1-beta-d-arabinofuranosylcytosine, mitoxantrone, and bevacizumab.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20040601

• Galloping ophthalmoplegia and numb chin in Burkitt lymphoma.

  Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20040601

• Etoposide, methylprednisolone, cytarabine and cisplatin successfully cytoreduces resistant myeloma patients and mobilizes them for transplant without adverse effects.

  British journal of haematology 20040601

• Treatment of isolated central nervous system relapse in high-risk lymphoid malignancy with allogeneic bone marrow transplantation and extended intrathecal therapy.

  British journal of haematology 20040601

• Dose-dense chemotherapy in breast cancer and lymphoma.

  Seminars in oncology 20040601

• [Development and characterization of a gemcitabine-resistant variant of human lung adenocarcinoma cell line A549].

  Ai zheng = Aizheng = Chinese journal of cancer 20040601

• Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report.

  Haematologica 20040601

• In vitro evaluation of cytochrome P450-mediated drug interactions between cytarabine, idarubicin, itraconazole and caspofungin.

  Hematology (Amsterdam, Netherlands) 20040601

• Continuous cytosine-b-D-arabinofuranoside infusion reduces ectopic granule cells in adult rat hippocampus with attenuation of spontaneous recurrent seizures following pilocarpine-induced status epilepticus.

  The European journal of neuroscience 20040601

• Imatinib mesylate in the treatment of chronic myelogenous leukemia.

  International journal of hematology 20040601

• Isolated recurrence of granulocytic sarcoma manifesting as extra- and intracranial masses--case report.

  Neurologia medico-chirurgica 20040601

• Investigational strategies in chronic myelogenous leukemia.

  Hematology/oncology clinics of North America 20040601

• Problems related to resistance to cytarabine in acute myeloid leukemia.

  Leukemia & lymphoma 20040601

• A randomized trial of continuous infusion versus bolus mitoxantrone in combination with cytarabine in newly diagnosed patients with acute myeloblastic leukemia.

  Hematological oncology 20040601

• Priming with granulocyte colony-stimulating factor--relation to high-dose cytarabine in acute myeloid leukemia.

  The New England journal of medicine 20040520

• JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12-0-tetradecanoylphorbol-13-acetate (TPA).

  British journal of cancer 20040517

• Yttrium-90 ibritumomab tiuxetan radioimmunotherapy in Richter syndrome.

  Cancer 20040515

• The MUC1 oncoprotein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts.

  The Journal of biological chemistry 20040514

• Disclosure of a pro-apoptotic glyceraldehyde-3-phosphate dehydrogenase promoter: anti-dementia drugs depress its activation in apoptosis.

  Life sciences 20040514

• Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells.

  The Journal of pharmacology and experimental therapeutics 20040501

• Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study.

  Leukemia 20040501

• Intracellular IL-4/IFN-gamma producing peripheral T lymphocyte subsets in B cell non-Hodgkin's lymphoma patients.

  European journal of haematology 20040501

• Co-existence of Philadelphia chromosome positive acute megakaryoblastic and B-lymphoblastic mixed blast crisis of chronic myeloid leukemia with chronic lymphocytic leukemia.

  European journal of haematology 20040501

• Drastic effect of cell density on the cytotoxicity of daunorubicin and cytosine arabinoside.

  Biochemical pharmacology 20040501

• Down-regulation and altered localization of gamma-catenin in cisplatin-resistant adenocarcinoma cells.

  Molecular pharmacology 20040501

• Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemia.

  Haematologica 20040501

• 5'-(3')-nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine.

  Haematologica 20040501

• Differentiating agents + low-dose chemotherapy in the management of old/poor prognosis patients with acute myeloid leukemia or myelodysplastic syndrome.

  Haematologica 20040501

• Recurrent syncope as presenting symptom of Burkitt's lymphoma at the carotid bifurcation.

  The Annals of otology, rhinology, and laryngology 20040501

• [Chronic active Epstein-Barr virus infection treated with reduced intensity stem cell transplantation].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20040501

• Mucocutaneous complications of chemotherapy in 74 patients from Maharaj Nakorn Chiang Mai Hospital.

  Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20040501

• Pulmonary infiltrates during chemotherapy-induced febrile neutropenia: incidence, patterns and outcomes.

  JPMA. The Journal of the Pakistan Medical Association 20040501

• Chronic myeloid leukemia.

  The Journal of the Association of Physicians of India 20040501

• Cytoprotective effect of glucosylceramide synthase inhibition against daunorubicin-induced apoptosis in human leukemic cell lines.

  The Journal of biological chemistry 20040430

• Rad9 protects cells from topoisomerase poison-induced cell death.

  The Journal of biological chemistry 20040430

• Design, synthesis, and characterization of a series of cytochrome P(450) 3A-activated prodrugs (HepDirect prodrugs) useful for targeting phosph(on)ate-based drugs to the liver.

  Journal of the American Chemical Society 20040428

• The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients.

  Blood 20040415

• Lack of effect of the human GM-CSF analog E21R on the survival of primary human acute myeloid leukemia cells.

  Blood 20040415

• Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040415

• Are prophylactic haematopoietic growth factors of value in the management of patients with aggressive non-Hodgkin's lymphoma?

  British journal of cancer 20040405

• Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.

  British journal of cancer 20040405

• Dose intense triplet chemotherapy with gemcitabine, carboplatin, paclitaxel with peripheral blood progenitor cell support for six cycles in advanced epithelial ovarian cancer.

  British journal of cancer 20040405

• Imatinib and beyond--the new CML study IV. A randomized controlled comparison of imatinib vs imatinib/interferon-alpha vs imatinib/low-dose AraC vs imatinib after interferon-alpha failure in newly diagnosed chronic phase chronic myeloid leukemia.

  Annals of hematology 20040401

• The development of targeted chemotherapy for CNS lymphoma-a pilot study of the IDARAM regimen.

  Cancer chemotherapy and pharmacology 20040401

• The neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) modulate several biochemical pathways in human leukemic myeloid cells.

  Journal of neuroimmunology 20040401

• Biphasic acute myeloid leukemia with near-tetraploidy and immunophenotypic transformation.

  Archives of pathology & laboratory medicine 20040401

• Isolated hyperbilirubinemia following standard dose cytosine arabinoside in a patient with relapsed acute myeloid leukemia.

  American journal of hematology 20040401

• The histone deacetylase inhibitor MS-275 interacts synergistically with fludarabine to induce apoptosis in human leukemia cells.

  Cancer research 20040401

• Homologous recombination is a highly conserved determinant of the synergistic cytotoxicity between cisplatin and DNA topoisomerase I poisons.

  Molecular cancer therapeutics 20040401

• Meningeal relapse in a patient with acute promyelocytic leukemia: a case report and review of the literature.

  Journal of Korean medical science 20040401

• Activated neural stem cells contribute to stroke-induced neurogenesis and neuroblast migration toward the infarct boundary in adult rats.

  Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20040401

• Tailored therapy of adult acute leukaemia in Jehovah's Witnesses: unjustified reluctance to treat.

  European journal of haematology 20040401

• Safety of rituximab therapy during the first trimester of pregnancy: a case history.

  European journal of haematology 20040401

• Phase II trial of cladribine and cytarabine in relapsed or refractory myeloid malignancies.

  Leukemia research 20040401

• A fludarabine, topotecan, and cytarabine regimen is active in patients with refractory acute myelogenous leukemia.

  Leukemia research 20040401

• Update in acute leukemia 2003: a risk adapted approach to acute myeloblastic leukemia in adults.

  Seminars in oncology 20040401

• Acute myeloid leukemia 4 years after Kaposi's sarcoma in a renal transplant recipient.

  Onkologie 20040401

• Phase I/II clinical study of topotecan and cytarabine in patients with myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia.

  Leukemia & lymphoma 20040401

• Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.

  Leukemia & lymphoma 20040401

• [Non-myeloablative stem cell transplantation from an HLA identical sibling donor in a case of treatment-related acute myelogenous leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20040401

• [Preliminary study of DA or HA regimen chemotherapy for the treatment of refractory and relapsed paroxysmal nocturnal hemoglobinuria].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20040401

• The analysis of correlations between drug resistance and clinical/laboratory measures found in a group of children with all treated by ALL-BFM 90 protocol.

  Bulletin du cancer 20040401

• Cryptococcus albidus infection in a patient undergoing autologous progenitor cell transplant.

  Transplantation 20040327

• Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

  The New England journal of medicine 20040325

• Mutations in the tyrosine kinase domain of FLT3 define a new molecular mechanism of acquired drug resistance to PTK inhibitors in FLT3-ITD-transformed hematopoietic cells.

  Blood 20040315

• Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase III trial (E2995).

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040315

• Repetitive cycles of high-dose cytarabine benefit patients with acute myeloid leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): results from CALGB 8461.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040315

• Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.

  Cancer 20040315

• Osteryoung square wave stripping voltammetry at mercury film electrode for monitoring ultra trace levels of Tarabine PFS and its interaction with ssDNA.

  Journal of pharmaceutical and biomedical analysis 20040310

• High performance liquid chromatographic determination of some co-administered anticancer drugs in pharmaceutical preparations and in spiked human plasma.

  Journal of pharmaceutical and biomedical analysis 20040310

• [Recent progress in diagnosis of and therapy for patients with leukemia].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040310

• In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.

  Leukemia 20040301

• Autologous peripheral blood stem cell transplantation with BCVAC conditioning in childhood acute myeloid leukemia.

  Bone marrow transplantation 20040301

• Expression of inducible Bcl-X(S) in myeloid leukemia: compensatory upregulation of Bcl-X(L) and Bcl-2 prevents apoptosis and chemosensitization.

  Cancer biology & therapy 20040301

• Guarding the Bcl-2 army.

  Cancer biology & therapy 20040301

• The paediatric cytarabine syndrome can be viewed as a drug-induced cytokine release syndrome.

  British journal of haematology 20040301

• Association of non-alcoholic steatohepatitis (NASH) with chronic neutrophilic leukemia.

  European journal of haematology 20040301

• Use of chemotherapy for treatment of a mixed-cell thoracic lymphoma in a horse.

  Journal of the American Veterinary Medical Association 20040301

• Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycolide) film: in vitro and in vivo studies.

  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20040301

• Granulocytic sarcoma of the testis.

  Urology 20040301

• [Salvage combination chemotherapy with cytarabine, carboplatin and steroids for relapsed or refractory non-Hodgkin's lymphoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20040301

• [Cytotoxic effects of arsenic trioxide in combination with chemotherapeutic drugs on acute non-promyelocytic leukemia cells].

  Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20040301

• An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma.

  Current opinion in oncology 20040301

• [Acute promyelocytic leukemia after living donor partial orthotopic liver transplantation].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20040301

• Artificial neural network as an alternative to multiple regression analysis in optimizing formulation parameters of cytarabine liposomes.

  AAPS PharmSciTech 20040301

• Conversion disorder with convulsion and motor deficit mimicking the adverse effects of high-dose Ara-C treatment in a posttransplant acute myeloid leukemia patient: a case report and review of the literature.

  Palliative & supportive care 20040301

• Cognitive status and quality of life after treatment for primary CNS lymphoma.

  Neurology 20040224

• Neural stem cell detection, characterization, and age-related changes in the subventricular zone of mice.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20040218

• Intensive sequential chemotherapy with hematopoietic growth factor support for non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus.

  Cancer 20040215

• Alteration in copy numbers of genes as a mechanism for acquired drug resistance.

  Cancer research 20040215

• Treatment-induced leukoencephalopathy in primary CNS lymphoma: a clinical and autopsy study.

  Neurology 20040210

• Mutagenicity of the cytidine analog zebularine in Escherichia coli.

  DNA repair 20040203

• Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML).

  Leukemia research 20040201

• Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury.

  Leukemia 20040201

• Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: single-center experience of 201 patients.

  Bone marrow transplantation 20040201

• Protein 4.1 deficiency and deletion of chromosome 20q are associated with acquired elliptocytosis in myelodysplastic syndrome.

  Clinical and laboratory haematology 20040201

• Gemcitabine-induced severe pulmonary toxicity.

  Fundamental & clinical pharmacology 20040201

• GH prevents apoptosis in cardiomyocytes cultured in vitro through a calcineurin-dependent mechanism.

  The Journal of endocrinology 20040201

• Antitumor activity of sugar-modified cytosine nucleosides.

  Cancer science 20040201

• Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial.

  British journal of haematology 20040201

• PEG-Ara-C conjugates for controlled release.

  European journal of medicinal chemistry 20040201

• GIMEMA ALL - Rescue 97: a salvage strategy for primary refractory or relapsed adult acute lymphoblastic leukemia.

  Haematologica 20040201

• Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature.

  International journal of hematology 20040201

• Suboccipital lateral injection of intrathecal chemotherapy in a patient with mantle cell lymphoma.

  Onkologie 20040201

• DNA polymerases as targets of anticancer nucleosides.

  Current drug targets 20040201

• [Orbital granulocytic sarcoma revealing acute myeloblastic syndrome: a case study].

  Journal francais d'ophtalmologie 20040201

• Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.

  Biochemical pharmacology 20040201

• Improving second-line therapy in aggressive non-Hodgkin's lymphoma.

  Seminars in oncology 20040201

• [Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma].

  Bulletin du cancer 20040201

• Isolated central nervous system relapse in lymphoid blast crisis chronic myeloid leukemia and acute lymphoblastic leukemia in patients on imatinib therapy.

  Leukemia & lymphoma 20040201

• Results of treatment of retinoblastoma that has infiltrated the optic nerve, is recurrent, or has metastasized outside the eyeball.

  International journal of clinical oncology 20040201

• Intrapleural chemotherapy with cisplatin and cytarabine in the management of malignant pleural effusion.

  Cancer research and treatment : official journal of Korean Cancer Association 20040201

• Long-lasting RNAi activity in mammalian neurons.

  FEBS letters 20040130

• Area under the curve of methotrexate and creatinine clearance are outcome-determining factors in primary CNS lymphomas.

  British journal of cancer 20040126

• Biochemical modulation of Ara-C effects by amidox, an inhibitor of ribonucleotide reductase in HL-60 promyelocytic human leukemia cells.

  Life sciences 20040116

• BEAM-alemtuzumab reduced-intensity allogeneic stem cell transplantation for lymphoproliferative diseases: GVHD, toxicity, and survival in 65 patients.

  Blood 20040115

• A phase 3 study of three induction regimens and of priming with GM-CSF in older adults with acute myeloid leukemia: a trial by the Eastern Cooperative Oncology Group.

  Blood 20040115

• The role of cytidine deaminase and GATA1 mutations in the increased cytosine arabinoside sensitivity of Down syndrome myeloblasts and leukemia cell lines.

  Cancer research 20040115

• Cancer treatment with kinase inhibitors: what have we learnt from imatinib?

  British journal of cancer 20040112

• 2', 3'-Dideoxycytidine represses thymidine kinases 1 and 2 expression in T-lymphoid cells.

  Life sciences 20040102

• Multidrug resistance genes in infant acute lymphoblastic leukemia: Ara-C is not a substrate for the breast cancer resistance protein.

  Leukemia 20040101

• Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.

  Leukemia 20040101

• Successful CD34+ cell mobilization by intermediate-dose Ara-C in chronic lymphocytic leukemia patients treated with sequential fludarabine and Campath-1H.

  Leukemia 20040101

• Children with acute myeloblastic leukemia presenting with extramedullary infiltration: the effects of high-dose steroid treatment.

  Leukemia research 20040101

• Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia.

  Leukemia research 20040101

• New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method.

  The Journal of antimicrobial chemotherapy 20040101

• A pilot study of cytoreductive chemotherapy combined with infusion of additional peripheral blood stem cells reserved at time of harvest for transplantation in case of relapsed hematologic malignancies after allogeneic peripheral blood stem cell transplant.

  Bone marrow transplantation 20040101

• Activation of protein kinase C by 1-beta-D-arabinofuranosylcytosine conjugates of phospholipid.

  International journal of oncology 20040101

• Fludarabine, cytosine arabinoside, granulocyte-colony stimulating factor with or without idarubicin in the treatment of high risk acute leukaemia or myelodysplastic syndromes.

  British journal of haematology 20040101

• Treatment options for newly diagnosed patients with chronic myeloid leukemia.

  Current hematology reports 20040101

• Pilot study of idarubicin-based intensive-timing induction therapy for children with previously untreated acute myeloid leukemia: Children's Cancer Group Study 2941.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20040101

• Pulmonary tuberculosis in a child receiving intensive chemotherapy for acute myeloblastic leukemia.

  Journal of pediatric hematology/oncology 20040101

• Molecular cloning and characterization of the mouse Acdp gene family.

  BMC genomics 20040101

• [Imatinib-New, molecular therapeutic possibility in chronic myeloid leukemia. The IRIS Study].

  Der Internist 20040101

• Acute myeloid leukemia with t(8;21)(q22;q22) manifesting as granulocytic sarcomas in the rhinopharynx and external acoustic meatus at relapse after high-dose cytarabine: case report and review of the literature.

  The hematology journal : the official journal of the European Haematology Association 20040101

• Outcome of children with high-risk acute lymphoblastic leukemia (HR-ALL): Nordic results on an intensive regimen with restricted central nervous system irradiation.

  Pediatric blood & cancer 20040101

• Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.

  Haematologica 20040101

• Salvage therapy with an outpatient DHAP schedule followed by PBSC transplantation in 79 lymphoma patients: an intention to mobilize and transplant analysis.

  European journal of haematology 20040101

• Oral treatment of acute myeloid leukaemia with etoposide, thioguanine, and idarubicin (ETI) in elderly patients: a prospective randomised comparison with intravenous cytarabine, idarubicin, and thioguanine in the second and third treatment cycle.

  European journal of haematology 20040101

• Ida-FLAG plus imatinib mesylate-induced molecular remission in a patient with chemoresistant Ph1+ acute myeloid leukemia.

  European journal of haematology 20040101

• Antiproliferative efficacy of the third-generation bisphosphonate, zoledronic acid, combined with other anticancer drugs in leukemic cell lines.

  International journal of hematology 20040101

• Extranodal multiple involvement of enteropathy-type T-cell lymphoma without expression of CC chemokine receptor 7.

  International journal of hematology 20040101

• Successful treatment with nonmyeloablative allogeneic hematopoietic stem cell transplantation in a patient with acute myeloid leukemia complicated with pulmonary infection.

  International journal of hematology 20040101

• [Successful bone marrow transplantation with a matched unrelated donor in an acute promyelocytic leukemia patient after reinduction therapy with arsenic trioxide].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20040101

• Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides.

  Nucleosides, nucleotides & nucleic acids 20040101

• Rescue therapy combining intermediate-dose cytarabine with amsacrine and etoposide in relapsed adult acute lymphoblastic leukemia.

  The hematology journal : the official journal of the European Haematology Association 20040101

• Repeated rituximab maintenance courses in fludarabine-failed young patients with chronic lymphocytic leukaemia responding to FAND chemotherapy.

  The hematology journal : the official journal of the European Haematology Association 20040101

• Acute myeloblastic leukemia in pregnancy: a case report and review of the literature.

  European journal of gynaecological oncology 20040101

• Action of troxacitabine on cells transduced with human cytidine deaminase cDNA.

  Cancer investigation 20040101

• The results of treatment with idarubicin in childhood acute nonlymphoblastic leukemia.

  The Turkish journal of pediatrics 20040101

• Chemotherapy combination treatment regimens with fludarabine in chronic lymphocytic leukemia.

  The hematology journal : the official journal of the European Haematology Association 20040101

• Use of fludarabine in the treatment of acute myeloid leukemia.

  The hematology journal : the official journal of the European Haematology Association 20040101

• Priming with GM-CSF for acute myelogenous leukemia (AML): GOELAM data.

  Annals of hematology 20040101

• Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cells.

  Annals of hematology 20040101

• Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461.

  Annals of hematology 20040101

• P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adults.

  Annals of hematology 20040101

• MRC trials in childhood acute myeloid leukaemia.

  Annals of hematology 20040101

• Maintenance therapy in childhood acute myeloid leukemia.

  Annals of hematology 20040101

• Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors.

  Molecular cancer 20040101

• Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer.

  World journal of surgical oncology 20040101

• Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene.

  BMC pharmacology 20040101

• Spotlight on imatinib mesylate in chronic myeloid leukemia.

  BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20040101

• A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes.

  The hematology journal : the official journal of the European Haematology Association 20040101

• Optimizing treatment of chronic myeloid leukemia: a rational approach.

  The oncologist 20040101

• ERK signaling pathway is differentially involved in erythroid differentiation of K562 cells depending on time and the inducing agent.

  Cell biology international 20040101

• Involvement of p53 in 1-beta-D-arabinofuranosylcytosine-induced rat fetal brain lesions.

  Neurotoxicology and teratology 20040101

• [Consolidation of therapy of acute myeloid leukemia with the AML-BFM 93 protocol in children in the Czech Republic].

  Casopis lekaru ceskych 20040101

• Interaction between the retinoblastoma protein and protein phosphatase 1 during the cell cycle.

  Methods in molecular biology (Clifton, N.J.) 20040101

• Clofarabine.

  Drugs in R&D 20040101

• Comparison of viability of B16 and Cl S91 cells in three cytotoxicity tests: cells counting, MTT and flow cytometry after cytostatic drug treatment.

  Acta poloniae pharmaceutica 20040101

• Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study.

  The hematology journal : the official journal of the European Haematology Association 20040101

• Topotecan, Ara-C, cisplatin and prednisolone (TOPOSHAP) for patients with refractory and relapsing lymphomas: results of a phase I trial.

  Acta haematologica 20040101

• Halofuginone inhibits serum-stimulated pericardial tissue retraction in vitro.

  Tissue engineering 20040101

• [Preliminary results of a multicenter randomized study on the treatment of acute promyelocytic leukemias].

  Terapevticheskii arkhiv 20040101

• [Damage of vascular endothelium in the treatment of acute leukemia: in vitro study].

  Terapevticheskii arkhiv 20040101

• Nasal-type NK/T-cell lymphoma successfully treated with ProMACE-CytaBOM therapy.

  Dermatology (Basel, Switzerland) 20040101

• All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.

  Indian journal of cancer 20040101

• New nucleoside analogs in the treatment of hematological disorders.

  Acta poloniae pharmaceutica 20040101

• Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.

  Journal of drugs in dermatology : JDD 20040101

• New nucleoside analogs in the treatment of solid tumors.

  Acta poloniae pharmaceutica 20040101

• Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities.

  Molecular cancer 20040101

• [Immunologic monitoring in children with acute lymphoblastic leukemia during maintenance treatment with regard to co-existing infections].

  Wiadomosci lekarskie (Warsaw, Poland : 1960) 20040101

• Effect of cytosine arabinoside and hydroxyurea on micronucleus formation induced by model clastogens in Chinese hamster V79 cells.

  Neoplasma 20040101

• [Treatment results in children with standard-risk acute lymphoblastic leukemia. Report of the Polish Pediatric Leukemia/Lymphoma Study Group].

  Przeglad lekarski 20040101

• [Autologous stem-cell transplantations in children with non-Hodgkin lymphomas].

  Przeglad lekarski 20040101

• [Diagnostic significance of reticulocyte analysis by flow cytometry, in children with acute lymphoblastic leukaemia (ALL) on chemotherapy].

  Medycyna wieku rozwojowego 20040101

• [Use of dexamethasone in treatment of high- and low-grade non-Hodgkin's lymphoma].

  Voprosy onkologii 20040101

• Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.

  Chirurgia italiana 20040101

• Neutropenic enterocolitis in acute myeloid leukemia.

  Acta chirurgica Iugoslavica 20040101

• Synthesis and biological evaluation of a cytarabine phosphoramidate prodrug.

  Molecular pharmaceutics 20040101

• [Second neoplasm in a 13-year-old boy complicated by Crohn's disease. Case report].

  Medycyna wieku rozwojowego 20040101

• Primary culture of cortical neurons, type-1 astrocytes, and microglial cells from cynomolgus monkey (Macaca fascicularis) fetuses.

  Journal of neuroscience methods 20031230

• A feasibility study of simultaneous administration of gemtuzumab ozogamicin with intensive chemotherapy in induction and consolidation in younger patients with acute myeloid leukemia.

  Blood 20031215

• Results of a prospective phase 2 study combining imatinib mesylate and cytarabine for the treatment of Philadelphia-positive patients with chronic myelogenous leukemia in chronic phase.

  Blood 20031215

• High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215

• Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215

• Long-term follow-up of autologous stem cell transplantation in patients with diffuse mantle cell lymphoma in first disease remission: the prognostic value of beta2-microglobulin and the tumor score.

  Cancer 20031215

• Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.

  Cancer 20031215

• 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031215

• Physical and functional interactions between USF and Sp1 proteins regulate human deoxycytidine kinase promoter activity.

  The Journal of biological chemistry 20031212

• Toxic interaction between hydroxyurea and 1-beta-D-arabino-furanosylcytosine on the DNA of a human hepatoma cell line (HEPG2).

  Toxicology letters 20031210

• Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.

  Cancer chemotherapy and pharmacology 20031201

• Mylotarg, fludarabine, cytarabine (ara-C), and cyclosporine (MFAC) regimen as post-remission therapy in acute myelogenous leukemia.

  Cancer chemotherapy and pharmacology 20031201

• Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

  Leukemia 20031201

• Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C.

  Leukemia 20031201

• High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201

• High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience.

  Annals of oncology : official journal of the European Society for Medical Oncology 20031201

• Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study.

  British journal of haematology 20031201

• Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031201

• More efficient mobilisation of peripheral blood stem cells with HiDAC+AMSA+G-CSF than with mini-ICE+G-CSF in patients with AML.

  Bone marrow transplantation 20031201

• Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.

  Bone marrow transplantation 20031201

• Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.

  American journal of clinical oncology 20031201

• Antitumour potential of a polysaccharide-rich substance from the fruit juice of Morinda citrifolia (Noni) on sarcoma 180 ascites tumour in mice.

  Phytotherapy research : PTR 20031201

• [Autogeneic peripheral blood hemopoietic stem cell transplantation for chronic myeloid leukemia with imatinib mesylate-induced negative Philadelphia chromosome].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031201

• Chloroma of the orbit in a non-leukemic adult: A case report.

  Orbit (Amsterdam, Netherlands) 20031201

• A pilot study of CODOX-M/IVAC in primary refractory or relapsed high-grade non-Hodgkin's lymphoma. A Scotland and Newcastle Lymphoma Group Study.

  Haematologica 20031201

• Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly.

  Haematologica 20031201

• [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].

  Ai zheng = Aizheng = Chinese journal of cancer 20031201

• MLL/AF-1p fusion in therapy-related early pre-B acute lymphoblastic leukemia with t(1;11)(p32;q23) translocation developing in the relapse phase of acute promyelocytic leukemia.

  International journal of hematology 20031201

• X-irradiated human lymphocytes with unstable aberrations and their preferential elimination by p53/survivin-dependent apoptosis.

  International journal of radiation biology 20031201

• [Anti-CD20 antibody and combination chemotherapy followed by autologous peripheral blood stem cell transplantation after high-dose chemotherapy induced complete remission in a case of multiple lymphomatous polyposis of the gastrointestinal tract].

  Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology 20031201

• Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor: methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone.

  Japanese journal of clinical oncology 20031201

• [Recent advances in the treatment of acute myelogenous leukemia: a view of the new agents].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20031201

• Imatinib: new indication. Chronic myeloid leukaemia, first-line option: favourable findings to be confirmed.

  Prescrire international 20031201

• The coherent feedforward loop serves as a sign-sensitive delay element in transcription networks.

  Journal of molecular biology 20031121

• Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031115

• Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20031115

• B-cell-specific transcription factor BACH2 modifies the cytotoxic effects of anticancer drugs.

  Blood 20031101

• Influence of cytarabine and cyclophosphamide on the disposition kinetics of cyclosporin A after bone marrow transplantation.

  Transplant international : official journal of the European Society for Organ Transplantation 20031101

• Effects of TNFalpha on the growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia with special reference to the role of NF-kappaB.

  Leukemia research 20031101

• Salvage by timed sequential chemotherapy in primary resistant acute myeloid leukemia: analysis of prognostic factors.

  Annals of hematology 20031101

• HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death.

  Leukemia 20031101

• Apoptosis induction in peripheral leukemia cells by remission induction treatment in vivo: selective depletion and apoptosis in a CD34+ subpopulation of leukemia cells.

  Leukemia 20031101

• Fe(II)-induced DNA damage in alpha-synuclein-transfected human dopaminergic BE(2)-M17 neuroblastoma cells: detection by the Comet assay.

  Journal of neurochemistry 20031101

• Transcript mapping of the 'early' genes of Orf virus.

  The Journal of general virology 20031101

• Acute myeloid leukemia presenting as non-neutropenic colitis in an infant.

  Journal of pediatric gastroenterology and nutrition 20031101

• Caspase regulation of genotoxin-induced neural precursor cell death.

  Journal of neuroscience research 20031101

• Protein expression of the glucocorticoid receptor in childhood acute lymphoblastic leukemia.

  Haematologica 20031101

• Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20031101

• The antimetabolite ara-CTP blocks long-term memory of conditioned taste aversion.

  Learning & memory (Cold Spring Harbor, N.Y.) 20031101

• Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk.

  European journal of haematology 20031101

• [Successful recovery of an acute myelogenous leukemia patient from a coma possibly due to leukoencephalopathy].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20031101

• [Acute myelogenous leukemia complicated with severe tumor lysis syndrome after a single day of idarubicin/cytarabine chemotherapy].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20031101

• [Topotecan-based combined chemotherapy for refractory or relapsed hematologic malignancies].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20031101

• Toxic pediatric parkinsonism: report of a child with metabolic studies and response to treatment.

  Journal of child neurology 20031101

• [Synergistic effect of Apo2L and chemotherapeutic agents on leukemia cells].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20031101

• Genetics in the management of adult de novo AML.

  Clinical advances in hematology & oncology : H&O 20031101

• Sensitization of ara-C-resistant lymphoma cells by a pronucleotide analogue.

  International journal of cancer 20031020

• Minimal residual disease in chronic myeloid leukemia.

  The New England journal of medicine 20031009

• Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.

  The New England journal of medicine 20031009

• Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.

  Cancer chemotherapy and pharmacology 20031001

• Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia.

  Leukemia research 20031001

• Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.

  Leukemia research 20031001

• Predictive value of early 18F-fluoro-deoxyglucose positron emission tomography in chemosensitive relapsed lymphoma.

  British journal of haematology 20031001

• Chemotherapy increases transgene expression in leukemic cells.

  The journal of gene medicine 20031001

• [Modified FLAG regimen in the management of refractory acute myeloid leukemia].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20031001

• [Hematologic tumors].

  Gan to kagaku ryoho. Cancer & chemotherapy 20031001

• [Intensive multi-drug chemotherapy for acute myeloid leukemia in a renal allograft recipient].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20031001

• cDNA microarray analysis of altered gene expression in Ara-C-treated leukemia cells.

  Biochemical and biophysical research communications 20030919

• Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030915

• Adoptive transfer of costimulated T cells induces lymphocytosis in patients with relapsed/refractory non-Hodgkin lymphoma following CD34+-selected hematopoietic cell transplantation.

  Blood 20030915

• Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome.

  Blood 20030915

• Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.

  Cancer 20030915

• BCL-2 antisense oligonucleotide genasense is active against imatinib-resistant BCR-ABL-positive cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030915

• Synthesis and cytotoxic activity of two novel 1-dodecylthio-2-decyloxypropyl-3-phosphatidic acid conjugates with gemcitabine and cytosine arabinoside.

  Journal of medicinal chemistry 20030911

• [Expanding possibilities, strategic considerations, and novel methods in the diagnosis and chemotherapy of adult acute myeloid leukemia].

  Orvosi hetilap 20030907

• BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study.

  Blood 20030901

• Oxidative DNA damage and repair in a cell lineage model of human proliferative breast disease (PBD).

  Toxicological sciences : an official journal of the Society of Toxicology 20030901

• Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.

  International journal of cancer 20030901

• Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia.

  Nature medicine 20030901

• Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes.

  Molecular pharmacology 20030901

• A multicenter, open, non-comparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, and G-CSF as induction therapy in refractory acute myeloid leukemia - a report of the Polish Adult Leukemia Group (PALG).

  European journal of haematology 20030901

• Accumulation of gamma-globin mRNA in human erythroid cells treated with angelicin.

  European journal of haematology 20030901

• Cytosine arabinoside rapidly activates Bax-dependent apoptosis and a delayed Bax-independent death pathway in sympathetic neurons.

  Cell death and differentiation 20030901

• Results of triple therapy with interferon-alpha, cytarabine, and homoharringtonine, and the impact of adding imatinib to the treatment sequence in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in early chronic phase.

  Cancer 20030901

• Patients with high-risk aggressive lymphoma treated with frontline intensive chemotherapy and autografting: evidence of marked differences in outcome between patients with age-adjusted International Prognostic Index scores 2 and 3.

  Cancer 20030901

• Primary central nervous system lymphoma: Phase I evaluation of infusional bromodeoxyuridine with whole brain accelerated fractionation radiation therapy after chemotherapy.

  Cancer 20030901

• Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030901

• Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.

  American journal of hematology 20030901

• [Treatment of systemic mastocytosis].

  La Revue de medecine interne 20030901

• FLAG chemotherapy followed by allogeneic stem cell transplant using nonmyeloablative conditioning induces regression of myelofibrosis with myeloid metaplasia.

  Bone marrow transplantation 20030901

• Cytarabine syndrome revisited.

  British journal of haematology 20030901

• A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.

  Leukemia 20030901

• No benefit from adding GM-CSF to induction chemotherapy in transforming myelodysplastic syndromes: better outcome in patients with less proliferative disease.

  Leukemia 20030901

• Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia.

  Journal of pediatric hematology/oncology 20030901

• Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.

  Annals of hematology 20030901

• First European case of serotype A MATa Cryptococcus neoformans infection.

  Emerging infectious diseases 20030901

• In vitro and in vivo evaluations of THAM derived telomers bearing RGD and Ara-C for tumour neovasculature targeting.

  European journal of medicinal chemistry 20030901

• A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).

  Leukemia & lymphoma 20030901

• Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).

  Leukemia & lymphoma 20030901

• The influence of imatinib mesylate (STI571) used alone or in combination with purine nucleoside analogues on the normal and chronic myelogenous leukaemia progenitor cells in vitro.

  Leukemia & lymphoma 20030901

• Extramedullary acute myeloid leukemia (granulocytic sarcoma) with arm paresis, maculopapular exanthema and organ involvement.

  Leukemia & lymphoma 20030901

• Pulmonary embolism and thrombotic thrombocytopenic purpura in acute promyelocytic leukemia treated with all-trans retinoic acid.

  Leukemia & lymphoma 20030901

• Chromosomal rearrangement in Down syndrome with acute myeloid leukemia.

  Indian journal of pediatrics 20030901

• Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.

  Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] 20030901

• Viridans streptococcus bacteremia in children on chemotherapy for cancer: an underestimated problem.

  Pediatric hematology and oncology 20030901

• Encouraging result of tamoxifen in a retinoblastoma patient with central nervous system metastasis.

  Pediatric hematology and oncology 20030901

• Isolated IgA deficiency after chemotherapy for acute myelogenous leukemia in an infant.

  Pediatric hematology and oncology 20030901

• Alpha-phosphono lactone analogues of cytidine and cytosine arabinoside diphosphates: synthesis via ring closing metathesis.

  The Journal of organic chemistry 20030822

• Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.

  The New England journal of medicine 20030821

• Cost-utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia.

  British journal of cancer 20030818

• Quinine as a multidrug resistance inhibitor: a phase 3 multicentric randomized study in adult de novo acute myelogenous leukemia.

  Blood 20030815

• Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030815

• The differential influence of allogeneic tumor cell death via DNA damage on dendritic cell maturation and antigen presentation.

  Cancer research 20030815

• Chronic myeloid leukemia: pathophysiology, diagnostic parameters, and current treatment concepts.

  Wiener klinische Wochenschrift 20030814

• Synthesis of 5'-amino-5'-phosphonate analogues of pyrimidine nucleoside monophosphates.

  The Journal of organic chemistry 20030808

• Survival of acute myeloid leukemia cells requires PI3 kinase activation.

  Blood 20030801

• High-dose hydroxyurea in the treatment of poor-risk myeloid leukemias.

  Annals of hematology 20030801

• Analysis of single nucleotide polymorphism C3435T of the multidrug resistance gene MDR1 in acute lymphoblastic leukemia.

  International journal of oncology 20030801

• Stem cell transplantation after salvage therapy with high-dose cytarabine and amsacrine in adults with high-risk leukaemia.

  Bone marrow transplantation 20030801

• Response to single-agent thalidomide and eligibility to undergo autotransplant for patients with multiple myeloma refractory to VAD.

  Bone marrow transplantation 20030801

• Evaluation and management of left atrial lymphoma guided by transesophageal echocardiography.

  Echocardiography (Mount Kisco, N.Y.) 20030801

• Acute promyelocytic leukaemia:a review.

  Expert opinion on pharmacotherapy 20030801

• Severe immune haemolysis in a group A recipient of a group O red blood cell unit.

  Transfusion medicine (Oxford, England) 20030801

• A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.

  Journal of mathematical biology 20030801

• Mitoxantrone and cytarabine induction, high-dose cytarabine, and etoposide intensification for pediatric patients with relapsed or refractory acute myeloid leukemia: Children's Cancer Group Study 2951.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030801

• Treatment of acute promyelocytic leukemia: strategy toward further increase of cure rate.

  Leukemia 20030801

• Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trial.

  Leukemia 20030801

• Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.

  Leukemia 20030801

• A novel t(15;17) translocation in acute myeloid leukaemia not associated with PML/RARalpha rearrangement.

  Clinical and laboratory haematology 20030801

• Acute arterial thrombosis in acute promyelocytic leukaemia.

  Clinical and laboratory haematology 20030801

• Arabinosylcytosine downregulates thymidine kinase and induces cross-resistance to zidovudine in T-lymphoid cells.

  Biochemical and biophysical research communications 20030801

• Cholelithiasis and choledocholithiasis after sequential cytarabine and asparaginase.

  Journal of pediatric hematology/oncology 20030801

• Recombinant human erythropoietin, epoetin beta, in patients with relapsed lymphoma treated with aggressive sequential salvage chemotherapy--results of a randomized trial.

  Annals of hematology 20030801

• Salvage chemotherapy according to the ASHAP protocol: a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas.

  Annals of hematology 20030801

• [Glivec in combination with HA regimen for treatment of 20 patients with Ph chromosome positive acute leukemia].

  Ai zheng = Aizheng = Chinese journal of cancer 20030801

• Telomerase activity in the subventricular zone of adult mice.

  Molecular and cellular neurosciences 20030801

• [Chemotherapy with ubenimex corresponding to patient age and organ disorder for 18 cases of acute myelogeneous leukemia in elderly patients--effects, complications and long-term survival].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030801

• Myeloid/natural killer cell precursor acute leukemia accompanied by homozygous protein C deficiency.

  International journal of hematology 20030801

• Reduction of thymosin beta4 and actin in HL60 cells during apoptosis is preceded by a decrease of their mRNAs.

  Molecular and cellular biochemistry 20030801

• Acute pericarditis and pleural effusion complicating cytarabine chemotherapy.

  Onkologie 20030801

• A synergistic increase of apoptosis utilizing Fas antigen expression induced by low doses of anticancer drug.

  Rinsho byori. The Japanese journal of clinical pathology 20030801

• Effect of fetal hemoglobin-stimulating medicines on the interaction of DNA and protein of important erythroid regulatory elements.

  Biochemistry and cell biology = Biochimie et biologie cellulaire 20030801

• [Clinical study of a new protocol for acute graft-versus host disease prophylaxis in HLA-haploidentical bone marrow transplantation (BMT)].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030801

• [Effect of differentiation inducer and heat stress on the expression of JWA protein and Hsp70 of K562 cells].

  Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases 20030801

• Cognitive functions in primary central nervous system lymphoma patients treated with chemotherapy and stem cell transplantation: preliminary findings.

  Clinical advances in hematology & oncology : H&O 20030801

• Synthesis and biological evaluation of resveratrol and analogues as apoptosis-inducing agents.

  Journal of medicinal chemistry 20030731

• New designs for phase 2 clinical trials.

  Blood 20030715

• Prognosis of inv(16)/t(16;16) acute myeloid leukemia (AML): a survey of 110 cases from the French AML Intergroup.

  Blood 20030715

• Long-term remission in mantle cell lymphoma following high-dose sequential chemotherapy and in vivo rituximab-purged stem cell autografting (R-HDS regimen).

  Blood 20030715

• Chemotherapy alone as initial treatment for primary CNS lymphoma in patients older than 60 years: a multicenter phase II study (26952) of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030715

• Mechanism of cytosine arabinoside-mediated apoptosis: role of Rel A (p65) dephosphorylation.

  Oncogene 20030710

• Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines.

  Leukemia research 20030701

• Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome.

  Medical and pediatric oncology 20030701

• A homoharringtonine-based regimen for childhood acute myelogenous leukemia.

  Medical and pediatric oncology 20030701

• Transient encephalopathy following high-dose methotrexate.

  Medical and pediatric oncology 20030701

• Implication of raft microdomains in drug induced apoptosis.

  Current medicinal chemistry. Anti-cancer agents 20030701

• Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation.

  Head & neck 20030701

• Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.

  British journal of haematology 20030701

• Human herpesvirus 6 encephalitis following flag chemotherapy.

  British journal of haematology 20030701

• In vitro induction of fetal hemoglobin in human erythroid progenitor cells.

  Experimental hematology 20030701

• Treatment stratification based on initial in vivo response in acute myeloid leukaemia in children without Down's syndrome: results of NOPHO-AML trials.

  British journal of haematology 20030701

• Medulloblastoma as a secondary malignancy after radiotherapy-free treatment for acute lymphoblastic leukemia.

  Journal of pediatric hematology/oncology 20030701

• Cytarabine-induced corneal toxicity.

  Eye (London, England) 20030701

• Generation of dendritic cells from the ventricular fluid in patients with meningeal carcinomatosis.

  Journal of neuroimmunology 20030701

• Role of IMP-selective 5'-nucleotidase (cN-II) in hematological malignancies.

  Leukemia & lymphoma 20030701

• BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy.

  Leukemia & lymphoma 20030701

• Involvement of central nervous system in prolymphocytoid transformation of chronic lymphocytic leukemia.

  Leukemia & lymphoma 20030701

• [Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20030701

• [A third complete remission of acute promyelocytic leukemia achieved by administering a gradual increase of all-trans retinoic acid following massive ascites due to retinoic acid syndrome].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20030701

• [Acute myeloblastic leukemia in adults: evaluation of the AML 06/96 protocol].

  La Tunisie medicale 20030701

• JNK-independent activation of c-Jun during neuronal apoptosis induced by multiple DNA-damaging agents.

  The Journal of biological chemistry 20030620

• Increased sensitivity to gemcitabine of P-glycoprotein and multidrug resistance-associated protein-overexpressing human cancer cell lines.

  British journal of cancer 20030616

• Treatment of Philadelphia chromosome-positive chronic myelogenous leukemia with weekly polyethylene glycol formulation of interferon-alpha-2b and low-dose cytosine arabinoside.

  Cancer 20030615

• Quality-of-life-adjusted survival comparison of sustained-release cytosine arabinoside versus intrathecal methotrexate for treatment of solid tumor neoplastic meningitis.

  Cancer 20030615

• Enforced expression of the tumor suppressor p53 renders human leukemia cells (U937) more sensitive to 1-[beta-D-arabinofuranosyl]cytosine (ara-C)-induced apoptosis.

  Biochemical pharmacology 20030615

• Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030615

• Drugs from the deep: marine natural products as drug candidates.

  Drug discovery today 20030615

• Cytosine arabinofuranoside-induced activation of astrocytes increases the susceptibility of neurons to glutamate due to the release of soluble factors.

  Neurochemistry international 20030601

• The absence of functional glucosylceramide synthase does not sensitize melanoma cells for anticancer drugs.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20030601

• Effect of endothelin-1 on astrocytic protein content.

  Glia 20030601

• Imatinib Mesylate (Gleevec) is a useful agent in the salvage treatment of adults with relapsed/refractory Philadelphia positive acute leukemias.

  Hematology (Amsterdam, Netherlands) 20030601

• Feasibility of fludarabine added to VAD during induction therapy in multiple myeloma: a randomised phase II-study.

  European journal of haematology 20030601

• Viridans streptococci bacteraemia in children with fever and neutropenia: a case-control study of predisposing factors.

  European journal of cancer (Oxford, England : 1990) 20030601

• In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C.

  Leukemia 20030601

• Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.

  Leukemia 20030601

• Doxorubicin-resistant, MRP1-expressing U-1285 cells are sensitive to idarubicin.

  Therapeutic drug monitoring 20030601

• Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.

  Bone marrow transplantation 20030601

• Quality of life in patients with newly diagnosed chronic phase chronic myeloid leukemia on imatinib versus interferon alfa plus low-dose cytarabine: results from the IRIS Study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030601

• Cytotoxic drugs enhance the ex vivo sensitivity of malignant cells from a subset of acute myeloid leukaemia patients to apoptosis induction by tumour necrosis factor receptor-related apoptosis-inducing ligand.

  British journal of haematology 20030601

• Ara-C induces apoptosis in monkey fibroblast cells.

  Toxicology in vitro : an international journal published in association with BIBRA 20030601

• Gastrointestinal involvement in disseminated Langerhans cell histiocytosis (LCH) with durable complete response to 2-chlorodeoxyadenosine and high-dose cytarabine.

  Journal of pediatric hematology/oncology 20030601

• Approval summary: imatinib mesylate capsules for treatment of adult patients with newly diagnosed philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030601

• Gemcitabine, Paclitaxel, and piritrexim: a phase I study.

  American journal of clinical oncology 20030601

• Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.

  Ophthalmology 20030601

• Sweet's syndrome masquerading as facial cellulitis.

  Cutis 20030601

• Two cases of acute myeloblastic leukemia evolving from aplastic anemia.

  International journal of hematology 20030601

• Pilot phase I/II study of new salvage therapy (CHASE) for refractory or relapsed malignant lymphoma.

  International journal of hematology 20030601

• Mantle cell lymphoma: clinicopathologic features and treatments.

  Oncology (Williston Park, N.Y.) 20030601

• The potential effect of short-course high-dose steroid on the maturation and apoptosis of leukemic cells in a child with acute megakaryoblastic leukemia.

  Leukemia & lymphoma 20030601

• Successful treatment for multiple cerebral hemorrhage in a newly diagnosed patient with acute promyelocytic leukemia.

  Leukemia & lymphoma 20030601

• [Successful treatment of acute promyelocytic leukemia in a pregnant patient with all-trans retinoic acid and chemotherapy resulting in a safe delivery].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20030601

• [High dose ara-C therapy induced bradycardia in an acute myeloid leukemia patient with inv (16)(p13q22)].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20030601

• [The therapeutic effects of FLAG regime for refractory and relapsing acute leukemia].

  Zhonghua nei ke za zhi 20030601

• [Central neurological manifestations during chemotherapy in children].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20030601

• Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway?

  Birth defects research. Part A, Clinical and molecular teratology 20030601

• Non-hodgkins lymphoma.

  Clinical evidence 20030601

• Combination of fludarabine and mitoxantrone in untreated stages III and IV low-grade lymphoma: S9501.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030515

• Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia.

  Blood 20030501

• Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses.

  Blood 20030501

• Maternal and fetal outcomes in pregnancy complicated with acute leukemia: a single institutional experience with 10 pregnancies at 16 years.

  Leukemia research 20030501

• A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

  Leukemia research 20030501

• Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines.

  Leukemia research 20030501

• Preclinical antitumor activity of 4'-thio-beta-D-arabinofuranosylcytosine (4'-thio-ara-C).

  Cancer chemotherapy and pharmacology 20030501

• Mucormycosis in acute myeloid leukaemia.

  British journal of haematology 20030501

• Immunophenotyping is an independent factor for risk stratification in AML.

  Cytometry. Part B, Clinical cytometry 20030501

• Adaptive randomized study of idarubicin and cytarabine versus troxacitabine and cytarabine versus troxacitabine and idarubicin in untreated patients 50 years or older with adverse karyotype acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030501

• Primary mediastinal large B-cell lymphoma with sclerosis in pediatric and adolescent patients: treatment and results from three therapeutic studies of the Berlin-Frankfurt-Münster Group.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030501

• All- trans-retinoic acid increases cytotoxicity of 1-beta-D-arabinofuranosylcytosine in NB4 cells.

  Cancer chemotherapy and pharmacology 20030501

• Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients.

  Haematologica 20030501

• The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921).

  Leukemia 20030501

• Comparison of fludarabine-containing salvage chemotherapy regimens for relapsed/refractory acute myelogenous leukemia.

  Leukemia 20030501

• A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.

  Human pathology 20030501

• Recent advances in the treatment of infant acute myeloid leukemia.

  Leukemia & lymphoma 20030501

• Treatment of relapsing refractory diffuse large cell lymphoma after matched unrelated donor bone marrow transplant with immunosuppression withdrawal and rituximab.

  Leukemia & lymphoma 20030501

• Multiple complete remissions in a patient with acute myeloid leukemia (M4eo) with low-dose cytosine arabinoside and all-trans retinoic acid.

  Leukemia & lymphoma 20030501

• Successful treatment with intermediate dose cytosine arabinoside for myelodysplastic syndrome with acute myelofibrosis.

  Leukemia & lymphoma 20030501

• In vitro antiproliferative effects on human tumor cell lines of extracts from the Bangladeshi medicinal plant Aegle marmelos Correa.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20030501

• [Successful attainment of the third chronic phase by autologous peripheral blood stem cell transplantation and imatinib in a patient with chronic myeloid leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20030501

• [Improvement of diabetes insipidus after allogeneic bone marrow transplantation in a patient with myelodysplastic syndrome].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20030501

• [Sub-cutaneous location of Burkitt's lymphoma. Apropos of 1 case at Yopougon Central University Hospital, Abidjan (Côte d'Ivoire)].

  Bulletin de la Societe de pathologie exotique (1990) 20030501

• [Relation between activation of NF-kappa B and chemotherapy induced apoptosis of leukemic cells].

  Zhonghua zhong liu za zhi [Chinese journal of oncology] 20030501

• Sustained complete hematologic remission after administration of the tyrosine kinase inhibitor imatinib mesylate in a patient with refractory, secondary AML.

  Blood 20030415

• Is there a cloud in the silver lining for imatinib?

  British journal of cancer 20030407

• Structural impact of the leukemia drug 1-beta-D-arabinofuranosylcytosine (Ara-C) on the covalent human topoisomerase I-DNA complex.

  The Journal of biological chemistry 20030404

• Timed sequential therapy of acute myelogenous leukemia in adults: a phase II study of retinoids in combination with the sequential administration of cytosine arabinoside, idarubicin and etoposide.

  Leukemia research 20030401

• A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia.

  Leukemia research 20030401

• Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.

  Cancer 20030401

• Comparison of allogeneic stem cell transplantation, high-dose cytarabine, and autologous peripheral stem cell transplantation as postremission treatment in patients with de novo acute myelogenous leukemia.

  Cancer 20030401

• Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.

  European journal of haematology 20030401

• Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib.

  European journal of haematology 20030401

• Acute myeloid leukemia mimicking primary testicular neoplasm. Presentation of a case with review of literature.

  European journal of haematology 20030401

• Acute myelogenous leukemia in an adult with thrombocytopenia with absent radii syndrome.

  European journal of haematology 20030401

• Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis--a case report.

  Lung cancer (Amsterdam, Netherlands) 20030401

• Imatinib: new preparation. For Chronic myeloid leukaemia: further assessment required.

  Prescrire international 20030401

• B large-cell lymphoma in children and adolescents.

  Cancer treatment reviews 20030401

• Adding arabinosylcytosine to idarubicin induction therapy may not improve survival for people with newly diagnosed acute promyelocytic leukaemia.

  Cancer treatment reviews 20030401

• Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.

  Journal of pediatric hematology/oncology 20030401

• HLA-DR antigen-negative acute myeloid leukemia.

  Leukemia 20030401

• Cognitive performance and magnetic resonance imaging findings after high-dose systemic and intraventricular chemotherapy for primary central nervous system lymphoma.

  Archives of neurology 20030401

• FLAG-IDA in the treatment of refractory/relapsed acute myeloid leukemia: single-center experience.

  Annals of hematology 20030401

• Unrelated donor bone marrow transplantation for acute mixed lineage (myeloid and B-lymphoid lineage) leukemia in an adult with Down syndrome.

  Annals of hematology 20030401

• [Delivery of twins after undergoing adjuvant LHRH analogue and CEF therapy].

  Gan to kagaku ryoho. Cancer & chemotherapy 20030401

• Autologous peripheral blood stem cell transplantation in first remission adult acute myeloid leukaemia--an intention to treat analysis and comparison of outcome using a predictive model based on the MRC AML10 cohort.

  Hematology (Amsterdam, Netherlands) 20030401

• Imatinib: a targeted clinical drug development.

  Seminars in hematology 20030401

• Imatinib in patients with newly diagnosed chronic-phase chronic myeloid leukemia.

  Seminars in hematology 20030401

• Quality of life on imatinib.

  Seminars in hematology 20030401

• Imatinib in combination with cytarabine for the treatment of Philadelphia-positive chronic myelogenous leukemia chronic-phase patients: rationale and design of phase I/II trials.

  Seminars in hematology 20030401

• Comparative efficacy and safety of gemtuzumab ozogamicin monotherapy and high-dose cytarabine combination therapy in patients with acute myeloid leukemia in first relapse.

  Clinical advances in hematology & oncology : H&O 20030401

• Protein kinase Cdelta is responsible for constitutive and DNA damage-induced phosphorylation of Rad9.

  The EMBO journal 20030317

• Lineage specific treatment of adult patients with acute lymphoblastic leukemia in first remission with anti-B4-blocked ricin or high-dose cytarabine: Cancer and Leukemia Group B Study 9311.

  Cancer 20030315

• Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.

  Cancer 20030315

• Randomized phase I/II study of troxacitabine combined with cytarabine, idarubicin, or topotecan in patients with refractory myeloid leukemias.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030315

• Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia.

  The New England journal of medicine 20030313

• Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia.

  British journal of cancer 20030310

• Emergence of clonal cytogenetic abnormalities in Ph- cells in some CML patients in cytogenetic remission to imatinib but restoration of polyclonal hematopoiesis in the majority.

  Blood 20030301

• Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.

  Leukemia research 20030301

• High survival rate in childhood non-Hodgkin lymphoma without CNS involvement: results of BFM 95 study in Kuwait.

  Pediatric hematology and oncology 20030301

• Benign intracranial hypertension in association with acute lymphoblastic leukemia.

  Pediatric hematology and oncology 20030301

• Atypical nuclear apoptosis downstream to caspase-3 activation in ara-C treated CCRF-CEM cells.

  International journal of oncology 20030301

• [Bacteremia due to Capnocytophaga spp.: two cases].

  Enfermedades infecciosas y microbiologia clinica 20030301

• A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.

  Cancer 20030301

• Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.

  The Journal of pharmacology and experimental therapeutics 20030301

• Fatal Bacillus cereus sepsis following resolving neutropenic enterocolitis during the treatment of acute leukemia.

  American journal of hematology 20030301

• Expression of deoxycytidine kinase in leukaemic cells compared with solid tumour cell lines, liver metastases and normal liver.

  European journal of cancer (Oxford, England : 1990) 20030301

• A phase II study of alpha-interferon and oral arabinosyl cytosine (YNK01) in chronic myeloid leukemia.

  Leukemia 20030301

• BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301

• 4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20030301

• Efficacy of SCH66336, a farnesyl transferase inhibitor, in conjunction with imatinib against BCR-ABL-positive cells.

  Molecular cancer therapeutics 20030301

• Purine nucleoside analogues in the treatment of myleoid leukemias.

  Leukemia & lymphoma 20030301

• The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.

  Leukemia & lymphoma 20030301

• Induction of apoptosis in the human mast cell leukemia cell line HMC-1 by various antineoplastic drugs.

  Leukemia & lymphoma 20030301

• Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.

  The Korean journal of internal medicine 20030301

• [Chronic myeloid leukemia. What's in the future therapy in Black Africa?].

  La Tunisie medicale 20030301

• Transcriptional regulation of the cystathionine-beta -synthase gene in Down syndrome and non-Down syndrome megakaryocytic leukemia cell lines.

  Blood 20030215

• Factors influencing outcome and incidence of long-term complications in children who underwent autologous stem cell transplantation for acute myeloid leukemia in first complete remission.

  Blood 20030215

• Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.

  Blood 20030215

• Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030215

• [Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].

  Zhonghua yi xue za zhi 20030210

• Perfusion MRI and SPECT of brain after treatment for childhood acute lymphoblastic leukemia.

  Medical and pediatric oncology 20030201

• Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agents.

  Journal of virology 20030201

• Combined-modality treatment of leptomeningeal gliomatosis.

  Neurosurgery 20030201

• (-)-Epigallocatechin-3-gallate enhances anti-tumor effect of cytosine arabinoside on HL-60 cells.

  Acta pharmacologica Sinica 20030201

• Acute myelogenous leukemia with the t(3;12)(q26;p13) translocation: case report and review of the literature.

  American journal of hematology 20030201

• Randomized, multicenter, open-label study of pegfilgrastim compared with daily filgrastim after chemotherapy for lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20030201

• [Foliculitis in a patient with Hodkins disease].

  Enfermedades infecciosas y microbiologia clinica 20030201

• Therapy-related erythroleukemia caused by the administration of UFT and mitomycin C in a patient with colon cancer.

  International journal of clinical oncology 20030201

• Pharmacokinetics of a standard dose of cytarabine in a patient with acute promyelocytic leukemia undergoing continuous ambulatory peritoneal dialysis.

  International journal of hematology 20030201

• Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytotoxic chemotherapeutics.

  Journal of hematotherapy & stem cell research 20030201

• [Design of antisense oligodeoxynucleotide targeting at bcl-2 mRNA and observation on its effect on the sensitivity of leukemia cells to arabinosyl cytosine].

  Zhongguo shi yan xue ye xue za zhi 20030201

• Disseminated infection due to Scedosporium apiospermum in a patient with acute myelogenous leukemia.

  Leukemia & lymphoma 20030201

• [The clinical research of nonmyeloablative allogeneic peripheral blood hematopoietic stem cells transplantation for hematological diseases].

  Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 20030201

• Posterior leukoencephalopathy following intrathecal chemotherapy with MRA-documented vasospasm.

  Neurology 20030128

• Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy.

  British journal of cancer 20030127

• Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.

  International journal of cancer 20030120

• Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia.

  Blood 20030115

• Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.

  Blood 20030101

• Vincristine neurotoxicity in the presence of hereditary neuropathy.

  Medical and pediatric oncology 20030101

• Microcystin-LR induces oxidative DNA damage in human hepatoma cell line HepG2.

  Toxicon : official journal of the International Society on Toxinology 20030101

• Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia.

  Leukemia research 20030101

• High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030101

• Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms.

  Molecular pharmacology 20030101

• Recent advances in pediatric acute lymphoblastic and myeloid leukemia.

  Current opinion in oncology 20030101

• Pilot study of Mylotarg, idarubicin and cytarabine combination regimen in patients with primary resistant or relapsed acute myeloid leukemia.

  Cancer chemotherapy and pharmacology 20030101

• Bilateral optic nerve infiltration in central nervous system leukemia.

  American journal of ophthalmology 20030101

• A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues.

  Cancer research 20030101

• The use of the MTT assay to study drug resistance in fresh tumour samples.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20030101

• Treosulfan in the treatment of metastatic melanoma: from chemosensitivity testing to clinical trials.

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 20030101

• Diphtheria toxin-interleukin-3 fusion protein (DT(388)IL3) prolongs disease-free survival of leukemic immunocompromised mice.

  Leukemia 20030101

• Timed sequential therapy of acute leukemia with flavopiridol: in vitro model for a phase I clinical trial.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20030101

• A novel fusion variant of the MORF and CBP genes detected in therapy-related myelodysplastic syndrome with t(10;16)(q22;p13).

  British journal of haematology 20030101

• The effects of chemotherapeutic agents on the regulation of thrombin on cell surfaces.

  British journal of haematology 20030101

• A functional single-nucleotide polymorphism in the human cytidine deaminase gene contributing to ara-C sensitivity.

  Pharmacogenetics 20030101

• Management decisions in chronic myeloid leukemia.

  Seminars in hematology 20030101

• Analysis of micronuclei in peripheral blood lymphocytes of traffic wardens: effects of exposure, metabolic genotypes, and inhibition of excision repair in vitro by ARA-C.

  Environmental and molecular mutagenesis 20030101

• Lithium stimulates progenitor proliferation in cultured brain neurons.

  Neuroscience 20030101

• Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graft.

  Bone marrow transplantation 20030101

• [How I treat...chronic myeloid leukemia].

  Revue medicale de Liege 20030101

• Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013.

  Leukemia & lymphoma 20030101

• In AML cell lines Ara-C combined with purine analogues is able to exert synergistic as well as antagonistic effects on proliferation, apoptosis and disruption of mitochondrial membrane potential.

  Leukemia & lymphoma 20030101

• High-dose daunorubicin as liposomal compound (Daunoxome) in elderly patients with acute lymphoblastic leukemia.

  The hematology journal : the official journal of the European Haematology Association 20030101

• Colon biopsies for evaluation of acute graft-versus-host disease (A-GVHD) in allogeneic bone marrow transplant patients.

  BMC gastroenterology 20030101

• [Effectiveness of dose-intensive polychemotherapy with autologous hemopoietic cell transplantation for high-grade non-Hodgkin lymphoma].

  Voprosy onkologii 20030101

• Impact of chemotherapy regimen and hematopoietic growth factor on mobilization and collection of peripheral blood stem cells in cancer patients.

  Annals of oncology : official journal of the European Society for Medical Oncology 20030101

• Primary colorectal T-cell lymphoma.

  Journal of gastroenterology 20030101

• Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716.

  Drugs in R&D 20030101

• Effect of bcl-2 antisense oligodeoxynucleotides on drug sensitivity of leukemic cells.

  The hematology journal : the official journal of the European Haematology Association 20030101

• [Analysis of causes of death during intensive chemotherapy according to treatment protocol AML-BFM 93].

  Klinische Padiatrie 20030101

• Cutaneous pustular leukemoid reactions in trisomy 21.

  Pediatric dermatology 20030101

• p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancer.

  Anticancer research 20030101

• [The assessment of plasma levels of insulin-like growth factor (IGF-I) and binding protein (IGFBP-3) during the maintenance therapy and after remissionof acute lymphoblastic leukemia (ALL)].

  Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych 20030101

• [The influence of age, gender and modifications of therapeutic protocols on physical development of children and adolescents after completion of therapy for acute lymphoblastic leukemia].

  Endokrynologia, diabetologia i choroby przemiany materii wieku rozwojowego : organ Polskiego Towarzystwa Endokrynologow Dzieciecych 20030101

• Troxacitabine: BCH 4556, SPD 758, Troxatyl.

  Drugs in R&D 20030101

• Development of secondary anaplastic oligoastrocytoma after matched unrelated bone marrow transplantation in a child with acute myeloid leukemia.

  Acta haematologica 20030101

• A case of leukemia of the appendix presenting as acute appendicitis.

  Acta haematologica 20030101

• Disposition of liposomal daunorubicin during cotreatment with cytarabine in patients with leukaemia.

  Clinical pharmacokinetics 20030101

• [Karyotype in acute myeloid leukemia: importance and type of aberrations in 30 patients at diagnosis].

  Revista da Associacao Medica Brasileira (1992) 20030101

• Chemo- and radiation sensitivity of xenografted acute lymphoblastic leukemias--correlation to the expression of multidrug resistance proteins.

  Anticancer research 20030101

• [Imatinib mesylate: a major breakthrough in the treatment of chronic myelogenous leukemia].

  Medecine sciences : M/S 20030101

• Enhancement of neutral endopeptidase activity in SK-N-SH cells by green tea extract.

  Phytomedicine : international journal of phytotherapy and phytopharmacology 20030101

• Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia.

  The hematology journal : the official journal of the European Haematology Association 20030101

• [Survival evaluation of children with acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munich trial].

  Jornal de pediatria 20030101

• [Improved results in children with acute lymphoblastic leukemia treated with the ALL-BFM 90 protocol in the Czech Republic].

  Casopis lekaru ceskych 20030101

• Aphidicolin decreases ex vivo resistance to cytosine arabinoside in childhood acute leukaemia.

  Oncology reports 20030101

• Structural basis for topoisomerase I inhibition by nucleoside analogs.

  Nucleosides, nucleotides & nucleic acids 20030101

• Decitabine: 2'-deoxy-5-azacytidine, Aza dC, DAC, dezocitidine, NSC 127716.

  Drugs in R&D 20030101

• Comparing cDNA and oligonucleotide array data: concordance of gene expression across platforms for the NCI-60 cancer cells.

  Genome biology 20030101

• Granulocytic sarcoma of the pancreas. A report of one case and review of the literature.

  Acta haematologica 20030101

• Combination effects of Ara-C and 5-fluorodeoxyuridine against leukemia cells in vitro and in mice.

  Anticancer research 20030101

• [Acute myeloid leukemia in childhood: 15-year experience in a single institution].

  Jornal de pediatria 20030101

• Insulin-like growth factor-I suppresses degradation of the pro-survival transcription factor myocyte enhancer factor 2D (MEF2D) during neuronal apoptosis.

  Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20030101

• The anticancer drug cytarabine does not interact with the human erythrocyte membrane.

  Zeitschrift fur Naturforschung. C, Journal of biosciences 20030101

• New agents in the treatment of small-cell lung cancer: focus on gemcitabine.

  Clinical lung cancer 20030101

• Pharmacological study of modified intermediate-dose cytarabine therapy in patients with acute myeloid leukemia.

  Anticancer research 20030101

• A severe hepatic disorder with myelodysplastic syndrome, treated with cytarabine ocfosfate, in a dog.

  Australian veterinary journal 20030101

• Imatinib results in better quality of life for CML patients than interferon/Ara-C.

  The journal of supportive oncology 20030101

• Stereoselective synthesis of the 5'-hydroxy-5'-phosphonate derivatives of cytidine and cytosine arabinoside.

  The Journal of organic chemistry 20021227

• Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

  Blood 20021215

• All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol.

  Blood 20021215

• Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma.

  Blood 20021215

• Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation.

  Blood 20021215

• Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461).

  Blood 20021215

• Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group Study 93-10.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021215

• Activation of SAPK/JNK signaling by protein kinase Cdelta in response to DNA damage.

  The Journal of biological chemistry 20021213

• Gamma-aminobutyric acid-induced calcium signalling in rat superior collicular neurones.

  Neuroscience letters 20021213

• p53 codon 72 genotype affects apoptosis by cytosine arabinoside in blood leukocytes.

  Biochemical and biophysical research communications 20021213

• [Chronic myeloid leukemia--case report].

  Deutsche medizinische Wochenschrift (1946) 20021206

• [Chronic myeloid leukemia--treatment].

  Deutsche medizinische Wochenschrift (1946) 20021206

• Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

  Blood 20021201

• Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation.

  Molecular pharmacology 20021201

• High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

  Bone marrow transplantation 20021201

• Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.

  Cancer chemotherapy and pharmacology 20021201

• Mylotarg combined with topotecan and cytarabine in patients with refractory acute myelogenous leukemia.

  Cancer chemotherapy and pharmacology 20021201

• CNS relapses of acute promyelocytic leukemia after all-trans retinoic acid.

  The Annals of pharmacotherapy 20021201

• Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs.

  Leukemia 20021201

• Cerebellar herniation after intrathecal chemotherapy including cytosine arabinoside in a boy with T acute lymphoblastic leukemia.

  Leukemia 20021201

• Modified ESHAP as salvage chemotherapy for recurrent or refractory non-Hodgkin's lymphoma: results of a single-center study of 32 patients. Modified etoposide, methylprednisolone, cytarabine and cisplatin.

  Chemotherapy 20021201

• Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.

  Bone marrow transplantation 20021201

• Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.

  Bone marrow transplantation 20021201

• Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.

  Bone marrow transplantation 20021201

• Long-term survival of renal graft complicated with Burkitt lymphoma.

  Pediatric nephrology (Berlin, Germany) 20021201

• Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients.

  Annals of hematology 20021201

• Acute myelogenous leukaemia presenting as a conjunctival lesion and red eye.

  Acta ophthalmologica Scandinavica 20021201

• Imatinib mesylate for chronic myeloid leukemia: what do we really know?

  Issues in emerging health technologies 20021201

• 1-beta-D-arabinofuranosylcytosine is cytotoxic in quiescent normal lymphocytes undergoing DNA excision repair.

  Japanese journal of cancer research : Gann 20021201

• [Progress in postoperative adjuvant chemotherapy in gastric cancer].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021201

• [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].

  Gan to kagaku ryoho. Cancer & chemotherapy 20021201

• Coeliac disease following high-dose chemotherapy.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20021201

• Optimal therapy of primary ocular lymphoma.

  Clinical oncology (Royal College of Radiologists (Great Britain)) 20021201

• [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].

  Ai zheng = Aizheng = Chinese journal of cancer 20021201

• Challenges in the management of Burkitt's lymphoma.

  Clinical lymphoma 20021201

• Fludarabine, ARA-C, idarubicin and G-CSF (FLAG-Ida), high dose ARA-C and early stem cell transplant. A feasable and effective therapeutic strategy for de novo AML patients.

  Journal of experimental & clinical cancer research : CR 20021201

• Protection by beverages, fruits, vegetables, herbs, and flavonoids against genotoxicity of 2-acetylaminofluorene and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in metabolically competent V79 cells.

  Mutation research 20021126

• Effects of isoprenoid analogues of SDB-ethylenediamine on multidrug resistant tumor cells alone and in combination with chemotherapeutic drugs.

  Journal of medicinal chemistry 20021121

• Randomized study to evaluate the use of high-dose therapy as part of primary treatment for 'aggressive' lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021115

• Isolated trisomy of chromosomes 8, 11, 13 and 21 is an adverse prognostic factor in adults with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

  International journal of oncology 20021101

• The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation.

  Blood 20021101

• Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular acute promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up.

  Blood 20021101

• Cellular drug resistance in childhood acute myeloid leukemia is related to chromosomal abnormalities.

  Blood 20021101

• Vaccinia virus induces apoptosis of infected macrophages.

  The Journal of general virology 20021101

• Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.

  Leukemia 20021101

• Predictive value of circulating immature cell counts in peripheral blood for timing of peripheral blood progenitor cell collection after G-CSF plus chemotherapy-induced mobilization.

  Transfusion 20021101

• The catalytic DNA topoisomerase II inhibitor ICRF-193 and all-trans retinoic acid cooperatively induce granulocytic differentiation of acute promyelocytic leukemia cells: candidate drugs for chemo-differentiation therapy against acute promyelocytic leukemia.

  Experimental hematology 20021101

• Impact of the expression of P glycoprotein, the multidrug resistance-related protein, bcl-2, mutant p53, and heat shock protein 27 on response to induction therapy and long-term survival in patients with de novo acute myeloid leukemia.

  Experimental hematology 20021101

• Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.

  Journal of pediatric hematology/oncology 20021101

• Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group.

  Journal of pediatric hematology/oncology 20021101

• Methotrexate polyglutamation may lack prognostic significance in children with B-cell precursor acute lymphoblastic leukemia treated with intensive oral methotrexate.

  Journal of pediatric hematology/oncology 20021101

• Blast crisis of chronic myeloid leukemia: diagnosis prompted by T(8;9).

  Journal of pediatric hematology/oncology 20021101

• Pharmacokinetics of 2-chlorodeoxyadenosine in a child undergoing hemofiltration and hemodialysis for acute renal failure.

  Journal of pediatric hematology/oncology 20021101

• New saponins from the starfish Certonardoa semiregularis.

  Journal of natural products 20021101

• Keratinocyte dysplasia: an usual finding after transplantation or chemotherapy.

  Journal of cutaneous pathology 20021101

• [Interferons and hematology].

  La Revue de medecine interne 20021101

• Proteasome inhibitors induce cerebellar granule cell death: inhibition of nuclear factor-kB activation.

  Annals of the New York Academy of Sciences 20021101

• Effects of antineoplastic agents on cytoplasmic and membrane-bound heat shock protein 70 (Hsp70) levels.

  Biological chemistry 20021101

• Chemotherapy induces bcl-2 cleavage in lymphoid leukemic cell lines.

  Leukemia & lymphoma 20021101

• Treatment of secondary myelodysplastic syndrome after heart transplantation with chemotherapy and nonmyeloablative stem-cell transplantation.

  Transplantation 20021027

• [Resistance to tumor specific therapy with imatinib by clonal selection of mutated cells].

  Deutsche medizinische Wochenschrift (1946) 20021018

• [Imatinib combination therapies--the new CML Study 4].

  Deutsche medizinische Wochenschrift (1946) 20021018

• Induction of DNA ligase I by 1-beta-D-arabinosylcytosine and aphidicolin in MiaPaCa human pancreatic cancer cells.

  Experimental cell research 20021015

• Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20021015

• Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.

  Cancer research 20021015

• Daunorubicin- and Ara-C-induced interphasic apoptosis of human type II leukemia cells is caspase-8-independent.

  Biochimica et biophysica acta 20021010

• Ara-C- and daunorubicin-induced recruitment of Lyn in sphingomyelinase-enriched membrane rafts.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20021001

• p53 deficiency fails to prevent increased programmed cell death in the Bcl-X(L)-deficient nervous system.

  Cell death and differentiation 20021001

• Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial.

  Blood 20021001

• Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation.

  Blood 20021001

• Cytarabine-induced acute generalized exanthematous pustulosis.

  Journal of the American Academy of Dermatology 20021001

• Comparison of colorimetric, fluorometric, and visual methods for determining anti-influenza (H1N1 and H3N2) virus activities and toxicities of compounds.

  Journal of virological methods 20021001

• High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma.

  Haematologica 20021001

• Peripheral blood stem cell collection in children with acute leukemia: effectiveness of the 'DIAVE' mobilizing regimen.

  Bone marrow transplantation 20021001

• Enterocolitis as initial presentation of acute myelogenous leukemia exacerbated by induction chemotherapy with idarubicin-cytosine arabinoside.

  Mayo Clinic proceedings 20021001

• Time-intensified dexamethasone/cisplatin/cytarabine: an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin's disease.

  Annals of oncology : official journal of the European Society for Medical Oncology 20021001

• ESHAP salvage therapy for relapsed or refractory non-Hodgkin's lymphoma.

  Journal of Korean medical science 20021001

• Melatonin: reducing the toxicity and increasing the efficacy of drugs.

  The Journal of pharmacy and pharmacology 20021001

• Allogeneic stem cell transplantation in treatment of aggressive lymphomas: case series.

  Croatian medical journal 20021001

• A method for assaying the sensitivity of Drosophila replication checkpoint mutants to anti-cancer and DNA-damaging drugs.

  Genome 20021001

• Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.

  Annals of hematology 20021001

• Fulminant tumour lysis syndrome in acute myelogenous leukaemia with inv(16)(p13;q22).

  European journal of haematology 20021001

• [Granulocytic sarcoma of the colon in chronic myelomonocytic leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20021001

• [Acute promyelocytic leukemia accompanied by retinoic acid syndrome with complications of acute myocardial infarction and cerebral infarction during treatment with all-trans retinoic acid].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20021001

• [WT1 gene expression in patients with acute myelogenous leukemia or high risk myelodysplastic syndrome successfully treated with the CAG regimen].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20021001

• A novel indolocarbazole, ICP-1, abrogates DNA damage-induced cell cycle arrest and enhances cytotoxicity: similarities and differences to the cell cycle checkpoint abrogator UCN-01.

  Molecular cancer therapeutics 20021001

• Long-term outcomes of acute myeloid leukemia in adults in Pakistan.

  JPMA. The Journal of the Pakistan Medical Association 20021001

• Erythematous eruption in a man with acute myeloid leukemia.

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20020917

• Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.

  British journal of cancer 20020909

• A lipid based depot (DepoFoam technology) for sustained release drug delivery.

  Progress in lipid research 20020901

• Loss of heterozygosity of p16 correlates with minimal residual disease at the end of the induction therapy in non-high risk childhood B-cell precursor acute lymphoblastic leukemia.

  Leukemia research 20020901

• Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesylate.

  Leukemia research 20020901

• Older adults with acute myeloid leukemia.

  Current oncology reports 20020901

• Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase.

  Blood 20020901

• A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group.

  British journal of haematology 20020901

• High-dose cytarabine in upfront therapy for adult patients with acute lymphoblastic leukaemia.

  British journal of haematology 20020901

• Sensitivity to ionizing radiation and chemotherapeutic agents in gemcitabine-resistant human tumor cell lines.

  International journal of radiation oncology, biology, physics 20020901

• Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child.

  Emerging infectious diseases 20020901

• Intensive chemotherapy in patients with chronic myelogenous leukaemia (CML) in accelerated or blastic phase--a report from the Swedish CML Group.

  British journal of haematology 20020901

• Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins.

  Leukemia 20020901

• Schedule-dependent synergism and antagonism between methotrexate and cytarabine against human leukemia cell lines in vitro.

  Leukemia 20020901

• Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.

  Leukemia 20020901

• Outcome of B-cell non-Hodgkin lymphoma protocol CCCG-B NHL97: a report from Chinese multi-center cooperative group.

  Medical and pediatric oncology 20020901

• Fludarabine, ara-C, novantrone and dexamethasone (FAND) in previously treated chronic lymphocytic leukemia patients.

  Haematologica 20020901

• Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.

  American journal of hematology 20020901

• Acute myocardial infarction as the presenting symptom of acute myeloblastic leukemia with extreme hyperleukocytosis.

  American journal of hematology 20020901

• Central nervous system relapse in acute promyelocytic leukemia.

  American journal of hematology 20020901

• Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020901

• Combination chemotherapy with high-dose methotrexate and cytarabine with or without brain irradiation for primary central nervous system lymphomas.

  Journal of neuro-oncology 20020901

• Allogeneic bone marrow transplantation in Shwachman-Diamond syndrome with malignant myeloid transformation. A case report.

  The Korean journal of internal medicine 20020901

• Acute myelogenous leukemia following treatment with cyclosporin A in a nephrotic patient.

  Internal medicine (Tokyo, Japan) 20020901

• Correlation of three methods of measuring cytogenetic response in chronic myelocytic leukemia.

  Cancer genetics and cytogenetics 20020901

• Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia.

  European journal of haematology 20020901

• High-dose cytosine arabinoside-induced cutaneous reactions.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20020901

• Factors determining the outcome of management of patients with Burkitt's lymphoma at the University College Hospital Ibadan, Nigeria--an eleven year review.

  The Nigerian postgraduate medical journal 20020901

• Imatinib: the first 3 years.

  European journal of cancer (Oxford, England : 1990) 20020901

• Imatinib mesylate (Gleevec, Glivec): a new therapy for chronic myeloid leukemia and other malignancies.

  Drugs of today (Barcelona, Spain : 1998) 20020901

• Isolation and characterization of canine satellite cells.

  In vitro cellular & developmental biology. Animal 20020901

• Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.

  Leukemia & lymphoma 20020901

• Combination effects of alkylphosphocholines and gemcitabine in malignant and normal hematopoietic cells.

  Cancer letters 20020828

• Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs.

  International journal of pharmaceutics 20020821

• A novel pH-sensitive liposome formulation containing oleyl alcohol.

  Biochimica et biophysica acta 20020819

• Phase 3 study of the multidrug resistance modulator PSC-833 in previously untreated patients 60 years of age and older with acute myeloid leukemia: Cancer and Leukemia Group B Study 9720.

  Blood 20020815

• Preclinical combination chemotherapy of nedaplatin with gemcitabine against gemcitabine-refractory human lung cancer.

  Cancer letters 20020808

• Reversible vincristine-related flaccid paralysis in a child with acute lymphoblastic leukemia.

  Medical and pediatric oncology 20020801

• Primary granulocytic sarcoma of the urinary bladder: case report and review of the literature.

  Urology 20020801

• SAB--a promising new treatment to improve remission rates in AML in the elderly?

  British journal of haematology 20020801

• The anti-apoptotic genes Bcl-X(L) and Bcl-2 are over-expressed and contribute to chemoresistance of non-proliferating leukaemic CD34+ cells.

  British journal of haematology 20020801

• Anti-angiogenic activity of the purine analog 6-thioguanine.

  Leukemia 20020801

• Inhibition of mitochondrial permeability transition and release of cytochrome c by anti-apoptotic nucleoside analogues.

  Biochemical pharmacology 20020801

• Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells.

  Biochemical pharmacology 20020801

• Increase in glutamate-induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C.

  Journal of neurochemistry 20020801

• A phase I study of idarubicin dose escalation with amisfostine and high-dose cytarabine in patients with relapsed acute myelogenous leukemia and myelodysplastic syndromes.

  Haematologica 20020801

• Intensified double induction therapy with high dose mitoxantrone, etoposide, m-amsacrine and high dose ara-C for elderly acute myeloid leukemia patients aged 61-65 years.

  Haematologica 20020801

• Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020801

• A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.

  Journal of Korean medical science 20020801

• Osteosarcoma cells, resistant to methotrexate due to nucleoside and nucleobase salvage, are sensitive to nucleoside analogs.

  Cancer chemotherapy and pharmacology 20020801

• The chemokine CCL21 protects normal marrow progenitors from Ara-C cytotoxicity.

  Cancer chemotherapy and pharmacology 20020801

• Neutropenic colitis after treatment of acute myelogenous leukemia with idarubicin and cytosine arabinoside.

  Mayo Clinic proceedings 20020801

• An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitt's lymphoma: results of United Kingdom Lymphoma Group LY06 study.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020801

• Effect of novel modulators of protein kinase C activity upon chemotherapy-induced differentiation and apoptosis in myeloid leukemic cells.

  Anti-cancer drugs 20020801

• In vitro activity of the novel cytotoxic agent CHS 828 in childhood acute leukemia.

  Anti-cancer drugs 20020801

• FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies.

  Leukemia research 20020801

• What is the optimal therapy for childhood AML?

  Oncology (Williston Park, N.Y.) 20020801

• Acute myocardial ischemia after high-dose therapy with BEAM regimen.

  Bone marrow transplantation 20020801

• A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.

  Cancer 20020801

• Acute rhabdomyolysis as a complication of cytarabine chemotherapy for acute myeloid leukemia: case report and review of literature.

  American journal of hematology 20020801

• A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2).

  Annals of hematology 20020801

• Cytometric evaluation of peripheral blood lymphocytes in dogs with lymphoma during chemotherapy.

  Journal of veterinary medicine. A, Physiology, pathology, clinical medicine 20020801

• [Quantitative analysis of Sokal's risk index in relation to 2 therapy protocols: their respective impact on clinical remission of chronic myeloid leukemia].

  Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA 20020801

• Segmental coecal cytomegalovirus colitis during fludarabine, cytarabine and mitoxantrone induction chemotherapy for myelodysplastic syndrome.

  Leukemia & lymphoma 20020801

• [Clinical pharmacology of nucleoside analogues].

  Bulletin du cancer 20020801

• [The role of gemcitabine in hematology].

  Bulletin du cancer 20020801

• [Preliminary study on DHAP regimen for patients with relapsed and refractory non-Hodgkin's lymphoma].

  Ai zheng = Aizheng = Chinese journal of cancer 20020801

• Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization.

  Japanese journal of cancer research : Gann 20020801

• Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

  Blood 20020715

• 3'-Azido-2',3'-dideoxythymidine induced deficiency of thymidine kinases 1, 2 and deoxycytidine kinase in H9 T-lymphoid cells.

  Biochemical pharmacology 20020715

• [Progress in the field of hematology in the last 100 years: Medical history of acute leukemia].

  Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20020710

• Potential mechanisms of resistance to cytarabine in AML patients.

  Leukemia research 20020701

• CD56 expression predicts occurrence of CNS disease in acute lymphoblastic leukemia.

  Leukemia research 20020701

• Combined SP-A-bleomycin effect on cytokines by THP-1 cells: impact of surfactant lipids on this effect.

  American journal of physiology. Lung cellular and molecular physiology 20020701

• Cytotoxic targeting of F9 teratocarcinoma tumours with anti-ED-B fibronectin scFv antibody modified liposomes.

  British journal of cancer 20020701

• Transforming Growth Factor-beta2 protects the small intestine during methotrexate treatment in rats possibly by reducing stem cell cycling.

  British journal of cancer 20020701

• Early chemosensitivity to VAD regimen predicts a favorable outcome after autologous stem cell transplantation in multiple myeloma.

  Haematologica 20020701

• Granulocyte colony-stimulating factor mobilized whole blood containing over 0.3 x 106/kg CD34+ cells is a sufficient graft in autologous transplantation for relapsed non-Hodgkin's lymphoma.

  British journal of haematology 20020701

• Use of high-dose cytarabine to enhance cisplatin cytotoxicity-effects on the response and overall survival rates of advanced head and neck cancer patients.

  European journal of cancer (Oxford, England : 1990) 20020701

• Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020701

• Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.

  Medical and pediatric oncology 20020701

• Variant translocations of 11q23 in infant acute lymphoblastic leukemia (ALL): do outcomes differ from t(4;11)?

  Medical and pediatric oncology 20020701

• Increased factor VIII activity and dural sinus thrombosis.

  Medical and pediatric oncology 20020701

• Unusual implantation site of a port-a-cath system via the right femoral vein.

  Journal of cancer research and clinical oncology 20020701

• [The mechanism of synergistic interaction between etoposide and cytarabine].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20020701

• Treatment of acute myeloid leukemia: state-of-the-art and future directions.

  Seminars in hematology 20020701

• Hypersensitivity pneumonitis in advanced non-small-cell lung cancer patients receiving gemcitabine and paclitaxel: report of two cases and a review of the literature.

  Clinical lung cancer 20020701

• [Experience with fludarabine treatment and review of the literature].

  Orvosi hetilap 20020616

• Gemtuzumab ozogamicin with or without interleukin 11 in patients 65 years of age or older with untreated acute myeloid leukemia and high-risk myelodysplastic syndrome: comparison with idarubicin plus continuous-infusion, high-dose cytosine arabinoside.

  Blood 20020615

• Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. Leucámie Aiqüe Myéloïde Enfant.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020615

• Intensive, very short-term chemotherapy for advanced Burkitt's lymphoma in children.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020615

• Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

  Lancet (London, England) 20020615

• [Diagnostic image (92). A man with fever during chemotherapy. Invasive pulmonary mycosis].

  Nederlands tijdschrift voor geneeskunde 20020615

• Not so NICE for CML.

  Lancet (London, England) 20020608

• Anti-neovascular therapy by liposomal DPP-CNDAC targeted to angiogenic vessels.

  FEBS letters 20020605

• A phase I study of combination chemotherapy with gemcitabine and oral UFT for advanced non-small cell lung cancer.

  British journal of cancer 20020605

• High-dose cytarabine as consolidation treatment for patients with acute myeloid leukemia with t(8;21).

  Leukemia research 20020601

• 1-beta-D-arabinofuranosylcytosine inhibits borna disease virus replication and spread.

  Journal of virology 20020601

• Inhibition of c-Abl with STI571 attenuates stress-activated protein kinase activation and apoptosis in the cellular response to 1-beta-D-arabinofuranosylcytosine.

  Molecular pharmacology 20020601

• Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatment.

  British journal of haematology 20020601

• Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.

  Cancer research 20020601

• Enhancement of cytarabine sensitivity in squamous cell carcinoma cell line transfected with deoxycytidine kinase.

  Archives of otolaryngology--head & neck surgery 20020601

• Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens.

  British journal of haematology 20020601

• In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.

  British journal of haematology 20020601

• High-throughput measurement of the Tp53 response to anticancer drugs and random compounds using a stably integrated Tp53-responsive luciferase reporter.

  Carcinogenesis 20020601

• Oral manifestations of acute myelomonocytic leukemia: a case report and review of the classification of leukemias.

  Journal of periodontology 20020601

• Long-term follow-up of allogeneic bone marrow transplantation after reduced-intensity conditioning in patients with chronic myelogenous leukemia in the chronic phase.

  International journal of hematology 20020601

• Flexible low-intensity combination chemotherapy for elderly patients with acute myeloid leukemia.

  International journal of hematology 20020601

• Transient abnormal myelopoiesis (TAM) causing multiple organ failure.

  Intensive care medicine 20020601

• Troxacitabine-based therapy of refractory leukemia.

  Expert review of anticancer therapy 20020601

• Tetrasomy 13 as the sole cytogenetic abnormality in acute myeloid leukemia M1 without maturation.

  Cancer genetics and cytogenetics 20020601

• [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20020601

• A case of acantholytic dermatosis and leukemia cutis: cause or effect?

  The American Journal of dermatopathology 20020601

• Phase III trial of a humanized anti-CD33 antibody (HuM195) in patients with relapsed or refractory acute myeloid leukemia.

  Clinical lymphoma 20020601

• Transfusion medicine illustrated. White out: extreme leukocytosis treated with WBC reduction.

  Transfusion 20020601

• [Primary cardiac lymphoma: cytological diagnosis and treatment with response to polychemotherapy and hematopoietic precursor autotransplant. Presentation of a case a review of the literature].

  Anales de medicina interna (Madrid, Spain : 1984) 20020601

• Autologous stem cell transplantation in patients with mantle cell lymphoma.

  Leukemia & lymphoma 20020601

• Gateways to Clinical Trials. June 2002.

  Methods and findings in experimental and clinical pharmacology 20020601

• Long-term follow-up of patients >or=60 yr old with acute myeloid leukaemia treated with intensive chemotherapy.

  European journal of haematology 20020601

• Troxacitabine activity in extramedullary myeloid leukemia.

  Hematology (Amsterdam, Netherlands) 20020601

• [Biological characterization of mouse erythroblastic leukemia cells in haploiden tical mice].

  Zhongguo shi yan xue ye xue za zhi 20020601

• Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.

  Biochemical and biophysical research communications 20020524

• Gene expression of D-amino acid oxidase in cultured rat astrocytes: regional and cell type specific expression.

  Neuroscience letters 20020517

• Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase.

  Blood 20020515

• Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020515

• Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020515

• Outcomes in patients treated with gemtuzumab ozogamicin for relapsed acute myelogenous leukemia.

  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20020515

• In vitro effects of STI 571-containing drug combinations on the growth of Philadelphia-positive chronic myelogenous leukemia cells.

  Cancer 20020515

• The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR-ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents.

  British journal of cancer 20020506

• Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning.

  British journal of cancer 20020506

• A novel approach towards studying non-genotoxic enediynes as potential anticancer therapeutics.

  Bioorganic & medicinal chemistry 20020501

• Long-term follow-up of intensive ara-C-based chemotherapy followed by bone marrow transplantation for adult acute lymphoblastic leukemia: impact of induction Ara-C dose and post-remission therapy.

  Leukemia research 20020501

• The role of high-dose cytarabine in induction therapy for adult ALL.

  Leukemia research 20020501

• Neoplastic meningitis.

  Current neurology and neuroscience reports 20020501

• Gynecomastia with marked cellular atypia associated with chemotherapy.

  Archives of pathology & laboratory medicine 20020501

• Bryostatin 1 increases 1-beta-D-arabinofuranosylcytosine-induced cytochrome c release and apoptosis in human leukemia cells ectopically expressing Bcl-x(L).

  The Journal of pharmacology and experimental therapeutics 20020501

• Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual disease.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020501

• Arsenic trioxide therapy for relapsed acute promyelocytic leukemia: a bridge to transplantation.

  Haematologica 20020501

• Chronic disseminated candidiasis in patients with hematologic malignancies. Clinical features and outcome of 29 episodes.

  Haematologica 20020501

• Pharmacodynamic modeling of thrombopoietin, platelet, and megakaryocyte dynamics in patients with acute myeloid leukemia undergoing dose intensive chemotherapy.

  Journal of clinical pharmacology 20020501

• Multi-modality therapy leads to longer survival in primary central nervous system lymphoma patients.

  The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20020501

• Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.

  Cancer genetics and cytogenetics 20020501

• Urate-oxidase in the prevention and treatment of metabolic complications in patients with B-cell lymphoma and leukemia, treated in the Société Française d'Oncologie Pédiatrique LMB89 protocol.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020501

• [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].

  Anales de medicina interna (Madrid, Spain : 1984) 20020501

• [Gastric interdigitating reticulum cell sarcoma: unusual presentation of a histiocytic tumor].

  Gastroenterologie clinique et biologique 20020501

• An open label trial of sustained-release cytarabine (DepoCyt) for the intrathecal treatment of solid tumor neoplastic meningitis.

  Journal of neuro-oncology 20020501

• Activity of all-trans-retinoic acid in a case of central nervous system extramedullary relapse of acute promyelocytic leukemia.

  European journal of haematology 20020501

• Biomonitoring of primary aluminium industry workers: detection of micronuclei and repairable DNA lesions by alkaline SCGE.

  Mutation research 20020426

• Telomerase overexpression in K562 leukemia cells protects against apoptosis by serum deprivation and double-stranded DNA break inducing agents, but not against DNA synthesis inhibitors.

  Cancer letters 20020425

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.

  Cancer research 20020415

• [Mobilization of autologous peripheral blood stem cells by cytosine arabinoside combined with recombinant human granulocyte colony-stimulating factor].

  Zhonghua yi xue za zhi 20020410

• Green urine in a critically ill patient.

  American journal of kidney diseases : the official journal of the National Kidney Foundation 20020401

• Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line.

  International journal of cancer 20020401

• Automated differential counts in acute promyelocytic leukemia patients may be misleading.

  Medical and pediatric oncology 20020401

• Clinical severe hepatic venoocclusive disease during induction treatment of acute monoblastic leukemia managed with defibrotide.

  American journal of hematology 20020401

• 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.

  Genes, chromosomes & cancer 20020401

• Treatment and outcome of infants with acute myeloid leukemia.

  Blood 20020401

• Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.

  Cancer 20020401

• Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.

  Gene therapy 20020401

• Enhancement of DNA ligase I level by gemcitabine in human cancer cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20020401

• Chemotherapy-induced neurotoxicity: assessment and interventions for patients at risk.

  The American journal of nursing 20020401

• Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.

  Leukemia 20020401

• Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective study.

  Leukemia 20020401

• Long-term follow-up of short intensive multiagent chemotherapy without high-dose methotrexate ('Orange') in children with advanced non-lymphoblastic non-Hodgkin's lymphoma: a children's cancer group report.

  Leukemia 20020401

• Burkitt's lymphoma: single-centre experience with modified BFM protocol.

  Clinical and laboratory haematology 20020401

• Current therapy of chronic myelogenous leukemia.

  Internal medicine (Tokyo, Japan) 20020401

• Acute basophilic leukemia lacking basophil-specific antigens: the importance of cytokine receptor expression in differential diagnosis.

  International journal of hematology 20020401

• An improved method for the expression of TRH in serum-supplemented primary cultures of fetal hypothalamic cells.

  Brain research. Brain research protocols 20020401

• De novo acute myeloid leukemia with multilineage dysplasia: treatment results and prognostic evaluation from a series of 44 patients treated with fludarabine, cytarabine and G-CSF (FLAG).

  European journal of haematology 20020401

• Mononucleosis syndrome and acute monocytic leukemia.

  European journal of haematology 20020401

• Gateways to Clinical Trials.

  Methods and findings in experimental and clinical pharmacology 20020401

• Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders.

  Leukemia & lymphoma 20020401

• Typhlitis complicating induction therapy in adult acute myeloid leukemia.

  Leukemia & lymphoma 20020401

• Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator.

  Thrombosis research 20020401

• A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantation.

  Bone marrow transplantation 20020401

• [The effect of interferon alone, cytosine arabinoside alone and their combined effect on hematopoietic progenitors of chronic myeloid leukemia in vitro].

  Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao 20020401

• Autologous stem cell transplantation for Hodgkin's lymphoma: results and prognostic factors in 51 high-risk patients.

  Advances in clinical pathology : the official journal of Adriatic Society of Pathology 20020401

• In lymphatic cells par-4 sensitizes to apoptosis by down-regulating bcl-2 and promoting disruption of mitochondrial membrane potential and caspase activation.

  Cancer research 20020315

• Apoptosis induced in an early step of African swine fever virus entry into vero cells does not require virus replication.

  Virology 20020315

• Cytotoxicity of 2-chlorodeoxyadenosine and arabinosylcytosine in leukaemic lymphoblasts from paediatric patients: significance of cellular nucleoside transporter content.

  British journal of haematology 20020301

• A randomized study of interferon-alpha versus interferon-alpha and low-dose arabinosyl cytosine in chronic myeloid leukemia.

  Blood 20020301

• Chemotherapy and pregnancy.

  Clinical obstetrics and gynecology 20020301

• Phase I trial with escalating doses of idarubicin and multidrug resistance reversal by short-course cyclosporin A, sequential high-dose cytosine arabinoside, and granulocyte colony-stimulating factor for adult patients with refractory acute leukemia.

  Haematologica 20020301

• Cuban experience in the treatment of acute promyelocytic leukemia with ALL transretinoic acid followed by intensive chemotherapy.

  Haematologica 20020301

• Granulocyte-macrophage colony-stimulating factor (GM-CSF) priming with successive concomitant low-dose Ara-C for elderly patients with secondary/refractory acute myeloid leukemia or advanced myelodysplastic syndrome.

  Leukemia 20020301

• Reactions of purines-containing butenolides with L-cysteine or N-acetyl-L-cysteine as model biological nucleophiles: a potent mechanism-based inhibitor of ribonucleotide reductase caused apoptosis in breast carcinoma MCF7 cells.

  European journal of medicinal chemistry 20020301

• Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia.

  European journal of pharmacology 20020301

• Acute myelogenous leukemia: advances and limitations of treatment.

  Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 20020301

• Treatment of granulomatous meningoencephalomyelitis in a dog.

  Veterinary ophthalmology 20020301

• Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis.

  Bone marrow transplantation 20020301

• Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation.

  Bone marrow transplantation 20020301

• CT and MRI appearances of methotrexate leucoencephalopathy.

  Australasian radiology 20020301

• Radiation myelitis in a 5-year-old girl.

  Journal of child neurology 20020301

• [Treatment of acute lymphoblastic leukemia in adults with seven-drug induction therapy and intensive consolidation with or without autologous stem cell transplantation followed by maintenance therapy. Experience of a single center].

  Casopis lekaru ceskych 20020301

• Anticancer drug delivery systems: N4-acyl poly(ethyleneglycol) prodrugs of ara-C. I. Efficacy in solid tumors.

  Journal of controlled release : official journal of the Controlled Release Society 20020219

• Anticancer drug delivery systems: multi-loaded N4-acyl poly(ethylene glycol) prodrugs of ara-C. II. Efficacy in ascites and solid tumors.

  Journal of controlled release : official journal of the Controlled Release Society 20020219

• Cytogenetic effects of hexavalent chromium in Bulgarian chromium platers.

  Mutation research 20020215

• Somatic recombination: a major genotoxic effect of two pyrimidine antimetabolitic chemotherapeutic drugs in Drosophila melanogaster.

  Mutation research 20020215

• Functional role of alternatively spliced deoxycytidine kinase in sensitivity to cytarabine of acute myeloid leukemic cells.

  Blood 20020215

• Schwann cell-enriched cultures from adult human peripheral nerve: a technique combining short enzymatic dissociation and treatment with cytosine arabinoside (Ara-C).

  Journal of neuroscience methods 20020215

• Modifications of deoxycytidine kinase and deaminase activities by docosahexaenoic acid in normal and transformed rat fibroblasts.

  Biochemical pharmacology 20020215

• Guidance of dopaminergic neuritic growth by immature astrocytes in organotypic cultures of rat fetal ventral mesencephalon.

  The Journal of comparative neurology 20020211

• Characterization of a novel pH-sensitive peptide that enhances drug release from folate-targeted liposomes at endosomal pHs.

  Biochimica et biophysica acta 20020210

• S-acyl-2-thioethyl (SATE) pronucleotides are potent inhibitors of HIV-1 replication in T-lymphoid cells cross-resistant to deoxycytidine and thymidine analogs.

  Antiviral research 20020201

• Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.

  Leukemia research 20020201

• Role of radiotherapy in the treatment of supratentorial primitive neuroectodermal tumors in childhood: results of the prospective German brain tumor trials HIT 88/89 and 91.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020201

• Gemcitabine-induced pulmonary toxicity: case report and review of the literature.

  American journal of clinical oncology 20020201

• Sugar specificity of bacterial CMP kinases as revealed by crystal structures and mutagenesis of Escherichia coli enzyme.

  Journal of molecular biology 20020201

• An MCL1-overexpressing Burkitt lymphoma subline exhibits enhanced survival on exposure to serum deprivation, topoisomerase inhibitors, or staurosporine but remains sensitive to 1-beta-D-arabinofuranosylcytosine.

  Cancer research 20020201

• AIDA treatment for high-risk acute promyelocytic leukemia in a pregnant woman at 21 weeks of gestation.

  Haematologica 20020201

• Rituximab: enhancing stem cell transplantation in mantle cell lymphoma.

  Bone marrow transplantation 20020201

• Hematopoietic cell transplantation beyond first remission.

  Leukemia 20020201

• Prognostic significance of the null genotype of glutathione S-transferase-T1 in patients with acute myeloid leukemia: increased early death after chemotherapy.

  Leukemia 20020201

• Positron emission tomography with [18F]2-fluoro-D-2-deoxyglucose (FDG-PET) predicts relapse of malignant lymphoma after high-dose therapy with stem cell transplantation.

  Leukemia 20020201

• Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.

  Leukemia 20020201

• Cisplatin, fludarabine, and cytarabine: a novel, pharmacologically designed salvage therapy for patients with refractory, histologically aggressive or mantle cell non-Hodgkin's lymphoma.

  Cancer 20020201

• High extracellular potassium protects against the toxicity of cytosine arabinoside but is not required for the survival of cerebellar granule cells in vitro.

  Molecular and cellular neurosciences 20020201

• Lethal pulmonary complications significantly correlate with individually assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation.

  International journal of radiation oncology, biology, physics 20020201

• Magnetic resonance imaging findings in a case of cytarabine-induced myelopathy.

  Military medicine 20020201

• Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin's lymphoma.

  Bone marrow transplantation 20020201

• Autologous stem cell transplantation for advanced acute myeloid leukemia.

  Bone marrow transplantation 20020201

• [Hypercalcemia mediated by parathyroid hormone-related protein in the blastic phase of chronic myelogenous leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20020201

• Treatment of a child with myeloid/NK cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation.

  International journal of hematology 20020201

• No major cognitive impairment in young children with acute lymphoblastic leukemia using chemotherapy only: a prospective longitudinal study.

  Journal of pediatric hematology/oncology 20020201

• Pediatric acute lymphoblastic leukemia: redefining outcomes.

  Journal of pediatric hematology/oncology 20020201

• Intermediate-dose cytarabine treatment delivered at moderate infusion rates for de novo acute myeloid leukemia-results of a phase I-II study.

  Leukemia & lymphoma 20020201

• In vitro drug resistance profiles of adult acute lymphoblastic leukemia: possible explanation for difference in outcome to similar therapeutic regimens.

  Leukemia & lymphoma 20020201

• Expression of P53 and bcl-2 proteins in T-cell lymphoblastic lymphoma: prognostic implications.

  Leukemia & lymphoma 20020201

• Acute myeloblastic leukemia achieving complete remission with amifostine alone.

  Leukemia & lymphoma 20020201

• Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue.

  Breast cancer research and treatment 20020201

• The evaluation of gemcitabine in resistant or relapsing multiple myeloma, phase II: a Southwest Oncology Group study.

  Investigational new drugs 20020201

• Opposite roles of GABA and excitatory amino acids on the control of GAD expression in cultured retina cells.

  Brain research 20020118

• Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53.

  Oncogene 20020117

• Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020115

• Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.

  Cancer 20020115

• PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism.

  Leukemia research 20020101

• Ventral polyradiculopathy with pediatric acute lymphocytic leukemia.

  Muscle & nerve 20020101

• More than one way to toy with ChAT and VAChT.

  Journal of physiology, Paris 20020101

• Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.

  Blood 20020101

• Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia.

  Blood 20020101

• Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20020101

• Effects of cytarabine and various anthracyclins on platelet activation: characterization of in vitro effects and their possible clinical relevance in acute myelogenous leukemia.

  International journal of cancer 20020101

• Collection of Philadelphia-negative stem cells using recombinant human granulocyte colony-stimulating factor in chronic myeloid leukemia patients treated with alpha-interferon.

  Haematologica 20020101

• Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

  Haematologica 20020101

• Preradiation chemotherapy for pediatric patients with high-grade glioma.

  Cancer 20020101

• Cutaneous drug reaction case reports: from the world literature.

  American journal of clinical dermatology 20020101

• Characterization of BTBD1 and BTBD2, two similar BTB-domain-containing Kelch-like proteins that interact with Topoisomerase I.

  BMC genomics 20020101

• Treatment of children and adolescents with localized parameningeal sarcoma: experience of the Intergroup Rhabdomyosarcoma Study Group protocols IRS-II through -IV, 1978-1997.

  Medical and pediatric oncology 20020101

• Clonal evolution of blasts in an elderly patient with CD56(+) relapsed acute promyelocytic leukemia.

  American journal of hematology 20020101

• Effects of combinations of therapeutic agents on the proliferation of progenitor cells in chronic myeloid leukaemia.

  British journal of haematology 20020101

• A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma.

  British journal of haematology 20020101

• Painful lesions in a pancytopenic patient.

  Clinical journal of oncology nursing 20020101

• Secondary acute promyelocytic leukemia in a patient with non-Hodgkin's lymphoma treated with VP-16 and MST-16.

  International journal of hematology 20020101

• Toxoplasmic encephalitis in a non-HIV patient with follicular lymphoma.

  International journal of hematology 20020101

• Prognosis of elderly patients with acute myelogenous leukemia: analysis of 126 AML cases.

  International journal of hematology 20020101

• Philadelphia chromosome-positive acute myeloid leukemia with tetraploidy.

  International journal of hematology 20020101

• [Acute myelogenous leukemia associated with severe esophageal stricture after chemotherapy].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20020101

• Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay).

  Archives of toxicology 20020101

• Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia.

  Journal of pediatric hematology/oncology 20020101

• Effects of an inadvertent dose of cytarabine in a child with Fanconi's anemia: reducing medication errors.

  Paediatric drugs 20020101

• Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case report.

  Acta haematologica 20020101

• A case of zygomycosis and invasive candidiasis involving the epiglottis and tongue in an immunocompromised patient.

  Scandinavian journal of infectious diseases 20020101

• Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: successful treatment with a fludarabine-containing regimen.

  European journal of haematology 20020101

• All trans retinoic acid in combination with intermediate-dose cytarabine and idarubicin in patients with relapsed or refractory non promyelocytic acute myeloid leukemia: a phase II randomized trial.

  The hematology journal : the official journal of the European Haematology Association 20020101

• Age-adjusted chemotherapy for primary central-nervous system lymphoma--a pilot study.

  Acta oncologica (Stockholm, Sweden) 20020101

• An evaluation of predictive factors involved in clinical or pathological response to primary chemotherapy in advanced breast cancer.

  Breast cancer (Tokyo, Japan) 20020101

• In vitro activity of glufosfamide in childhood acute leukemia.

  Anticancer research 20020101

• Timed sequential chemotherapy with concomitant granulocyte colony-stimulating factor for high-risk acute myelogenous leukemia: a single arm clinical trial.

  BMC cancer 20020101

• Mitochondrial disappearance from cells: a clue to the role of autophagy in programmed cell death and disease?

  Biochimie 20020101

• In vivo use of all-trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia.

  Medical oncology (Northwood, London, England) 20020101

• Central nervous system prophylaxis in haematological malignancies.

  Internal medicine journal 20020101

• Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer.

  Breast cancer research : BCR 20020101

• ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.

  Annals of oncology : official journal of the European Society for Medical Oncology 20020101

• c-myc amplification and enhancement of sensitivity to cytosine arabinoside: an in vitro and in vivo study on four sublines established from a pulmonary adenocarcinoma.

  Surgery today 20020101

• Inv(4)(p14q27) in a case with de novo acute nonlymphocytic leukemia.

  Acta haematologica 20020101

• CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside.

  Acta haematologica 20020101

• Clinical pharmacokinetics of cytarabine formulations.

  Clinical pharmacokinetics 20020101

• [Minimal residual disease in acute myeloid leukemia in children--standardization and evaluation of immunophenotyping in the AML-BFM-98 study].

  Klinische Padiatrie 20020101

• [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].

  Klinische Padiatrie 20020101

• The combination regimen of idarubicin and taxotere is effective against human drug-resistant leukemic cell lines.

  Anticancer research 20020101

• DNA-dependent protein kinase in leukaemia cells and correlation with drug sensitivity.

  Anticancer research 20020101

• Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis.

  Cancer biology & therapy 20020101

• [Liposomal daunorubicin and interferon-alfa in combination with all-retinoic acid--a new regime for the treatment of acute promyelocytic leukemia].

  Terapevticheskii arkhiv 20020101

• Prolonged administration of all-trans retinoic acid in combination with intensive chemotherapy and G-CSF for adult acute myelogenous leukemia: single-centre pilot study in different risk groups.

  The hematology journal : the official journal of the European Haematology Association 20020101

• Immune reconstitution during intensive chemotherapy in patients with human immunodeficiency virus related non-Hodgkin lymphoma.

  The hematology journal : the official journal of the European Haematology Association 20020101

• Ambulatory electrocardiographic evaluation of the heart in patients treated by megachemotherapy and bone marrow transplantation.

  Haematologia 20020101

• Treatment of blastic phase chronic myeloid leukemia with mitoxantrone, cytosine arabinoside and high dose methylprednisolone.

  Haematologia 20020101

• Evaluation of minimal residual disease in patients with chronic myeloid leukaemia on IFN-alpha 2b therapy using conventional cytogenetics and fluorescence in situ hybridization.

  The National medical journal of India 20020101

• Potent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers.

  Oncology reports 20020101

• Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine.

  The hematology journal : the official journal of the European Haematology Association 20020101

• Kinetic evidence for covalent phosphoryl-enzyme intermediate in phosphotransferase activity of human red cell pyrimidine nucleotidases.

  Methods in enzymology 20020101

• [High-dose chemotherapy with autologous bone marrow transplantation in children with high-risk malignant neoformations].

  Voprosy onkologii 20020101

• [Results of the treatment of childhood acute lymphoblastic leukemia according to the Berlin-Moscow-91 protocol in 1991-2000].

  Voprosy onkologii 20020101

• Recurrent palmar-plantar erythrodysaesthesia following high-dose cytarabine treatment for acute lymphoblastic leukemia.

  European journal of haematology 20020101

• Molecular and cellular characterization of imexon-resistant RPMI8226/I myeloma cells.

  Molecular cancer therapeutics 20020101

• The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.

  Cancer treatment and research 20020101

• Primary cultures of prostate cells and their ability to activate carcinogens.

  Prostate cancer and prostatic diseases 20020101

• [Treatment of residual disease in chronic myeloid leukemia with STI-571 (Glivec)].

  Acta medica Austriaca. Supplement 20020101

• The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells.

  Anticancer research 20020101

• Intrathecal chemotherapy in carcinomatous meningitis from breast cancer.

  Anticancer research 20020101

• [Effectiveness of high-dose polychemotherapy and autologous hemopoietic cell transplantation in patients with low-grade non-Hodgkin lymphoma].

  Voprosy onkologii 20020101

• Delayed dedifferentiation and retention of properties in dissociated adult skeletal muscle fibers in vitro.

  In vitro cellular & developmental biology. Animal 20020101

• [Ocular relapse of acute lymphoblastic leukemia].

  Bulletin de la Societe belge d'ophtalmologie 20020101

• [Effects of small-dose cytarabine on the course of atheromatosis in over 60 years of age patients with acute myeloblastic leukemia (description of 2 cases)].

  Terapevticheskii arkhiv 20020101

• The treatment of acute myeloid leukemia with mitoxantrone, etoposide and low-dose cytarabine in elderly patients - a report of Polish Acute Leukemia Group (PALG) phase II study.

  Neoplasma 20020101

• Role of MRIT/cFLIP in protection against chemotherapy-induced apoptosis.

  Cancer biology & therapy 20020101

• Prediction of treatment response using gene expression profiles.

  Journal of proteome research 20020101

• Apoptosis of leukemia cells induced by CD34+ cells transferred exogenous Fas ligand.

  Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20020101

• Diphtheria toxin conjugate therapy of cancer.

  Cancer chemotherapy and biological response modifiers 20020101

• [Thyroid cancer and chronic granulocytic leukemia in the same patient: Cernobyl or coincidence?].

  Chirurgia (Bucharest, Romania : 1990) 20020101

• Dietary docosahexaenoic acid levels influence the outcome of arabinosylcytosine chemotherapy in L1210 leukemic mice.

  Nutrition and cancer 20020101

• Severe hyperglycemia as a complication of big ICE chemotherapy in a patient with acute myeloblastic leukemia.

  Haematologia 20020101

• Some drug effects on the activity of erythrocyte hexokinase and glucose 6-phosphate dehydrogenase enzymes in vitro and in vivo.

  Polish journal of pharmacology 20020101

• The use of G-CSF during first line chemotherapy adversely affects the yield of PBSC mobilization in non-Hodgkin's lymphoma patients.

  Advances in clinical pathology : the official journal of Adriatic Society of Pathology 20020101

• Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts.

  Blood 20011215

• Superior outcome of infant acute myeloid leukemia with intensive chemotherapy: results of the Japan Infant Leukemia Study Group.

  Blood 20011215

• High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma.

  Journal of acquired immune deficiency syndromes (1999) 20011215

• Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.

  Blood 20011201

• Induction of cyclin E and inhibition of DNA synthesis by the novel acronycine derivative S23906-1 precede the irreversible arrest of tumor cells in S phase leading to apoptosis.

  Molecular pharmacology 20011201

• Negative regulation of the SHPTP1 protein tyrosine phosphatase by protein kinase C delta in response to DNA damage.

  Molecular pharmacology 20011201

• Continuous oral cytarabine ocfosfate with interferon-alpha-2b for patients with newly diagnosed chronic myeloid leukaemia: a pilot study.

  British journal of haematology 20011201

• Treatment of relapse after allogeneic bone marrow transplantation with reduced intensity conditioning (FLAG +/- Ida) and second allogeneic stem cell transplant.

  British journal of haematology 20011201

• Effects of signal transduction inhibitor 571 in acute myelogenous leukemia cells.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20011201

• Internal tandem duplications of the FLT3 and MLL genes are mainly observed in atypical cases of therapy-related acute myeloid leukemia with a normal karyotype and are unrelated to type of previous therapy.

  Leukemia 20011201

• Clinical relevance of in vitro chemoresistance in childhood acute myeloid leukemia.

  Leukemia 20011201

• Uncertain role of increased intensity chemotherapy with high-dose cytarabine in acute promyelocytic leukemia.

  Leukemia 20011201

• Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay.

  Cancer 20011201

• The role of purine analogue combinations in the management of acute leukemias.

  Hematological oncology 20011201

• Idarubicin, cytarabine, and topotecan in patients with refractory or relapsed acute myelogenous leukemia and high-risk myelodysplastic syndrome.

  American journal of hematology 20011201

• [Chemotherapy and radiation therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20011201

• [Interferon-alpha therapy].

  Nihon rinsho. Japanese journal of clinical medicine 20011201

• [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].

  Harefuah 20011201

• Meningeal and cerebral involvement in multiple myeloma patients.

  Annals of hematology 20011201

• Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21).

  Annals of hematology 20011201

• Hand-foot syndrome associated with short infusions of combination chemotherapy with gemcitabine and vinorelbine.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011201

• An oxaliplatin-based chemotherapy in patients with relapsed or refractory intermediate and high-grade non-Hodgkin's lymphoma.

  British journal of haematology 20011201

• Randomized, double-blind, crossover, placebo-controlled trial of intravenous ondansetron for the prevention of intrathecal chemotherapy-induced vomiting in children.

  Journal of pediatric hematology/oncology 20011201

• Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.

  Journal of pediatric hematology/oncology 20011201

• Renal cell carcinoma as a secondary malignancy after treatment of acute promyelocytic leukemia.

  Journal of pediatric hematology/oncology 20011201

• Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation.

  Journal of pediatric hematology/oncology 20011201

• Successful treatment of refractory Langerhans cell histiocytosis with unrelated cord blood transplantation.

  Journal of pediatric hematology/oncology 20011201

• Unrelated cord blood transplantation for an infant with chemotherapy-resistant progressive Langerhans cell histiocytosis.

  Journal of pediatric hematology/oncology 20011201

• Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.

  Cancer treatment reviews 20011201

• Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease.

  Blood 20011115

• Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy.

  Blood 20011115

• Amino acid phosphoramidate nucleosides: potential ADEPT/GDEPT substrates.

  Bioorganic & medicinal chemistry letters 20011105

• Acquisition of human concentrative nucleoside transporter 2 (hcnt2) activity by gene transfer confers sensitivity to fluoropyrimidine nucleosides in drug-resistant leukemia cells.

  Molecular pharmacology 20011101

• Mylotarg: antibody-targeted chemotherapy comes of age.

  Current opinion in oncology 20011101

• And the sun keeps shining.

  The Journal of pediatrics 20011101

• Chronic myelogenous leukemia: the news you have and haven't heard.

  Cleveland Clinic journal of medicine 20011101

• Proinflammatory cytokines mediate the systemic inflammatory response associated with high-dose cytarabine treatment in children.

  Medical and pediatric oncology 20011101

• High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells.

  Bone marrow transplantation 20011101

• Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemia.

  Bone marrow transplantation 20011101

• A novel type of metastatically spreading subcutaneous aspergillosis without epidermal lesions following allogeneic stem cell transplantation.

  Bone marrow transplantation 20011101

• Gemcitabine-induced systemic capillary leak syndrome.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011101

• Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS.

  Blood 20011015

• High-dose chemotherapy in high-risk myelodysplastic syndrome: covariate-adjusted comparison of five regimens.

  Cancer 20011015

• Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20011015

• Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria.

  Biochemical and biophysical research communications 20011012

• Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.

  Leukemia research 20011001

• Bone marrow stromal cells regulate caspase 3 activity in leukemic cells during chemotherapy.

  Leukemia research 20011001

• Selective protection of mitogenically stimulated human lymphocytes but not leukemic cells from cytosine arabinoside-induced apoptosis by LY294002, a phosphoinositol-3 kinase inhibitor.

  International journal of oncology 20011001

• Clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate.

  International journal of radiation oncology, biology, physics 20011001

• Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia.

  Medical and pediatric oncology 20011001

• Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion.

  Journal of cellular physiology 20011001

• Mechanisms of uptake and resistance to troxacitabine, a novel deoxycytidine nucleoside analogue, in human leukemic and solid tumor cell lines.

  Cancer research 20011001

• In vitro effects of dexrazoxane (Zinecard) and classical acute leukemia therapy: time to consider expanded clinical trials?

  Leukemia 20011001

• Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.

  The Journal of rheumatology. Supplement 20011001

• Application of autologous peripheral blood stem cell transplantation in children with malignant tumor.

  Chinese medical journal 20011001

• [Combination chemotherapy with VP-16 in the treatment of lung cancer and malignant lymphoma].

  Gan to kagaku ryoho. Cancer & chemotherapy 20011001

• Severe alveolar proteinosis following chemotherapy for acute myeloid leukemia in a lung allograft recipient.

  Journal of thoracic imaging 20011001

• Outcome and long-term side effects after synchronous radiochemotherapy for childhood brain stem gliomas.

  Pediatric neurosurgery 20011001

• Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.

  Bone marrow transplantation 20011001

• Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.

  Bone marrow transplantation 20011001

• Optimal duration of therapy with trastuzumab.

  Seminars in oncology 20011001

• Acute arterial occlusion as the presenting feature in acute promyelocytic leukaemia.

  British journal of haematology 20011001

• Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.

  British journal of haematology 20011001

• Dose-reduced conditioning for allografting in 44 patients with chronic myeloid leukaemia: a retrospective analysis.

  British journal of haematology 20011001

• Dexamethasone, high-dose cytarabine, and oxaliplatin (DHAOx) as salvage treatment for patients with initially refractory or relapsed non-Hodgkin's lymphoma.

  Annals of oncology : official journal of the European Society for Medical Oncology 20011001

• Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.

  Bone marrow transplantation 20011001

• FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia.

  European journal of haematology 20011001

• Benign thymic hyperplasia after chemotherapy for acute myeloid leukemia.

  European journal of haematology 20011001

• Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation.

  Journal of pediatric hematology/oncology 20011001

• Protein phosphatase 1alpha-mediated stimulation of apoptosis is associated with dephosphorylation of the retinoblastoma protein.

  Oncogene 20010927

• Development of obesity and neurochemical backing in aurothioglucose-treated mice.

  Autonomic neuroscience : basic & clinical 20010917

• Expression of high Km 5'-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia.

  Blood 20010915

• Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia.

  The Journal of clinical investigation 20010915

• Poor prognosis acute myelogenous leukemia: 3--biological and molecular biological changes during remission induction therapy.

  Leukemia research 20010901

• Impact of treatment on the outcome of acute myeloid leukemia with inversion 16: a single institution's experience.

  Leukemia 20010901

• Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemia.

  Leukemia 20010901

• Induction of chemoresistance in HL-60 cells concomitantly causes a resistance to apoptosis and the synthesis of P-glycoprotein.

  Leukemia 20010901

• Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial.

  Blood 20010901

• The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.

  Blood 20010901

• Fatal cardiac toxicity in two patients receiving same-day administration of cyclophosphamide and cytarabine as conditioning for hematopoietic stem cell transplantation.

  Haematologica 20010901

• Efficiency of homocysteine plus copper in inducing apoptosis is inversely proportional to gamma-glutamyl transpeptidase activity.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010901

• Cross-resistance to cytosine arabinoside in a multidrug-resistant human promyelocytic cell line selected for resistance to doxorubicin: implications for combination chemotherapy.

  British journal of haematology 20010901

• Locoregional intrasplenic chemotherapy for hypersplenism in myelofibrosis.

  British journal of haematology 20010901

• Unrelated cord blood transplantation for adult patients with myelodysplastic syndrome-related secondary acute myeloid leukaemia.

  British journal of haematology 20010901

• Therapeutic options for acute myelogenous leukemia.

  Cancer 20010901

• Close correlation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate, an intracellular active metabolite, to the therapeutic efficacy of N(4)-behenoyl-1-beta-D-arabinofuranosylcytosine therapy for acute myelogenous leukemia.

  Japanese journal of cancer research : Gann 20010901

• [Acute myeloid leukemia].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010901

• [Chronic myelogenous leukemia].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010901

• Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.

  Cancer gene therapy 20010901

• Therapy-related CD7+ acute myeloid leukemia with trisomy 8 following acute monocytic leukemia.

  Anti-cancer drugs 20010901

• [Comparison of the effectiveness of idarubicin (Zavedos) and mitoxantrone (Refador) in induction therapy of acute myeloid leukemia in elderly patients (55-75) (a prospective multicenter randomized study conducted 1998-2000].

  Vnitrni lekarstvi 20010901

• Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukaemia in first relapse.

  Expert opinion on biological therapy 20010901

• Chemotherapy-induced bullous acral erythema in a subject with B-cell lymphoma.

  Journal of the European Academy of Dermatology and Venereology : JEADV 20010901

• Primary central nervous system T-cell lymphoma.

  Neurology 20010828

• A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20010815

• Molecular cloning and disruption of a novel gene encoding UDP-glucose: tetrahydrobiopterin alpha-glucosyltransferase in the cyanobacterium Synechococcus sp. PCC 7942.

  FEBS letters 20010803

• Interaction of cytosine arabinoside and lovastatin in human leukemia cells.

  Leukemia research 20010801

• The widening role of statins: RAS signal transduction and drug-induced cytotoxicity in human leukemia: a commentary to 'interaction of cytosine arabinoside and lovastatin in human leukemia cells'.

  Leukemia research 20010801

• Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.

  Blood 20010801

• A FLT3 tyrosine kinase inhibitor is selectively cytotoxic to acute myeloid leukemia blasts harboring FLT3 internal tandem duplication mutations.

  Blood 20010801

• Erythroleukaemia in the north of England: a population based study.

  Journal of clinical pathology 20010801

• Convection-enhanced intraparenchymal delivery (CEID) of cytosine arabinoside (AraC) for the treatment of HIV-related progressive multifocal leukoencephalopathy (PML).

  Journal of neurovirology 20010801

• Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside.

  Journal of neurovirology 20010801

• The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation.

  Journal of neurochemistry 20010801

• Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study.

  British journal of haematology 20010801

• Reversal of cytosine arabinoside (ara-C) resistance by the synergistic combination of 6-thioguanine plus ara-C plus PEG-asparaginase (TGAP) in human leukemia lines lacking or expressing p53 protein.

  Cancer chemotherapy and pharmacology 20010801

• Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia.

  Onkologie 20010801

• [CD7(+) acute myeloid leukemia (M0) associated with a mediastinal bulky mass lesion].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20010801

• [Successful second transplant from one-locus HLA-mismatched unrelated donor for graft rejection following initial transplant from another unrelated donor in a patient with chronic myelogenous leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20010801

• [Therapy of acute myeloid leukemia in the elderly patient].

  Zeitschrift fur Gerontologie und Geriatrie 20010801

• Remission induction therapy: the more intensive the better?

  Cancer chemotherapy and pharmacology 20010801

• Acute myeloid leukemia in adults: where do we go from here?

  Cancer chemotherapy and pharmacology 20010801

• Correlation between decreased apoptosis and multidrug resistance (MDR) in murine leukemic T cell lines.

  Leukemia & lymphoma 20010801

• Acute basophilic leukemia.

  European journal of haematology 20010801

• Synergistic effects of geldanamycin and antitumor drugs.

  Yao xue xue bao = Acta pharmaceutica Sinica 20010801

• No disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010715

• Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

  Neurology 20010710

• Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells.

  Biochemical pharmacology 20010701

• Early onset Pneumocystis carinii pneumonia after allogeneic peripheral blood stem cell transplantation.

  American journal of hematology 20010701

• Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas.

  International journal of radiation oncology, biology, physics 20010701

• Combined systemic and intraventricular chemotherapy in primary CNS lymphoma: a pilot study.

  Journal of neurology, neurosurgery, and psychiatry 20010701

• Oxidative stress-induced activation of Lyn recruits sphingomyelinase and is requisite for its stimulation by Ara-C.

  FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010701

• High-dose liposomal daunorubicin and high-dose cytarabine combination in patients with refractory or relapsed acute myelogenous leukemia.

  Cancer 20010701

• Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside.

  Journal of neurochemistry 20010701

• Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.

  Medical and pediatric oncology 20010701

• Deletion mutants of human deoxycytidine kinase mRNA in cells resistant to antitumor cytosine nucleosides.

  Japanese journal of cancer research : Gann 20010701

• Effect of simvastatin alone and in combination with cytosine arabinoside on the proliferation of myeloid leukemia cell lines.

  Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20010701

• Interferon-alfa-based treatment of chronic myeloid leukemia and implications of signal transduction inhibition.

  Seminars in hematology 20010701

• Acute life-threatening toxicity of cancer treatment.

  Critical care clinics 20010701

• Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant?

  Annals of hematology 20010701

• Involvement of the NUP98 gene in a chromosomal translocation t(11;20)(p15;q11.2) in a patient with acute monocytic leukemia (FAB-M5b).

  International journal of hematology 20010701

• Myelodysplastic syndrome progresses rapidly into erythroleukemia associated with synchronous double cancers of the stomach and the papilla of Vater.

  International journal of hematology 20010701

• Repetitious appearance and disappearance of different kinds of clonal cytogenetic abnormalities after allogeneic bone marrow transplantation.

  International journal of hematology 20010701

• AraC-based pharmacotherapy of chronic myeloid leukaemia.

  Expert opinion on pharmacotherapy 20010701

• Outpatient supportive care following chemotherapy for acute myeloblastic leukemia.

  Leukemia & lymphoma 20010701

• Cytosine arabinoside, idarubicin and divided dose etoposide for the treatment of acute myeloid leukemia in elderly patients.

  Leukemia & lymphoma 20010701

• CAM-cytarabine, aclarubicin plus macrophage colony-stimulating factor in the treatment of acute myelogenous leukemia with trilineage dysplasia: usefulness of in vitro apoptosis in leukemic cells.

  Leukemia & lymphoma 20010701

• Bid regulation of neuronal apoptosis.

  Brain research. Developmental brain research 20010629

• Cellular pharmacokinetics and pharmacodynamics of the deoxycytidine analog 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine (CNDAC).

  Biochemical pharmacology 20010615

• Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.

  Blood 20010615

• Collateral sensitivity to gemcitabine (2',2'-difluorodeoxycytidine) and cytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines.

  Biochemical pharmacology 20010601

• High-dose cytosine arabinoside and idarubicin treatment of chronic myeloid leukemia in myeloid blast crisis.

  American journal of hematology 20010601

• Resistance of human leukemic cell lines to 1-beta-D-arabinofuranosylcytosine: characterization of an experimental model.

  International journal of oncology 20010601

• The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.

  Blood 20010601

• CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma.

  International journal of radiation oncology, biology, physics 20010601

• Comparison of 'sequential' versus 'standard' chemotherapy as re-induction treatment, with or without cyclosporine, in refractory/relapsed acute myeloid leukaemia (AML): results of the UK Medical Research Council AML-R trial.

  British journal of haematology 20010601

• Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia.

  British journal of haematology 20010601

• Experience with 2-chlorodeoxyadenosine in previously untreated children with newly diagnosed acute myeloid leukemia and myelodysplastic diseases.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010601

• Induction of apoptosis by the marine sponge (Mycale) metabolites, mycalamide A and pateamine.

  Apoptosis : an international journal on programmed cell death 20010601

• Nucleoside analogues: mechanisms of drug resistance and reversal strategies.

  Leukemia 20010601

• Magnetic resonance imaging detection of avascular necrosis of the bone in children receiving intensive prednisone therapy for acute lymphoblastic leukemia or non-Hodgkin lymphoma.

  Leukemia 20010601

• Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.

  Leukemia 20010601

• The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients.

  Leukemia 20010601

• High level resistance to glucocorticoids, associated with a dysfunctional glucocorticoid receptor, in childhood acute lymphoblastic leukemia cells selected for methotrexate resistance.

  Leukemia 20010601

• Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy.

  Leukemia 20010601

• Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia.

  Cancer genetics and cytogenetics 20010601

• Acute cerebellar syndrome following intermediate-dose cytarabine.

  British journal of haematology 20010601

• Accumulation of gamma-globin mRNA and induction of erythroid differentiation after treatment of human leukaemic K562 cells with tallimustine.

  British journal of haematology 20010601

• Proliferative activity of leukaemic blasts and cytosine arabinoside pharmacodynamics are associated with cytogenetically defined prognostic subgroups in acute myeloid leukaemia.

  British journal of haematology 20010601

• An efficient method for the preparation of 1'alpha-branched-chain sugar pyrimidine ribonucleosides from uridine: the first conversion of a natural nucleoside into 1'-substituted ribonucleosides.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20010601

• [Primary pulmonary manifestation of extramedullary acute myelocytic leukemia].

  Pneumologie (Stuttgart, Germany) 20010601

• Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.

  Cancer chemotherapy and pharmacology 20010601

• Efficacy of fludarabine, intermittent sequential high-dose cytosine arabinoside, and mitoxantrone (FIS-HAM) salvage therapy in highly resistant acute leukemias.

  Annals of hematology 20010601

• Cost of de novo acute myeloid leukemia induction therapy in adults: analysis of EORTC-GIMEMA AML10 and FLANG regimens.

  Journal of experimental & clinical cancer research : CR 20010601

• Remyelination in vitro following protein kinase C activator-induced demyelination.

  Neurochemical research 20010601

• Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.

  Bone marrow transplantation 20010601

• Nucleoside analogues in the treatment of haematological malignancies.

  Expert opinion on pharmacotherapy 20010601

• New experimental model of multiple myeloma.

  Bulletin of experimental biology and medicine 20010601

• [A prospective study of histological changes after AraAMP treatment in patients with chronic hepatitis B infection].

  Zhonghua nei ke za zhi 20010601

• Synthesis and biological evaluation of purine-containing butenolides.

  Journal of medicinal chemistry 20010524

• Design, synthesis, and biological evaluation of analogues of the antitumor agent, 2-(4-[(7-chloro-2-quinoxalinyl)oxy]phenoxy)propionic acid (XK469).

  Journal of medicinal chemistry 20010524

• Design, synthesis and enzymatic activity of highly selective human mitochondrial thymidine kinase inhibitors.

  Bioorganic & medicinal chemistry letters 20010521

• Improved treatment results in high-risk pediatric acute myeloid leukemia patients after intensification with high-dose cytarabine and mitoxantrone: results of Study Acute Myeloid Leukemia-Berlin-Frankfurt-Münster 93.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010515

• Analysis of repair and PCNA complex formation induced by ionizing radiation in human fibroblast cell lines.

  Mutagenesis 20010501

• Prophylactic intravesical instillation of mitomycin C and cytosine arabinoside for prevention of recurrent bladder tumors following surgery for upper urinary tract tumors: a prospective randomized study.

  International journal of urology : official journal of the Japanese Urological Association 20010501

• Outcomes of treatment of children and adolescents with recurrent non-Hodgkin's lymphoma and Hodgkin's disease with dexamethasone, etoposide, cisplatin, cytarabine, and l-asparaginase, maintenance chemotherapy, and transplantation: Children's Cancer Group Study CCG-5912.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010501

• Chronotropic effect of angiotensin II via type 2 receptors in rat brain neurons.

  Journal of neurophysiology 20010501

• Combined action of PSC 833 (Valspodar), a novel MDR reversing agent, with mitoxantrone, etoposide and cytarabine in poor-prognosis acute myeloid leukemia.

  Leukemia 20010501

• Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML).

  Leukemia 20010501

• Monitoring of intracellular 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in 1-beta-D-arabinofuranosylcytosine therapy at low and conventional doses.

  Japanese journal of cancer research : Gann 20010501

• The antitumor mechanism of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)-cytosine: effects of its triphosphate on mammalian DNA polymerases.

  Japanese journal of cancer research : Gann 20010501

• Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.

  Experimental hematology 20010501

• Immunoablative therapy with autologous stem cell transplantation in the treatment of poor risk multiple sclerosis.

  Transplantation proceedings 20010501

• Interferon-alpha combined with cytarabine in chronic myelogenous leukemia - clinical benefits.

  Leukemia & lymphoma 20010501

• Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide.

  British journal of haematology 20010501

• Permanent cerebellar toxicity of cytosine arabinoside (Ara C) in a young woman.

  Movement disorders : official journal of the Movement Disorder Society 20010501

• Improved efficiency of remission induction facilitates autologous BMT harvesting and improves overall survival in adults with AML: 108 patients treated at a single institution.

  Bone marrow transplantation 20010501

• Consolidation treatment with autologous peripheral blood progenitor cell transplantation in acute myeloid leukemia: a single center experience.

  Annals of hematology 20010501

• Involvement of oxygen radicals in cytarabine-induced apoptosis in human polymorphonuclear cells.

  Biochemical pharmacology 20010415

• The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses.

  Blood 20010415

• Micellar electrokinetic capillary chromatography quantification of cytosine arabinoside and its metabolite, uracil arabinoside, in human serum.

  Journal of chromatography. B, Biomedical sciences and applications 20010415

• Cell cycle-related changes in regulatory volume decrease and volume-sensitive chloride conductance in mouse fibroblasts.

  Journal of cellular physiology 20010401

• Combination chemotherapy of intermediate-dose cytarabine, idarubicin, plus etoposide and subsequent mobilized donor leukocyte infusion for relapsed acute leukemia after allogeneic bone marrow transplantation.

  Leukemia research 20010401

• 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine: a novel anticancer nucleoside analog that causes both DNA strand breaks and G(2) arrest.

  Molecular pharmacology 20010401

• Primary high-grade mucosa-associated lymphoid tissue-type lymphoma of the cervix presenting as a common endocervical polyp.

  Archives of pathology & laboratory medicine 20010401

• Respiratory chain-generated oxidative stress following treatment of leukemic blasts with DNA-damaging agents.

  Experimental cell research 20010401

• In vitro cytotoxic effects of a tyrosine kinase inhibitor STI571 in combination with commonly used antileukemic agents.

  Blood 20010401

• Lenograstim and filgrastim effects on neutrophil motility in patients undergoing chemotherapy: evaluation by computer-assisted image analysis.

  American journal of hematology 20010401

• Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010401

• The neuron-glia signal beta-neuregulin promotes Schwann cell motility via the MAPK pathway.

  Glia 20010401

• Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).

  Experimental hematology 20010401

• Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.

  Biological & pharmaceutical bulletin 20010401

• The association of topotecan and cytarabine in the treatment of secondary or relapsed acute myeloid leukemia.

  Haematologica 20010401

• Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol.

  British journal of haematology 20010401

• Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.

  British journal of haematology 20010401

• Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides.

  Anti-cancer drugs 20010401

• Long-term outcome of treatment with protocols AL841, AL851, and ALHR88 in children with acute lymphoblastic leukemia: results obtained by the Kyushu-Yamaguchi Children's Cancer Study Group.

  International journal of hematology 20010401

• Cell cycle regulatory protein expression in fresh acute myeloid leukemia cells and after drug exposure.

  Leukemia 20010401

• Cytarabine-induced aseptic meningitis.

  Leukemia 20010401

• Results of therapy with interferon alpha and cyclic combination chemotherapy in patients with philadelphia chromosome positive chronic myelogenous leukemia in early chronic phase.

  Leukemia & lymphoma 20010401

• Fludarabine and cytarabine as a sequential infusion regimen for treatment of adults with recurrent, refractory or poor prognosis acute leukemia.

  Leukemia & lymphoma 20010401

• High remission rate in acute myeloblastic leukemia with only two days of chemotherapy.

  Leukemia & lymphoma 20010401

• Bone marrow stromal dysfunction in mice administered cytosine arabinoside.

  European journal of haematology 20010401

• Prognostic factors and treatment effects on survival in acute myeloid leukemia of M6 subtype: a retrospective study of 54 cases.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010401

• Dose escalation of cytotoxic drugs using haematopoietic growth factors: a randomized trial to determine the magnitude of increase provided by GM-CSF.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010401

• Clinical aspects and prognosis of ependymoma in infants and children. A single institution experience.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 20010401

• Acute promyelocytic leukemia with additional chromosome abnormalities in a renal transplant case.

  Annals of hematology 20010401

• Double reinforcement with fludarabine/high-dose cytarabine enhances the impact of autologous stem cell transplantation in acute myeloid leukemia patients.

  Bone marrow transplantation 20010401

• Successful salvage of RAEB/AML relapsing early post allograft with FLAG-Ida conditioned mini-allograft: a report of two cases.

  Clinical and laboratory haematology 20010401

• Marine organisms as a source of new anticancer agents.

  The Lancet. Oncology 20010401

• Total body irradiation before allogeneic bone marrow transplantation: is more dose better?

  International journal of radiation oncology, biology, physics 20010315

• Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010315

• Isodicentric 7p, idic(7)(q11.2), in acute myeloid leukemia associated with older age and favorable response to induction chemotherapy: a new clinical entity?

  Genes, chromosomes & cancer 20010301

• Combination chemotherapy utilizing continuous infusion of intermediate-dose cytarabine for refractory or recurrent acute myeloid leukemia.

  Leukemia research 20010301

• Severe hepatic injury associated with lipid formulations of amphotericin B.

  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20010301

• Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells.

  Leukemia 20010301

• Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93. AML-BFM Study Group.

  Leukemia 20010301

• Cytogenetic subgroups in acute myeloid leukemia differ in proliferative activity and response to GM-CSF.

  Leukemia 20010301

• Circumvention of ara-C resistance by aphidicolin in blast cells from patients with AML.

  British journal of cancer 20010301

• Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials.

  Medical and pediatric oncology 20010301

• [All-trans retinoic acid combined with low-dose cytosine arabinoside treatment for acute myelogenous leukemia with trilineage myelodysplasia--a case report].

  Gan to kagaku ryoho. Cancer & chemotherapy 20010301

• Neutrophilic eccrine hidradenitis in two neutropaenic patients.

  Clinical and experimental dermatology 20010301

• Outcome of relapsed or refractory childhood B-cell acute lymphoblastic leukaemia and B-cell non-Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols.

  British journal of haematology 20010301

• Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy.

  Bone marrow transplantation 20010301

• Successful unrelated donor bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.

  Bone marrow transplantation 20010301

• Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery.

  Annals of oncology : official journal of the European Society for Medical Oncology 20010301

• Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia.

  Leukemia & lymphoma 20010301

• [Skin toxicity associated with bolus infusion of low-dose cytarabine].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20010301

• Pretreatment leukaemia cell drug resistance is correlated to clinical outcome in acute myeloid leukaemia.

  European journal of haematology 20010301

• Acute myeloid leukaemia (AML): treatment of the older patient.

  Best practice & research. Clinical haematology 20010301

• Characterization of DNA fragmentation events caused by genotoxic and non-genotoxic agents.

  Mutation research 20010220

• Topoisomerase II inhibitor induced leukemia in a patient with AIDS.

  AIDS (London, England) 20010216

• Dose-intensive epirubicin-based chemotherapy is superior to an intensive intravenous cyclophosphamide, methotrexate, and fluorouracil regimen in metastatic breast cancer: a randomized multinational study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010215

• Transfusion of peripheral blood stem cells from donor homozygous for a shared HLA-haplotype: avoiding fatal transfusion-associated graft-versus-host disease while preserving anti-leukemic effect.

  Transplantation 20010215

• [Palpable mantel cell lymphoma in the breast].

  Presse medicale (Paris, France : 1983) 20010203

• Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20010201

• Survival in patients with intermediate or high grade non-Hodgkin's lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP.

  British journal of cancer 20010201

• Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia.

  British journal of haematology 20010201

• [Is it useful to perform a (67)gallium scintigraphy in the follow-up of patients with gastric lymphoma?].

  Revista espanola de medicina nuclear 20010201

• Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.

  American journal of clinical pathology 20010201

• Bilateral breast relapse in acute myelogenous leukemia.

  Journal of pediatric hematology/oncology 20010201

• Primary central nervous system lymphoma in childhood presenting as progressive panhypopituitarism.

  Journal of pediatric hematology/oncology 20010201

• Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.

  Journal of pediatric hematology/oncology 20010201

• Chemotherapy for acute myelogenous leukemia in the elderly with cytarabine, mitoxantrone, and granulocyte-macrophage colony-stimulating factor.

  American journal of clinical oncology 20010201

• Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.

  Hematology/oncology clinics of North America 20010201

• [Philadelphia chromosome-positive acute lymphoblastic leukemia with monosomy 7 successfully treated with intermediate- and high-dose ara-C].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20010201

• Effect of granulocyte colony-stimulating factor on chemotherapeutic activity of cytosine arabinoside in acute leukemic cell lines.

  International journal of hematology 20010201

• Molecular remission following high-dose hydroxyurea and fludarabine plus cytarabine in a patient with simultaneous acute myeloid leukemia and low-grade lymphoma.

  Leukemia & lymphoma 20010201

• Upregulation of preprodynorphin and preproenkephalin mRNA expression by selective activation of group I metabotropic glutamate receptors in characterized primary cultures of rat striatal neurons.

  Brain research. Molecular brain research 20010131

• JP-8 jet fuel-induced DNA damage in H4IIE rat hepatoma cells.

  Mutation research 20010125

• Activation of deoxycytidine kinase by inhibition of DNA synthesis in human lymphocytes.

  Biochemical pharmacology 20010115

• The chicken Pdcd4 gene is regulated by v-Myb.

  Oncogene 20010111

• Targeting and anti-tumor efficacy of liposomal 5'-O-dipalmitoylphosphatidyl 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine in mice lung bearing B16BL6 melanoma.

  Cancer letters 20010110

• Standard chemotherapy with or without high-dose chemotherapy for aggressive non-Hodgkin's lymphoma: randomized phase III EORTC study.

  Journal of the National Cancer Institute 20010103

• Chemotherapy and marrow transplantation for congenital leukaemia.

  Archives of disease in childhood. Fetal and neonatal edition 20010101

• Porcine Choroid plexus epithelial cells in culture: regulation of barrier properties and transport processes.

  Microscopy research and technique 20010101

• Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.

  Leukemia research 20010101

• De novo acute myeloid leukemia in the elderly; a consistent fraction of long-term survivors by standard-dose chemotherapy.

  Leukemia research 20010101

• Reduced cellular transport and activation of fluoropyrimidine nucleosides and resistance in human lymphocytic cell lines selected for arabinosylcytosine resistance.

  Biochemical pharmacology 20010101

• Evidence against apoptosis as a major mechanism for reproductive cell death following treatment of cell lines with anti-cancer drugs.

  British journal of cancer 20010101

• Serum LDH, a prognostic factor in elderly patients with acute myelogenous leukaemia.

  British journal of cancer 20010101

• Fludarabine, cytarabine and topotecan (FLAT) as induction therapy for acute myeloid leukemia in the elderly: a preliminary report.

  Haematologica 20010101

• Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.

  Cancer 20010101

• Acute progranulocytic leukemia.

  Current opinion in oncology 20010101

• Bcl-X(L)-caspase-9 interactions in the developing nervous system: evidence for multiple death pathways.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 20010101

• PBPC mobilization with chemotherapy and G-CSF in patients with chronic myeloid leukemia: quantification of bcr/abl-positive cells by interphase fluorescence in situ hybridization and competitive PCR.

  Transfusion 20010101

• Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine.

  British journal of cancer 20010101

• Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients.

  British journal of haematology 20010101

• A multicentre, open, non-comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation.

  British journal of haematology 20010101

• Therapy of acute myeloid leukemia.

  Cancer control : journal of the Moffitt Cancer Center 20010101

• Aseptic meningitis in a child after systemic treatment with high dose cytarabine.

  The Pediatric infectious disease journal 20010101

• Simultaneous treatment with 1-beta-D-arabinofuranosylcytosine and daunorubicin induces cross-resistance to both drugs due to a combination-specific mechanism in HL60 cells.

  Cancer research 20010101

• Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.

  Cancer research 20010101

• Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside.

  Pediatric dermatology 20010101

• Results of IDA-FLAG programme in the treatment of recurrent acute myeloblastic leukaemia--preliminary report.

  Medical science monitor : international medical journal of experimental and clinical research 20010101

• [Outcome of acute myelogenous leukemia in 41 patients treated with idarubicin: the prognosis of t(8;21) cases].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 20010101

• Cyclosporin increases cellular idarubicin and idarubicinol concentrations in relapsed or refractory AML mainly due to reduced systemic clearance.

  Leukemia 20010101

• The biology and treatment of chronic myelogenous leukemia.

  Oncology (Williston Park, N.Y.) 20010101

• The CAG regimen (low-dose cytarabine, aclarubicin hydrochloride and granulocyte colony-stimulating factor) for the treatment of elderly acute myelomonocytic leukaemia: a case study.

  The Journal of international medical research 20010101

• Allogeneic bone marrow transplantation in children failing prior autologous bone marrow transplantation.

  Bone marrow transplantation 20010101

• Prognostic value of day 14 blast percentage and the absolute blast index in bone marrow of children with acute lymphoblastic leukemia.

  Pediatric hematology and oncology 20010101

• Parotid mucoepidermoid carcinoma following chemotherapy for childhood acute lymphoblastic leukemia.

  Pediatric hematology and oncology 20010101

• Development of a double-drug-resistant human leukemia model to cytosine arabinoside and L-asparaginase: evaluation of cross-resistance to other treatment modalities.

  Anticancer research 20010101

• Noncardiogenic pulmonary edema: an unusual and serious complication of anticancer therapy.

  The oncologist 20010101

• Polymeric prodrug for release of an antitumoral agent by specific enzymes.

  Bioconjugate chemistry 20010101

• [Low-dose cytosine-arabinoside (Ara-C) therapy for chronic myeloid leukemia].

  Voprosy onkologii 20010101

• Nodal gamma/delta T cell lymphoma in complete remission following allogeneic bone marrow transplantation from an HLA-matched unrelated donor.

  Acta haematologica 20010101

• Intrathecal chemotherapy with antineoplastic agents in children.

  Paediatric drugs 20010101

• Primary isolated lymphoma of the fourth ventricle: case report.

  Journal of neuro-oncology 20010101

• Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.

  Journal of cancer research and clinical oncology 20010101

• Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam technology.

  Cancer journal (Sudbury, Mass.) 20010101

• STI571: targeting BCR-ABL as therapy for CML.

  The oncologist 20010101

• Expression and activation of SHC/MAP kinase pathway in primary acute myeloid leukemia blasts.

  The hematology journal : the official journal of the European Haematology Association 20010101

• Risk-oriented postremission strategies in adult acute lymphoblastic leukemia: prospective confirmation of anthracycline activity in standard-risk class and role of hematopoietic stem cell transplants in high-risk groups.

  The hematology journal : the official journal of the European Haematology Association 20010101

• Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.

  American journal of hematology 20010101

• Treatment of 'poor risk' acute myeloid leukemia with fludarabine, cytarabine and G-CSF (flag regimen): a single center study.

  Leukemia & lymphoma 20010101

• First line therapy with fludarabine combinations in 42 patients with either post myelodysplastic syndrome or therapy related acute myeloid leukaemia.

  Leukemia & lymphoma 20010101

• Fludarabine, arabinosyl cytosine and idarubicin (FLAI) for remission induction in poor-risk acute myeloid leukemia.

  Leukemia & lymphoma 20010101

• Leukemia cutis in an elderly patient treated with low dose cytosine arabinoside and etoposide.

  Leukemia & lymphoma 20010101

• A systematic overview of chemotherapy effects in acute myeloid leukaemia.

  Acta oncologica (Stockholm, Sweden) 20010101

• Intensive postremission chemotherapy in Taiwanese adults with acute myelogenous leukemia.

  Advances in therapy 20010101

• Parvovirus B19 infection in a child with acute lymphoblastic leukemia during induction therapy.

  Journal of pediatric hematology/oncology 20010101

• Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical trial.

  Cancer investigation 20010101

• Time sequential expression of markers of apoptosis induced by 1-beta-D-arabinofuranosylcytosine in human T-lymphoblastic leukemia CCRF-CEM cells.

  Anticancer research 20010101

• Application of high-performance, thin-layer chromatography to quality control of antimetabolite analogue infusion bags.

  Journal of AOAC International 20010101

• Target cells promote the development and functional maturation of neurons derived from a sympathetic precursor cell line.

  Developmental neuroscience 20010101

• [Treatment of acute lymphoblastic leukemia in adults as an unsolved problem].

  Terapevticheskii arkhiv 20010101

• [Improved treatment results in children with AML: Results of study AML-BFM 93].

  Klinische Padiatrie 20010101

• In vitro activity of liposomal N4octadecyl-1-beta-D-arabinofuranosylcytosine (NOAC), a new lipophilic derivative of 1-beta-D-arabinofuranocylcytosine on biopsized clonogenic human tumor cells and hematopoietic precursor cells.

  Investigational new drugs 20010101

• Effect of substituting arabinonucleosides for deoxynucleotides in the DNA priming strand on the polymerase action of HIV-1 RT.

  Nucleosides, nucleotides & nucleic acids 20010101

• Cytarabine treatment of human T-lymphoid cells induces decreased HIV-1 receptor expression and reduced HIV-1 susceptibility.

  Nucleosides, nucleotides & nucleic acids 20010101

• [Relationship between the induction of MDR1, a multidrug resistance gene in tumor cells, and apoptosis].

  Ontogenez 20010101

• MR findings in Balint's syndrome, following intrathecal methotrexate and cytarabine therapy in adult acute lymphoblastic leukemia.

  European neurology 20010101

• Empirical therapy of febrile neutropenic patients with mucositis: challenge of risk-based therapy.

  Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20010101

• Age and cytogenetics as predictors of event free survival in patients with acute non-lymphocytic leukemia receiving high dose cytosine arabinoside and daunorubicin as consolidation chemotherapy.

  Leukemia & lymphoma 20010101

• Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia with different clinical stages.

  Acta haematologica 20010101

• Cocaine-contaminated allogeneic bone marrow transplantation.

  Acta haematologica 20010101

• Rituximab in combination with interferon-alpha in relapsed and refractory diffuse large B-cell non-Hodgkin's lymphoma.

  Acta haematologica 20010101

• Taxotere and vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor (VEGF) by wild-type and drug-resistant human leukemia T-cell lines.

  Anticancer research 20010101

• Therapeutic management of refractory or relapsed primary central nervous system lymphomas.

  Annals of hematology 20010101

• High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.

  Annals of hematology 20010101

• Favorable outcome for children and adolescents with T-cell lymphoblastic lymphoma with an intensive ALL-type therapy without local radiotherapy.

  Annals of hematology 20010101

• Late effects of anticancer therapy on kidney function in children with acute lymphoblastic leukemia.

  Bratislavske lekarske listy 20010101

• X-ray-induced chromosome aberrations in human lymphocytes in vitro are potentiated under simulated microgravity conditions (Clinostat).

  Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) 20010101

• Transplantation of highly purified CD34+Thy-1+ hematopoietic stem cells in patients with recurrent indolent non-Hodgkin's lymphoma.

  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 20010101

• Cellular abundance of es nucleoside transporters and differential drug toxicity in myelodysplastic syndrome (MDS) bone marrow cell subpopulations.

  Proceedings of the Western Pharmacology Society 20010101

• Ajoene, a garlic-derived natural compound, enhances chemotherapy-induced apoptosis in human myeloid leukaemia CD34-positive resistant cells.

  Anticancer research 20010101

• Bronchiolitis obliterans organizing pneumonia in a patient with chronic myelogenous leukemia developing after initiation of interferon and cytosine arabinoside.

  European journal of haematology 20010101

• Communication challenges in a young man with Hodgkin's disease.

  Cancer practice 20010101

• Painful blistered hands and feet.

  Clinical journal of oncology nursing 20010101

• Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-C.

  Leukemia & lymphoma 20010101

• Marrow mesenchymal cell transplantation for genetic disorders of bone.

  Cytotherapy 20010101

• Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH (+/- fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion.

  Cytotherapy 20010101

• [Interferon-alpha in treatment of patients with chronic myeloid leukemia--indications and results].

  Polskie Archiwum Medycyny Wewnetrznej 20010101

• The effect of the Fas/FasL pathway during chemotherapeutic drug-induced apoptosis of leukaemeic cells.

  Journal of Tongji Medical University = Tong ji yi ke da xue xue bao 20010101

• Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.

  Medical and pediatric oncology 20001101

• White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings.

  Medical and pediatric oncology 20001101

• Cytosine arabinoside induced acute interstitial nephritis in a patient treated for refractory anemia with excess of blasts in transformation.

  Nephron 20001101

• Cerebellar toxicity of cytosine arabinoside: clinical and neuropsychological signs.

  Neurology 20001024

• Heterotopia in microcephaly induced by cytosine arabinoside: hippocampus in the neocortex.

  Acta neuropathologica 20001001

• Neonatal mouse cardiac myocytes exhibit cardioprotection induced by hypoxic and pharmacologic preconditioning and by transgenic overexpression of human Cu/Zn superoxide dismutase.

  Journal of molecular and cellular cardiology 20001001

• Treatment for primary CNS lymphoma: the next step.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20000901

• Methotrexate treatment protocols and the central nervous system: significant cure with significant neurotoxicity.

  Journal of child neurology 20000901

• Oxidative stress interferes with cancer chemotherapy: inhibition of lymphoma cell apoptosis and phagocytosis.

  Blood 20000701

• High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission.

  Leukemia 20000701

• Captopril inhibits in vitro and in vivo the proliferation of primitive haematopoietic cells induced into cell cycle by cytotoxic drug administration or irradiation but has no effect on myeloid leukaemia cell proliferation.

  British journal of haematology 20000601

• Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.

  Cancer 20000501

• Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias.

  Clinical cancer research : an official journal of the American Association for Cancer Research 20000501

• Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.

  Cancer gene therapy 20000501

• Pseudotumor cerebri induced by all-trans-retinoic acid in a child treated for acute promyelocytic leukemia.

  Medical and pediatric oncology 20000401

• Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: analysis of Cancer and Leukemia Group B 9013.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20000301

• A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes.

  Annals of hematology 20000301

• Visual loss following high-dose cytosine arabinoside (ARA-C).

  European journal of haematology 20000301

• Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome.

  Blood 20000101

• Differential transport of cytosine-containing nucleosides by recombinant human concentrative nucleoside transporter protein hCNT1.

  Nucleosides, nucleotides & nucleic acids 20000101

• Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone.

  Journal of pediatric hematology/oncology 20000101

• Misdiagnosis of broad-complex tachycardia.

  Heart & lung : the journal of critical care 20000101

• Unexpected high incidence of severe toxicities associated with alpha interferon, low-dose cytosine arabinoside and all-trans retinoic acid in patients with chronic myelogenous leukemia.

  Leukemia & lymphoma 19991101

• Skin toxicity after administration of low-dose cytarabine.

  Medical and pediatric oncology 19991001

• Efficacy and toxicity of IFN-alpha2b combined with cytarabine in chronic myelogenous leukaemia.

  British journal of haematology 19990901

• Contribution of single-photon emission computed tomography in the diagnosis and follow-up of CNS toxicity of a cytarabine-containing regimen in pediatric leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19990901

• Involvement of hydrogen peroxide and hydroxyl radical in chemically induced apoptosis of HL-60 cells.

  Biochemical pharmacology 19990615

• Pseudotumor cerebri secondary to intermediate-dose cytarabine HCl.

  The Annals of pharmacotherapy 19990501

• Protection by short-chain fatty acids against 1-beta-D-arabinofuranosylcytosine-induced intestinal lesions in germfree mice.

  Antimicrobial agents and chemotherapy 19990401

• Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis.

  Journal of neurochemistry 19990301

• Low-dose cytarabine-induced hepatic and renal dysfunction in a patient with myelodysplastic syndrome.

  Anti-cancer drugs 19990301

• Behenoyl cytarabine-associated reversible encephalopathy in a patient with acute myelogenous leukemia.

  Journal of Korean medical science 19990201

• A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside.

  The Journal of neuroscience : the official journal of the Society for Neuroscience 19990115

• [Topotecan: a new field of use].

  Tumori 19990101

• Azidothymidine resistance of H9 human T-cell lymphoma cells is associated with decreased sensitivity to antitumor agents and inhibition of apoptosis.

  International journal of molecular medicine 19981201

• Efficacy of select antivirals against Cryptosporidium parvum in vitro.

  FEMS microbiology letters 19981101

• Transient tetraparesis after intrathecal and high-dose systemic methotrexate.

  Annals of hematology 19981101

• [Cytarabine-induced pericarditis].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19981101

• Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.

  Blood 19981015

• Evidence for sinoatrial blockade associated with high dose cytarabine therapy.

  Leukemia research 19980801

• Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.

  Experimental hematology 19980801

• Synchronous radiochemotherapy in unfavorable brain tumors of children and young adults.

  Journal of neuro-oncology 19980801

• Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy.

  Seminars in oncology 19980801

• The tetrapeptide AcSDKP reduces the sensitivity of murine CFU-MK and CFU-GM progenitors to aracytine in vitro and in vivo.

  International journal of hematology 19980801

• Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment.

  Cell death and differentiation 19980701

• Cytosine arabinoside-induced vasculitis.

  Mayo Clinic proceedings 19980301

• Navoban (tropisetron, ICS 205-930) and dexamethasone combination in the prevention of vomiting for patients receiving preconditioning high-dose chemotherapy before marrow transplantation.

  Japanese journal of clinical oncology 19980201

• ATRA-induced pseudotumour cerebri--one case report.

  The Kaohsiung journal of medical sciences 19980101

• Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model.

  Cancer chemotherapy and pharmacology 19980101

• Increased p21/WAF-1 and p53 protein levels following sequential three drug combination regimen of fludarabine, cytarabine and docetaxel induces apoptosis in human leukemia cells.

  Anticancer research 19980101

• Peripheral blood progenitor cell mobilisation in patients with multiple myeloma following oral idarubicin and dexamethasone (Z-Dex) induction therapy.

  Leukemia 19971201

• Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature.

  Bone marrow transplantation 19971101

• Assessment of brain perfusion by 99mTc-HMPAO SPECT in akinetic mutism due to high-dose intravenous methotrexate therapy.

  Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 19971001

• Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and Bcl-2alpha down-regulation.

  The Journal of biological chemistry 19970919

• A facile, alternative synthesis of 4'-thioarabinonucleosides and their biological activities.

  Journal of medicinal chemistry 19970704

• S-HAM induction chemotherapy with or without GM-CSF in patients with high-risk myelodysplastic syndromes.

  Annals of hematology 19970501

• Retreatment with low-dose cytarabine in patients with previous central nervous system toxicity.

  American journal of hematology 19970401

• Severe central nervous adverse effect of intrathecal chemotherapy in a 16-yr-old patient with Burkitt's type lymphoma.

  European journal of haematology 19970401

• High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19970201

• Pericarditis induced by high-dose cytosine arabinoside chemotherapy.

  Annals of hematology 19970101

• Double knockout of the MRP gene leads to increased drug sensitivity in vitro.

  Cancer research 19961201

• Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency.

  American journal of hematology 19961101

• Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.

  Cancer 19961101

• [Disseminated pneumoperitoneum during the therapy of lymphoma with methotrexate and cytosine arabinoside].

  Deutsche medizinische Wochenschrift (1946) 19961018

• Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.

  Cancer research 19961015

• Modulation of protein kinase C activity and calcium-sensitive isoform expression in human myeloid leukemia cells by bryostatin 1: relationship to differentiation and ara-C-induced apoptosis.

  Experimental cell research 19961010

• Intrathecal leucovorin after intrathecal methotrexate overdose.

  Journal of pediatric hematology/oncology 19960801

• Functional characterization of a recombinant sodium-dependent nucleoside transporter with selectivity for pyrimidine nucleosides (cNT1rat) by transient expression in cultured mammalian cells.

  The Biochemical journal 19960715

• [Paraplegia following intrathecal chemotherapy].

  Schweizerische medizinische Wochenschrift 19960622

• [Two patients with acute promyelocytic leukemia whose relapse was noted by cytodiagnosis of middle ear discharge].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19960401

• All-trans-retinoic acid (ATRA) responsive skin relapses of acute promyelocytic leukaemia followed by ATRA-induced pseudotumour cerebri.

  British journal of haematology 19960301

• Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19960301

• A randomized study of high-dose cytarabine in induction in acute myeloid leukemia.

  Blood 19960301

• Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis: a pilot study in 13 patients.

  Surgical neurology 19960301

• Steroid-free chemotherapy decreases the risk of hepatitis flare-up in hepatitis B virus carriers with non-Hodgkin's lymphoma.

  Blood 19960201

• Association of busulfan area under the curve with veno-occlusive disease following BMT.

  Bone marrow transplantation 19960201

• [Three cases of drug-induced hemolytic uremic syndrome].

  Gan to kagaku ryoho. Cancer & chemotherapy 19960201

• Transient Ara-C leukoencephalopathy: MR findings.

  Journal of computer assisted tomography 19960101

• Rhabdomyolysis: an unusual complication of cytotoxic chemotherapy.

  Medical oncology (Northwood, London, England) 19951201

• Comparative activity of selected antiviral compounds against clinical isolates of varicella-zoster virus.

  European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 19950401

• [Acute right ventricular insufficiency reversible following anthracycline treatment].

  Revista espanola de cardiologia 19950301

• Cytarabine-induced pericarditis: a case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy.

  Leukemia research 19950201

• [Ischemic hepatitis due to anthracycline-induced cardiac insufficiency in a patient with acute myelocytic leukemia (M0)].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19950101

• A randomized, double-blind, cross-over study comparing a levosulpiride-based and a metoclopramide-based combination in the prevention of ProMECE-CytaBOM-induced emesis.

  Haematologica 19950101

• [Cerebellar toxicity of cytosine-arabinoside in a young man following cerebral anoxia].

  Annales de medecine interne 19950101

• Fludarabine + Ara-C + G-CSF: cytotoxic effect and induction of apoptosis on fresh acute myeloid leukemia cells.

  Leukemia 19941201

• Ocular toxicology.

  Current opinion in ophthalmology 19941201

• Fetal marrow suppression after maternal chemotherapy for leukaemia.

  Archives of disease in childhood. Fetal and neonatal edition 19941101

• Myositis with tretinoin.

  Lancet (London, England) 19941015

• Idarubicin, high-dose cytarabine and etoposide for remission induction in therapy-related acute myeloid leukemia.

  Leukemia & lymphoma 19940901

• Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19940901

• Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.

  Leukemia 19940401

• Toxicity of tretinoin in acute promyelocytic leukaemia.

  Lancet (London, England) 19940205

• Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimens.

  Annals of oncology : official journal of the European Society for Medical Oncology 19940101

• Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma: high remission rates and reversion to negative of peripheral blood bcl-2 rearrangement.

  Annals of oncology : official journal of the European Society for Medical Oncology 19940101

• A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma: results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma Study.

  Annals of oncology : official journal of the European Society for Medical Oncology 19940101

• Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia.

  Brain & development 19940101

• Modulation of 1-[beta-D-arabinofuranosyl] cytosine-induced apoptosis in human myeloid leukemia cells by staurosporine and other pharmacological inhibitors of protein kinase C.

  Oncology research 19940101

• High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells.

  Blood 19931115

• Prolactinemia in adolescent males surviving malignancies in childhood: impaired dating activity.

  The Journal of adolescent health : official publication of the Society for Adolescent Medicine 19931101

• Pentostatin increases the acute toxicity of high dose cyclophosphamide.

  Bone marrow transplantation 19930901

• Methotrexate-induced neurotoxicity: appearance on indium-111-white blood cells, gallium-67-citrate and thallium-201-chloride scintigraphy.

  Journal of nuclear medicine : official publication, Society of Nuclear Medicine 19930801

• Transformation of BALB/c-3T3 cells: IV. Rank-ordered potency of 24 chemical responses detected in a sensitive new assay procedure.

  Environmental health perspectives 19930701

• Encephalopathy, myelopathy, optic neuropathy, and anosmia associated with intravenous cytosine arabinoside.

  Clinical neuropharmacology 19930601

• Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.

  The New England journal of medicine 19930408

• Pre-CFU-S quiescence and stem cell exhaustion after cytostatic drug treatment: protective effects of the inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK).

  Blood 19930401

• Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia.

  Leukemia & lymphoma 19930301

• Neurotoxicity associated with fludarabine and cytosine arabinoside chemotherapy for acute leukemia and myelodysplasia.

  Leukemia 19930301

• Bradycardia after rapid intravenous infusin of amphotericin B.

  Lancet (London, England) 19930206

• Sick sinus syndrome in a teenager treated with idarubicin.

  Journal of cardiothoracic and vascular anesthesia 19930201

• Cardiorespiratory decompensation following methylprednisolone administration.

  Pediatric hematology and oncology 19930101

• Pulmonary edema and shock after high-dose aracytine-C for lymphoma; possible role of TNF-alpha and PAF.

  European cytokine network 19930101

• High-dose cytarabine neurotoxicity: MR findings during the acute phase.

  AJNR. American journal of neuroradiology 19930101

• Piperacillin-induced acute interstitial nephritis.

  Nephron 19930101

• Acute neurotoxicity after intrathecal cytosine arabinoside in two adolescents with acute lymphoblastic leukemia of B-cell type.

  Cancer 19930101

• Reversible cardiopathy after accidental overdose of mitoxantrone.

  Pediatric hematology and oncology 19930101

• Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells.

  Blood 19921201

• Bradycardia due to anthracyclines.

  Lancet (London, England) 19921003

• Fulminant hepatic failure after high-dose cytosine arabinoside and mitoxantrone treatment for relapse of acute myelogenous leukaemia.

  European journal of haematology 19921001

• Idarubicin cardiotoxicity in acute myeloid leukaemia.

  Lancet (London, England) 19920718

• Chemistry and anti-HIV properties of 2'-fluoro-2',3'-dideoxyarabinofuranosylpyrimidines.

  Journal of medicinal chemistry 19920612

• Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19920601

• Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine.

  Journal of the National Cancer Institute 19920401

• Pseudotumour cerebri following high-dose cytosine arabinoside.

  British journal of haematology 19920401

• Polyneuritis after HD Ara-C therapy for malignant lymphoma.

  Italian journal of neurological sciences 19920201

• Substrate specificity of human deoxycytidine kinase toward antiviral 2',3'-dideoxynucleoside analogs.

  Biochemical pharmacology 19920122

• The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.

  Cancer chemotherapy and pharmacology 19920101

• Transient encephalopathy following a single exposure of high-dose methotrexate in a child with acute lymphoblastic leukemia.

  Pediatric hematology and oncology 19920101

• Substitutive therapy in a case of methotrexate neurotoxicity.

  European journal of cancer (Oxford, England : 1990) 19920101

• Long-term neuropsychologic sequelae of childhood leukemia: comparison of two CNS prophylactic regimens.

  International journal of radiation oncology, biology, physics 19920101

• A pilot study of carboplatin augmentation therapy for patients with poor risk acute non-lymphocytic leukemia.

  Leukemia research 19920101

• Meningeal fluid granulocytosis after cytarabine.

  European journal of cancer (Oxford, England : 1990) 19920101

• Behavioral effects of corticosteroids in children with acute lymphoblastic leukemia.

  Medical and pediatric oncology 19920101

• Fatal peripheral neuropathy associated with axonal degeneration after high-dose cytosine arabinoside in acute leukaemia.

  British journal of haematology 19911101

• Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia.

  Cancer 19910915

• Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.

  Journal of medicinal chemistry 19910801

• Low-dose chemotherapy with central nervous system prophylaxis and zidovudine maintenance in AIDS-related lymphoma. A prospective multi-institutional trial.

  JAMA 19910703

• Particular characteristics of the anti-human cytomegalovirus activity of (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) in vitro.

  Antiviral research 19910701

• Broad-spectrum antiviral and cytocidal activity of cyclopentenylcytosine, a carbocyclic nucleoside targeted at CTP synthetase.

  Biochemical pharmacology 19910615

• Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity.

  Molecular pharmacology 19910501

• Daunorubicin, amsacrine, and sinus arrest.

  The Western journal of medicine 19910401

• Rare neurotoxicity related to intrathecal Cytosar.

  Oncology nursing forum 19910401

• Protection from arabinofuranosylcytosine and n-mustard-induced myelotoxicity using hemoregulatory peptide pGlu-Glu-Asp-Cys-Lys monomer and dimer.

  Blood 19910315

• The effect of anti-neoplastic drugs on murine acquired immunodeficiency syndrome.

  Science (New York, N.Y.) 19910118

• Acute reversible neurological deficit following intrathecal chemotherapy.

  Cancer chemotherapy and pharmacology 19910101

• Bulbar and pseudobulbar palsy complicating therapy with high-dose cytosine arabinoside in children with leukemia.

  Medical and pediatric oncology 19910101

• Acute fatal myeloencephalopathy after combined intrathecal chemotherapy in a child with acute lymphoblastic leukemia.

  Medical and pediatric oncology 19910101

• Inhibition of hematopoietic stem cell proliferation by hemoregulatory peptide pyroGlu-Glu-Asp-Cys-Lys (pEEDCK) provides protection against short-term neutropenia and long-term damage.

  Annals of the New York Academy of Sciences 19910101

• Severe polyneuropathy and motor loss after intrathecal thiotepa combination chemotherapy: description of two cases.

  Anti-cancer drugs 19901001

• The use of haemoregulatory peptides (pEEDCK monomer and dimer) for reduction of cytostatic drug induced haemopoietic damage.

  Cancer treatment reviews 19900901

• Comparative activities of several nucleoside analogs against duck hepatitis B virus in vitro.

  Antimicrobial agents and chemotherapy 19900701

• Jaundice and hepatorenal syndrome associated with cytosine arabinoside.

  Journal of the National Medical Association 19900301

• Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks.

  Antimicrobial agents and chemotherapy 19900301

• Early blindness and coma during intrathecal chemotherapy for meningeal carcinomatosis.

  Cancer 19900201

• Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.

  Cancer research 19900115

• An adult case of acute lymphoblastic leukemia with necrotizing leukoencephalopathy.

  Japanese journal of medicine 19900101

• Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.

  Cancer chemotherapy and pharmacology 19900101

• Horner's syndrome and demyelinating peripheral neuropathy caused by high-dose cytosine arabinoside.

  American journal of hematology 19891201

• Hypersensitivity reaction to high-dose cytarabine.

  British journal of haematology 19891001

• The association between high-dose cytarabine neurotoxicity and renal insufficiency.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19891001

• Reversible treatment-related leukoencephalopathy.

  Journal of child neurology 19890701

• Acral erythema secondary to high-dose cytosine arabinoside with pain worsened by cyclosporine infusions.

  Cancer 19890615

• Intrathecal cytosine arabinoside-induced acute, rapidly reversible paralysis.

  The American journal of medicine 19890601

• Acute cerebral oedema induced by methotrexate.

  BMJ (Clinical research ed.) 19890513

• [Acute leukemia complicated by hyperbilirubinemia due to high dose cytosine arabinoside therapy].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19890201

• Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings.

  AJR. American journal of roentgenology 19890201

• Inhibitor of hematopoietic pluripotent stem cell proliferation: purification and determination of its structure.

  Proceedings of the National Academy of Sciences of the United States of America 19890201

• Salvage of relapsed malignant histiocytosis by autologous bone marrow transplant.

  Bone marrow transplantation 19890101

• [Painful legs and moving toes. Neuropathy caused by cytarabine].

  Revue neurologique 19890101

• [Ventricular fibrillation in a patient with myelodysplastic syndrome treated with small doses of cytarabine].

  Kardiologia polska 19890101

• Treatment of refractory or relapsed adult acute leukemia by using mitoxantrone-containing regimens.

  Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association 19890101

• Drug-induced toxicities associated with high-dose cytosine arabinoside infusions.

  Pharmacotherapy 19890101

• Aggressive treatment improves survival in adult acute lymphoblastic leukemia.

  European journal of haematology 19881101

• 1-(2,3-Anhydro-beta-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virus.

  Journal of medicinal chemistry 19880701

• Ara-C vasculitis.

  European journal of haematology 19880701

• Busulfan-induced sideroblastic anemia.

  American journal of hematology 19880701

• [Acute pericarditis caused by daunorubicin in acute myelocytic leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19880601

• The mechanism of cytosine arabinoside toxicity on quiescent astrocytes in vitro appears to be analogous to in vivo brain injury.

  Brain research 19880531

• Southwest Oncology Group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

  Seminars in hematology 19880401

• Deferoxamine (Desferal)-induced ocular toxicity.

  Pediatric hematology and oncology 19880101

• Severe persistent cerebellar dysfunction complicating cytosine arabinoside therapy.

  Acta medica Scandinavica 19880101

• Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).

  Blood 19880101

• Toxicity evaluation of dihydroxyanthracenedione (DHAD) in combination with cytosine arabinoside (Ara-C).

  Investigational new drugs 19871201

• Preventing amsacrine-induced cardiac arrhythmias.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19871201

• Absence of fungistatic antagonism between flucytosine and cytarabine in vitro and in vivo.

  The Journal of antimicrobial chemotherapy 19871001

• Acute cerebellar syndrome, conjunctivitis, and hearing loss associated with low-dose cytarabine administration.

  Drug intelligence & clinical pharmacy 19871001

• The neurotoxicity of high-dose cytosine arabinoside is age-related.

  Cancer 19871001

• [Daunomycin-induced cardiogenic shock in a case of acute myelogenous leukemia].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19870901

• Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia.

  American journal of hematology 19870701

• Cerebellar toxicity with high-dose cytosine arabinoside.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19870601

• Central nervous system effects of high-dose cytosine arabinoside.

  Seminars in oncology 19870601

• Treatment of refractory acute leukemia with high-dose cytosine arabinoside.

  Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association 19870601

• In vitro exposure of leukemic cells to low concentration Arabinosyl Cytosine: no evidence of differentiation inducing activity.

  Blut 19870501

• Southwest oncology group clinical trials for intermediate- and high-grade non-Hodgkin's lymphomas.

  Seminars in hematology 19870401

• High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemia.

  Blood 19870301

• Cytarabine-induced cerebellar syndrome: case report and literature review.

  Drug intelligence & clinical pharmacy 19870201

• Use of charcoal hemoperfusion with sequential hemodialysis to reduce serum methotrexate levels in a patient with acute renal insufficiency.

  The American journal of medicine 19870201

• Nucleosides. 139. Synthesis and anticytomegalovirus and antiherpes simplex virus activity of 5'-modified analogues of 2'-fluoroarabinosylpyrimidine nucleosides.

  Journal of medicinal chemistry 19870101

• Parkinsonism induced by high-dose cytosine arabinoside.

  Movement disorders : official journal of the Movement Disorder Society 19870101

• Antiemetic therapy in patients treated with high-dose cytosine arabinoside.

  Oncology 19870101

• High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.

  Oncology 19870101

• Reversible bilateral lateral rectus muscle palsy associated with high-dose cytosine arabinoside and mitoxantrone therapy.

  Cancer 19861015

• [Effectiveness and toxicity of high-dosage Ara-C. Clinical observations in 10 cases and review of the literature].

  Schweizerische medizinische Wochenschrift 19861011

• Myelin basic protein in CSF of children receiving intrathecal chemotherapy.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19861001

• Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia.

  The American journal of medicine 19860901

• Peripheral neuropathy associated with high-dose Ara-C therapy.

  Cancer 19860815

• High-dose cytosine arabinoside: treatment and cellular pharmacology of chronic myelogenous leukemia blast crisis.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19860701

• Neurotoxicity associated with systemic high-dose cytosine arabinoside.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19860401

• Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside. A Pediatric Oncology Group study.

  Cancer 19860315

• Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus.

  Antiviral research 19860301

• Effects of 2,2'-O-cyclocytidine and acyclovir on latent herpes simplex virus in trigeminal ganglia of mice.

  Antimicrobial agents and chemotherapy 19860201

• Cerebellar dysfunction during high dose cytosine arabinoside therapy in a case of acute myelogenous leukaemia.

  Scandinavian journal of haematology 19860201

• Peripheral neuropathy after high-dose cytosine arabinoside, daunorubicin, and asparaginase consolidation for acute nonlymphocytic leukemia.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19860101

• Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2.

  Antimicrobial agents and chemotherapy 19860101

• High dose Ara-C related leukoencephalopathy.

  Journal of neuro-oncology 19860101

• Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside.

  Cancer chemotherapy and pharmacology 19860101

• Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy.

  Acta medica Scandinavica 19860101

• Cerebellar toxicities associated with cytosine arabinoside: a nursing perspective.

  Oncology nursing forum 19860101

• Acute neurological toxicity of intrathecal cytosine arabinoside. A case report.

  Cancer chemotherapy and pharmacology 19860101

• Ara-C syndrome during low-dose continuous infusion therapy.

  Medical and pediatric oncology 19860101

• High-dose cytosine arabinoside-associated pancreatitis.

  Cancer 19851015

• Comparative anti-herpesvirus activities of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, acyclovir, and two 2'-fluoropyrimidine nucleosides.

  Antiviral research 19851001

• Central nervous system toxicity with high-dose Ara-C.

  Neurology 19851001

• Brachial plexus neuropathy following high-dose cytarabine in acute monoblastic leukemia.

  Cancer treatment reports 19850901

• Convulsions and encephalopathy in a patient with leukemia after treatment with metronidazole.

  Journal of clinical pathology 19850901

• Continuous infusion of high-dose cytosine arabinoside for treatment of childhood acute leukemia and non-Hodgkin's lymphoma in relapse.

  Seminars in oncology 19850601

• Central nervous system toxicity with high-dose cytosine arabinoside.

  Seminars in oncology 19850601

• Central nervous system toxicity of high-dose cytosine arabinoside.

  Seminars in oncology 19850601

• [Congestive heart failure after high dose cytosine arabinoside therapy in an ALL patient].

  [Rinsho ketsueki] The Japanese journal of clinical hematology 19850501

• Cytosine-arabinoside-induced colitis and peritonitis: nonoperative management.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19850501

• Cerebellar toxicity following high-dose cytosine arabinoside.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19850501

• Synthesis and antitumor and antiviral activities of a series of 1-beta-D-ribofuranosyl-5-halocytosine (5-halocytidine) cyclic 3',5'-monophosphates.

  Journal of medicinal chemistry 19850401

• Palmar-plantar erythrodysesthesia and cytarabine.

  Annals of internal medicine 19850401

• Severe central nervous system toxicity from high-dose cytarabine: expressive aphasia occurring after the second day of treatment.

  Cancer treatment reports 19850301

• [Non-hematologic toxicity in high-dose cytarabine therapy].

  Onkologie 19850201

• Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report.

  Cancer treatment reports 19850201

• Neurotoxicity of high-dose cytosine arabinoside.

  Progress in experimental tumor research 19850101

• High-dose 1-beta-D-arabinofuranosylcytosine in advanced breast cancer.

  Oncology 19850101

• Neurotoxicity of high-dose Ara-C and intracarotid chemotherapy.

  Progress in experimental tumor research 19850101

• Combination intraperitoneal chemotherapy with cisplatin, cytarabine, and doxorubicin for refractory ovarian carcinoma and other malignancies principally confined to the peritoneal cavity.

  Journal of clinical oncology : official journal of the American Society of Clinical Oncology 19841201

• Hepatic dysfunction and jaundice following high-dose cytosine arabinoside.

  Cancer 19841201

• Acute cerebellar toxicity after high-dose cytarabine associated with CNS accumulation of its metabolite, uracil arabinoside.

  Cancer treatment reports 19841001

• Pericarditis induced by high-dose cytarabine therapy.

  Archives of internal medicine 19840901

• Phase I clinical evaluation of cytarabine and cisplatin in patients with advanced cancer.

  Cancer treatment reports 19840901

• Acute cerebellar dysfunction with high-dose Ara-C therapy.

  Cancer 19840615

• Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.

  Antimicrobial agents and chemotherapy 19840601

• Neuroanatomical study of somatomotor cortex in microcephalic mice induced by cytosine arabinoside.

  Brain & development 19840101

• Neurological complications of antineoplastic therapy.

  Acta neurologica Scandinavica. Supplementum 19840101

• Vascular changes of methotrexate-related disseminated necrotizing leukoencephalopathy.

  Acta neuropathologica 19840101

• Drug-induced stomatocytosis and anemia during consolidation chemotherapy of childhood acute leukemia.

  The American journal of the medical sciences 19840101

• Cerebellar degeneration caused by high-dose cytosine arabinoside: a clinicopathological study.

  Annals of neurology 19831101

• Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirus.

  Antimicrobial agents and chemotherapy 19830901

• High-dose cytosine arabinoside therapy for refractory leukemia.

  Blood 19830801

• Paraparesis following intrathecal chemotherapy.

  Neurology 19830801

• Therapeutic activities of 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-iodocytosine and -thymine alone and in combination with acyclovir and vidarabine in mice infected intracerebrally with herpes simplex virus.

  Antimicrobial agents and chemotherapy 19830701

• Acral erythema and hydroxyurea.

  Annals of internal medicine 19830501

• Acute cerebellar dysfunction with high-dose ARA-C therapy.

  Cancer 19830201

• Pulmonary and neurologic complications of treatment with FIAC (2'fluoro-5-iodo-aracytosine) in patients with acquired immune deficiency syndrome (AIDS).

  AIDS research 19830101

• Doxorubicin-associated delayed ventricular fibrillation in acute promyelocytic leukemia.

  Acta haematologica 19830101

• Two simple high-performance liquid chromatographic methods for simultaneous determination of 2'-deoxycytidine 5'-triphosphate and cytosine arabinoside 5'-triphosphate concentrations in biological samples.

  Journal of chromatography 19821210

• Efficiency and selectivity of (E)-5-(2-bromovinyl)-2'-deoxyuridine and some other 5-substituted 2'-deoxypyrimidine nucleosides as anti-herpes agents.

  Antiviral research 19820501

• Acute pancreatitis in association with cytosine arabinoside therapy.

  Cancer 19820401

• In vitro susceptibility of varicella-zoster virus to E-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.

  Antimicrobial agents and chemotherapy 19820101

• The pathogenesis of abnormal cytoarchitecture in the cerebral cortex and hippocampus of the mouse treated transplacentally with cytosine arabinoside.

  Acta neuropathologica 19820101

• Central nervous system toxicity of high-dose systemic cytosine arabinoside.

  Cancer 19811215

• Evaluation of carbodine, the carbocyclic analog of cytidine, and related carbocyclic analogs of pyrimidine nucleosides for antiviral activity against human influenza Type A viruses.

  Antimicrobial agents and chemotherapy 19811201

• Focal encephalopathy following methotrexate therapy. Administration via a misplaced intraventricular catheter.

  Archives of neurology 19810701

• Selective inhibition of herpesvirus deoxyribonucleic acid synthesis by acycloguanosine, 2'-fluoro-5-iodo-aracytosine, and (E)-5-(2-bromovinyl)-2'-deoxyuridine.

  Antimicrobial agents and chemotherapy 19810501

• The cytosine arabinoside (Ara-C) syndrome.

  Medical and pediatric oncology 19810101

• Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.

  Cancer chemotherapy and pharmacology 19810101

• Antiviral, antimetabolic and antineoplastic activities of 2'- or 3'-amino or -azido-substituted deoxyribonucleosides.

  Biochemical pharmacology 19800615

• Cellular differentiation, cytidine analogs and DNA methylation.

  Cell 19800501

• 2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent.

  Antimicrobial agents and chemotherapy 19800501

• Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.

  Cancer 19800315

• In vitro antiherpesviral activity of 5-alkyl derivatives of 1-beta-D-arabinofuranosyluracil.

  Antimicrobial agents and chemotherapy 19790801

• (E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.

  Proceedings of the National Academy of Sciences of the United States of America 19790601

• Synthesis and antitumor and antiviral activities of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-iminopyrimidine and its derivatives.

  Journal of medicinal chemistry 19790501

• Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides.

  Journal of medicinal chemistry 19790101

• Paraplegia following intrathecal cytosine arabinoside.

  Cancer 19790101

• Seizures following intrathecal cytosine arabinoside in young children with acute lymphoblastic leukemia.

  Cancer 19780701

• 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group.

  Nature 19780413

• 5-Propyl-2'-deoxyuridine: a specific anti-herpes agent.

  Antimicrobial agents and chemotherapy 19780301

• Accidental intrathecal administration of vincristine.

  Medical and pediatric oncology 19780101

• Transient aphasia with lithium toxicity.

  Psychosomatics 19780101

• Paraparesis following intrathecal cytosine arabinoside: a case report with neuropathologic findings.

  Cancer 19771201

• Intracranial calcifications in childhood leukemia. An association with systemic chemotherapy.

  The Journal of pediatrics 19771201

• Antiviral activity of some beta-diketones. 1. Aryl alkyl diketones. In vitro activity against both RNA and DNA viruses.

  Journal of medicinal chemistry 19770601

• Antiviral activity of some beta-diketones. 2. Aryloxy alkyl diketones. In vitro activity against both RNA and DNA viruses.

  Journal of medicinal chemistry 19770601

• Antiviral activities of acyl derivatives of 2,2'-anhydro-1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosylcytosine in cell culture.

  Antimicrobial agents and chemotherapy 19770201

• Veno-occlusive disease of the liver after chemotherapy of acute leukemia. Report of two cases.

  Annals of internal medicine 19761101

• Endomyocardial fibrosis associated with daunorubicin therapy.

  British heart journal 19760801

• Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus.

  Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 19760301

• Selective inhibition of herpes simplex virus by 5-amino-2,5-dideoxy-5-iodouridine.

  Journal of virology 19750501

• Antiviral activity of O'-alkylated derivatives of cytosine arabinoside.

  Biochemical pharmacology 19750215

• Taratogenic effects of the pyrimidine analogues 5-iododeoxyuridine and cytosine arabinoside in late fetal mice and rats.

  Teratology 19750201

• Colchicine-induced lesions in the rat duodenum.

  Pathologia Europaea 19750101

• Phase I. evaluation of cyclocytidine (NSC-145668).

  Cancer chemotherapy reports 19750101

• Letter: neuropathy due to cytosine arabinoside.

  British medical journal 19741214

• Assessment of cytosine arabinoside as an antiviral agent in humans.

  Antimicrobial agents and chemotherapy 19741101

• Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide.

  Archives of internal medicine 19740201

• Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial.

  The New England journal of medicine 19731025

• Letter: Neurotoxicity of intrathecal chemotherapy for leukaemia.

  British medical journal 19731006

• Treatment of central nervous system leukemia with intrathecal cytosine arabinoside.

  Cancer 19731001

• Antiviral activity of cytarabine in herpesvirus-infected rats.

  Antimicrobial agents and chemotherapy 19731001

• Antiviral effects of aphidicolin, a new antibiotic produced by Cephalosporium aphidicola.

  Antimicrobial agents and chemotherapy 19730901

• DNA synthesis inhibition, cytotoxicity and their relationship to teratogenesis following administration of a nicotinamide antagonist, aminothiadiazole, to pregnant rats.

  Journal of embryology and experimental morphology 19730801

• DNA virus inhibitory activity of 1- -D-arabinofuranosylcytosine-3',5'-cyclic phosphate.

  Nature: New biology 19730418

• In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.

  Antimicrobial agents and chemotherapy 19730201

• Severe cyclophosphamide hemorrhagic cystitis controlled with phenol.

  Journal of pediatric surgery 19730201

• Synthesis and antitumor and antiviral activities of 1- -D-arabinofuranosylpyrimidine 3',5'-cyclic phosphates.

  Journal of medicinal chemistry 19721201

• Daunorubicin. Results in childhood leukaemia.

  Archives of disease in childhood 19720401

• Combination sequential chemotherapy in advanced reticulum cell sarcoma.

  Cancer 19720301

• The antiviral activity of 9-beta-D-arabinofuranosyladenine (ARA-A).

  Chemotherapia 19680101